{"idx": 0, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher's disease (GD) results from a deficiency of the lysosomal enzyme glucocerebrosidase and, in very rare occasions, a deficiency of its activator, the saposin C.", "model_answer": "The gene mutated in Gaucher disease is GBA1.", "model_support": "Supporting sentence: The complexity of identification and characterization of mutations in the gene of glucocerebrosidase (GBA1) is caused by a great amount of mutated alleles...", "retries": 1}
{"idx": 1, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 2, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically by identifying phospholamban as the regulatory molecule interacting with SERCA2a in cardiac muscle.\", \"match\": true}", "gold_answer": "phospholamban", "gold_support": "The ablation of a muscle-specific sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) inhibitor, phospholamban, rescued the spectrum of phenotypes that resemble human heart failure.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.  \nThis sentence directly identifies **phospholamban** as the regulatory molecule interacting with SERCA2a (sarcoplasmic reticulum calcium ATPase) in cardiac muscle.", "retries": 1}
{"idx": 3, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model supporting sentence is logical and connects SAMe to histone methylation (H3K27me3), which indirectly supports its role as a methyl donor. However, it is slightly less direct than the gold supporting sentence, which explicitly states that SAMe is the major methyl donor for histone methylation.\", \"match\": true}", "gold_answer": "S-adenosylmethionine", "gold_support": "S-adenosylmethionine (SAMe), the major methyl donor for DNA and histone methylation was fed with ethanol for 1month in order to modify the effects of ethanol on rat liver.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"SAMe feeding prevented most of the changes in gene expression induced by ethanol feeding, presumably by inducing H3K27me3 and gene silencing.\"  \n\nThis sentence connects SAMe to histone methylation (H3K27me3), which directly implicates SAMe as the methyl donor for histone methyltransferases, as H3K27me3 involves the transfer of methyl groups to histone proteins. While the context does not explicitly use the term \"methyl donor,\" the role of SAMe in inducing histone methylation (H3K27me3) aligns with its known biochemical function as a methyl donor.", "retries": 1}
{"idx": 4, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional information ('transient ischaemic attack (TIA)') that is not explicitly part of the gold answer ('Stroke'). The supporting sentence is somewhat lengthy and indirectly relevant, as it mentions the broader context of the study rather than focusing specifically on the ROSIER scale's use for stroke identification. While the logic connecting the answer and the supporting sentence is reasonable, the supporting sentence could be more concise and directly tied to the gold answer.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.  \n\nThis sentence explicitly states the purpose of the study, which is to evaluate clinical scores (including the ROSIER scale) for the **identification of stroke and transient ischaemic attack (TIA)**. The answer is directly derived from this statement.", "retries": 1}
{"idx": 5, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 6, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a correct explanation of FSHD being caused by issues with DUX4 expression, but it is slightly more verbose than necessary. The gold supporting sentence is much more concise while still implying the connection between FSHD and DUX4.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: FSHD", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 7, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('CGRP receptor') is correct in essence but does not fully match the gold standard ('calcitonin gene-related peptide'). The supporting sentence is incorrect because it states that the context does not mention the CGRP receptor, while the gold supporting sentence explicitly identifies telcagepant as a calcitonin gene-related peptide receptor antagonist. The model's supporting sentence fails to reference this key information from the context, leading to a lower score.\", \"match\": false}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is an oral calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.", "model_answer": "Answer: CGRP receptor", "model_support": "The context provided does not explicitly mention the CGRP receptor or any specific receptor targeted by telcagepant. The background and methods describe telcagepant as a drug combined with analgesics for migraine treatment but do not specify its mechanism of action or receptor target. \n\n**Supporting sentence:** None. The context does not contain a sentence that directly identifies the CGRP receptor as the target of telcagepant. The answer \"CGRP receptor\" appears to rely on external knowledge rather than the provided text.", "retries": 1}
{"idx": 8, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying that CT-011 interacts with PD-1. Minor extra details are acceptable as they do not detract from the clarity or correctness of the reasoning.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "CT-011 is a humanized IgG1 monoclonal antibody that modulates the immune response through interaction with PD-1, a protein belonging to the B7 receptor family present on lymphocytes.", "model_answer": "Answer: PD-1", "model_support": "Supporting sentence: CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.", "retries": 1}
{"idx": 9, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. Although the model initially mentioned that there was no supporting sentence in the provided context, the actual gold supporting sentence is concise, directly relevant, and logically explains that JTV519 is a derivative of 1,4-benzothiazepine. The information is clear and covers the answer appropriately without excessive detail.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: None. The context provided does not mention JTV519. The answer \"1,4-benzothiazepine\" is derived from prior knowledge or a different context, as the current text references K201 and its derivatives but not JTV519. \n\nHowever, if the question inadvertently conflates K201 with JTV519 (as in the example context), the supporting sentence from the example would be:  \n**\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"**  \nBut this sentence is not present in the provided context.", "retries": 1}
{"idx": 10, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "This progress has largely revolved around the discovery of the X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivation.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: In adult cells Xist is transcribed exclusively from the inactive X chromosome.", "retries": 1}
{"idx": 11, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'S-adenosylmethionine (AdoMet),' does not match the gold standard ('adenosylmethionine') because the context specifies that SMM, not AdoMet, is the primary methyl donor in the described system. The supporting sentence provided by the model mentions AdoMet but focuses on its role as a precursor rather than directly supporting its function as the methyl donor for histone methyltransferases, which is not explicitly stated in the context. While AdoMet is mentioned as a methyl donor in vitro, this is not sufficient to justify it as the correct answer over SMM. Thus, the answer and supporting sentence are relevant but do not cover the gold answer accurately.\", \"match\": false}", "gold_answer": "adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "Answer: S-adenosylmethionine (AdoMet)", "model_support": "Supporting sentence: \"Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).\"  \n\n**Note**: While the context explicitly states that **SMM** (not AdoMet) is the methyl donor for Met synthesis, the answer provided (\"S-adenosylmethionine (AdoMet)\") appears to conflate the precursor (AdoMet) with the actual methyl donor (SMM). The sentence above is the only one mentioning AdoMet, but it does not directly support the answer as stated. The question may contain an error, as the context does not explicitly identify AdoMet as the methyl donor for histone methyltransferases (a topic not addressed in the text).", "retries": 1}
{"idx": 12, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.\"", "retries": 1}
{"idx": 13, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence establishes Fanconi anemia as a genomic instability disorder but does not explicitly mention hypersensitivity to DNA crosslinking agents or chromosomal aberrations, which are key details in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "The disease is manifested by defects in DNA repair, hypersensitivity to DNA crosslinking agents, and a high degree of chromosomal aberrations.", "model_answer": "Answer: Fanconi anemia", "model_support": "Supporting sentence: Fanconi anemia (FA) is an autosomal disorder that causes genome instability.  \n\nThis sentence directly identifies Fanconi anemia as the disease associated with genome instability, which aligns with the question's context of sensitivity to DNA crosslinking agents and chromosomal aberrations (implied through \"genome instability\"). While the exact phrase \"sensitive to DNA crosslinking agents\" is not explicitly stated, the sentence establishes Fanconi anemia as the disease in question.", "retries": 1}
{"idx": 14, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly more verbose than necessary. The additional details about dosages and combinations add some redundancy, though the core information about ibrutinib's effectiveness in CLL is clear.\", \"match\": true}", "gold_answer": "Ibrutinib", "gold_support": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: In phase I/II trials, ibrutinib 420 mg or 840 mg - given continuously as single agent or at a dose of 420 mg daily in combination with a monoclonal antibody or chemoimmunotherapy - has been associated with high response rates and durable clinical remissions.  \n\n**Note**: While the context does not explicitly state that ibrutinib is a \"Bruton's tyrosine kinase inhibitor,\" the question assumes this knowledge (as ibrutinib is a well-established BTK inhibitor). The supporting sentence identifies ibrutinib as the drug under discussion for CLL treatment.", "retries": 1}
{"idx": 15, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "p53 is well known as the 'guardian of the genome' for differentiated and neoplastic cells.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: p53 is well known as the \"guardian of the genome\" for differentiated and neoplastic cells.", "retries": 1}
{"idx": 16, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions 'acute ischemic stroke' and ties it to the study's focus on functional recovery, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "acute ischemic stroke", "gold_support": "MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.", "model_answer": "The treatment of acute ischemic stroke was investigated in the MR CLEAN study.", "model_support": "Supporting sentence: \"However, a beneficial effect of IAT on functional recovery in patients with acute ischemic stroke remains unproven.\"  \n\nThis sentence explicitly states that the study investigates the treatment of **acute ischemic stroke**, as it mentions \"patients with acute ischemic stroke\" and the focus on functional recovery in this patient population.", "retries": 1}
{"idx": 17, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and contains correct information about calsequestrin's calcium-binding capacity. However, it is slightly less comprehensive than the gold supporting sentence, which provides additional context about calsequestrin's role as a calcium buffer and sensor in the sarcoplasmic reticulum.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium for release through the RyR and acts as a luminal calcium sensor for the channel via its interactions with triadin and junctin.", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: \"The phosphorylation status of calsequestrin 1 is deemed important: it influences the Ca(2+) binding capacity of calsequestrin.\"  \n\nThis sentence explicitly identifies calsequestrin as a calcium-binding protein by referencing its \"Ca(2+) binding capacity,\" directly supporting the answer.", "retries": 1}
{"idx": 18, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the broader context of potential investigational drugs for hereditary angioedema. The supporting sentence acknowledges that DX-88 is not mentioned in the provided context, which is factually correct, but it fails to connect DX-88 to ecallantide as the gold answer requires. Instead, the supporting sentence focuses on the absence of the term without leveraging the indirect hint provided in the context about novel therapies, which would have allowed a connection to be made.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "Several novel therapies have completed phase III trials in the US, including: (i) plasma-derived C1-INH replacement therapies (Berinert P and Cinryze); (ii) a recombinant C1-INH replacement therapy (conestat alfa; Rhucin); (iii) a kallikrein inhibitor (ecallantide [DX-88]); and (iv) a bradykinin-2-receptor antagonist (icatibant).", "model_answer": "Answer: DX-88 is the investigational name of a drug for hereditary angioedema, but it is not mentioned in the provided context.", "model_support": "Supporting sentence: The context does not mention DX-88.  \nExplanation: The provided text discusses hereditary angioedema (HAE) treatments, including Berinert P, Cinryze, and other therapies, but explicitly states that \"US FDA approval for other novel agents to treat HAE... is pending.\" However, no specific mention of \"DX-88\" is made in the context. The absence of any reference to DX-88 directly supports the conclusion that it is not discussed.", "retries": 1}
{"idx": 19, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by specifying FSHD as the disease caused by issues with DUX4 expression.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: FSHD", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 20, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer ('papulovesicular rash') is very close to the gold standard ('Dermatitis herpetiformis'), as it correctly describes the rash associated with gluten sensitivity. However, the gold answer focuses on the name of the condition rather than a description of the rash itself. The supporting sentence is somewhat lengthy and includes irrelevant details about the mouse model, though it does logically connect the rash to gluten sensitivity. The reasoning is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is a papulovesicular rash.", "model_support": "Supporting sentence: A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 21, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The context explicitly mentions growth hormone deficiency as one of the endocrine abnormalities in Costello syndrome, but the model incorrectly states that no hormone deficiency is mentioned. The supporting sentence is relevant to the context but fails to cover the gold answer (growth hormone deficiency) and instead focuses on hyperinsulinism, which is unrelated to the question. This results in a score of 2, as the answer is incorrect but the supporting sentence is somewhat relevant.\",\n  \"match\": false\n}", "gold_answer": "growth hormone", "gold_support": "Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described.", "model_answer": "Answer: There is no mentioned hormone deficiency in Costello syndrome.", "model_support": "Supporting sentence: The mechanism of persistent hyperinsulinism in patients with Costello syndrome is unclear.  \nThis sentence implies that the text does not identify a hormone deficiency as the cause of hyperinsulinemic hypoglycemia in Costello syndrome, instead highlighting the absence of a clear explanation for the condition. The context explicitly mentions hyperinsulinism (excess insulin) rather than a hormone deficiency, and no hormone deficiency is stated or implied.", "retries": 1}
{"idx": 22, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about the mode of inheritance, referencing the dominant form of mutations in FBN1 related to Acromicric dysplasia. However, it includes additional details about GD and specific exons that are not necessary to directly support the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).", "model_answer": "Answer: Acromicric dysplasia has an autosomal dominant mode of inheritance.", "model_support": "Supporting sentence: \"We then identified mutations in ADAMTSL2 in the recessive form of GD and a hotspot of mutations in FBN1 in the dominant form of GD and in AD (exon 41-42, encoding TGFβ binding protein-like domain 5 (TB5) of FBN1).\"  \n\nThis sentence explicitly states that Acromicric dysplasia (AD) is associated with mutations in FBN1 in the \"dominant form,\" indicating an autosomal dominant mode of inheritance.", "retries": 1}
{"idx": 23, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'SERCA2a itself,' does not match the gold standard, which is 'phospholamban.' However, the answer is present in the context as SERCA2a is discussed as a key molecule in cardiac muscle function. The supporting sentence is relevant to SERCA2a's role but does not address the regulatory aspect provided by phospholamban, and thus does not cover the gold answer. Therefore, while somewhat related, the model's response misses the critical regulatory molecule mentioned in the gold standard.\", \"match\": false}", "gold_answer": "phospholamban", "gold_support": "SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholamban, protein phosphatase 1, inhibitor-1, and PKCα.", "model_answer": "Answer: SERCA2a itself.", "model_support": "Supporting sentence: SERCA2a mediates Ca²+ reuptake into the SR in cardiomyocytes.  \n\nThis sentence directly identifies SERCA2a as the molecule responsible for regulating Ca²+ cycling in cardiac muscle, which underpins its role as the primary regulatory component of SERCA2a function. While the context also mentions post-translational modifications (e.g., SUMOylation, acetylation) as factors influencing SERCA2a activity, the question specifically asks for the \"main regulatory molecule,\" which refers to SERCA2a itself as the central player in this process.", "retries": 1}
{"idx": 24, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Subclinical hypothyroidism' is very close to the gold answer 'thyroid,' as subclinical hypothyroidism is a specific thyroid-related abnormality. However, it does not fully encompass the broader category of 'thyroid' abnormalities mentioned in the gold answer. The supporting sentence is somewhat lengthy and focuses specifically on subclinical hypothyroidism, while the gold supporting sentence provides a more general reference to thyroid abnormalities. Logic is reasonable but could be more concise and inclusive of the broader category.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Answer: Subclinical hypothyroidism.", "model_support": "Supporting sentence: None of our patients had overt hypothyroidism; 29 patients (31.5%) had subclinical hypothyroidism.", "retries": 1}
{"idx": 25, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Gevokizumab targets IL-1β by modulating its signaling. This aligns perfectly with the gold supporting sentence while maintaining clarity and brevity.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is IL-1β.", "model_support": "Supporting sentence: \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"  \n\nThis sentence directly states that Gevokizumab targets IL-1β by modulating its signaling, confirming the molecule it acts upon.", "retries": 1}
{"idx": 26, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer 'Three' does not match the gold standard '7', and there is no explicit or implicit information in the supporting sentence to justify this number. The context provided does not specify the number of TAp73 isoforms, making the answer incorrect. Additionally, the supporting sentence discusses the role of TAp73 isoforms in tumorigenesis and genomic stability but does not address the number of isoforms at all. Therefore, both the answer and supporting sentence are irrelevant to the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Three", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial. However, as we have recently shown, the generation of TAp73-deficient (TAp73(-/-)) mice reveals that TAp73 isoforms exert tumor-suppressive functions, indicating an emerging role for Trp-73 in the maintenance of genomic stability.  \n\n**Note**: The context does not explicitly state the number of TAp73 isoforms. The answer \"Three\" may rely on external knowledge (e.g., TAp73, ΔNp73, and other variants), but the provided text does not directly specify this number.", "retries": 1}
{"idx": 27, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it contains slight redundancy by mentioning 'both eukaryotic and bacterial SelL genes,' which is not necessary to directly explain the term 'SECIS element.' The logic is sound, but more concise phrasing could improve it.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Selenocysteine (Sec, U) insertion into proteins is directed by translational recoding of specific UGA codons located upstream of a stem-loop structure known as Sec insertion sequence (SECIS) element.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: Both eukaryotic and bacterial SelL genes use single SECIS elements for insertion of two Sec.", "retries": 1}
{"idx": 28, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Naloxone should be administered when managing patients with suspected acute opioid overdose' matches the gold standard 'naloxone' in essence, though it is phrased as a complete sentence rather than a concise term. The supporting sentence is relevant and provides context about the study comparing naloxone administration methods, which logically supports the use of naloxone. However, the supporting sentence is somewhat lengthy and could be more concise while still covering the essential point. Overall, the logic is sound but slightly verbose.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone should be administered when managing patients with suspected acute opioid overdose.", "model_support": "Supporting sentence: A prospective, sequential, observational cohort study of 196 consecutive patients with suspected opioid overdose was conducted in an urban out-of-hospital setting, comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation.  \n\n**Note**: While the sentence does not explicitly name \"naloxone\" in the initial description, the context of the study (comparing routes of naloxone administration and its use in opioid overdose) implicitly establishes that naloxone is the medication being evaluated. The specific administration details (e.g., \"administering naloxone 0.4 mg i.v.\") in the METHODS section further confirm this. However, the provided context does not include a direct sentence stating \"naloxone should be administered\" as a standalone statement. The answer is inferred from the study's focus on naloxone for opioid overdose management.", "retries": 1}
{"idx": 29, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.", "retries": 1}
{"idx": 30, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly more detailed than necessary, introducing information about the pHMMs that is not required to directly support the answer.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 31, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') as it correctly identifies facio-scapulo-humeral dystrophy (FSHD) in full form. The supporting sentence is relevant and provides useful context, but it contains slight redundancy by mentioning 'dysregulation of 4q35- and muscle-specific genes,' which is not directly necessary to support the answer. It could be more concise by focusing solely on the link between DUX4 expression and FSHD.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is facio-scapulo-humeral dystrophy (FSHD).", "model_support": "Supporting sentence: Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.", "retries": 1}
{"idx": 32, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. While it correctly explains a biochemical aspect of medicarpin, the chosen sentence is less direct than the gold supporting sentence, which explicitly states that medicarpin is the major phytoalexin in alfalfa.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein. \n\nThis sentence directly identifies **medicarpin** as the compound in question, which is a phytoalexin in alfalfa. The context focuses on enzymes involved in its biosynthesis (e.g., IOMT), further confirming its role as the major phytoalexin.", "retries": 1}
{"idx": 33, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies that the name of the Bruton's tyrosine kinase inhibitor is not mentioned in the provided context. However, it fails to extract the relevant information about ibrutinib from the context, which is necessary to cover the gold answer.\", \"match\": false}", "gold_answer": "ibrutinib", "gold_support": "Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1.", "model_answer": "The name of Bruton's tyrosine kinase inhibitor used for treatment of chronic lymphocytic leukemia is not mentioned in the provided context.", "model_support": "Supporting sentence: The context does not mention the name of a Bruton's tyrosine kinase inhibitor used for the treatment of chronic lymphocytic leukemia.  \n\nExplanation: The provided context focuses on Lymphocyte cytosolic protein 1 (LCP1) as a membrane-associated target in CLL and describes experimental methods to identify it. However, it does not reference any specific Bruton's tyrosine kinase (BTK) inhibitors or their use in CLL treatment. The absence of such information directly supports the answer.", "retries": 1}
{"idx": 34, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA),' which is not part of the gold answer. The supporting sentence provides relevant context about the identification of stroke and TIA, but it is somewhat lengthy and indirectly covers the gold answer. While the logic connecting the ROSIER scale to stroke is reasonable, the sentence could be more concise and focused directly on stroke alone.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.  \n\nThis sentence explicitly states the purpose of the study, which is to evaluate scores (including ROSIER) for the identification of stroke and TIA. Additionally, the objective reinforces this by stating the comparison of \"bedside diagnostic stroke scales in patients with suspected stroke,\" aligning with the disorder targeted by the ROSIER scale.", "retries": 1}
{"idx": 35, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence, as it correctly identifies thyroid hormone abnormalities as characteristic to Pendred syndrome. The supporting sentence is relevant but slightly verbose and less direct compared to the gold supporting sentence, which succinctly mentions the key diagnostic triad including hypothyroidism. The model's supporting sentence provides context about measuring thyroid hormone levels but does not explicitly mention hypothyroidism or the iodine organification defect, making it less precise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities are characteristic to Pendred syndrome.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured.", "retries": 1}
{"idx": 36, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence is slightly more concise than the gold supporting sentence but still captures the essential information.\", \"match\": true}", "gold_answer": "development", "gold_support": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.", "model_answer": "Answer: Development.", "model_support": "Supporting sentence: \"some of which have been implicated in the regulation of crucially important processes, including development.\"", "retries": 1}
{"idx": 37, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'), and the supporting sentence is relevant and supports the answer. However, the supporting sentence is slightly indirect and requires inference from the context to fully connect SEA0400 with NCX inhibition, whereas the gold supporting sentence explicitly mentions 'Na(+)/Ca(2+) exchange inhibitor SEA0400,' making it more direct and clear.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400.  \nExplanation: The context states that SNP increased Ca²⁺ influx and intracellular Ca²⁺ levels, which are mediated by NCX (as mentioned earlier in the text: \"SNP causes apoptotic-like cell death in cultured glial cells via NCX-mediated pathways\"). Since SEA0400 prevented these effects (Ca²⁺ influx and downstream signaling), it implies that SEA0400 inhibits the Na⁺/Ca²⁺ exchanger (NCX), even though the sentence does not explicitly name NCX. The connection is inferred from the mechanism described.", "retries": 1}
{"idx": 38, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the model's answer, explaining that the text does not address prevalence, but it fails to cover the gold answer, which can be directly inferred from the numerical data in the results section.\", \"match\": false}", "gold_answer": "women", "gold_support": "RESULTS: We studied 312 women and 126 men with early RA.", "model_answer": "Answer: The text does not provide information on the overall prevalence of Rheumatoid Arthritis in men or women.", "model_support": "Supporting sentence: The text does not provide information on the overall prevalence of Rheumatoid Arthritis in men or women.  \n\nExplanation: The context focuses on disease expression, clinical parameters, and treatment differences between genders in early RA patients but never mentions the overall prevalence or incidence rates of RA in men versus women. The study population size (438 patients) and analysis of variables like ESR, radiological changes, and treatment do not include data on gender-based prevalence.", "retries": 1}
{"idx": 39, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is less direct than the gold supporting sentence. While it references p53 and provides context about its role in cancer management, it does not explicitly include the phrase 'guardian of the genome,' which would make it more concise and directly relevant. The reasoning provided in the note is accurate but the supporting sentence itself could be improved by being more specific.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.  \n\n**Note:** While the exact phrase \"guardian of the genome\" is not explicitly stated in the context, p53 is universally recognized as \"the guardian of the genome\" in scientific literature due to its critical role in maintaining genomic stability. The context emphasizes p53's essential functions in cell cycle regulation, DNA repair, and apoptosis, which align with this nickname. However, the direct reference to p53 as the tumor suppressor in the title and throughout the text supports the answer.", "retries": 1}
{"idx": 40, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'). However, the supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, whereas the gold supporting sentence clearly identifies betrixaban as part of the group of orally active direct factor Xa inhibitors. The model should have extracted this relevant sentence from the context. Despite this oversight, the answer itself is correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention betrixaban or the specific clotting factor it inhibits. Therefore, there is no supporting sentence in the given text to answer the question. \n\n**Note:** While betrixaban is known in real-world pharmacology to inhibit Factor Xa, this information is not present in the provided context. The context only references dabigatran and rivaroxaban, which are direct thrombin inhibitors (dabigatran) and Factor Xa inhibitors (rivaroxaban), but does not mention betrixaban.", "retries": 1}
{"idx": 41, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional information ('transient ischaemic attack (TIA)') which, while relevant in context, does not directly match the concise gold answer 'Stroke.' The supporting sentence provides relevant context by mentioning the identification of stroke and TIA but is somewhat lengthy and not as direct as the gold supporting sentence. Logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.", "retries": 1}
{"idx": 42, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model answer 'Na+/Ca2+ exchanger' aligns with the gold answer 'Na(+)/Ca(2+) exchanger', and the supporting sentence provides accurate information about the NCX's function. However, it does not directly mention SEA0400 as the specific inhibitor, which is a key part of the question and gold supporting sentence.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "Concerning the role of NCX in NO cytotoxicity, we have found, using the specific inhibitor of NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), that NCX is involved in NO-induced cytotoxicity in cultured microglia, astrocytes, and neuronal cells.", "model_answer": "Answer: Na+/Ca2+ exchanger", "model_support": "Supporting sentence: The plasma membrane Na(+)/Ca(2+) exchanger (NCX) is a bidirectional ion transporter that couples the translocation of Na(+) in one direction with that of Ca(2+) in the opposite direction.  \n\n**Note**: The context does not mention \"SEA0400\" explicitly. The answer \"Na+/Ca2+ exchanger\" aligns with the review's focus on NCX, but the question about SEA0400 appears unrelated to the provided text. If the intended question was about NCX, the above sentence directly supports the answer.", "retries": 1}
{"idx": 43, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they support the explanation without being excessive.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "Answer: FSHD (Facioscapulohumeral Dystrophy)", "model_support": "Supporting sentence: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"", "retries": 1}
{"idx": 44, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'EAE (Experimental Autoimmune Encephalomyelitis)' is equivalent to 'Experimental autoimmune encephalomyelitis (EAE)'. The supporting sentence is relevant and provides logical support by emphasizing the utility of EAE in studying MS. However, it contains slight redundancy by mentioning both immune-mediated CNS pathology and the progressive clinical course of MS, which makes it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE), a widely recognized animal model of multiple sclerosis (MS), is highly useful for studying inflammation, demyelination, and neurodegeneration in the central nervous system (CNS).", "model_answer": "The most widely used model for the study of multiple sclerosis (MS) is EAE (Experimental Autoimmune Encephalomyelitis).", "model_support": "Supporting sentence: EAE exhibits many similarities with MS, which is a chronic inflammatory disease affecting CNS white matter in humans. Various studies have indicated that EAE is a particularly useful animal model for understanding both the mechanisms of immune-mediated CNS pathology and also the progressive clinical course of MS.", "retries": 1}
{"idx": 45, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence is somewhat indirect and does not explicitly mention that betrixaban inhibits Factor Xa. It discusses the broader class of new oral anticoagulants, which includes Factor Xa inhibitors, but this requires inference and is less concise than the gold supporting sentence. The logic is reasonable but could be more direct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The recently introduced oral anticoagulants, dabigatran, rivaroxaban and apixaban, were shown, in randomized controlled trials, to be at least as effective and safe as monitored warfarin therapy for the treatment of venous thromboembolism and stroke prevention in atrial fibrillation.  \n\n**Note:** While the context does not explicitly state that betrixaban inhibits Factor Xa, the answer is inferred from the context's mention of rivaroxaban and apixaban (known Factor Xa inhibitors) as part of the \"new oral anticoagulants\" class. However, the supporting sentence provided here contextualizes the class of drugs (including Factor Xa inhibitors) to which betrixaban belongs, even though it does not directly name Factor Xa as the target.", "retries": 1}
{"idx": 46, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' is synonymous with 'benzothiazepine'). The supporting sentence is concise, directly relevant, and logically supports the answer by linking JTV519 to the 1,4-benzothiazepine group as stated in the context. Minor extra details are acceptable since the logic is strong and clear.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.  \n\n(Note: The context refers to **S107** as a 1,4-benzothiazepine derivative, not JTV519. However, the question incorrectly asks about JTV519. If the intended drug were S107, this sentence supports the answer. If the question is indeed about JTV519, the context provided contains no relevant information.)", "retries": 1}
{"idx": 47, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning co-localization, which is additional information not directly needed to support the answer.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: We demonstrated co-localization in the nucleus between transfected FANCA and BRG1.", "retries": 1}
{"idx": 48, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly states that [18F]altanserin is used to determine 5-HT2A receptor availability, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.\"  \n\nThis sentence explicitly states that [18F]altanserin is used to evaluate **5-HT2A receptors** in the rat brain, directly answering the question.", "retries": 1}
{"idx": 49, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect in stating that there is no relevant context, as the gold supporting sentence shows that the context does indeed link 'LY450139' to 'Semagacestat.' Despite this error, the model's answer is correct based on external knowledge.\", \"match\": true}", "gold_answer": "Semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "Answer: Semagacestat", "model_support": "The context provided does not mention \"LY450139\" or any investigational name for \"Semagacestat.\" Therefore, **there is no supporting sentence** in the given context to confirm the answer. The context only states:  \n\"**Semagacestat is currently being studied in two phase III clinical trials.**\"  \n\nThis sentence does not link \"LY450139\" to \"Semagacestat\" or provide any information about investigational names. The answer appears to be based on external knowledge (e.g., LY450139 is indeed an investigational name for Semagacestat), but the context provided does not contain this information.", "retries": 1}
{"idx": 50, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in essence, though it is slightly more detailed. The supporting sentence is relevant and provides context for betrixaban being a factor Xa inhibitor, but it contains some redundancy by discussing broader classes of anticoagulants rather than directly focusing on betrixaban as a factor Xa inhibitor. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.  \n\n**Reasoning**: The context explicitly categorizes betrixaban as part of the \"new classes of orally administered anticoagulants\" alongside direct thrombin inhibitors and factor Xa inhibitors. While the text does not directly state that betrixaban inhibits Factor Xa, it is implied by its classification as a novel anticoagulant within this group. The mention of \"factor Xa inhibitors\" in the introduction directly supports the answer that betrixaban targets Factor Xa.", "retries": 1}
{"idx": 51, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.", "retries": 1}
{"idx": 52, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it refers to the central amygdaloid nucleus rather than directly addressing Lewy bodies in the substantia nigra, making it slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals.", "retries": 1}
{"idx": 53, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'AIP gene,' does not match the gold standard answer, 'aryl hydrocarbon receptor interacting protein,' but it is a known synonym in broader literature. However, the context provided does not explicitly mention AIP or its role in familial isolated pituitary adenoma (FIPA), so the supporting sentence fails to justify or cover the gold answer. The supporting sentence highlights this gap by acknowledging that the context lacks relevant evidence, though it doesn't directly support the gold answer either.\",\n  \"match\": false\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "Answer: AIP gene", "model_support": "The context provided does not explicitly mention the AIP gene or any specific gene mutation associated with familial isolated pituitary adenoma (FIPA). The text discusses the challenges in identifying molecular markers for pituitary tumours but does not reference the AIP gene or its role in familial cases. \n\n**Supporting sentence:** None. The context does not contain a sentence implicating the AIP gene in familial isolated pituitary adenoma. \n\n**Note:** While the AIP gene is known in broader literature to be implicated in FIPA, this specific context does not provide the necessary evidence to support the answer.", "retries": 1}
{"idx": 54, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence, although mentioning that the context does not explicitly state the molecule targeted, correctly identifies interleukin-5 (IL-5) as the target based on external knowledge. Furthermore, the gold supporting sentence directly backs this up by stating that mepolizumab is a monoclonal antibody against interleukin-5. The logic is clear and accurate.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "The context provided does not explicitly state which molecule is targeted by mepolizumab. However, based on external knowledge, mepolizumab is a monoclonal antibody that targets **interleukin-5 (IL-5)**. The supporting sentence would typically be something like *\"Mepolizumab is a monoclonal antibody that targets interleukin-5 (IL-5).\"* However, this specific sentence is **not present** in the given context. \n\nIf the question assumes prior knowledge (as the answer suggests), the context does not provide direct evidence for this claim. \n\n**Note:** The answer \"Interleukin-5 (IL-5)\" is scientifically accurate for mepolizumab, but the context provided does not include a sentence that explicitly supports this.", "retries": 1}
{"idx": 55, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, as it states 'One' TAp73 isoform has been identified, while the gold answer specifies 7. The supporting sentence mentions five N-terminal isoforms, but this does not logically support the model’s answer of 'One.' Furthermore, the sentence does not address the correct number of TAp73 isoforms specifically and introduces confusion by referencing a different set of isoforms. Both the answer and supporting sentence fail to align with the gold standard and lack logical relevance.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR.  \n\nThis sentence explicitly lists \"TAp73\" as one of the five distinct N-terminal isoforms, confirming that **one** TAp73 isoform has been identified.", "retries": 1}
{"idx": 56, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but uses 'active gene strand' instead of the more precise 'transcribed strand.' The supporting sentence is relevant and supports the concept of TCR targeting active genes, but it does not specifically mention the 'transcribed strand,' which reduces its precision. The logic is reasonable but could be more concise and directly aligned with the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Answer: The gene strand targeted by transcription-coupled repair (TCR) is the active gene strand.", "model_support": "Supporting sentence: CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes.", "retries": 1}
{"idx": 57, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional information about other disorders that can accompany McLeod syndrome, which slightly increases verbosity without being directly necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).", "retries": 1}
{"idx": 58, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for Alzheimer's disease research, but it is slightly vague and lacks specificity regarding PBT2's testing in the context of the metals hypothesis. It does not directly reference PBT2 or the clinical trial, which makes it less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "PBT2 has been tested for Alzheimer's disease.", "model_support": "Supporting sentence: Drug development based on the metals hypothesis of Alzheimer's disease.  \n\nThis sentence establishes the context of research focused on Alzheimer's disease, which includes the testing of compounds like PBT2 as part of medicinal chemistry approaches targeting the metals hypothesis. While PBT2 is not explicitly named in the first sentence, the entire passage is framed within the scope of Alzheimer's disease, making this the foundational supporting statement.", "retries": 1}
{"idx": 59, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('5-HT2A receptors' vs. '5-HT2A'), though it includes a slight elaboration by specifying 'receptors,' which is acceptable. The supporting sentence is relevant and provides substantial context about the reproducibility of 5-HT2A receptor measurements, directly linking to the use of [18F]altanserin PET. However, it contains additional details (e.g., specific percentages) that, while informative, are not strictly necessary for supporting the answer. This makes it slightly verbose but still logically sound.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: In cortical brain regions with a high density of 5-HT2A receptors, the outcome parameter (binding potential, BP1) showed high reproducibility, with a median difference between the two group measurements of 6% (range 5-12%), whereas in regions with a low receptor density, BP1 reproducibility was lower, with a median difference of 17% (range 11-39%).", "retries": 1}
{"idx": 60, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'PCSK9' matches the gold standard 'proprotein convertase subtilisin/kexin type 9' in terms of meaning, as PCSK9 is a widely accepted abbreviation. However, the supporting sentence discusses the tolerability and adverse events of PCSK9 inhibitors rather than directly explaining the mechanism or role of PCSK9, which is the focus of the gold supporting sentence. While the supporting sentence is relevant, it contains slight redundancy and does not cover the gold answer as precisely as it could.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab and alirocumab are fully human monoclonal antibodies inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds to hepatic LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Answer: PCSK9", "model_support": "Supporting sentence: Phase II (for evolocumab and alirocumab) and III (for evolocumab) trials show that PCSK9 inhibitors are equally well tolerated, with adverse events mainly limited to mild-to-moderate nasopharyngitis, injection-site pain, arthralgia and back pain.", "retries": 1}
{"idx": 61, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context as a partial truth (the etiology being unknown). However, the supporting sentence does not cover the gold answer ('iron') and instead focuses on the unknown nature of the syndrome. The correct association with iron deficiency is missing.\", \"match\": false}", "gold_answer": "iron", "gold_support": "The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.", "model_answer": "Answer: The cause of restless leg syndrome is unknown.", "model_support": "Supporting sentence: The etiology is unknown, sometimes it is familial.", "retries": 1}
{"idx": 62, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'acute stroke' is slightly more specific than the gold answer 'stroke,' but it is still correct and aligns with the context. The supporting sentence is relevant and covers the answer well, though it includes a minor extra detail ('from stroke mimics') that, while accurate, is not strictly necessary to support the answer. This makes the sentence slightly more verbose than needed.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 63, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'BCR-ABL1' is very close to the gold standard 'Bcr-Abl', using a slightly different but acceptable format (all caps with numbers instead of mixed case). However, the supporting sentence does not directly mention BCR-ABL1 or clearly explain that it is the target of Imatinib. Instead, it discusses treatment challenges with tyrosine kinase inhibitors in general, which is relevant but lacks specificity. The logic is reasonable but could be more concise and directly tied to the gold answer.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) arises as a consequence of a chromosomal translocation giving rise to the Philadelphia chromosome and Bcr-Abl oncogene.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: \"However, the success of tyrosine kinase inhibitors, as rationally designed first-line therapies, has been tempered by problems of disease persistence and resistance.\"  \n\n**Note**: While the context does not explicitly name **BCR-ABL1**, it implies that tyrosine kinase inhibitors (TKIs) target the pathogenic mechanism of Philadelphia-chromosome-positive CML (a well-established fact in biomedical knowledge). However, the provided context does not directly state the target kinase. The sentence above is the closest relevant statement, as it links TKIs to CML treatment, which is historically tied to BCR-ABL1 inhibition.", "retries": 1}
{"idx": 64, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'BCR-ABL1' is very close to the gold standard 'BCR-ABL' and is correct in the context of biomedical knowledge. However, the supporting sentence does not directly mention BCR-ABL1 or explicitly state that imatinib targets this kinase. It discusses the effectiveness of imatinib in CML but lacks concise and direct logical coverage of the gold answer. The reasoning could be more focused and aligned with the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) originates from a hematopoietic stem cell carrying the Philadelphia (Ph) chromosome and oncogenic BCR-ABL1 fusion gene.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The first tyrosine-kinase inhibitor (TKI) imatinib was introduced to clinical practice 10 years ago, and it radically improved the outcome of CML patients.  \n\n**Note**: While the context does not explicitly name **BCR-ABL1**, the question relies on standard biomedical knowledge that imatinib targets the **BCR-ABL1** tyrosine kinase in Philadelphia-chromosome positive CML. The provided context implicitly supports this by framing imatinib as a TKI effective against CML, which is driven by the BCR-ABL1 fusion protein. However, the exact target is not mentioned in the text.", "retries": 1}
{"idx": 65, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa' in meaning, though it is slightly more verbose. The supporting sentence provides relevant information and logically supports the answer by linking betrixaban to anti-Xa activity, but it includes additional details about PRT4445, which are not necessary for answering the question directly. This makes the supporting sentence somewhat redundant.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban is an anticoagulant targeting Factor Xa, as PRT4445 is described as a reversal agent for \"anticoagulants with anti-Xa activity,\" suggesting betrixaban inhibits Factor Xa.", "retries": 1}
{"idx": 66, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The additional context contrasting BACH1 with Nrf2 further strengthens the explanation without introducing unnecessary verbosity.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1, one of the most inducible phase 2 proteins.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Redox regulation of the transcriptional repressor Bach1.\"  \n\nThis directly states that BACH1 functions as a transcriptional repressor. Additionally, the context contrasts BACH1 with the \"transactivator Nrf2,\" further confirming BACH1's role as a repressor.", "retries": 1}
{"idx": 67, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence references multiple system atrophy rather than Parkinson's disease or Lewy body dementia as stated in the gold supporting sentence. While it correctly identifies alpha-synuclein as forming pathological inclusions, it does not directly reference Lewy bodies, making it slightly less relevant to the specific question about Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.", "retries": 1}
{"idx": 68, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Tick' is not specific enough to match the gold standard 'Ixodes ricinus,' but it is related to the context as ticks are the vector. The supporting sentence mentions the tick-borne nature of the virus but does not specify the exact species of the vector (Ixodes ricinus), which is necessary for full accuracy. Therefore, while relevant, the supporting sentence does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "Ixodes ricinus", "gold_support": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.", "model_answer": "Answer: Tick", "model_support": "Supporting sentence: We used Susceptible Infected Recovered (SIR) models parameterized for the tick-borne louping ill virus (LIV) system.", "retries": 1}
{"idx": 69, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence discusses the exclusion of APOBEC3B from chromatin during mitosis, which is relevant but does not cover the gold answer regarding its nuclear localization after mitosis. The logic focuses on mitosis rather than the post-mitotic phase highlighted in the gold supporting sentence.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "Supporting sentence: APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.  \n\n**Reasoning**: During mitosis, the nuclear envelope disassembles, allowing cytoplasmic proteins to access the former nuclear space. The exclusion of APOBEC3B from chromatin (which is distributed in the cytoplasm during mitosis) implies its predominant localization is cytoplasmic, as it does not associate with the chromatin. This aligns with the answer that APOBEC3B is predominantly cytoplasmic.", "retries": 1}
{"idx": 70, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Eosinophils,' does not match the gold standard, 'interleukin-5,' but is present in the context as mepolizumab indirectly targets eosinophils by targeting interleukin-5. The supporting sentence is relevant but does not cover the gold answer; it focuses on eosinophils rather than interleukin-5, which is the molecule directly targeted by mepolizumab.\", \"match\": false}", "gold_answer": "interleukin-5", "gold_support": "We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.", "model_answer": "Answer: Eosinophils", "model_support": "Supporting sentence: \"Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.\"", "retries": 1}
{"idx": 71, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "methyl-CpG-binding protein 2 (Mecp2)", "gold_support": "The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction.", "model_answer": "Answer: Mecp2", "model_support": "Supporting sentence: Recent studies have begun to characterize the breathing phenotype of Mecp2 mutant mice and to define underlying electrophysiological and neurochemical deficits.", "retries": 1}
{"idx": 72, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is somewhat more complex and indirect compared to the gold supporting sentence. Instead of directly stating that dermatitis herpetiformis is the skin manifestation of gluten sensitivity, the model's supporting sentence raises a question about its classification, which introduces some redundancy. However, the logic connecting dermatitis herpetiformis to gluten-related conditions is still sound.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: The question should be asked whether the rash in dermatitis herpetiformis is a classic autoimmune blistering disease or whether it has an immune complex basis, which is the most likely alternative.  \n\nThis sentence directly references \"the rash in dermatitis herpetiformis,\" implicitly identifying dermatitis herpetiformis as the rash associated with gluten-related conditions (as discussed earlier in the context). While the sentence is phrased as a question, it frames dermatitis herpetiformis as the specific rash under consideration in the context of gluten sensitivity.", "retries": 1}
{"idx": 73, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly states that flumazenil is used for reversal in benzodiazepine toxicity, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: Bolus doses of flumazenil are usually adequate to achieve reversal; however, when medical conditions may lead to a prolonged half-life of the benzodiazepine involved, continuous infusion may be warranted. \n\nThis sentence explicitly states that flumazenil is used to achieve reversal (antidote effect) in benzodiazepine toxicity, directly supporting the answer.", "retries": 1}
{"idx": 74, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('Stroke') but is present in the context. The supporting sentence is relevant to the topic of stroke identification but does not directly cover the gold answer, as it refers to a study's general objective rather than specifically stating that ROSIER is used for diagnosing stroke.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.", "retries": 1}
{"idx": 75, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'PCSK9' is correct and matches the gold standard conceptually, though it is an abbreviation of the full enzyme name provided in the gold answer. The supporting sentence acknowledges that the context does not explicitly state the enzyme but correctly references external knowledge about evolocumab targeting PCSK9. However, it introduces slight redundancy by mentioning that there is no explicit supporting sentence in the context, which could have been more concise.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "BACKGROUND: Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies.", "model_answer": "Answer: PCSK9", "model_support": "The context does not explicitly mention the enzyme targeted by evolocumab. However, based on external knowledge, evolocumab is a PCSK9 inhibitor. Since the provided context does not include a sentence stating this, there is no supporting sentence within the given text. \n\n**Answer:** The context does not contain a sentence explicitly stating the enzyme targeted by evolocumab. However, evolocumab is known to target PCSK9, a well-established mechanism in clinical pharmacology.", "retries": 1}
{"idx": 76, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and providing some context that distinguishes LAD from dermatitis herpetiformis, does not directly highlight the gluten dependency of the rash in dermatitis herpetiformis as clearly as the gold supporting sentence. It is somewhat indirect and lacks the explicit mention of gluten dependency, which slightly reduces its effectiveness.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "This contrasts to the situation in dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: These data add further to the evidence that LAD and dermatitis herpetiformis are separate entities.", "retries": 1}
{"idx": 77, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 78, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The phrase 'Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation' is somewhat verbose compared to the gold supporting sentence, which directly explains DNMT1's role in maintenance DNA methylation with clarity and conciseness.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation.", "retries": 1}
{"idx": 79, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by referring to 'these enzymes' instead of directly focusing on Dnmt1 alone. The logic is sound but could be more specific.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining the methylation marks through cell division.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Manipulation of these enzymes, especially Dnmt1, provides a means to alter DNA methylation levels.", "retries": 1}
{"idx": 80, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by focusing on the methylation process rather than directly stating medicarpin's role as the major phytoalexin.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\"  \n\nThis sentence directly identifies **medicarpin** as the phytoalexin in question, as it describes its biosynthetic pathway and context within alfalfa's stress response.", "retries": 1}
{"idx": 81, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'BCR-ABL1', is correct in the context of chronic myelogenous leukemia and its association with the Philadelphia chromosome, but it does not exactly match the gold answer 'bcr-abl'. The supporting sentence provided by the model discusses the impact of the mobilization procedure on leukemia levels measured by bcr-abl but does not directly explain that Imatinib targets bcr-abl tyrosine kinase. The supporting sentence is relevant to the context but does not fully cover the gold answer or reasoning.\",\n  \"match\": false\n}", "gold_answer": "bcr-abl", "gold_support": "Imatinib mesylate (Glivec) is a selective inhibitor of bcr-abl tyrosine kinase, the product of the Philadelphia chromosome, which is the hallmark of chronic myeloid leukaemia (CML).", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: There was no impact of the mobilisation procedure on the level of leukaemia as measured by serial blood bcr-abl levels using real-time quantitative PCR with either protocol.", "retries": 1}
{"idx": 82, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.", "retries": 1}
{"idx": 83, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise and directly relevant, clearly establishing the role of NCX1 (a Na+/Ca2+ exchanger) in retinal cell death and implying that SEA0400 targets this exchanger. The logic is strong, and the sentence covers the answer without excessive content.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.  \n\n**Explanation**: While the context does not explicitly state that SEA0400 is an inhibitor of NCX, the first sentence establishes NCX1's role in retinal cell death, and the subsequent experiments (e.g., reduced damage in NCX1(+/-) mice and effects of SEA0400) imply that SEA0400 targets NCX1. The answer is inferred from the context's focus on NCX1's involvement and SEA0400's protective effects, aligning with the conclusion that NCX1 plays a critical role in the observed pathologies.", "retries": 1}
{"idx": 84, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.\"  \n\nThis sentence explicitly states that [(18) F]altanserin is used for imaging 5-HT2A receptors, which directly answers the question.", "retries": 1}
{"idx": 85, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'Factor Xa' is equivalent to 'Xa'. The supporting sentence is relevant and provides logical reasoning by mentioning that direct factor Xa inhibitors target factor Xa. However, it contains slight redundancy in discussing the class of inhibitors rather than directly focusing on betrixaban’s action as specified in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.", "retries": 1}
{"idx": 86, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer logically, but it includes additional information about glycemia and inflammation that is not necessary to directly support the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Answer: Interleukin (IL)-1β", "model_support": "Supporting sentence: This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.", "retries": 1}
{"idx": 87, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence mentions the NF1 gene in a context that aligns well with the question, despite being slightly different from the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis 1 gene (NF1 ) fulfills the criteria of a tumor suppressor gene and is deleted or mutated heterozygously in patients with NF1.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.  \nThe context explicitly states \"neurofibromatosis 1 gene (NF1)\" as the gene associated with the condition, directly answering the question.", "retries": 1}
{"idx": 88, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is slightly more detailed than the gold standard, mentioning both stroke and TIA, while the gold answer focuses only on 'stroke.' However, the inclusion of TIA is accurate based on the context and does not detract from the correctness. The supporting sentence is relevant but contains some redundancy by quoting the study's objective rather than focusing directly on the ROSIER scale’s use for stroke identification. Overall, it provides logical support but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.  \n\nThis sentence explicitly states the purpose of the study, which is to evaluate clinical scores (including the ROSIER scale) for the **identification of stroke and transient ischaemic attack (TIA)**.", "retries": 1}
{"idx": 89, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but not as concise as the gold standard. The supporting sentence is somewhat lengthy and focuses on study details rather than directly stating the key medication, naloxone. While it logically connects to the context of opioid overdose management, it includes unnecessary information and does not explicitly name naloxone, reducing clarity and conciseness.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone should be administered when managing patients with suspected acute opioid overdose.", "model_support": "Supporting sentence: A prospective, sequential, observational cohort study of 196 consecutive patients with suspected opioid overdose was conducted in an urban out-of-hospital setting, comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation. (n = 122), for respiratory depression of <10 breaths/min.  \n\n**Note:** While the sentence does not explicitly name \"naloxone,\" the context implicitly focuses on its use (e.g., \"naloxone given subcutaneously\" in the title and \"naloxone 0.8 mg s.q. and naloxone 0.4 mg i.v.\" in the conclusion). The study's purpose and methodology center on comparing routes of naloxone administration for opioid overdose, making it the key medication discussed.", "retries": 1}
{"idx": 90, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (Xist/XIST), and the supporting sentence provided in the gold answer is concise, directly relevant, and logically explains the role of XIST in X-chromosome inactivation. Although the model initially doubted the context's relevance, the gold supporting sentence clearly validates the answer.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "Answer: The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The context does not mention the transcript responsible for X-chromosome inactivation (Xist). The provided text discusses mechanisms of X-inactivation, the Xce locus, and the XIC (X-inactivation center), but it does not explicitly reference **Xist** or any specific transcript. \n\n**Supporting sentence:** None.  \nThe answer \"Xist\" is not supported by the given context.", "retries": 1}
{"idx": 91, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('SECIS element' is equivalent to 'SECIS'). The supporting sentence is relevant and supports the answer by mentioning the SECIS element in the context of the 3'UTR sequences. However, it includes additional details about alternative splicing, which are not directly necessary to answer the question, leading to slight redundancy.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "Cotranslational incorporation of Sec into SelS depends on the recoding of the UGA codon, which requires a Selenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: \"The human SelS gene encodes two transcripts (variants 1 and 2), which differ in their 3'UTR sequences due to an alternative splicing event that removes the SECIS element from the variant 1 transcript.\"  \n\nThis sentence explicitly identifies the **SECIS element** as a component of the 3'UTR sequences in the SelS gene, which is directly related to the question about the stem-loop structure in the 3' end of selenoprotein-encoding genes.", "retries": 1}
{"idx": 92, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; the first supporting sentence is concise and relevant but slightly less specific than the gold supporting sentence. The second supporting sentence adds redundancy by introducing another point ('suppression of estradiol'), which is not necessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways...\"  \nAnother supporting sentence: \"Orteronel can suppress serum estradiol concentrations... through selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 93, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and contains accurate information about alpha-synuclein immunoreactivity, but it is less comprehensive compared to the gold supporting sentence. It does not explicitly mention Lewy bodies or the broader context of their immunoreactivity in Parkinson's disease and related disorders. The logic is sound but slightly narrower in scope.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein.", "retries": 1}
{"idx": 94, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('BCR-ABL1' is a valid variant of 'BCR-ABL'). The supporting sentence is concise, directly relevant, and provides clear reasoning by linking imatinib to its well-known target, BCR-ABL. Although it acknowledges that the exact term isn't explicitly mentioned in the context, the logic strongly supports the answer based on established biomedical knowledge.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib mesylate is a tyrosine kinase inhibitor with high affinity for the BCR-ABL fusion protein expressed by the hematopoietic cells in chronic myelogenous leukemia (CML).", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The context does not explicitly mention \"BCR-ABL1,\" but the question's answer is inferred from the association between imatinib (Gleevec) and its well-established target, BCR-ABL1, which is a tyrosine kinase involved in Philadelphia-chromosome positive CML. While the context does not directly state this, the drug's mechanism in treating CML aligns with this target. \n\nHowever, if strict adherence to the context is required, there is **no explicit sentence** in the provided text that directly states \"BCR-ABL1\" as the target. The answer relies on external biomedical knowledge rather than the given context. \n\nIf the question requires a sentence from the context, the answer cannot be supported by the provided text.", "retries": 1}
{"idx": 95, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy and does not directly cite the evidence as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "celiac disease", "gold_support": "Retrospective chart review was performed to detect associated disease processes, such as celiac disease.", "model_answer": "Answer: Celiac disease", "model_support": "Supporting sentence: \"identifying a number of key features that may help the interpreting radiologist in suggesting the underlying histologic subtype and whether the presence of underlying celiac disease is likely.\"", "retries": 1}
{"idx": 96, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK gene' is equivalent to 'XK'). The supporting sentence provided by the model is relevant and accurate, drawing on external knowledge to explain the association of McLeod syndrome with the XK gene. However, it contains slight redundancy in mentioning that the context does not explicitly state this, which is unnecessary since the logic is already strong. The gold supporting sentence is more concise while still covering the answer directly from the context.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: The context does not explicitly mention the XK gene. However, based on external knowledge, McLeod syndrome is caused by mutations in the **XK gene**. The provided context focuses on the phenotypic variability and a specific deletion (938-942delCTCTA) but does not directly name the gene. \n\n**Note**: The answer \"XK gene\" is correct based on established medical literature, but the context provided does not include a sentence explicitly stating this.", "retries": 1}
{"idx": 97, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence mentions five N-terminal isoforms but fails to address the total number of TAp73 isoforms, which is the specific question. Furthermore, the reasoning provided in the evaluation incorrectly interprets the context given. The correct number of TAp73 isoforms according to the gold answer is 7, not one.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR. \n\nThis sentence explicitly lists \"TAp73\" as one of the five N-terminal isoforms, confirming that **one** TAp73 isoform has been identified.", "retries": 1}
{"idx": 98, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly covers the answer with logical reasoning by specifying that mutations in the ZFHX1B gene are associated with Mowat-Wilson syndrome.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 99, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX') in essence, as 'Na+/Ca2+ exchanger (NCX)' is a synonymous and more descriptive way of expressing the same concept. The supporting sentence provided by the model is relevant and directly references NCX1, which aligns with the gold supporting sentence. However, the model's supporting sentence does not explicitly mention that SEA0400 is a selective NCX inhibitor, which is a key detail present in the gold supporting sentence. This omission makes the model's supporting sentence slightly less comprehensive than the gold standard, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.  \n\n**Explanation**: The context establishes that NCX1 (Na+/Ca²⁺ exchanger) plays a critical role in retinal cell death mechanisms (e.g., NMDA injection and ischemia-reperfusion). While the text does not explicitly state that SEA0400 is an inhibitor of NCX1, the question's answer (\"Na+/Ca2+ exchanger (NCX)\") is directly inferred from the context's focus on NCX1's involvement in the pathophysiology and the experimental results showing that SEA0400 reduces retinal damage linked to NCX1-mediated processes. The first sentence explicitly identifies NCX1 as the ion exchanger in question, making it the supporting statement for the answer.", "retries": 1}
{"idx": 100, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning that covers the answer. Although the model supporting sentence includes additional details about other repair mechanisms, this does not detract from the clarity or accuracy of the response.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) acts solely on the transcribed strand of expressed genes, while global genomic repair (GGR) is responsible for the ubiquitous repair of the genome.", "model_answer": "Answer: Transcribed strand", "model_support": "Supporting sentence: The proposed subcategories of NER are as follows: (i) TCR, responsible for maintenance of transcribed strands; (ii) GGR, responsible for ubiquitous genome repair; and (iii) non-transcribed strand repair (NTSR), predominantly responsible for the repair of the NTS in arrested cells.", "retries": 1}
{"idx": 101, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is equivalent to '5-HT2A'). The supporting sentence is relevant and supports the answer by linking [18F]altanserin to its use in studying serotonin 5-HT2A receptors. However, the sentence includes some additional details about test-retest variability that are not directly necessary for supporting the specific answer, making it slightly verbose.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 102, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'Acute stroke', is very close to the gold standard 'stroke', with only a minor addition of the word 'acute', which does not detract from the core correctness. The supporting sentence is relevant and covers the answer adequately but includes slight redundancy in mentioning 'stroke mimics,' which isn't necessary for directly supporting the answer. Overall, it provides logical support but could be more concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 103, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard in essence, as 'Glucocerebrosidase gene (GBA)' refers to the same gene as 'glucocerebrosidase.' The supporting sentence is relevant and provides useful information about mutations in the glucocerebrosidase gene; however, it contains slight redundancy by emphasizing the phenotypic unpredictability rather than directly focusing on the gene mutation itself. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "glucocerebrosidase", "gold_support": "In Gaucher disease (GD), the inherited deficiency of glucocerebrosidase results in the accumulation of glucocerebroside within lysosomes.", "model_answer": "Answer: Glucocerebrosidase gene (GBA)", "model_support": "Supporting sentence: Although almost 300 mutations in the glucocerebrosidase gene (GBA) have been identified, the ability to predict phenotype from genotype is quite limited.", "retries": 1}
{"idx": 104, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence explains that no direct information was present in the context but acknowledges the correctness of the answer based on external knowledge, which aligns with the gold supporting sentence's content when combined with general medical facts.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation.", "model_answer": "Wilson's disease is inherited in an autosomal recessive manner.", "model_support": "The context does not explicitly mention the mode of inheritance of Wilson's disease. The sentence \"As WD is an inherited disease of the nervous system...\" only states that it is inherited but does not specify the inheritance pattern (e.g., autosomal recessive). Therefore, **no supporting sentence** in the provided context directly answers the question. \n\nHowever, the correct answer (autosomal recessive) is a well-established medical fact outside the scope of the given text.", "retries": 1}
{"idx": 105, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'elevated TSH levels,' is correct but too specific and does not fully match the gold answer 'thyroid,' which encompasses broader thyroid-related abnormalities. The supporting sentence mentions TSH elevation declining with age but fails to cover the full scope of thyroid involvement (e.g., hypoplasia) as described in the gold supporting sentence. While relevant, it does not adequately support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid involvement in Williams syndrome (WS) was recently reported in two small groups of patients, both showing an increased prevalence of elevation of TSH serum concentration; in one of the two reports, 70% of the patients demonstrated a hypoplasia of thyroid gland as well.", "model_answer": "Common hormone abnormalities in Williams syndrome include elevated TSH levels.", "model_support": "Supporting sentence: Moreover, we demonstrated that TSH elevation declines with age.", "retries": 1}
{"idx": 106, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'FSHD1' is correct and matches the gold standard 'FSHD,' as FSHD is commonly used as an abbreviation encompassing both FSHD1 and FSHD2. The supporting sentence is relevant and provides a direct link between DUX4 and FSHD1 by referencing the D4Z4 units, but it is slightly less specific than the gold supporting sentence in explaining the contraction of the repeat array, which directly causes the disease. Overall, the logic is sound, but the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array on chromosome 4 to a size of 1-10 units.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is FSHD1.", "model_support": "Supporting sentence: \"Each unit contains a copy of the DUX4 retrogene.\"  \nThis sentence directly links the DUX4 gene to the D4Z4 units, which are associated with FSHD1, establishing the connection between ectopic DUX4 expression and the disease.", "retries": 1}
{"idx": 107, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence mentions Xce haplotypes and methylation in a region near Xist, which is related but less direct compared to the gold supporting sentence that explicitly describes Xist as a candidate for Xic.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The recently characterized Xist sequence (X-inactive-specific transcript) is thought to be a possible candidate for Xic.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: Xce haplotypes show modified methylation in a region of the active X chromosome lying 3' to Xist.  \n\n**Reasoning**: The context explicitly mentions \"Xist\" in the context of X-chromosome inactivation, particularly in relation to methylation patterns and the inactivation process. While the text does not explicitly state \"Xist is the transcript responsible for X-chromosome inactivation,\" the mention of Xist in the vicinity of regions associated with inactivation (e.g., \"3' to Xist\") aligns with its established role as the non-coding RNA transcript critical for X-chromosome inactivation. The answer \"Xist\" is directly tied to the genetic mechanism described, making this sentence the supporting evidence.", "retries": 1}
{"idx": 108, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in substance, though not in exact formatting. The supporting sentence is relevant and provides context for betrixaban being a factor Xa inhibitor, but it contains slight redundancy by discussing broader classes of anticoagulants instead of directly referencing betrixaban as a 'direct factor Xa inhibitor.' This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.  \n\nThis sentence establishes that betrixaban, as a novel anticoagulant, belongs to the class of factor Xa inhibitors, which is explicitly mentioned in the context. While the text does not directly state \"betrixaban inhibits Factor Xa,\" it frames betrixaban within the broader category of \"novel anticoagulants\" that include factor Xa inhibitors, making this the foundational support for the answer.", "retries": 1}
{"idx": 109, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('small cell lung cancer'). The supporting sentence is concise and acknowledges that while the context does not explicitly state the association, the answer is correct based on external medical knowledge. It directly addresses the question and aligns logically with the gold supporting sentence, which mentions small-cell lung cancer in connection with Lambert-Eaton syndrome.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.", "model_answer": "Answer: Small cell lung cancer.", "model_support": "The context provided does not explicitly mention any specific type of lung cancer or its association with Lambert-Eaton syndrome (LEMS). While it is well-established in medical literature that **small cell lung cancer (SCLC)** is the most strongly associated with LEMS, the given text does not include this information. \n\n**Supporting sentence:** None.  \nThe context discusses paraneoplastic syndromes and LEMS but does not specify the type of lung cancer linked to LEMS. The answer \"small cell lung cancer\" relies on external medical knowledge, not the provided text.", "retries": 1}
{"idx": 110, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking 'X-linked dystonia-parkinsonism' with 'Lubag disease'.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-Linked Dystonia-Parkinsonism (XDP or \"Lubag\") is a progressive neurodegenerative disorder unique to the Island of Panay in the Philippines.", "model_answer": "The synonym of Lubag disease is X-linked dystonia-parkinsonism (XDP).", "model_support": "Supporting sentence: Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.", "retries": 1}
{"idx": 111, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying 'dermatitis herpetiformis' as the typical rash associated with gluten. The supporting sentence is concise and directly relevant, logically linking the rash to gluten ingestion by referencing the study on dermatitis herpetiformis. Although slightly less detailed than the gold supporting sentence, it still provides clear reasoning without unnecessary verbosity.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: \"Tolerance to oats in dermatitis herpetiformis.\"  \n\nThis sentence directly identifies **dermatitis herpetiformis** as the condition under study, which is the typical rash associated with gluten sensitivity (as mentioned in the context's objectives and conclusions). Additionally, the phrase \"gluten-sensitive small bowel mucosa\" in the conclusions further links the rash to gluten.", "retries": 1}
{"idx": 112, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by mentioning 'meta-analysis' which is not directly necessary to support the specific answer about the MR CLEAN study. The sentence could be more concise by focusing solely on acute ischemic stroke as investigated in the MR CLEAN study.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The treatment of acute ischemic stroke was investigated in the MR CLEAN study.", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.  \n\n**Note**: The context does not explicitly mention the \"MR CLEAN study,\" but it explicitly states that the meta-analysis investigated **acute ischemic stroke** (AIS) as the disease. The answer provided by the user aligns with the disease being studied in the context, even though the MR CLEAN study itself is not named. The supporting sentence directly references the disease (acute ischemic stroke) evaluated in the analysis.", "retries": 1}
{"idx": 113, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('Xa'), though it is slightly more verbose than necessary. The supporting sentence references the correct concept of 'factor Xa inhibitors' and their role as replacements for warfarin, which logically supports the answer. However, it includes some redundancy by mentioning two sentences instead of focusing on the most concise and relevant information directly tied to betrixaban as a factor Xa inhibitor. Overall, the logic is strong but could be more succinct.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.\"  \nAdditionally: \"Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin.\"  \n\n(Note: While the context does not explicitly mention \"betrixaban,\" the question's answer (\"Factor Xa\") is supported by the repeated emphasis on \"factor Xa inhibitors\" in the text, which aligns with the mechanism of action implied for betrixaban as a direct factor Xa inhibitor.)", "retries": 1}
{"idx": 114, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Parallel') does not match the gold standard ('antiparallel'), but the supporting sentence is relevant to the context of spectrin heterodimer formation. However, the supporting sentence does not logically support the incorrect answer and fails to directly address the orientation (parallel or antiparallel). The reasoning provided by the model misinterprets the evidence, as the mention of stoichiometric binding and high affinity does not inherently imply a parallel arrangement. Therefore, while the supporting sentence is somewhat relevant, it does not cover the gold answer, resulting in a score of 2.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Answer: Parallel", "model_support": "Supporting sentence: \"Both the alpha20-21/beta1-2 complex and the alpha20-21EF/betaABD1-2 complex showed stoichiometric binding with similar binding affinities (K(d) approximately 10 nM) using isothermal titration calorimetry.\"  \n\n**Analysis**: While the context does not explicitly state whether the heterodimers are parallel or antiparallel, the formation of \"stoichiometric binding\" (1:1 ratio) and \"high affinity heterodimers\" suggests a specific, stable interaction between alpha- and beta-spectrin subunits. This implies a directional (parallel) arrangement, as antiparallel configurations might not achieve the same stoichiometric and high-affinity binding without additional structural constraints. The absence of explicit mention of antiparallel orientation further supports the inference of parallel alignment.", "retries": 1}
{"idx": 115, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' differing only in specificity. The supporting sentence is relevant and covers the answer well, but it includes slightly more detail than necessary by specifying 'initial differentiation of acute stroke from stroke mimics,' which makes it somewhat redundant.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 116, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: \"A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase).\"  \n\nThis sentence directly indicates that APOBEC3B undergoes nuclear import, supporting the conclusion that it is predominantly nuclear.", "retries": 1}
{"idx": 117, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly linking pridopidine to Huntington disease. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or relevance.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 118, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it is slightly less detailed compared to the gold supporting sentence. It mentions 'BACH1 repressor turnover,' which aligns with the gold answer, but does not explicitly state that FBXL17 controls the transcription of the NRF2 target HMOX1 via this turnover, making it somewhat less comprehensive.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.", "retries": 1}
{"idx": 119, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant as it discusses the two main isoform types (TA and deltaN), but it does not cover the gold answer of '7' and lacks sufficient information about the total number of identified TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two.", "model_support": "Supporting sentence: Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms.", "retries": 1}
{"idx": 120, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('IXa and Xa') does not match the gold standard ('Xa'), as it incorrectly includes 'IXa,' which is not mentioned in the context. The supporting sentence explains that the context lacks specific information about betrixaban, but it fails to directly support the gold answer by pointing out that betrixaban is explicitly listed as a factor Xa inhibitor in the gold supporting sentence. While the model correctly identifies that betrixaban is not discussed in detail, its answer introduces incorrect content ('IXa'), leading to a lower score.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: IXa and Xa.", "model_support": "The context provided does not mention \"betrixaban\" or any specific inhibition of clotting factors by this drug. The only anticoagulant explicitly discussed is **dabigatran**, which is described as a \"direct thrombin antagonist\" (targeting factor IIa). There is no reference to betrixaban or its mechanism of action in the given text. \n\n**Supporting sentence:** None. The context does not contain information about betrixaban or its target clotting factors. \n\n**Note:** The answer \"IXa and Xa\" refers to factor Xa inhibitors (e.g., rivaroxaban, apixaban), but betrixaban is not discussed in the provided context. This suggests a potential discrepancy between the question and the given text.", "retries": 1}
{"idx": 121, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, referencing the treatment of Huntington disease with pridopidine.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 122, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but focuses more on the Set1 complex rather than MLL1 specifically. While it logically supports the answer by confirming H3K4 as the residue methylated, it introduces additional details about Set1's prominence, which slightly detracts from direct relevance to MLL1.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "In yeast, the macromolecular complex Set1/COMPASS is capable of methylating H3K4, a posttranslational modification associated with actively transcribed genes.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: \"the human Set1 complex plays a more widespread role in H3K4 trimethylation than do the MLL complexes in mammalian cells.\"  \n\nThis sentence explicitly states that H3K4 trimethylation is the target of both Set1 and MLL complexes, with Set1 being more prominent. While MLL complexes are mentioned as less robust, the residue methylated by MLL1 (and other MLL complexes) is clearly identified as H3K4 in the context.", "retries": 1}
{"idx": 123, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Insulin receptor function is altered') does not directly match the gold answer ('insulin'), although it is related to the context of Donohue syndrome. The supporting sentence discusses mutations in the insulin receptor gene but focuses on Rabson-Mendenhall syndrome rather than Donohue syndrome, making it less relevant to the specific question and gold answer. While there is some connection between insulin receptor mutations and the condition, the supporting sentence does not directly cover the gold answer regarding insulin binding impairment.\", \"match\": false}", "gold_answer": "insulin", "gold_support": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.", "model_answer": "Answer: Insulin receptor function is altered in patients with Donohue syndrome.", "model_support": "Supporting sentence: Two novel mutations in the insulin binding subunit of the insulin receptor gene without insulin binding impairment in a patient with Rabson-Mendenhall syndrome.  \n\nThis sentence directly identifies the insulin receptor gene as the site of mutations, establishing that insulin receptor function is altered in the context of the described syndrome. While the patient presented with Donohue syndrome-like features, the mutations in the insulin receptor gene (and the subsequent functional abnormalities in subunit distribution) underlie the altered receptor function.", "retries": 1}
{"idx": 124, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard. However, the supporting sentence provided by the model is incorrect because it states that the context does not explicitly support the claim, whereas the gold supporting sentence directly provides relevant information from the context that supports the answer. The correct supporting sentence should have been derived from the context as shown in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "Supporting sentence: The context does not explicitly state that medulloblastoma is the most common type of pediatric cerebellar tumor. The provided text focuses on medulloblastoma metastasis to the marrow and its clinical features but does not directly address the prevalence of pediatric cerebellar tumors. \n\nHowever, if the answer is assumed based on general medical knowledge (not explicitly stated in the context), there is no supporting sentence within the given text to confirm this claim.", "retries": 1}
{"idx": 125, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'GBA gene,' does not match the gold standard 'glucocerebrosidase,' although it is factually correct based on external knowledge. The supporting sentence is relevant but too verbose and does not directly cover the gold answer. It discusses the N370S mutation and indirectly implies the GBA gene without explicitly linking it to 'glucocerebrosidase,' which reduces its relevance to the gold answer.\",\n  \"match\": false\n}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population.", "model_answer": "Answer: The gene mutated in Gaucher disease is the GBA gene.", "model_support": "Supporting sentence: The context does not explicitly mention the GBA gene. However, the N370S mutation is a well-known mutation in the GBA gene, which is the gene associated with Gaucher disease. The sentence \"the frequency of this mutation was accurately determined in the Portuguese population\" refers to the N370S mutation, which is linked to the GBA gene. While the context does not directly state the gene name, the mutation's association with Gaucher disease implies the GBA gene. \n\n**Note:** The answer \"GBA gene\" is correct based on external knowledge, but the context provided does not explicitly name the gene. The supporting sentence would require the gene name to be directly stated.", "retries": 1}
{"idx": 126, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning 'active gene,' which is not strictly necessary for the logic. The gold supporting sentence is more concise while still providing clear reasoning.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of an active gene.", "model_support": "Supporting sentence: Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.", "retries": 1}
{"idx": 127, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'CGRP receptor,' does not fully match the gold standard, 'calcitonin gene-related peptide,' though it is closely related and present in the context. The supporting sentence acknowledges that the context does not explicitly mention the receptor, which is accurate. However, the gold supporting sentence directly provides the needed information about telcagepant being a CGRP receptor antagonist, which the model fails to utilize. The model's supporting sentence does not cover the gold answer adequately.\", \"match\": false}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant (MK-0974) is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.", "model_answer": "Answer: CGRP receptor", "model_support": "The context does not explicitly mention the CGRP receptor or any specific receptor targeted by telcagepant. The provided text focuses on the development of an analytical method for quantifying telcagepant in plasma and its efficacy in clinical trials for migraine treatment, but it does not state the receptor mechanism of action. \n\n**Supporting sentence:** None explicitly stated in the context.  \n**Note:** The answer \"CGRP receptor\" is likely based on external knowledge (e.g., telcagepant is a CGRP receptor antagonist), but the context provided does not include this information.", "retries": 1}
{"idx": 128, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'AIP gene' matches the gold standard 'Aryl hydrocarbon receptor interacting protein' in essence, as AIP is the accepted abbreviation for the gene. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by discussing phenotypic diversity when a more concise statement could suffice. Overall, the logic is strong, but minor verbosity reduces the score.\", \"match\": true}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 129, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, DNMT3B, does not match the gold standard, DNMT1. However, DNMT3B is mentioned in the context and is relevant to DNA methylation. The supporting sentence is related to DNMT3B and its role in modulating DNA methylation but does not directly support the gold answer, DNMT1. Therefore, while the answer is incorrect, it is present in the context, and the supporting sentence is relevant but does not cover the gold answer.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "DNA methylation patterns are established and maintained by three DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B.", "model_answer": "Answer: DNMT3B", "model_support": "Supporting sentence: A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding.", "retries": 1}
{"idx": 130, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ZEB2 gene,' does not match the gold standard 'ZFHX1B.' However, ZEB2 is a correct synonym for ZFHX1B, so the answer is scientifically valid but not consistent with the context provided. The supporting sentence acknowledges that the context does not explicitly mention ZEB2 or ZFHX1B, making it relevant but unable to directly support the gold answer. Thus, while the answer is present in broader scientific knowledge, it fails to align with the specific details of the context.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "Genitourinary anomalies in Mowat-Wilson syndrome with deletion/mutation in the zinc finger homeo box 1B gene (ZFHX1B).", "model_answer": "Answer: ZEB2 gene", "model_support": "The context does not explicitly mention the gene responsible for Mowat-Wilson syndrome (MWS). While the answer \"ZEB2 gene\" is scientifically accurate (as MWS is caused by mutations in ZEB2), the provided context does not include this information. The supporting sentence for the answer would need to reference ZEB2, but such a sentence is absent in the given text. \n\n**Answer:** The context does not provide a sentence identifying the gene responsible for Mowat-Wilson syndrome.", "retries": 1}
{"idx": 131, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context about RET-positive cases being linked to MEN2, which aligns with the gold answer. However, it includes additional information about stage IVc MTCs that is not directly necessary to support the answer, making it slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "RESULTS: We identified RET mutations in seven of 13 MTCs: five RET-positive cases revealed a mutation in exon 16 (M918T) and two a mutation in exon 10 (C618S and C620S).", "model_answer": "Answer: RET", "model_support": "Supporting sentence: These cases reflect the known MEN2 genotype-phenotype correlation. Three of the five stage IVc MTCs were inherited RET-positive cases.", "retries": 1}
{"idx": 132, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as 'thyroid' encompasses the abnormalities mentioned (subclinical and overt hypothyroidism). However, the supporting sentence, while relevant, is somewhat detailed and specific about percentages, which isn't necessary to support the general concept of thyroid abnormalities. It could be more concise to directly align with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Answer: Thyroid function abnormalities, including subclinical and overt hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).", "retries": 1}
{"idx": 133, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod syndrome resulting from a novel XK mutation.", "retries": 1}
{"idx": 134, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'AIP gene' matches the gold standard 'aryl hydrocarbon receptor interacting protein' since AIP is the accepted abbreviation for the gene. The supporting sentence is relevant and covers the answer, but it is slightly less comprehensive than the gold supporting sentence. It mentions the R304* AIP mutation specifically, which is a narrower example compared to the broader context provided in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: We describe our experience with a large family with R304* AIP mutation.", "retries": 1}
{"idx": 135, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that mutations in the RET gene are responsible for MEN2, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "Multiple endocrine neoplasia type 2 (MEN2) is an inherited, autosomal-dominant disorder caused by deleterious mutations within the RET protooncogene.", "model_answer": "Answer: RET", "model_support": "Supporting sentence: \"MEN2 RET mutations are mainly heterozygous, missense sequence changes found in RET exons 10, 11, and 13-16.\"  \n\nThis sentence explicitly states that the **RET** gene is the target of mutations in MEN2, directly answering the question.", "retries": 1}
{"idx": 136, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Repressor') matches the gold standard ('repressor'), but the supporting sentence is incorrect. The model claims there is no supporting sentence in the context, whereas the context explicitly mentions that Bach1 is a 'transcriptional repressor.' The supporting sentence should have referenced this fact directly. As a result, the logic and relevance are lacking.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1, a transcriptional repressor that is negatively regulated by heme in mammalian cells;", "model_answer": "Answer: Repressor", "model_support": "The context does not mention BACH1 or its function as an activator or repressor. Therefore, there is no supporting sentence in the provided text to answer the question about BACH1. \n\n**Answer:** The context does not include information about BACH1.", "retries": 1}
{"idx": 137, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and provides accurate information about p53, but it does not explicitly mention the phrase 'guardian of the genome,' which would have made it more directly aligned with the question. The sentence is slightly less concise than the gold supporting sentence but still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Note**: While the context does not explicitly mention \"the guardian of the genome,\" the question assumes prior knowledge that p53 is widely recognized as \"the guardian of the genome.\" The supporting sentence directly identifies the tumor suppressor in question (p53) as the subject of the study.", "retries": 1}
{"idx": 138, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect as it describes the effect of Bach1 ablation rather than explicitly stating that Bach1 represses HO-1. The supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.", "retries": 1}
{"idx": 139, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing 'antiparallel spectrin heterodimers,' which aligns with the gold answer.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: \"Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.\"", "retries": 1}
{"idx": 140, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides logical support for the answer by connecting betrixaban to its anti-Xa activity through the mention of PRT4445. However, the supporting sentence contains slight redundancy and verbosity, as the key information about betrixaban being a direct factor Xa inhibitor could have been more directly extracted from the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban is an anticoagulant with anti-Xa activity (i.e., inhibits Factor Xa), as PRT4445 is described as a \"factor Xa decoy\" designed to reverse anticoagulants targeting Factor Xa. While the text does not explicitly state that betrixaban inhibits Factor Xa, the context frames betrixaban as part of the \"novel anticoagulants\" alongside factor Xa inhibitors, and the mention of PRT4445's purpose aligns with Factor Xa as the target.", "retries": 1}
{"idx": 141, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('FSHD'). The supporting sentence is relevant and aligns with the context of FSHD and DUX4, but it does not directly reference the aberrant expression of DUX4 as the cause of FSHD. Instead, it discusses a potential application to suppress DUX4, making it slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Aberrant expression of DUX4 from the last unit of the D4Z4 array has been proposed to be the cause of FSHD.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: The findings of this study suggest that the same principle may be applied to suppress the aberrantly expressed DUX4 in FSHD.", "retries": 1}
{"idx": 142, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'CGRP receptor' is essentially correct and aligns with the gold standard 'Calcitonin gene-related peptide,' as both refer to the same receptor targeted by telcagepant. However, the supporting sentence provided by the model incorrectly states that the context does not mention the receptor, when in fact the background explicitly mentions 'Calcitonin gene-related peptide receptor antagonists.' The correct supporting sentence from the context directly supports the gold answer. Thus, while the answer matches the gold standard, the supporting sentence contains a minor inaccuracy regarding the availability of relevant information in the context.\", \"match\": true}", "gold_answer": "Calcitonin gene-related peptide", "gold_support": "BACKGROUND: Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a population for whom triptans are contraindicated.", "model_answer": "Answer: CGRP receptor", "model_support": "The context provided does not explicitly mention the CGRP receptor or any specific receptor targeted by telcagepant. The study focuses on the drug's efficacy and tolerability in treating migraines among patients with coronary artery disease, but it does not reference the mechanism of action or receptors involved. \n\n**Supporting sentence:** None present in the context.  \n\nThe answer \"CGRP receptor\" appears to be based on external knowledge about telcagepant (a CGRP receptor antagonist), but this information is not included in the provided text.", "retries": 1}
{"idx": 143, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('lumbosacral') conceptually, though it is slightly more verbose by specifying 'Lumbosacral vertebral region' instead of just 'lumbosacral.' The supporting sentence is relevant and captures the correct context of the lumbosacral region but contains redundancy by quoting the title rather than focusing on the specific description of the congenital abnormality in the lumbosacral vertebrae. It could be more concise.\",\n  \"match\": true\n}", "gold_answer": "lumbosacral", "gold_support": "Bertolotti's syndrome is a spine disorder characterized by the occurrence of a congenital lumbar transverse mega-apophysis in a transitional vertebral body that usually articulates with the sacrum or the iliac bone.", "model_answer": "Answer: Lumbosacral vertebral region", "model_support": "Supporting sentence: Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolatti's syndrome.  \n\nThis sentence explicitly identifies the **lumbosacral vertebral region** as the anatomical area associated with Bertolotti's syndrome, which is central to the diagnostic and therapeutic focus of the study.", "retries": 1}
{"idx": 144, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('ultrasound') but is present in the context as a vague reference to technological developments. The supporting sentence is relevant but does not cover the gold answer, as it discusses new technological developments without specifically mentioning ultrasound, which is key to the gold answer.\", \"match\": false}", "gold_answer": "ultrasound", "gold_support": "PURPOSE OF REVIEW: This manuscript reviews the information that became available over the last 12 months on the measurement of bladder/detrusor wall thickness and ultrasound-estimated bladder weight in patients with benign prostatic enlargement.", "model_answer": "Bladder wall thickness is measured using technological developments that allow for accurate and repeatable measurements, though the specific method is not detailed in the context.", "model_support": "Supporting sentence: \"Preliminary results from new technological developments suggest a very accurate measure of bladder volume and good repeatability of bladder wall and bladder weight measurements.\" \n\nThis sentence directly supports the answer by stating that bladder wall thickness is measured using \"new technological developments\" that enable accurate and repeatable measurements, while not specifying the exact method.", "retries": 1}
{"idx": 145, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by emphasizing co-localization rather than directly stating the association between FANCA and BRG1 as a component of the SWI/SNF complex.\",\n  \"match\": true\n}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: Finally, we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.", "retries": 1}
{"idx": 146, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the kallikrein family but does not explicitly mention the number '15'. The provided sentence focuses on KLK3 and its role as a biomarker, which is somewhat indirect but still relates to the kallikrein family. Slight redundancy exists in discussing prostate-specific antigen without directly supporting the count of genes.\", \"match\": true}", "gold_answer": "15", "gold_support": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions.", "model_answer": "Answer: 15", "model_support": "Supporting sentence: The kallikrein family is also emerging as a rich source of disease biomarkers with KLK3, commonly known as prostate-specific antigen, being the current serum biomarker for prostate cancer.  \n\n**Note:** The context does not explicitly state the number of tissue kallikrein genes (e.g., \"15\") in the human genome. The answer \"15\" may rely on external knowledge or an implicit assumption, but the provided text does not directly support this number. The sentence above mentions KLK3 as part of the kallikrein family, but no specific count of genes is given.", "retries": 1}
{"idx": 147, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively highlights the key information from the context that mepolizumab targets interleukin-5.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a monoclonal antibody to interleukin-5, which reduces peripheral blood eosinophils.", "model_answer": "Answer: Interleukin-5", "model_support": "Supporting sentence: No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.  \nExplanation: The phrase \"anti-interleukin-5 therapy (mepolizumab)\" explicitly states that mepolizumab is a monoclonal antibody targeting interleukin-5.", "retries": 1}
{"idx": 148, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer '1,4-benzothiazepine' does not match the gold standard 'benzothiazepine' exactly, but it is present in the context. The supporting sentence is relevant to JTV519 but does not cover the gold answer directly, as it discusses clinical effects rather than the chemical classification. The logic connecting the supporting sentence to the gold answer is weak.\", \"match\": false}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In conclusion, JTV519 is a novel pharmacological agent that has been demonstrated for the first time to have clinical potential for the treatment of acute coronary syndrome by its efficacy in administration at the time of reperfusion, by its suppression of reperfusion-related intracellular Ca²⁺ overload with no significant interaction with I(Ca), and by its subsequent ability of strong myocardial protection.\n\n**Note:** The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. The answer \"1,4-benzothiazepine\" appears to be based on prior knowledge or a different context (e.g., the earlier example in the user's message). In the given text, the chemical classification of JTV519 is not mentioned.", "retries": 1}
{"idx": 149, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Keratin intermediate filaments' is very close to the gold standard 'intermediate filaments,' with only a slight addition of 'keratin,' which does not detract from its correctness. The supporting sentence is relevant and supports the answer well, but it introduces context about cancer progression that is not directly necessary for answering the question, making it slightly redundant. Overall, the logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "intermediate filaments", "gold_support": "Keratins form the intermediate filaments of the cytoskeleton and provide scaffold structures within cells.", "model_answer": "Answer: Keratin intermediate filaments.", "model_support": "Supporting sentence: \"Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.\"  \n\nThis sentence directly identifies \"keratin intermediate filaments\" as the structures formed by keratin molecules, aligning with the answer.", "retries": 1}
{"idx": 150, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'BCR-ABL1', is very close to the gold standard 'BCR-ABL' and can be considered correct given the context. However, the supporting sentence provided by the model is lengthy and includes irrelevant historical details about arsenic therapy and general discoveries in CML, rather than focusing directly on the (9;22) translocation or the BCR-ABL transcript as the target of imatinib. The logic connecting the Philadelphia chromosome to the answer is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "There followed definition of the breakpoint cluster region on chromosome 22 in 1984 and the demonstration of the BCR-ABL transcript in CML in 1985.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The only well-documented therapy in the 19th century was use of arsenic in one or other form, which did undoubtedly reduce the leukocyte count but probably did little or nothing to prolong life. These early cases were probably examples of chronic myeloid leukemia (CML) (then called chronic granulocytic leukemia). In the 20th century important steps in unraveling the pathogenesis of CML were the discovery of the Philadelphia chromosome in 1960, and of the (9;22) translocation in 1973.  \n\n**Note**: While the context does not explicitly mention *BCR-ABL1*, the Philadelphia chromosome (resulting from the (9;22) translocation) is the genetic hallmark of CML and the target of imatinib. The sentence about the Philadelphia chromosome and (9;22) translocation indirectly supports the answer, as *BCR-ABL1* arises from this translocation. However, the exact term \"BCR-ABL1\" is not present in the provided context.", "retries": 1}
{"idx": 151, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX'), and the supporting sentence is relevant, providing a logical explanation for how SEA0400 acts as an inhibitor of the Na(+)/Ca(2+) exchanger. However, the supporting sentence chosen by the model is slightly verbose and includes additional details (e.g., about ERK, p38 MAPK phosphorylation, and ROS) that are not strictly necessary to justify the answer. The gold supporting sentence is more concise while still being fully relevant and sufficient.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: SNP increased Ca(2+) influx and intracellular Ca(2+) levels. In addition, SNP increased ERK and p38 MAPK phosphorylation, and production of reactive oxygen species (ROS) in an extracellular Ca(2+)-dependent manner. These effects of SNP were prevented by SEA0400. \n\nThis sentence indicates that SEA0400 blocked SNP-induced Ca(2+) influx, which is mediated by the Na(+)/Ca(2+) exchanger (NCX) as established earlier in the context. The prevention of Ca(2+) influx by SEA0400 directly implicates it as an inhibitor of NCX.", "retries": 1}
{"idx": 152, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about autosomal sequences and inefficiency, which are not necessary to directly support the answer. The logic is sound, but slightly more concise reasoning could have been used.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X inactivation in female mammals involves transcriptional silencing of an entire chromosome in response to a cis-acting noncoding RNA, the X inactive-specific transcript (Xist).", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: Xist can also inactivate autosomal sequences, for example, in X;autosome translocations; but here, silencing appears to be relatively inefficient.", "retries": 1}
{"idx": 153, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence explains p53's role in DNA damage and related functions, which indirectly supports why it is called 'the guardian of the genome.' However, it does not explicitly include the phrase or the direct reasoning provided in the gold supporting sentence, making it slightly less concise and specific.\", \"match\": true}", "gold_answer": "p53", "gold_support": "For this reason it is called 'the guardian of the genome' and is considered one of the most important players in the development of cancer.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The classical functions of p53 protein are those related to its role on DNA damage, cell growth arrest, senescence and apoptosis.  \n\n**Explanation**: While the exact phrase \"guardian of the genome\" is not explicitly stated in the context, the reference to p53's classical functions \"related to its role on DNA damage\" directly aligns with its well-established designation as \"the guardian of the genome\" due to its critical role in maintaining genomic integrity. The sentence underscores p53's foundational role in DNA protection, which justifies the answer.", "retries": 1}
{"idx": 154, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant and includes an explanation about external knowledge rather than directly quoting or summarizing the relevant sentence from the context. While it acknowledges the correct reasoning, it could be more concise by focusing solely on the information provided in the text, such as the specific mention of tofacitinib in relation to JAK inhibitors.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "In patients treated with the JAK inhibitor tofacitinib, RR for hypercholesterolaemia was 1.70 (1.10 to 2.63) that was dose related.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: The context does not explicitly mention Tofacitinib or any specific JAK inhibitor. However, the answer \"Tofacitinib\" is a well-established JAK inhibitor approved for rheumatoid arthritis, and the context refers to \"Janus kinase (JAK)\" as one of the families of protein kinase inhibitors (PKi) studied. While the text does not name specific JAK inhibitors, the question's answer is inferred from external knowledge, not directly stated in the provided context. \n\n**Note**: The provided context does not include a sentence explicitly naming Tofacitinib as the JAK inhibitor approved for RA. The answer relies on prior medical knowledge rather than the given text.", "retries": 1}
{"idx": 155, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.", "retries": 1}
{"idx": 156, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is effectively equivalent to '5-HT2A'). The supporting sentence provided by the model is concise, directly relevant, and logically explains that [18F]altanserin is used for PET studies specifically targeting 5-HT2A receptors. This aligns well with the gold supporting sentence without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "The regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: 5-HT2A receptors.", "model_support": "Supporting sentence: \"the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 157, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer '5-HT2aR' is very close to the gold standard '5-HT2a,' with only a minor difference in formatting (including 'R' for receptor). The supporting sentence is relevant and directly ties the use of [18F]altanserin to its interaction with 5-HT2aR, which aligns well with the gold answer. However, the supporting sentence contains slight redundancy by elaborating on the experimental findings rather than focusing solely on the direct relationship between [18F]altanserin and 5-HT2a receptors. Overall, it provides strong logical support but could be more concise.\", \"match\": true}", "gold_answer": "5-HT2a", "gold_support": "Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.", "model_answer": "Answer: 5-HT2aR", "model_support": "Supporting sentence: A higher BP(nd) for [(18)F]altanserin during WM versus control was found in the orbitofrontal cortex (OFC) pointing towards an increased [(18)F]altanserin/5-HT2aR interaction in OFC.", "retries": 1}
{"idx": 158, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the context does not explicitly state approval for rheumatoid arthritis, the model correctly infers 'Tofacitinib' as the specific JAK inhibitor discussed.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "OBJECTIVE: Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.  \n\n**Note**: While the context does not explicitly state that tofacitinib is approved for rheumatoid arthritis, it identifies tofacitinib as a JAK inhibitor and describes its mechanism of action. The answer \"Tofacitinib\" is inferred from the context as the specific JAK inhibitor discussed, even though the approval for rheumatoid arthritis is not directly mentioned.", "retries": 1}
{"idx": 159, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning TCR and its role in repairing transcribed strands, but it introduces additional details about Cockayne syndrome gene products that are not necessary for directly supporting the answer, making it slightly verbose.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: Transcribed strand", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 160, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by identifying 'molecular target of rapamycin' as part of the pathway name, which directly links to mTOR.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "PURPOSE: The phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR) pathway is involved in the development of tumor resistance to endocrine therapy in breast cancer cell lines and represents an attractive target for pharmacologic intervention.", "model_answer": "Answer: mTOR", "model_support": "Supporting sentence: Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.  \n\nThis sentence explicitly identifies \"molecular target of rapamycin\" as part of the pathway name, directly linking Rapamycin to mTOR (the molecular target).", "retries": 1}
{"idx": 161, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly mention ZEB2, this is accurate since the supporting sentence was missing from the initial model output. The gold supporting sentence provided directly and concisely supports the answer with clear relevance. Minor acknowledgment of external knowledge doesn't detract from the strong logical basis.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported.", "model_answer": "Answer: The gene responsible for the development of Mowat-Wilson syndrome is ZEB2.", "model_support": "The context provided does not explicitly mention the gene responsible for Mowat-Wilson syndrome (ZEB2). The text focuses on the clinical features, diagnostic approach, and importance of standard autopsy in syndromic cases but does not reference the genetic basis of the condition. \n\n**Supporting sentence:** None. The context does not include information about the ZEB2 gene. \n\n**Note:** While the answer \"ZEB2\" is biologically accurate (as Mowat-Wilson syndrome is caused by mutations in ZEB2), the provided context does not contain a sentence supporting this claim. The question may require external knowledge rather than direct extraction from the given text.", "retries": 1}
{"idx": 162, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is close to the gold standard but specifies 'congenital hypothyroidism' rather than just 'thyroid,' which makes it slightly more detailed than necessary. The supporting sentence is relevant and provides a direct link between Williams syndrome and congenital hypothyroidism, though it contains minor redundancy by specifying 'important thyroid hypoplasia.' Overall, the logic is strong, but the answer could be more concise to exactly match the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Common hormone abnormalities in Williams syndrome include congenital hypothyroidism.", "model_support": "Supporting sentence: \"We describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"  \n\nThis sentence directly links Williams syndrome (WBS) with congenital hypothyroidism as a reported abnormality in the context.", "retries": 1}
{"idx": 163, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While it correctly identifies that Pendred syndrome involves a defect in iodide transport via the pendrin protein, it fails to directly mention 'thyroid' as the characteristic hormone-related abnormality, which is central to the gold answer. The supporting sentence provides relevant context about pendrin's role in iodide transport but does not cover the gold answer or align with the gold supporting sentence, which emphasizes thyroid goiter as a key feature of Pendred syndrome.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by congenital deafness and thyroid goiter.", "model_answer": "Answer: Pendred syndrome is not directly characterized by hormone abnormalities, but it involves a defect in the pendrin protein, which affects iodide transport in the thyroid.", "model_support": "Supporting sentence: Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells.  \n\nThis sentence directly links Pendred syndrome to a defect in the pendrin protein (encoded by the PDS gene) rather than hormone abnormalities, as it emphasizes pendrin's role in iodide transport and its regulation by thyroglobulin.", "retries": 1}
{"idx": 164, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and identifies Xist as the transcript responsible for X-chromosome inactivation, but it contains slight redundancy by referencing marsupials, which is not directly required to explain the role of Xist in eutherian mammals. Nevertheless, the logic connecting Xist to its function is clear.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "In eutherian mammals X inactivation is regulated by the X-inactive specific transcript (Xist), a cis-acting non-coding RNA that triggers silencing of the chromosome from which it is transcribed.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"Genes flanking Xist in mouse and human are separated on the X chromosome in American marsupials.\"  \n\nThis sentence directly identifies **Xist** as the transcript of interest in the context of X-chromosome inactivation, as it references Xist in the genomic region associated with X inactivation mechanisms. Additionally, the phrase \"flank the Xist locus\" further emphasizes Xist's role in this process.", "retries": 1}
{"idx": 165, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'One' does not match the gold standard '7', but the context implies multiple TAp73 isoforms, making the model's answer incorrect. The supporting sentence is relevant as it discusses TAp73 isoforms, but it fails to specify the number of isoforms and does not fully support the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.  \n\n**Note**: The context mentions \"TAp73 isoforms\" (plural), which would imply multiple isoforms, but the provided answer states \"One.\" This creates a discrepancy. The sentence above is the only one referencing TAp73, but it does not explicitly specify the number of isoforms. The answer may be incorrect based on the context.", "retries": 1}
{"idx": 166, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer matches gold standard but is present in context; supporting sentence is relevant but does not cover gold answer. The supporting sentence discusses diltiazem, a 1,5-benzothiazepine derivative, which does not directly support the model's answer regarding JTV519 being a 1,4-benzothiazepine derivative.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note:** While the context explicitly refers to diltiazem as a \"1,5-benzothiazepine derivative,\" it does not directly state that JTV519 is a \"1,4-benzothiazepine derivative.\" However, based on the answer provided, the intended supporting sentence likely appears in a different version of the context (e.g., a prior example or a corrected version). In the given text, the connection between JTV519 and 1,4-benzothiazepine is not explicitly stated.", "retries": 1}
{"idx": 167, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information about Xist being regulated during X inactivation, but it contains slight redundancy by mentioning the goal of understanding its regulation rather than directly stating its role as a regulator. Despite this, the logic is clear and it supports the answer well.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The X-inactive-specific transcript (Xist) locus is a cis-acting switch that regulates X chromosome inactivation in mammals.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"Over recent years an important goal has been to understand how Xist is regulated at the initiation of X inactivation.\"  \n\nThis sentence directly identifies *Xist* as the transcript central to X-chromosome inactivation, as it specifies that Xist is the focus of regulation during the initiation of X inactivation. Additionally, the conclusion reinforces this by stating that \"X chromosome choice is determined by the balance of Xist sense and antisense transcription,\" explicitly linking *Xist* to the process.", "retries": 1}
{"idx": 168, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer 'XK gene' is very close to the gold standard 'XK' and can be considered correct. However, the supporting sentence selected by the model does not explicitly mention the XK gene, instead referencing a more general association with the X chromosome. While this provides some relevant context, it lacks the precision of the gold supporting sentence, which directly names the XK gene. The supporting sentence mixes relevant (linked to X chromosome) and less relevant content (does not name the gene), making it somewhat less concise and logically weaker compared to the gold standard.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod Syndrome, one of the core neuroacanthocytosis syndromes, is a rare X-linked disorder caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities and late-onset neurological and muscular defects.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: The context does not explicitly mention the XK gene. However, the sentence \"linked to X chromosome\" is the closest reference to the genetic basis of McLeod syndrome. While the answer \"XK gene\" is correct in medical knowledge, the provided context does not directly state this. \n\nIf forced to select based on the given text, the supporting sentence would be:  \n\"McLeod syndrome: Multisystem involvement associated with neuroacanthocytosis linked to X chromosome.\"  \n\nThis implies a genetic link to the X chromosome, though it does not name the XK gene. The absence of the gene name in the context makes this answer partially supported.", "retries": 1}
{"idx": 169, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to extract the implicit conclusion that no clinical trials for off-label drugs in neonates were cited. Instead, the model focuses on the absence of explicit mention, which leads to a mismatch.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The literature does not cite the number of clinical trials for off-label drugs in neonates.", "model_support": "Supporting sentence: The literature does not cite the number of clinical trials for off-label drugs in neonates.  \n**Note**: The context does not explicitly mention clinical trials for off-label drugs in neonates. The answer reflects that the provided text does not contain this specific information, and the conclusion about the \"small number of submissions\" relates to Paediatric Investigation Plans (PIPs) for pain drugs, not neonatal off-label trials. The supporting sentence here is the answer itself, as the context does not provide any data on this exact topic.", "retries": 1}
{"idx": 170, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about stroke recognition tools, including ROSIER, but it contains slight redundancy by introducing additional background details rather than directly focusing on the specific use of ROSIER as a stroke recognition tool. Despite this, the logic connecting ROSIER to stroke recognition is clear.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: BACKGROUND: Stroke recognition tools have been shown to improve diagnostic accuracy in adults. Development of a similar tool in children is needed to reduce lag time to diagnosis. A critical first step is to determine whether adult stoke scales can be applied in childhood stroke.  \n\nThis sentence establishes that ROSIER (and FAST) are adult stroke recognition tools, implying their use for stroke diagnosis. The context explicitly frames ROSIER as part of \"adult stroke scales\" evaluated for applicability in childhood stroke, directly linking it to stroke recognition.", "retries": 1}
{"idx": 171, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer 'GBA' is correct in real-world knowledge but does not match the gold standard 'Glucocerebrosidase.' The supporting sentence acknowledges that the specific gene is not explicitly mentioned in the context provided, which is accurate. However, the supporting sentence does not directly cover the gold answer, as it fails to reference the Glucocerebrosidase gene from the context, leading to a lower score.\", \"match\": false}", "gold_answer": "Glucocerebrosidase", "gold_support": "SHORT INTRODUCTION: Gaucher's disease (GD) is an autosomal recessive disease produced by mutations of the Glucocerebrosidase gene.", "model_answer": "The gene mutated in Gaucher disease is the GBA gene.", "model_support": "The context does not explicitly mention the specific gene mutated in Gaucher's disease. While the answer \"GBA\" is correct in real-world knowledge, the provided text does not include a supporting sentence identifying the gene. \n\n**Supporting sentence:** None explicitly stated in the context.", "retries": 1}
{"idx": 172, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides logical reasoning by referencing the role of Dnmt1 in maintenance methylation, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "The DNA methyltransferase Dnmt1 is responsible for the propagation of methylation patterns to the next generation via its preferential methylation of hemimethylated CpG sites in the genome; however, how Dnmt1 maintains methylation patterns is not fully understood.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1).", "retries": 1}
{"idx": 173, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer correctly identifies LAMP-2A as the receptor for Chaperone Mediated Autophagy, which matches the gold standard. However, while the supporting sentence provided by the model is relevant and describes part of the CMA process, it does not explicitly mention LAMP-2A or directly support why LAMP-2A is the correct answer. It focuses on the recognition by HSPA8/HSC70 without linking this step to LAMP-2A binding at the lysosome surface. The gold supporting sentence explicitly mentions LAMP2A and its role in substrate binding and translocation, making it more precise and complete.\",\n  \"match\": true\n}", "gold_answer": "LAMP2A", "gold_support": "Once there, substrate proteins bind to the lysosome-associated membrane protein type 2 isoform A (LAMP2A), inducing assembly of this receptor protein into a higher molecular weight protein complex that is used by the substrate proteins to reach the lysosomal lumen.", "model_answer": "The receptor for substrates of Chaperone Mediated Autophagy is the lysosomal membrane receptor LAMP-2A.", "model_support": "Supporting sentence: CMA substrates are cytosolic proteins bearing a pentapeptide motif in their sequence that, when recognized by the cytosolic chaperone HSPA8/HSC70, targets them to the surface of the lysosomes.  \n\n**Note**: While the context does not explicitly name **LAMP-2A** as the receptor, it implies that the lysosomal membrane harbors a receptor (not named) that interacts with the chaperone-HSPA8/HSC70-substrate complex. The answer \"LAMP-2A\" is biologically accurate but not directly stated in the provided text. The sentence above describes the general mechanism involving the lysosomal surface, which aligns with the role of LAMP-2A in CMA.", "retries": 1}
{"idx": 174, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold standard 'stroke,' making it a match. The supporting sentence is concise, directly relevant, and logically explains the purpose of the ROSIER scale in differentiating acute stroke, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 175, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 176, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by explaining that SEA0400's effects are downstream of NCX-mediated Ca²⁺ influx, which directly ties to the Na⁺/Ca²⁺ exchanger. However, it introduces slight redundancy by elaborating on ERK phosphorylation and lipid peroxidation, which are not strictly necessary for supporting the answer. The gold supporting sentence is more concise while still covering the key information.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: These findings suggest that SEA0400 protects against MPTP-induced neurotoxicity probably by blocking ERK phosphorylation and lipid peroxidation which are downstream of NCX-mediated Ca²⁺ influx.  \n\nThis sentence directly connects SEA0400's protective mechanism to the Na⁺/Ca²⁺ exchanger (NCX) by stating that its effects occur \"downstream of NCX-mediated Ca²⁺ influx,\" implying that NCX is the target of SEA0400's inhibitory action.", "retries": 1}
{"idx": 177, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but focuses on a specific enzymatic step rather than directly stating that medicarpin is the major phytoalexin. While logical, it is slightly less direct than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: One of the final steps of medicarpin biosynthesis, from vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, is catalyzed by vestitone reductase.", "retries": 1}
{"idx": 178, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions hypothyroidism, which is related to thyroid dysfunction and aligns with the gold answer 'thyroid,' but it also includes hearing loss, which, while correct for Pendred syndrome, does not match the gold answer. The supporting sentence provided by the model incorrectly states that the context does not mention Pendred syndrome, even though the context explicitly discusses it in relation to defective iodide organification and thyroid function. However, the supporting sentence fails to directly connect to the gold answer or cover the relevant information about thyroid abnormalities.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "The discovery of mutations in the SLC26A4 gene in patients with Pendred syndrome (congenital deafness, goiter, and defective iodide organification) suggested a possible role for the encoded protein, pendrin, as an apical iodide transporter.", "model_answer": "Answer: Pendred syndrome is characterized by abnormalities in thyroid function, including hypothyroidism, and hearing loss.", "model_support": "The context does not mention Pendred syndrome or its associated hormone abnormalities. The provided answer about hypothyroidism and hearing loss is not directly supported by any sentence in the context, which focuses on TSH's role in regulating pendrin and iodide efflux in thyroid cells. \n\n**Supporting sentence:** None. The context does not reference Pendred syndrome or its characteristics.", "retries": 1}
{"idx": 179, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Two') does not match the gold standard ('7'), but it is plausible given the context, which implies multiple isoforms without specifying the exact number. The supporting sentence is relevant as it mentions 'transactivating p73 isoforms (TAp73),' hinting at multiple forms, but it does not explicitly support the specific answer of 'Two' or cover the gold answer ('7'). Therefore, while the supporting sentence is somewhat relevant, it fails to adequately justify the model's answer in relation to the gold standard.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two.", "model_support": "Supporting sentence: BRCA1-deficient ovarian carcinoma cells exhibit hypermethylation within a p73 regulatory region, which includes the binding site for the p73 transcriptional repressor ZEB1, leading to the abrogation of ZEB1 binding and increased expression of transactivating p73 isoforms (TAp73).  \n\n**Note**: The context does not explicitly state the number of TAp73 isoforms. However, the phrase \"transactivating p73 isoforms (TAp73)\" implies the existence of multiple isoforms (plural \"isoforms\") under the TAp73 designation, which aligns with the answer \"Two\" (as TAp73 and ΔNp73 are the two well-known isoforms of p73, though this specific distinction is not mentioned in the text). The supporting sentence is interpreted to suggest the presence of multiple TAp73 isoforms.", "retries": 1}
{"idx": 180, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states there are two TAp73 isoforms, while the gold standard indicates there are seven. The supporting sentence does not provide any evidence to support the correct number of isoforms and instead discusses interactions with p53 isoforms, which is irrelevant to the question. The information provided neither matches the gold answer nor supports it logically.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two (TAp73α and TAp73β)", "model_support": "Supporting sentence: \"all six p53 isoforms examined can form complexes with TAp73β, whereas only Δ133p53α/β/γ isoforms form complex with TAp73α.\"  \n\nThis sentence explicitly references two TAp73 isoforms (TAp73β and TAp73α), confirming the answer.", "retries": 1}
{"idx": 181, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'AIP gene' is correct and matches the gold standard conceptually, as 'Aryl hydrocarbon receptor interacting protein' is the full name of the AIP gene. However, it does not exactly match the gold answer verbatim. The supporting sentence provides relevant information about AIP-mutated FIPA patients but includes additional details about phenotypic diversity that are not necessary to support the answer, making it slightly verbose. Overall, the logic is strong, and the connection between the answer and supporting sentence is clear.\", \"match\": true}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 182, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('AUS') but is technically correct in stating that the gold standard is not explicitly mentioned in the provided context. However, the supporting sentence is relevant but overly focused on justifying the absence of a stated gold standard, while the gold supporting sentence ('It compares favourably with AUS') implies that AUS is indeed the benchmark for comparison, which the model fails to capture.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "Answer: The gold standard treatment is not explicitly mentioned in the context.", "model_support": "Supporting sentence: The gold standard treatment for Iatrogenic male incontinence is not explicitly mentioned in the context.  \n\n**Explanation**: The context discusses the outcomes of BAUS (bone-anchor sub-urethral sling) as a \"safe, effective, minimally invasive option\" for iatrogenic male incontinence but does not reference any other treatment as the \"gold standard.\" The conclusion emphasizes BAUS's efficacy without comparing it to alternative therapies or explicitly stating it as the gold standard. Thus, the absence of a stated gold standard is supported by the lack of comparative language or references to other treatments in the text.", "retries": 1}
{"idx": 183, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model acknowledges that no explicit supporting sentence was found in the context, but the gold supporting sentence confirms that the answer is correct and directly supported by the text. The gold sentence clearly states that the main component of Lewy bodies is alpha-synuclein, validating the model's response.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The context provided does not explicitly mention the main component of Lewy bodies. While the answer \"alpha-synuclein\" is scientifically accurate, the text here does not include any sentence specifying this composition. The context focuses on the classification and historical development of Lewy body disease (LBD) but does not describe the molecular components of Lewy bodies. \n\n**Supporting sentence:** None found in the context.", "retries": 1}
{"idx": 184, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking CENP-A to centromeres through its role in kinetochore formation, but it introduces additional proteins (Cenpc, BubR1, Mad2, Zw10) not directly necessary to justify the localization of CENP-A, leading to slight redundancy.\", \"match\": true}", "gold_answer": "centromeres", "gold_support": "CENP-A is an essential histone H3-like protein that localizes to the centromeric region of eukaryotic chromosomes.", "model_answer": "Answer: Centromeres", "model_support": "Supporting sentence: Cenpag/g embryos assemble functional kinetochores that bind to a host of centromere-specific structural and mitotic spindle checkpoint proteins (Cenpc, BubR1, Mad2 and Zw10).  \n\nThis sentence directly links CENPA (via its role in kinetochore formation) to centromere-specific localization, as the kinetochore's association with centromere-specific proteins implies the presence of CENPA at centromeres.", "retries": 1}
{"idx": 185, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model notes that the context provided does not explicitly contain the supporting sentence, it correctly identifies the gold supporting sentence when assuming access to the broader context. This meets the criteria for a perfect score.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not contain a sentence explicitly stating that JTV-519 is a derivative of 1,4-benzothiazepine. The answer \"1,4-benzothiazepine\" appears to be based on prior knowledge or external information, as the given context focuses on JTV-519's modulatory effects on cisplatin resistance and does not mention its chemical classification. \n\nHowever, if the question assumes the same context as the example (which includes the sentence about JTV519 being a 1,4-benzothiazepine derivative), then the supporting sentence would be:  \n**\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"**  \n\nBut in the current context provided, there is **no supporting sentence**.", "retries": 1}
{"idx": 186, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'BCR-ABL1' is very close to the gold standard 'BCR-ABL,' with only a minor difference in formatting (adding '1'). This is acceptable as it aligns with common biomedical shorthand. However, the supporting sentence does not directly mention that imatinib targets BCR-ABL1, which is central to the question. Instead, it provides general information about the introduction of imatinib for CML treatment, which is relevant but lacks specificity to fully support the answer.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia).", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The tyrosine kinase inhibitor imatinib mesylate was introduced into the treatment regimen for CML in 1998.  \n**Note**: While the context does not explicitly name *BCR-ABL1* as the target, it is widely established in biomedical knowledge that imatinib targets the BCR-ABL1 tyrosine kinase in Philadelphia-chromosome-positive CML. However, the provided context does not include this specific detail.", "retries": 1}
{"idx": 187, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence is relevant but contains slight redundancy by discussing broader classes of anticoagulants instead of directly stating that betrixaban is a factor Xa inhibitor. The logic is sound, but the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.  \n**Reasoning**: The context explicitly identifies \"factor Xa inhibitors\" as one of the two new classes of anticoagulants. Since betrixaban is described as a \"novel oral anticoagulant\" and the question asks which clotting factor it inhibits, the sentence linking factor Xa inhibitors to the broader class of anticoagulants directly supports the answer. While the text does not explicitly state that betrixaban targets Factor Xa, it is implied by its classification as a novel anticoagulant within this group.", "retries": 1}
{"idx": 188, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'GBA' is correct and matches the gold standard indirectly, as GBA is the gene encoding glucocerebrosidase. However, the gold answer specifies the gene by its descriptive name rather than its abbreviation. The supporting sentence is relevant and covers the answer well but contains slight redundancy by mentioning details about probes and controls that are not essential to directly support the answer. Overall, it provides logical support with minor verbosity.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease.", "model_answer": "Answer: GBA", "model_support": "Supporting sentence: Genomic DNA from 20 patients with recombinant GBA alleles and five controls was evaluated to identify DNA rearrangements or copy number variation using six probes specific for either the GBA gene or pseudogene.", "retries": 1}
{"idx": 189, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'EGFR' matches the gold standard 'epidermal growth factor receptor (EGFR) gene' in essence, as both refer to the same gene. The supporting sentence is relevant and covers the answer but contains slight redundancy by specifying the dose of erlotinib without directly emphasizing the mutations in the EGFR gene. It could be more concise and clearer in linking the drug response to the gene mutations.\", \"match\": true}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "PURPOSE: The tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are effective in non-small cell lung cancers (NSCLCs) with epidermal growth factor receptor (EGFR) gene mutations.", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.", "retries": 1}
{"idx": 190, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and supports the answer but contains slight redundancy by focusing on rare neuronal soma rather than directly mentioning Lewy bodies. It could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein.", "retries": 1}
{"idx": 191, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking Dnmt1 knockdown to demethylation and gene reexpression, which aligns with its role in maintaining DNA methylation. However, the supporting sentence is slightly verbose and includes additional details (e.g., about Nnat and H19) that are not strictly necessary to justify the answer.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "In the absence of a human pituitary tumor cell line, small interfering RNA-mediated knockdown of the maintenance methyltransferase DNA methyltransferase (cytosine 5)-1 (Dnmt1) was used in the murine pituitary adenoma cell line AtT-20.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Sustained knockdown induced reexpression of the fully methylated and normally imprinted gene neuronatin (Nnat) in a time-dependent manner. Combined bisulfite restriction analysis (COBRA) revealed that reexpression of Nnat was associated with partial CGI demethylation, which was also observed at the H19 differentially methylated region.  \n\nThis sentence demonstrates that Dnmt1 knockdown led to demethylation (reduced DNA methylation) and reactivation of silenced genes, directly implicating Dnmt1 in the maintenance of DNA methylation.", "retries": 1}
{"idx": 192, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('gene regulation') does not match the gold standard ('development'). While 'gene regulation' is mentioned in the context and is a related concept, it is broader and less specific than the gold answer. The supporting sentence is relevant but does not directly address the gold answer; it discusses conserved noncoding sequences being regulatory without specifying their association with development. Therefore, the answer and supporting sentence do not fully align with the gold standard.\", \"match\": false}", "gold_answer": "development", "gold_support": "The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development.", "model_answer": "The process that conserved noncoding elements mostly regulate is gene regulation.", "model_support": "Supporting sentence: Mammalian genomes contain millions of highly conserved noncoding sequences, many of which are regulatory.", "retries": 1}
{"idx": 193, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's answer '5-HT2A receptors' is equivalent to the gold answer '5-HT2A,' and the supporting sentence accurately reflects the context by connecting the reduction in binding to the specific loss of 5-HT2A receptors. However, it is slightly more verbose than necessary compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 194, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The sodium-calcium exchanger (NCX) is one of the transporters contributing to the control of intracellular calcium (Ca(2+)) concentration by normally mediating net Ca(2+) efflux.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: \"implementing a T(1)-mapping method and inhibiting the NCX with SEA0400.\"", "retries": 1}
{"idx": 195, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK') in essence, though it includes 'gene,' which is slightly more verbose but still correct. The supporting sentence provides relevant information about the XK missense mutation and its association with McLeod syndrome, aligning well with the gold supporting sentence. However, the model's supporting sentence contains a bit of redundancy by mentioning additional details that, while accurate, are not strictly necessary for concise support of the answer.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"  \n\nAdditionally, the context explicitly states: \"Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional.\" This confirms the mutation in the **XK gene** is linked to McLeod syndrome.", "retries": 1}
{"idx": 196, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "The molecular target of rapamycin (mTOR), which is a member of the phosphoinositide 3-kinase related kinase (PIKK) family and a central modulator of cell growth, is a prime strategic target for anti-cancer therapeutic development.", "model_answer": "Answer: mTOR", "model_support": "Supporting sentence: The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.  \n\nThis sentence explicitly states that mTOR is the molecular target of rapamycin, directly answering the question.", "retries": 1}
{"idx": 197, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'non-small cell lung cancer (NSCLC),' is correct but too broad and does not match the specificity of the gold answer, 'EGFR-mutant NSCLC.' The supporting sentence mentions NSCLC but lacks detail about the EGFR mutations that are critical to the gold answer. While relevant, it does not fully cover the gold standard.\", \"match\": false}", "gold_answer": "EGFR-mutant NSCLC", "gold_support": "Reversible ATP-competitive inhibitors targeting the epidermal growth factor receptor (EGFR) have been established as the most effective treatment of patients with advanced non-small cell lung cancer (NSCLC) harboring \"activating\" mutations in exons 19 and 21 of the EGFR gene.", "model_answer": "Afatinib is used for non-small cell lung cancer (NSCLC).", "model_support": "Supporting sentence: \"Clinical perspective of afatinib in non-small cell lung cancer.\"", "retries": 1}
{"idx": 198, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence explicitly identifies tofacitinib as the JAK inhibitor studied, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "The in vitro, ex vivo and in vivo effects of a JAK inhibitor CP-690,550 (tofacitinib) for the treatment of RA are reported.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: In vitro experiments indicated that the effects of tofacitinib were mediated through suppression of interleukin 17 (IL-17) and interferon γ production and proliferation of CD4 T cells, presumably Th1 and Th17.  \n\nThis sentence explicitly identifies **tofacitinib** as the JAK inhibitor studied in the context, directly answering the question.", "retries": 1}
{"idx": 199, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'Xa' in essence, though it is slightly more verbose. The supporting sentence is relevant and supports the answer by discussing anti-Xa activity and a factor Xa decoy related to betrixaban, but it includes some additional information about PRT4445 that is not strictly necessary. This makes it somewhat redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban acts on Factor Xa (via its anti-Xa activity), as PRT4445 is a \"factor Xa decoy\" designed to counteract anticoagulants that inhibit Factor Xa.", "retries": 1}
{"idx": 200, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence by specifying 'Thyroid hormone (TH)', which is a more detailed but accurate response. The supporting sentence is relevant and provides logical backing through linking MCT8 mutations to altered TH levels, although it includes slightly more detail than necessary, leading to minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid hormone (TH) levels.", "model_answer": "Answer: Thyroid hormone (TH) concentrations are altered.", "model_support": "Supporting sentence: \"Mutations in the TH transporter, monocarboxylate transporter 8 (MCT8), are associated with AHDS.\"  \nAdditionally: \"MCT8 knock-out mice exhibit impaired TH levels;\"  \n\nThese sentences directly link MCT8 mutations (associated with AHDS) to altered thyroid hormone (TH) concentrations.", "retries": 1}
{"idx": 201, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While it does not include the exact phrasing of the gold supporting sentence, it effectively conveys the same key information about HEXA mutations in Tay-Sachs disease.\",\n  \"match\": true\n}", "gold_answer": "HEXA", "gold_support": "We have identified three mutations in the beta-hexoseaminidase A (HEXA) gene in a juvenile Tay-Sachs disease (TSD) patient, which exhibited a reduced level of HEXA mRNA.", "model_answer": "Answer: HEXA", "model_support": "Supporting sentence: Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing and nonsense-mediated mRNA decay.", "retries": 1}
{"idx": 202, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, but the supporting sentence is somewhat indirect and refers to diltiazem rather than JTV519. Although the logic connecting the model's sentence to the correct answer exists (contrasting chemical structures), it mixes relevant and less relevant content by discussing diltiazem instead of focusing solely on JTV519 as a 1,4-benzothiazepine derivative.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note:** While the context explicitly mentions diltiazem as a \"1,5-benzothiazepine derivative,\" it does not directly state that JTV519 is a \"1,4-benzothiazepine derivative.\" The answer provided (1,4-benzothiazepine) may rely on external knowledge or an inconsistency in the context. The sentence above is the closest relevant reference in the text.", "retries": 1}
{"idx": 203, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about factor Xa and betrixaban, but it introduces additional details about a reversal agent that are not necessary to directly support the answer. The logic is sound, but the extra content makes it slightly verbose.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 204, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about factor Xa inhibitors, but it does not explicitly mention betrixaban or provide the specific list of examples from the gold supporting sentence. The logic is sound but slightly less precise due to the lack of direct reference to betrixaban.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors. \n\n(Note: While betrixaban is not explicitly mentioned in the context, the sentence identifies \"factor Xa inhibitors\" as a class of drugs, and the answer \"Factor Xa\" aligns with this classification. The context does not directly name betrixaban, but the question assumes prior knowledge that betrixaban is a factor Xa inhibitor.)", "retries": 1}
{"idx": 205, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the information is not provided, whereas the context clearly mentions JNK as the kinase responsible for c-Jun phosphorylation. The supporting sentence also incorrectly claims a lack of information instead of identifying JNK from the context. Both are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "Answer: The question does not provide information about which MAP kinase phosphorylates c-Jun.", "model_support": "Supporting sentence: The question does not provide information about which MAP kinase phosphorylates c-Jun.  \n\n**Note**: The context explicitly focuses on c-Jun's role in anticancer mechanisms, cyclin A2 regulation, and the PI3K_PDK1_eEF2 signaling cascade but never mentions any MAP kinase (e.g., JNK, ERK, p38) or its involvement in phosphorylating c-Jun. Thus, the answer reflects the absence of relevant information in the text.", "retries": 1}
{"idx": 206, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly mention 'lubag disease' or its synonym. However, the supporting sentence simply restates the answer and does not provide relevant evidence from the text to support the gold answer, which is 'X-linked dystonia-parkinsonism.' While the model's reasoning reflects an accurate conclusion, it fails to extract or reference the key information from the context that directly supports the gold answer.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Three affected siblings were found to share an identical haplotype at the X-linked dystonia-parkinsonism locus (XDP; Lubag; OMIM*314250).", "model_answer": "The context does not mention \"lubag disease\" or its synonym.", "model_support": "Supporting sentence: The context does not mention \"lubag disease\" or its synonym.  \n\n**Note**: The context explicitly does not contain the term \"lubag disease\" or any related synonym. The answer is correct, but there is no specific sentence in the context that directly states this absence. The provided \"supporting sentence\" reflects the conclusion drawn from the absence of information in the text.", "retries": 1}
{"idx": 207, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'hydrocephalus,' does not match the gold standard, 'craniosynostosis.' However, hydrocephalus is mentioned in the context as a feature found in Shprintzen-Goldberg syndrome. The supporting sentence is relevant to the model's answer but does not cover the gold answer or provide logical support for it, as it focuses on hydrocephalus rather than craniosynostosis.\",\n  \"match\": false\n}", "gold_answer": "craniosynostosis", "gold_support": "Shprintzen-Goldberg syndrome is one of a group of disorders characterized by craniosynostosis and marfanoid habitus.", "model_answer": "Answer: Hydrocephalus", "model_support": "Supporting sentence: \"an abnormality of the first and second cervical vertebrae, hydrocephalus, dilatation of the lateral ventricles, and a Chiari-I malformation of the brain were found only in the patients with Shprintzen-Goldberg syndrome.\"", "retries": 1}
{"idx": 208, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is directly related to the answer, but it focuses on a specific experimental detail (arsenite) rather than the broader role of DUSPs in modulating JNK activation. The logic is strong but slightly narrower in scope compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.", "model_answer": "Answer: JNK", "model_support": "Supporting sentence: Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite.", "retries": 1}
{"idx": 209, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context about flumazenil being a benzodiazepine antagonist studied for efficacy and safety, but it does not explicitly state that flumazenil is effective and safe in treating benzodiazepine overdose, as the gold supporting sentence does. It contains slight redundancy by referencing the trial setup rather than focusing directly on the conclusion.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "We conclude that flumazenil is an effective and safe drug in the treatment of benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the benzodiazepine antagonist, flumazenil.", "retries": 1}
{"idx": 210, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer logically, but contains additional details about the conditions treated by the drug, which slightly increases verbosity without being necessary for supporting the answer.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 211, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to TAp73 isoforms but does not specify the number of isoforms and fails to cover the gold answer. The context hints at multiple isoforms, yet the model incorrectly states 'One.'\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One.", "model_support": "Supporting sentence: \"tazarotene modulates the expression of the p73 gene in immortalized keratinocyte cell lines by inducing the pro-apoptotic and anti-proliferative TAp73 isoforms and by repressing the anti-apoptotic and pro-proliferative DeltaNp73 isoforms.\"  \n\n**Note**: The context mentions \"TAp73 isoforms\" in plural, which would imply more than one isoform. However, the answer provided (\"One\") may reflect a specific context or clarification not explicitly stated in the text. The sentence above is the closest to addressing the question but does not explicitly state the number of TAp73 isoforms.", "retries": 1}
{"idx": 212, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'peroxidase,' does not match the gold standard 'antioxidant,' but it is present in the context as peroxidases can have antioxidant functions. The supporting sentence discusses the augmentation of H₂O₂ when PRDX2 is suppressed, which indirectly supports its role in reducing oxidative stress, but it does not directly align with the gold answer or supporting sentence. The reasoning provided by the model is plausible but incomplete and less precise compared to the gold standard.\",\n  \"match\": false\n}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2) has been known to act as an antioxidant enzyme whose main function is H(2)O(2) reduction in cells.", "model_answer": "Answer: Peroxiredoxin 2 is a peroxidase.", "model_support": "Supporting sentence: Furthermore, suppression of PRDX2 resulted in the augmentation of endogenous H(2)O(2), and the ability to eliminate the exogenous H(2)O(2) was attenuated.  \n\nThis sentence implies PRDX2's role in detoxifying hydrogen peroxide (H₂O₂), a hallmark function of peroxidases, even though the term \"peroxidase\" is not explicitly used in the context. The enzyme's activity in eliminating H₂O₂ aligns with its classification as a peroxidase.", "retries": 1}
{"idx": 213, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the text does not specify the localization, whereas the gold answer clearly identifies APOBEC3B as nuclear. The supporting sentence from the model also incorrectly claims no specification is present, while the gold supporting sentence directly provides evidence of nuclear localization. Both the answer and supporting sentence are thus inaccurate and fail to align with the context or gold standard.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "Answer: The text does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.", "model_support": "Supporting sentence: The text does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.  \n**Note**: The context provided does not include any explicit information about the subcellular localization (cytoplasmic or nuclear) of APOBEC3B. The answer is derived from the absence of such details in the text.", "retries": 1}
{"idx": 214, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence provides relevant information and confirms the association between the XK gene and McLeod syndrome. However, it includes additional details ('Additionally...') that slightly increase verbosity without enhancing logical clarity.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome.  \nAdditionally: \"A variety of XK mutations has been reported...\" and \"the responsible XK mutation was characterized...\" further confirm the association.", "retries": 1}
{"idx": 215, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it contains slight redundancy by focusing on the assessment of surgical targeting rather than directly stating the effectiveness of GPi stimulation for dystonia. It could be more concise while still covering the key information.\",\n  \"match\": true\n}", "gold_answer": "globus pallidus internus", "gold_support": "Bilateral pallidal deep brain stimulation (BP-DBS) of the globus pallidus internus (GPi) is an effective treatment for primary dystonia, but the effect of this reversible surgical procedure on dystonia-choreoathetosis CP, which is a subtype of secondary dystonia, is unknown.", "model_answer": "Neurostimulation of the globus pallidus internus (GPi) is used for the treatment of dystonia.", "model_support": "Supporting sentence: The accuracy of surgical targeting to the GPi was assessed masked to the results of neurostimulation.", "retries": 1}
{"idx": 216, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Matriptase,' does not match the gold standard, 'LEKTI.' However, matriptase is mentioned in the context as a contributing factor in the disease mechanism. The supporting sentence is relevant to the model's answer but does not cover the gold answer, which identifies LEKTI deficiency as the root cause of Netherton syndrome.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.", "model_answer": "Answer: Matriptase", "model_support": "Supporting sentence: Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.", "retries": 1}
{"idx": 217, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer is incorrect as it states the question is unrelated, while the gold answer 'Rac1' is present in the context. The supporting sentence similarly does not address the gold answer but instead claims irrelevance, which is inaccurate. However, the model's supporting sentence correctly identifies that the context doesn't explicitly discuss G proteins or lamellipodia formation in depth, which partially explains the confusion. Despite this, the model fails to extract the relevant information about Rac1 from the context.\", \"match\": false}", "gold_answer": "Rac1", "gold_support": "We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination.", "model_answer": "The question is unrelated to the context provided.", "model_support": "Supporting sentence: The question is unrelated to the context provided. \n\nThe context discusses light-activated dimerization (LAD) technology, protein interactions involving FKF1 and GIGANTEA (GI) proteins, and applications in signaling molecules, but it does not mention G proteins, lamellipodia, or their formation/function. The answer is correct because the context contains no information related to the question.", "retries": 1}
{"idx": 218, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and does not directly quote the most concise supporting evidence from the context. The model provides a correct but general explanation of *Clostridium botulinum* being the causative agent, relying on external knowledge rather than directly referencing the specific sentence in the context that explicitly mentions 'type A Clostridium botulinum.'\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "An epidemiological investigation and laboratory detection studies showed that sausage contaminated by type A Clostridium botulinum caused this outbreak of food poisoning.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context provided does not explicitly mention the bacterium responsible for botulism. However, based on standard biomedical knowledge, *Clostridium botulinum* is the well-established causative agent of botulism. Since the context does not include a direct statement about the bacterium, there is no supporting sentence within the given text. \n\nIf forced to identify a sentence from the context that indirectly relates to the answer, the closest would be:  \n**\"Multilocus outbreak of foodborne botulism linked to contaminated sausage in Hebei province, China.\"**  \nThis implies the presence of a pathogen (e.g., *Clostridium botulinum*) causing botulism via contaminated food, but it does not explicitly name the bacterium.  \n\n**Note:** The answer \"*Clostridium botulinum*\" is correct based on external knowledge, but the context provided does not contain a sentence that directly supports this answer.", "retries": 1}
{"idx": 219, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions iron deficiency, which aligns with the gold answer but is presented as an association rather than a definitive cause. The supporting sentence does not directly back the answer using the provided context, instead focusing on the lack of explicit evidence in the text. While the answer is correct and present in the context, the supporting sentence fails to properly reference the relevant sentence from the context that directly mentions iron deficiency as a secondary cause of RLS.\", \"match\": true}", "gold_answer": "iron", "gold_support": "RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.", "model_answer": "Answer: The cause of restless leg syndrome is not definitively known, but it is associated with iron deficiency.", "model_support": "Supporting sentence: The context does not explicitly mention any deficiency as the cause of restless leg syndrome (RLS). While the answer states \"iron deficiency\" is associated with RLS, the provided text only notes that \"correction of underlying problem wherever possible is important in the management of secondary RLS\" without specifying iron deficiency or other deficiencies.  \n\n**Analysis**: The context does not contain a sentence directly linking RLS to iron deficiency or any other specific deficiency. The answer relies on external knowledge, but the provided text lacks supporting evidence for this claim.", "retries": 1}
{"idx": 220, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose and includes additional details about the methods used, which are not necessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: Thus, we examined the effect of SEA0400 on NCX currents and I/R induced intracellular Ca²⁺ overload in mouse ventricular myocytes using patch clamp techniques and fluorescence measurements.", "retries": 1}
{"idx": 221, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning the CPSS comparison, which is not necessary for directly supporting the answer. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "Supporting sentence: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 222, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Autosomal dominant' is correct and matches the gold standard, but the supporting sentence does not cover the gold answer because it explicitly states that the context does not mention the mode of inheritance. While the model acknowledges the answer is accurate based on external knowledge, it fails to utilize the provided context, which includes a clear statement about the autosomal dominant mode of inheritance. The supporting sentence should have referenced the relevant part of the context.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "Answer: Autosomal dominant.", "model_support": "The context provided does not explicitly mention the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD). While the answer \"Autosomal dominant\" is scientifically accurate for FSHD, the text here focuses on clinical presentation, diagnosis (genetic deletion of D4Z4), and management strategies, but it does not include any information about inheritance patterns. \n\n**Supporting sentence:** None. The context does not contain a sentence stating the mode of inheritance. \n\nNote: The answer \"Autosomal dominant\" is correct based on external knowledge, but it is not supported by the provided text.", "retries": 1}
{"idx": 223, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains some redundancy by including the study's title and additional details about ubiquitin, which slightly detracts from conciseness. However, the logic connecting the antibody to alpha-synuclein is strong.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "Answer: alpha-Synuclein", "model_support": "Supporting sentence: alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.  \n\nThis sentence explicitly states the focus of the study, which is alpha-synuclein immunoreactivity, indicating the antibody used for immunostaining targets alpha-synuclein. Additionally, the text repeatedly references \"alpha-synuclein immunostaining\" and \"double alpha-synuclein and ubiquitin immunostaining,\" further confirming the antibody's target.", "retries": 1}
{"idx": 224, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, 'PTEN' is mentioned in the context as a tumor suppressor and referred to as a 'new guardian of the genome', making it relevant but incorrect for this specific question. The supporting sentence is relevant to the model's answer but does not support the gold answer, missing the well-established role of p53 as the 'guardian of the genome'.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 225, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly linking pridopidine to Huntington disease treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 226, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence is relevant and provides accurate information about the XK gene being associated with McLeod syndrome. However, it is slightly more verbose than necessary and does not directly mention the specific missense mutation (E327K) highlighted in the gold supporting sentence. Despite this, the model's supporting sentence still logically supports the answer.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.", "retries": 1}
{"idx": 227, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'One' does not match the gold standard '7'. However, the supporting sentence is relevant as it discusses the TAp73 isoform and its inclusion among other isoforms. The supporting sentence fails to cover the gold answer since it does not provide any indication of there being seven TAp73 isoforms in humans. The logic is limited because the sentence focuses only on the enumeration of N-terminal isoforms without clarifying the diversity within the TAp73 category.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR.  \n\nThis sentence explicitly lists \"TAp73\" as one of the five N-terminal isoforms, confirming that **one** TAp73 isoform is identified in humans (as distinct from other isoforms like DeltaNp73 or Ex2p73). The answer \"One\" aligns with this enumeration.", "retries": 1}
{"idx": 228, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model states that there is no supporting sentence in the context provided, the gold supporting sentence confirms that the mode of inheritance (autosomal recessive) is indeed mentioned directly in the context. The model's acknowledgment of the lack of explicit support is accurate, but this does not detract from the correctness of the answer.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease is a rare genetic disorder of copper metabolism with autosomal recessive inheritance.", "model_answer": "Answer: Autosomal recessive.", "model_support": "The context does not mention the mode of inheritance of Wilson's disease. Therefore, there is no supporting sentence provided in the text to confirm the answer \"Autosomal recessive.\" \n\n**Supporting sentence:** None.  \nThe context focuses on symptoms, diagnosis, treatment, and breast milk composition in Wilson's disease but does not address genetic inheritance patterns.", "retries": 1}
{"idx": 229, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning the analysis of crystal structures, which is not directly necessary to support the answer.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: We have analyzed the crystal structures of canakinumab and gevokizumab antibody binding fragment (Fab) as well as of their binary complexes with IL-1β.", "retries": 1}
{"idx": 230, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly provide the inheritance pattern, the supporting sentence acknowledges that the answer is based on general medical knowledge, which aligns with the gold standard. The gold supporting sentence directly confirms this reasoning, making the model's response accurate and logically sound despite the lack of explicit context.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The context does not explicitly state the inheritance pattern of myotonic dystrophy. While the text discusses genetic mutations (e.g., (CCTG)n expansions) and familial linkage, it does not directly mention \"autosomal dominant\" or any specific inheritance mechanism. The answer \"autosomal dominant\" is a well-established fact about myotonic dystrophy in general medical knowledge but is not explicitly supported by a sentence in the provided context. \n\n**Supporting sentence:** None directly stated in the context.  \n**Note:** The answer relies on external knowledge rather than the provided text.", "retries": 1}
{"idx": 231, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation. \n\n**Note**: While the context does not explicitly mention \"betrixaban,\" the question assumes knowledge that direct factor Xa inhibitors (a class including betrixaban) target Factor Xa. The supporting sentence directly states the inhibition of Factor Xa by this class of drugs.", "retries": 1}
{"idx": 232, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'parallel' while the gold standard specifies 'antiparallel.' The supporting sentence provided by the model correctly acknowledges that the context does not explicitly mention the orientation of the subunits, but this results in an inability to logically support any answer. Since the model's answer is wrong and no valid supporting evidence is present, the score is 1.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "Mapping the stress-dependent labeling kinetics of α- and β-spectrin by LC-MS/MS identifies Cys in these antiparallel chains that are either force-enhanced or force-independent in labeling, with structural analyses indicating the force-enhanced sites are sequestered either in spectrin's triple-helical domains or in interactions with actin or ankyrin.", "model_answer": "Answer: Parallel", "model_support": "The context does not explicitly mention the orientation (parallel or antiparallel) of alpha-spectrin and beta-spectrin subunits. Therefore, **no supporting sentence** is present in the provided text to directly answer the question. The answer \"Parallel\" would require external knowledge about spectrin's structure, as the context focuses on shear sensitivity, labeling, and interactions with actin/ankyrin rather than subunit arrangement. \n\nIf forced to infer from the text, the closest reference is the mention of \"spectrin-actin membrane skeleton,\" but this does not specify subunit orientation. Thus, the answer cannot be validated by the given context. \n\n**Answer:** No supporting sentence is present in the context.", "retries": 1}
{"idx": 233, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (Nf1 is the gene symbol for neurofibromatosis type 1, and NF1 is the human equivalent); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they do not detract from the core relevance.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas.", "model_answer": "Answer: Nf1", "model_support": "Supporting sentence: Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.", "retries": 1}
{"idx": 234, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights DNMT1's recruitment to DNA damage sites, which indirectly supports its role as the maintenance methyltransferase. Minor extra details do not detract from the strong logic.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We and others have shown that DNA methyltransferase 1 (DNMT1), the maintenance methyltransferase, contributes to the cellular response to DNA damage, yet DNMT1's exact role in this process remains unclear.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery.  \n\n**Explanation**: While the context primarily discusses DNMT1's role in DNA damage response, the question asks for the enzyme involved in maintaining DNA (cytosine-5-)-methylation. DNMT1 is a well-established DNA methyltransferase responsible for maintaining DNA methylation patterns during cell division. The supporting sentence directly identifies DNMT1 as the enzyme under study, even though the context emphasizes its role in DNA repair rather than methylation maintenance. This aligns with the answer, as DNMT1 is the canonical enzyme for this function.", "retries": 1}
{"idx": 235, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: Serotonin 5-HT2A receptors.", "model_support": "Supporting sentence: \"Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.\"  \n\nThis sentence explicitly states that [18F]altanserin is used to evaluate serotonin 5-HT2A receptor binding, directly answering the question.", "retries": 1}
{"idx": 236, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by mentioning TA-p73 and p63, which are not directly necessary to support the specific role of p53 as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors.  \n\n**Note**: While the context does not explicitly use the phrase \"guardian of the genome,\" p53 is historically and widely recognized as \"the guardian of the genome\" in biomedical literature. The sentence above identifies p53 as a tumor suppressor, which aligns with its established role and nickname.", "retries": 1}
{"idx": 237, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is logical but has slight redundancy. The model's supporting sentence could be more concise as it includes details about the effects of L-DOPA/benserazide (e.g., increased locomotion, parkinsonism improvement), which are not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "They were injected subcutaneously (s.c.) with L-DOPA methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-DOPA/benserazide) alone or in combination with (-)-OSU6162 (1.0, 3.0, 6.0 or 10 mg/kg, s.c.).", "model_answer": "Answer: L-DOPA", "model_support": "Supporting sentence: \"L-DOPA/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\"  \nThis sentence explicitly states that benserazide is co-administered with L-DOPA, as the combination is referred to as \"L-DOPA/benserazide.\"", "retries": 1}
{"idx": 238, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect and verbose compared to the gold supporting sentence. The model's supporting sentence discusses the release of medicarpin from a conjugate, which is relevant but not as concise or direct as the gold supporting sentence that clearly mentions its rapid accumulation upon elicitation.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Treatment of (14)C-labeled, elicited cells with l-alpha-aminooxy-beta-phenylpropionic acid... resulted in the initial appearance of labeled medicarpin of very low specific activity, suggesting that the phytoalexin could be released from a preformed conjugate under these conditions.\"  \n\nThis sentence identifies **medicarpin** as the phytoalexin, as it explicitly links the compound to being released from a preformed conjugate during elicitation.", "retries": 1}
{"idx": 239, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('calcineurin' and 'CaN (calcineurin)' are equivalent). The supporting sentence is concise, directly relevant, and logically explains the role of calcineurin in NFAT activation by stating that dephosphorylation of NFAT by CaN is required for its nuclear localization. No excessive content or redundancy is present.\",\n  \"match\": true\n}", "gold_answer": "calcineurin", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: CaN (calcineurin)", "model_support": "Supporting sentence: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 240, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence highlights the key finding about ZFHX1B mutations being present in patients with the characteristic phenotype, which directly supports the answer.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "\"Mowat-Wilson\" syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Direct sequencing demonstrated truncating ZFHX1B mutations in all four patients with the characteristic facial phenotype, but not in the patient with syndromic Hirschsprung disease without the distinct facial appearance.", "retries": 1}
{"idx": 241, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information about FSHD being linked to DUX4 and PITX1 up-regulation, but it does not directly mention that DUX4 is a candidate gene for FSHD, leading to slight redundancy. It could be more concise by focusing on the direct relationship between DUX4 and FSHD.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: By comparing genome-wide gene expression data from muscle biopsies of patients with FSHD to those of 11 other neuromuscular disorders, paired-like homeodomain transcription factor 1 (PITX1) was found specifically up-regulated in patients with FSHD.", "retries": 1}
{"idx": 242, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence refers to the active nuclear import process of A3B, which aligns with the gold supporting sentence stating its steady-state nuclear localization.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase).", "retries": 1}
{"idx": 243, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"  \n\nThis sentence explicitly identifies betrixaban as a direct inhibitor of factor Xa, which directly answers the question.", "retries": 1}
{"idx": 244, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly less detailed compared to the gold supporting sentence. It mentions the effect of phospholamban on SERCA2a but does not explicitly highlight its role as a 'key regulator of myocyte Ca(2+) cycling' or its significance in heart failure, which are important points in the gold sentence.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban (PLN), the reversible inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), is a key regulator of myocyte Ca(2+) cycling with a significant role in heart failure.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.", "retries": 1}
{"idx": 245, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by discussing both genetic inactivation and ibrutinib, whereas the gold supporting sentence is more concise and directly highlights ibrutinib's role in inhibiting BTK in CLL.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.", "retries": 1}
{"idx": 246, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('thyroid'), as it correctly identifies thyroid hormone abnormalities as common in Williams syndrome. The supporting sentence is relevant and supports the answer, but it includes extra details (e.g., 'In this report we describe an infant...') that slightly increase verbosity without being strictly necessary. This makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Thyroid hormone abnormalities, such as congenital hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 247, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Itching and blistering rash,' is close but not an exact match to the gold answer, 'Dermatitis herpetiformis.' While the description of the rash is accurate based on external medical knowledge, the question specifically asks for the 'typical rash associated with gluten,' which directly refers to the condition's name, not its symptoms. The supporting sentence is somewhat lengthy and mixes general reasoning with indirect references from the text. Although it covers the answer reasonably, it could be more concise and focused on the direct relationship between gluten and dermatitis herpetiformis as stated in the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.", "model_answer": "Answer: Itching and blistering rash.", "model_support": "The context does not explicitly state the typical rash associated with gluten. However, the answer \"Itching and blistering rash\" is a well-established clinical feature of dermatitis herpetiformis (DH), which is the condition discussed in the context. While the text does not directly describe the rash's appearance, the mention of DH and its association with gluten sensitivity implies this characteristic rash. \n\nIf forced to identify a supporting sentence from the text, the closest reference might be:  \n**\"The diagnosis of DH was made from clinical findings, histological examination of the involved skin...\"**  \nThis implies the presence of a skin rash (DH) as part of the clinical presentation, though it does not specify \"itching and blistering.\"  \n\n**Note:** The answer relies on external medical knowledge about DH, as the context does not explicitly describe the rash's characteristics.", "retries": 1}
{"idx": 248, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct compared to the gold supporting sentence. It implies the role of ibrutinib in inhibiting BTK but does not explicitly highlight its outstanding activity or oral bioavailability as clearly as the gold standard.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Answer: Ibrutinib", "model_support": "Supporting sentence: \"Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse...\"", "retries": 1}
{"idx": 249, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the model's supporting sentence incorrectly states that no sentence in the context supports the answer, while the gold supporting sentence is present in the provided context and directly supports the answer. Despite this oversight, the logic behind the answer is correct, and the supporting sentence would have been valid if appropriately identified.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We propose a new model that suggests that the maintenance of DNA methylation relies not only on the recognition of hemimethylated DNA by DNA methyltransferase 1 (DNMT1) but also on the localization of the DNMT3A and DNMT3B enzymes to specific chromatin regions that contain methylated DNA.", "model_answer": "Answer: DNA methyltransferase 1 (DNMT1)", "model_support": "The context provided does not explicitly mention the enzyme DNA methyltransferase 1 (DNMT1) or any specific enzyme involved in DNA methylation maintenance. Therefore, **no sentence in the given context supports the answer**. The answer (DNMT1) is biologically accurate but cannot be derived from the provided text. \n\nIf the context were part of a larger text that includes details about DNMT1, the supporting sentence would need to be identified from that specific section. As it stands, the current context lacks the necessary information.", "retries": 1}
{"idx": 250, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (e.g., 'impaired iodine organification') that are not explicitly required by the gold answer, which simply states 'thyroid.' The supporting sentence is somewhat lengthy and focuses on dyshormonogenetic goitres rather than directly emphasizing thyroid hormone abnormalities in a concise manner. While the reasoning connects the content logically, it could be more focused and succinct.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene.", "model_answer": "Answer: Pendred syndrome is characterized by thyroid hormone abnormalities, including goiter and impaired iodine organification.", "model_support": "Supporting sentence: \"It is known that dyshormonogenetic goitres have a tendency to grow despite appropriate treatment with L-thyroxine.\"  \n\nThis sentence highlights the characteristic thyroid hormone abnormalities (dyshormonogenetic goitres) associated with Pendred syndrome, as the condition involves impaired thyroid hormone synthesis (e.g., iodine organification defects) leading to goitre formation. While the context does not explicitly mention \"iodine organification,\" the term \"dyshormonogenetic\" inherently relates to defects in hormone production, which aligns with the answer.", "retries": 1}
{"idx": 251, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is inferred and relies on external knowledge rather than directly quoting the context provided. While it correctly identifies the mechanism of Orteronel in suppressing androgen levels, it does not explicitly mention CYP17A1 or its role as stated in the gold supporting sentence. The logic is strong but slightly indirect.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Answer: CYP17A1", "model_support": "The context does not explicitly mention the enzyme CYP17A1. However, the answer is inferred based on the known mechanism of Orteronel as a CYP17A1 inhibitor, which is not directly stated in the provided text. \n\n**Supporting sentence (implied but not explicitly stated):**  \n\"Preclinical studies demonstrate that orteronel treatment suppresses androgen levels and causes shrinkage of androgen-dependent organs, such as the prostate gland.\"  \n\nThis sentence implies that Orteronel inhibits androgen synthesis, which is primarily mediated by **CYP17A1**, but the enzyme name is not explicitly mentioned in the context. The answer relies on external knowledge of Orteronel's mechanism.", "retries": 1}
{"idx": 252, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing treatment of multiple myeloma with bortezomib, but it includes additional details about the time frame and database that are not necessary for directly supporting the answer, making it slightly redundant.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, indicated for multiple myeloma (MM) treatment, is available in 3.5-mg vials, a quantity higher than the average dose commonly prescribed.", "model_answer": "Velcade (bortezomib) is mainly used for multiple myeloma.", "model_support": "Supporting sentence: From November 2007 to October 2009 all patients with MM treated with bortezomib were identified via the Evidências database.", "retries": 1}
{"idx": 253, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically establishes BCR-ABL as the target of imatinib by referencing its critical role in CML treatment. Although the model's supporting sentence includes a bit more context about the discovery, it does not detract from the clarity or accuracy of the explanation.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a hematopoietic stem cell cancer driven by the BCR-ABL fusion protein that arises from the translocation of chromosomes 9 and 22.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: The discovery of the Ph and, subsequently, the identification of BCr-ABL revolutionized the treatment of CML.  \n\nThis sentence directly links the identification of **BCR-ABL** to the treatment of Philadelphia-chromosome positive CML, establishing it as the target of imatinib (Gleevec). Additionally, the context explicitly mentions that imatinib resistance is caused by mutations in **BCR-ABL**, further confirming its role as the tyrosine kinase targeted by the drug.", "retries": 1}
{"idx": 254, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and states that the question is unrelated, while the gold answer clearly indicates that the synonym for lubag disease is 'X-linked dystonia-parkinsonism,' which is present in the context. The supporting sentence incorrectly claims that the context does not mention lubag disease or its synonym, when in fact the context explicitly mentions 'lubag (X-linked dystonia-Parkinsonism syndrome).' Both the answer and supporting sentence fail to address the gold standard.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The question is unrelated to the context provided.", "model_support": "Supporting sentence: The context does not mention \"lubag disease\" or any synonym for it.  \nExplanation: The context discusses emergency tracheostomy, botulinum toxin injections, aspiration, and lingual dystonia but never references \"lubag disease\" or its synonyms. The question is unrelated to the provided information.", "retries": 1}
{"idx": 255, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It identifies dermatitis herpetiformis as the typical rash associated with gluten, aligning perfectly with the gold answer and supporting sentence.\", \"match\": true}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "BACKGROUND: Dermatitis herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80% of DH patients have gluten sensitive enteropathy manifested by crypt hyperplasia and villous atrophy.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. \n\nThis sentence explicitly identifies \"dermatitis herpetiformis\" (DH) as the condition associated with the skin lesions discussed in the context, directly linking it to the typical rash linked to gluten sensitivity.", "retries": 1}
{"idx": 256, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the text does not provide information about the subcellular localization of APOBEC3B, while the gold answer clearly identifies it as nuclear. The supporting sentence is also incorrect because the context explicitly mentions that 'APOBEC3B appeared predominantly nuclear.' Thus, both the answer and supporting sentence are inconsistent with the gold standard and do not logically support the correct answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The text does not provide information about the subcellular localization of APOBEC3B protein.", "model_support": "Supporting sentence: The text does not provide information about the subcellular localization of APOBEC3B protein.  \n\n**Note**: While the context does not explicitly state this, the answer is justified because none of the provided sentences mention the subcellular localization (cytoplasmic or nuclear) of APOBEC3B. The absence of such information in the text directly supports the conclusion.", "retries": 1}
{"idx": 257, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing acute ischemic stroke, but it does not explicitly mention the MR CLEAN study, leading to slight ambiguity. It contains some redundancy by broadly referring to a meta-analysis rather than directly focusing on the MR CLEAN trial as described in the gold supporting sentence.\", \"match\": true}", "gold_answer": "acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke.", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.  \n\nNote: While the context does not explicitly mention the \"MR CLEAN study,\" it references a meta-analysis of endovascular therapies for **acute ischemic stroke (AIS)**. The answer aligns with the broader focus of the study described, even though the specific MR CLEAN trial is not named in the provided text.", "retries": 1}
{"idx": 258, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence, while relevant and logical, contains additional information about PRT4445, which is not directly necessary to support the answer. The logic connecting betrixaban to Factor Xa is clear but slightly indirect compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.  \n\nThis sentence implies that betrixaban targets Factor Xa (as it is mentioned in the context of a \"factor Xa decoy\" being evaluated alongside it), aligning with the answer that betrixaban inhibits Factor Xa.", "retries": 1}
{"idx": 259, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains some redundancy by including an additional sentence that, while related, isn't strictly necessary to support the answer. The logic is strong, but the extra information could be trimmed for conciseness.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "Answer: PD-1", "model_support": "Supporting sentence: \"We examined the effect of PD-1 blockade on T-cell response to DC/tumor fusions ex vivo.\"  \nAdditionally: \"PD-1 expression is increased in T cells of patients with active myeloma, and that CT-011 enhances activated T-cell responses after DC/tumor fusion stimulation.\"  \n\nThese sentences directly link PD-1 as the target of the intervention (PD-1 blockade) and CT-011's mechanism of action, even though MK-3475 is not explicitly mentioned in the context. The answer assumes prior knowledge that MK-3475 is another name for a PD-1-targeting antibody (e.g., pembrolizumab), but the context only references CT-011.", "retries": 1}
{"idx": 260, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "fibroblast growth factor receptor 3 (FGFR3)", "gold_support": "These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.", "model_answer": "Answer: FGFR3 gene", "model_support": "Supporting sentence: Hypochondroplasia due to FGFR3 gene mutation (N540K) and mosaic form of Down syndrome in the same patient.", "retries": 1}
{"idx": 261, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but fails to cover the gold answer, as it incorrectly states that the context does not mention any specific MAP kinase, when in fact JNK is mentioned as the mediator of c-Jun phosphorylation.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "Answer: The question does not provide information about which MAP kinase phosphorylates c-Jun.", "model_support": "Supporting sentence: The context does not mention any specific MAP kinase involved in phosphorylating c-Jun.  \nExplanation: The provided text discusses tylophorine's effects on c-Jun protein accumulation, G1 phase arrest, and regulation of cyclin A2, but it does not identify which MAP kinase (e.g., JNK, ERK, p38) phosphorylates c-Jun. The answer is correct because the context lacks this information.", "retries": 1}
{"idx": 262, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 263, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and discussing the NF1 gene, focuses on the methodology (LOH analysis) rather than directly supporting the relationship between NF1 germline mutations and type 1 neurofibromatosis as described in the gold supporting sentence. It contains slight redundancy by providing procedural details that are not necessary for answering the question.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "It is well known that patients with von Recklinghausen syndrome (NF-1) (OMIM 162200) carrying NF1 germline mutations are predisposed to endocrine tumors including pheochromocytomas and duodenal somatostatinomas.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: Loss of heterozygosity (LOH) analysis of the NF1 gene was carried out using 3 intragenic microsatellite markers on 17q11.2.", "retries": 1}
{"idx": 264, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'peroxidase,' does not match the gold standard 'antioxidant.' However, peroxiredoxin 2 can indeed be classified as a peroxidase, which is correct but not the expected answer based on the context provided. The supporting sentence discusses 'Prx-like activity' and links it to gliotoxin, which indirectly supports the classification of PRDX2 as a peroxidase; however, this reasoning does not directly address the gold answer ('antioxidant') or the provided gold supporting sentence. The supporting sentence is relevant but fails to cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "antioxidant", "gold_support": "Here, we offer the first evidence that an antioxidant enzyme has a key role in this transition.", "model_answer": "Answer: Peroxiredoxin 2 is a peroxidase.", "model_support": "Supporting sentence: \"the natural compound gliotoxin, which is known to exert a Prx-like activity,\"  \n**Reasoning**: The term \"Prx-like activity\" refers to peroxiredoxin-like activity, and peroxiredoxins (including PRDX2) are classified as peroxidases. While the context does not explicitly state \"peroxidase,\" the mention of \"Prx-like activity\" implicitly identifies PRDX2 as a member of the peroxidase enzyme family.", "retries": 1}
{"idx": 265, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively highlights the context of pridopidine being tested for Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 266, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('S-adenosylmethionine' vs. 'S-Adenosyl methionine'), with only minor formatting differences that do not affect correctness. However, the model incorrectly states that there is no supporting sentence in the context, while the gold supporting sentence explicitly mentions S-Adenosyl methionine as the methyl donor. Despite this oversight, the correct answer demonstrates knowledge of the biochemical process, and the reasoning would have been stronger had the model identified the relevant sentence.\", \"match\": true}", "gold_answer": "S-Adenosyl methionine", "gold_support": "To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine.", "model_answer": "Answer: S-adenosylmethionine (SAM)", "model_support": "The context does not mention the methyl donor of histone methyltransferases. Therefore, there is no supporting sentence in the provided text to confirm that \"S-adenosylmethionine (SAM)\" is the methyl donor. The answer relies on external biochemical knowledge rather than the given context. \n\n**Supporting sentence:** None explicitly stated in the context.", "retries": 1}
{"idx": 267, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the symptoms listed (spastic hemiplegia, microcephaly, developmental delay, and recurrent seizures) are indeed associated with Dyke-Davidoff-Masson syndrome, the characteristic feature that directly defines the condition is 'cerebral hemiatrophy,' as stated in the gold answer. The supporting sentence mentions relevant clinical features but does not cover the gold answer ('cerebral hemiatrophy') or align with the gold supporting sentence, which focuses on the diagnostic imaging findings.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic features of Dyke-Davidoff-Masson syndrome include spastic hemiplegia, microcephaly, developmental delay, and recurrent seizures.", "model_support": "Supporting sentence: A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains.", "retries": 1}
{"idx": 268, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'One' does not match the gold standard of '7', but the context does mention TAp73 isoforms (plural), which could imply more than one. The supporting sentence is relevant as it discusses TAp73 isoforms, but it does not cover the gold answer and instead supports the incorrect model answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One.", "model_support": "Supporting sentence: Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions. \n\n**Note**: The context explicitly mentions \"TAp73 isoforms\" (plural), which contradicts the provided answer of \"One.\" However, the question asks for the sentence supporting the given answer, and this sentence is the only one referencing TAp73 isoforms. The discrepancy between the context and the answer may indicate an error in the answer.", "retries": 1}
{"idx": 269, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's answer correctly identifies BACH1 as a repressor, aligning with the gold answer. The supporting sentence provides context about feedback regulation and HO-1 protection but does not explicitly state that BACH1 is a repressor, making it slightly less direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "BTB and CNC homolog 1 (Bach1) is a transcriptional repressor of heme oxygenase-1 (HO-1).", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: It plays an important role in the feedback regulation of HO-1 expression, which protects cells from various insults including oxidative stress and inflammatory cytokines.  \n\n**Analysis**: The context states that Bach1 regulates HO-1 expression, and the study's results (e.g., increased HO-1 immunopositivity in Bach1-deficient mice) imply that Bach1 normally represses HO-1. While the sentence does not explicitly use the term \"repressor,\" the role of Bach1 in feedback regulation and the observed upregulation of HO-1 upon its deficiency strongly suggest that Bach1 acts as a repressor of HO-1. This aligns with the answer that BACH1 is a repressor.", "retries": 1}
{"idx": 270, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Bach1 acts as a repressor in the context of heme-dependent regulation, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.", "retries": 1}
{"idx": 271, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. Although the model notes that the context doesn't explicitly mention the bacterium, the background clearly identifies Clostridium botulinum as the cause of botulism, making the answer accurate.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "BACKGROUND: Botulism is a serious neuroparalytic disease caused by toxins of Clostridium botulinum.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly mention the bacterium responsible for botulism (Clostridium botulinum). While the text discusses botulinum toxin and botulism cases, it does not include a direct statement identifying the bacterium. The answer \"Clostridium botulinum\" is based on general knowledge, not the provided context. \n\n**Supporting sentence:** None found in the context.", "retries": 1}
{"idx": 272, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by focusing on specific details like 'novel partial gene deletions' which are not essential to directly support the gene's role in the syndrome. The logic is strong, but it could be more concise.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2 gene", "model_support": "Supporting sentence: \"Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\"  \n\nThis sentence directly identifies *ZEB2* as the gene associated with Mowat-Wilson syndrome through mutations and deletions observed in the patient cohort.", "retries": 1}
{"idx": 273, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is relevant but contains some redundancy and does not directly focus on the specific role of Clostridium botulinum as the cause of botulism. The gold supporting sentence is more precise in mentioning the disease's association with Clostridium botulinum strains, particularly group III. The model’s supporting sentence mentions a method (multiplex real-time PCR) that is not directly essential to the answer, making it slightly less focused.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease in animals is mainly caused by toxins produced by Clostridium botulinum strains belonging to group III, although outbreaks due to toxins produced by group I and II organisms have been recognized.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: Multiplex real-time PCR for detecting and typing Clostridium botulinum group III organisms and their mosaic variants.", "retries": 1}
{"idx": 274, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context by linking nestin to specific growth conditions that increase its expression, but it contains slight redundancy compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "Only a minority of stem cells expressed nestin, a marker for neural precursor cells.", "model_answer": "Answer: Nestin", "model_support": "Supporting sentence: Cultivation in serum-free medium supplemented with specific growth factors resulted in a markedly higher percentage of nestin-positive cells.", "retries": 1}
{"idx": 275, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but includes slight redundancy by mentioning Synphilin-1's interaction with alpha-synuclein, which is not necessary to directly support the role of alpha-synuclein as the main component of Lewy bodies.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"  \nAlthough this sentence mentions Synphilin-1's presence in Lewy bodies, the broader context clarifies that alpha-synuclein is recruited to synphilin-1A inclusion bodies, which resemble Lewy bodies. The answer \"alpha-synuclein\" is supported by the implication that these inclusion bodies (similar to Lewy bodies) contain alpha-synuclein, as stated in the sentence: \"accumulation of ubiquitylated synphilin-1 leads to massive formation of inclusion bodies, which resemble Lewy bodies by their ability to recruit alpha-synuclein.\" This directly ties alpha-synuclein to the composition of Lewy bodies.", "retries": 1}
{"idx": 276, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer 'Icatibant' is incorrect and does not match the gold standard 'ecallantide.' The supporting sentence acknowledges that there is no evidence in the context to support the answer, which confirms the lack of relevance and correctness. Therefore, both the answer and supporting sentence fail to align with the gold standard and context.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "DX-88 (ecallantide), a 60-amino acid recombinant protein discovered through phage display technology, is a highly specific, potent inhibitor of human plasma kallikrein that has been used successfully in the treatment of patients experiencing acute HAE attacks.", "model_answer": "Answer: Icatibant", "model_support": "The context does not explicitly mention \"Icatibant\" or directly link \"DX-88\" to Icatibant. Therefore, there is no supporting sentence in the provided text to confirm that DX-88 is the investigational name of Icatibant. The answer may rely on external knowledge, but based solely on the context, the connection is not stated. \n\n**Supporting sentence:** None found in the context.", "retries": 1}
{"idx": 277, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('semagacestat'), but it is present in the context as LY450139 is indeed a γ-secretase inhibitor. However, the supporting sentence, while relevant, does not cover the gold answer because it fails to mention 'semagacestat,' which is critical for fully answering the question.\", \"match\": false}", "gold_answer": "semagacestat", "gold_support": "The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.", "model_answer": "Answer: LY450139 is the investigational name of a γ-secretase inhibitor.", "model_support": "Supporting sentence: \"the γ-secretase inhibitor LY450139, or vehicle with a dosing interval of 1 week.\"  \n\nThis sentence explicitly identifies LY450139 as a γ-secretase inhibitor, directly answering the question.", "retries": 1}
{"idx": 278, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly ('cysteine'). The supporting sentence is relevant and covers the answer by referencing genetic variants related to cysteine, but it contains slight redundancy and does not directly state that cysteine mutations are the most common, as implied by the gold supporting sentence. Overall, the logic is sound but could be more precise.\", \"match\": true}", "gold_answer": "cysteine", "gold_support": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease due to mutations involving loss or gain of a cysteine residue in the NOTCH3 gene.", "model_answer": "Answer: Cysteine", "model_support": "Supporting sentence: \"Moreover genetic variants different from loss or gain of a cysteine residue are identified and presented.\"  \n\n**Note**: While the context does not explicitly state that *cysteine* is the most commonly mutated residue, the phrase \"loss or gain of a cysteine residue\" implies that cysteine mutations (e.g., substitution, deletion, or addition) are a known mechanism in CADASIL. This aligns with the broader scientific understanding of CADASIL (which involves NOTCH3 mutations, often affecting cysteine residues in EGF-like domains), even though the context itself does not directly quantify cysteine mutations as the most common. The provided sentence is the closest reference to cysteine in the text.", "retries": 1}
{"idx": 279, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('p53'). The supporting sentence selected is concise, directly relevant, and covers the answer with clear and logical reasoning by explaining p53's role as a tumor suppressor gene. Although the model notes that the exact phrase 'the guardian of the genome' is not present in the context, it still logically connects p53 to its widely recognized role, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "di", "gold_support": "The p53 gene has been referred to as 'the guardian of the genome' because it controls apoptosis and cell cycle arrest.", "model_answer": "Answer: p53", "model_support": "The context does not explicitly mention the term \"the guardian of the genome\" or directly attribute this nickname to p53. However, the study focuses on p53 as a tumor suppressor gene, and the answer \"p53\" is widely recognized in biomedical literature as \"the guardian of the genome.\" Since the question asks for a supporting sentence **from the context**, but no such phrasing exists in the provided text, there is **no direct supporting sentence**. \n\nIf forced to select a sentence related to p53's role, the closest would be:  \n**\"The purpose of this study was to evaluate the association of p53 codon 72 genetic polymorphism and the p53 immunohistochemistry with Helicobacter pylori-associated gastroduodenal diseases...\"**  \nThis implies p53's significance as a tumor suppressor, but it does not explicitly state the nickname.  \n\n**Answer:** The context does not include a sentence explicitly stating that p53 is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 280, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides logical support by explaining that direct factor Xa inhibitors target Factor Xa, which includes betrixaban. However, it is slightly less specific than the gold supporting sentence, which directly lists betrixaban as one of the inhibitors targeting Factor Xa. The model's supporting sentence could be improved by explicitly referencing betrixaban.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.  \n\n**Note**: While the context does not explicitly mention \"betrixaban,\" the question assumes general knowledge that betrixaban is a direct factor Xa inhibitor. The supporting sentence establishes that the class of \"direct factor Xa inhibitors\" targets Factor Xa, which applies to betrixaban as a member of this class.", "retries": 1}
{"idx": 281, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"p53, often referred to as the 'guardian of the genome.'\"", "retries": 1}
{"idx": 282, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, though it omits the abbreviation '(CMA)' which is present in the gold answer. The supporting sentence is relevant and concise, capturing the key relationship between the KFERQ motif and chaperone-mediated autophagy, but it does not explicitly mention Hsc70 or LAMP-2A as the gold supporting sentence does, resulting in slight incompleteness.\",\n  \"match\": true\n}", "gold_answer": "chaperone-mediated autophagy (CMA)", "gold_support": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes through the LAMP-2A (Lysosome-associated membrane protein type 2A) receptor.", "model_answer": "Answer: Chaperone-mediated autophagy", "model_support": "Supporting sentence: \"The KFERQ motif in cytosolic proteins targets them for chaperone-mediated autophagy (CMA).\"", "retries": 1}
{"idx": 283, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly mention the gene strand, the gold supporting sentence from the context directly supports the answer by stating that TCR preferentially repairs the transcribed strand. The model’s explanation aligns well with the scoring criteria, as the correct reasoning is implicit in the context provided.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "It has been previously shown that disruption of RAD26 in yeast strain W303-1B results in a strain that is deficient in transcription-coupled repair (TCR), the preferential repair of the transcribed strand of an expressed gene over the non-transcribed strand and the rest of the genome.", "model_answer": "Answer: The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "The context does not explicitly mention which gene strand is targeted by transcription-coupled repair (TCR). The answer \"the transcribed strand\" is a general biological fact (TCR specifically repairs the transcribed strand of DNA during transcription), but the provided context does not include a sentence supporting this specific claim. \n\n**Supporting sentence:** None explicitly stated in the context. \n\nThe context focuses on RAD26's role in chromatin remodeling and TCR proficiency, but it does not address the specific gene strand targeted by TCR.", "retries": 1}
{"idx": 284, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'SERCA2a' is very close to the gold answer 'SERCA2,' as SERCA2a is a specific isoform of the SERCA2 gene. The supporting sentence is relevant and accurate, mentioning that SERCA2a is the main isoform in the heart; however, it does not explicitly connect to the broader term 'SERCA2' as the gold answer requires. The logic is strong but slightly less general than ideal.\", \"match\": false}", "gold_answer": "SERCA2", "gold_support": "During diastole, muscle relaxation occurs as Ca2+ is again removed from cytosol, predominantly by accumulation into SR via the action of SERCA2a.", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: SERCA is mainly represented by the SERCA2a isoform in the heart.", "retries": 1}
{"idx": 285, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is concise, but it does not fully cover the function of the NF1 gene as described in the gold supporting sentence. The model's supporting sentence focuses on the tumor-suppressor role without mentioning neurofibromin or its regulatory role in RAS function, which are key details in the gold standard.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "The NF1 gene codes for a protein called \"neurofibromin.\" It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: The evidence points to the NF1 gene being a tumor-suppressor gene.", "retries": 1}
{"idx": 286, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by identifying the COMPASS family as H3K4 methylases, which includes MLL1.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "Methylation of histone H3 lysine 4 (H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax (Trx).", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: The COMPASS family of H3K4 methylases in Drosophila.  \n\nThis sentence directly states that the COMPASS family (which includes MLL1 as part of its human counterparts) is responsible for methylating H3K4, as the name \"H3K4 methylases\" explicitly identifies the histone residue targeted.", "retries": 1}
{"idx": 287, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'p16INK4a', is present in the context but does not match the gold standard exactly ('p16INK4'). The supporting sentence mentions p16INK4a in relation to Bmi-1, but it highlights the lack of correlation rather than regulation, which does not directly support the gold answer. While the answer is relevant, the supporting sentence fails to cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "p16INK4", "gold_support": "Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.", "model_answer": "Answer: p16INK4a", "model_support": "Supporting sentence: However, there was no correlation between expression of Bmi-1 and p16INK4a, p14ARF, or h-TERT. \n\n**Note**: While the sentence explicitly states *no correlation* between Bmi-1 and p16INK4a, the question's answer (\"p16INK4a\") is directly referenced in this sentence. The context does not provide evidence of regulation but acknowledges p16INK4a as a target in the discussion of Bmi-1's potential mechanisms.", "retries": 1}
{"idx": 288, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to extract the specific information about Semagacestat being the drug corresponding to LY450139.\", \"match\": false}", "gold_answer": "Semagacestat", "gold_support": "The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.", "model_answer": "Answer: Not mentioned in the context.", "model_support": "Supporting sentence: The context does not mention LY450139.  \nExplanation: The context discusses γ-secretase modulators (GSMs) like Tarenflurbil and their mechanisms but does not reference LY450139 or its corresponding drug. Therefore, the answer \"Not mentioned in the context\" is accurate, and no supporting sentence exists.", "retries": 1}
{"idx": 289, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly more specific than necessary. The model's supporting sentence focuses on a particular case of genomic DNA confirmation, whereas the gold supporting sentence provides a broader description of the disease in women. However, the logic and relevance are still strong.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: In a Filipino woman with suspected Parkinson disease, we confirmed the presence of all changes specific for X-linked dystonia-parkinsonism in genomic DNA.", "retries": 1}
{"idx": 290, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antiparallel') in meaning, and the supporting sentence is relevant and provides context about antiparallel structures. However, the chosen supporting sentence focuses on the structure of R16 (antiparallel alpha-helices) rather than explicitly stating that alpha- and beta-spectrin form an antiparallel heterodimer, which makes it slightly less direct compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "Supporting sentence: R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.  \n\nThis sentence directly states that the spectrin repeat (R16) consists of **antiparallel alpha-helices**, which aligns with the formation of antiparallel heterodimers between alpha-spectrin and beta-spectrin subunits via their interacting helices.", "retries": 1}
{"idx": 291, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa' vs. 'Factor Xa'), which is acceptable as it conveys the same meaning with slightly different wording. The supporting sentence is relevant and supports the answer by referencing a factor Xa decoy, implying betrixaban's role in inhibiting Factor Xa. However, the supporting sentence contains slight redundancy by introducing additional information about PRT4445, which is not necessary for directly supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban inhibits Factor Xa, as PRT4445 is described as a \"factor Xa decoy\" designed to reverse anticoagulants targeting Factor Xa.", "retries": 1}
{"idx": 292, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but specifies '1,4-benzothiazepine' instead of the more general 'benzothiazepine,' which could still be considered correct though less precise. The supporting sentence provided by the model does not directly support the answer as it discusses diltiazem, a 1,5-benzothiazepine derivative, rather than JTV519 itself. However, the context implies that JTV519 belongs to the benzothiazepine group, making the logic reasonable but not fully concise or directly supportive.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note:** The context provided does not explicitly state that JTV519 is a 1,4-benzothiazepine derivative. The sentence above mentions diltiazem as a 1,5-benzothiazepine derivative but does not classify JTV519. This suggests a discrepancy between the answer and the context. If the answer is \"1,4-benzothiazepine,\" the supporting sentence would need to explicitly state that JTV519 is a derivative of this group, which is absent in the provided text.", "retries": 1}
{"idx": 293, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (ZFHX1B is the same as Zfhx1b in a case-insensitive context); supporting sentence is concise, directly relevant, and logically covers the answer by linking the removal of Zfhx1b to Mowat-Wilson syndrome.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "Answer: Zfhx1b", "model_support": "Supporting sentence: Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.", "retries": 1}
{"idx": 294, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about alpha-synuclein (AS) and its aggregation, but it focuses more on the interaction with beta-synuclein rather than directly stating that alpha-synuclein is the main component of Lewy bodies. This makes it slightly less concise and direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Beta-synuclein (BS) inhibits AS aggregation in vitro and in vivo and has been shown to interact directly with AS regulating its functionality and preventing its oligomerization.\"  \n\n**Explanation**: While the context does not explicitly state that alpha-synuclein is the main component of Lewy bodies, the mention of \"AS aggregation\" (where AS refers to alpha-synuclein) and its role in oligomerization aligns with the well-established pathological association of alpha-synuclein with Lewy bodies. The study's focus on synuclein expression in Lewy body disorders (e.g., Parkinson disease) further supports this inference.", "retries": 1}
{"idx": 295, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard, which states that there are 7 TAp73 isoforms. Additionally, the supporting sentence provided by the model discusses upregulation of certain isoforms in tumors but does not address the number of isoforms, making it irrelevant to the question. The supporting sentence also fails to logically support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "model_answer": "Answer: One", "model_support": "Supporting sentence: TAp73, DeltaNp73 and DeltaN'p73 were significantly upregulated in tumors.", "retries": 1}
{"idx": 296, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that there is no supporting sentence in the provided context, the gold supporting sentence directly confirms the answer with concise and relevant information. The model's reasoning acknowledges this gap but correctly identifies the answer.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15-1788).", "model_answer": "Answer: Flumazenil", "model_support": "The context provided does not include any information about antidotes for benzodiazepine overdose or mention of Flumazenil. Therefore, there is no supporting sentence in the given context to justify the answer. \n\nSupporting sentence: *Not present in the provided context.* \n\n(Note: The correct antidote for benzodiazepine overdose is Flumazenil, but this conclusion cannot be drawn from the given context.)", "retries": 1}
{"idx": 297, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies medicarpin as the phytoalexin in question and ties it to its biosynthesis through isoflavone reductase, which aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence explicitly identifies **medicarpin** as the phytoalexin whose biosynthesis involves IFR, confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 298, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('CGRP receptor' is equivalent to 'calcitonin gene-related peptide'). However, the supporting sentence introduces ambiguity by stating that the context does not explicitly mention the CGRP receptor, which is incorrect since the gold supporting sentence clearly identifies telcagepant as a CGRP receptor antagonist. The model's supporting sentence contains slight redundancy and unnecessary doubt, but the logic is still valid.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.", "model_answer": "Answer: CGRP receptor", "model_support": "Supporting sentence: The context does not explicitly mention the CGRP receptor or the specific receptor targeted by telcagepant. However, based on prior knowledge, telcagepant is a CGRP receptor antagonist, but this information is not included in the provided text. \n\nIf the answer is expected to be derived solely from the context, there is no supporting sentence. However, if the answer is based on external knowledge, the context does not contain the necessary information. \n\n**Note:** The provided context focuses on tolerability and adverse events comparisons between telcagepant and rizatriptan but does not specify the receptor targeted by telcagepant.", "retries": 1}
{"idx": 299, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about Dnmt1's role in methylation, but it is slightly less comprehensive than the gold supporting sentence, which explains the broader importance of Dnmt1 in the inheritance of DNA methylation patterns.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "The maintenance methylation of hemimethylated CpG sites by the DNA methyltransferase Dnmt1 is the molecular basis of the inheritance of DNA methylation patterns.", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.", "retries": 1}
{"idx": 300, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights the abundance of modified α-synuclein in Lewy bodies, aligning perfectly with the gold answer.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "The main component of Lewy bodies is α-synuclein.", "model_support": "Supporting sentence: \"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.\"  \n\nThis sentence directly identifies α-synuclein (AS) as a key component of Lewy bodies, as the context explicitly links AS modifications to their composition.", "retries": 1}
{"idx": 301, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it only mentions two specific isoforms rather than the total number of TAp73 isoforms identified in humans.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: p73, the first p53 gene homologue, encodes an array of p73 proteins including p73 alpha full-length (TAp73 alpha) and amino-truncated isoforms (Delta Np73 alpha), two proteins with opposite biological functions.", "retries": 1}
{"idx": 302, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about TCR targeting the transcribed strand via recognition of stalled RNA polymerase, but it contains slight redundancy by mentioning Cockayne syndrome gene products without directly emphasizing 'transcribed strand' as clearly as the gold supporting sentence. Overall, it logically supports the answer but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 303, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('The ZEB2 gene') does not match the gold standard ('ZFHX1B'), but it is correct based on external knowledge. The supporting sentence acknowledges that the context does not provide this information and no relevant supporting sentence is available from the text. However, the gold supporting sentence explicitly mentions 'ZFHX1B,' which the model failed to extract.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "Haploinsufficiency of a gene termed ZFHX1B (also known as SIP1) on chromosome 2 is responsible for this condition, and clinical genetic testing for MWS recently became available.", "model_answer": "Answer: The ZEB2 gene.", "model_support": "The context provided does not mention the ZEB2 gene or any specific gene responsible for Mowat-Wilson syndrome. Therefore, **there is no supporting sentence** in the given text that directly identifies the gene. \n\nHowever, if the answer is based on external knowledge (as ZEB2 is indeed the gene associated with Mowat-Wilson syndrome), the context here does not include this information. The text focuses on clinical features, management, and prevalence but does not reference the genetic cause. \n\n**Supporting sentence (if available in the context):** None.  \n**Note:** The answer \"ZEB2\" is correct based on medical literature, but it is not supported by the provided context.", "retries": 1}
{"idx": 304, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly verbose and includes additional details about the experiment setup rather than directly focusing on the key role of CYP17A1 as the enzyme inhibited by orteronel.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on CYP17A1 enzymatic activity, steroid production in monkey adrenal cells and human adrenal tumor cells...\"", "retries": 1}
{"idx": 305, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 306, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by specifying 'chronic hemoptysis in cystic fibrosis,' which is not necessary to explain the cause of restless leg syndrome.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.", "model_answer": "Answer: Iron deficiency", "model_support": "Supporting sentence: Restless leg syndrome manifested by iron deficiency from chronic hemoptysis in cystic fibrosis.", "retries": 1}
{"idx": 307, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The additional details about semagacestat being a γ-secretase inhibitor and its development for Alzheimer's disease are relevant but do not detract from the clarity or correctness of the response.\", \"match\": true}", "gold_answer": "semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "Answer: Semagacestat", "model_support": "Supporting sentence: Semagacestat (LY450139) is a novel γ-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD).  \n\nThis sentence explicitly states that \"Semagacestat\" is the drug name associated with the investigational name \"LY450139.\"", "retries": 1}
{"idx": 308, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'SERCA' is an acceptable abbreviation and matches the gold standard conceptually, though it is not the full term. The supporting sentence mentions SERCA in the context of its role and modulation but does not directly state its function as the calcium pump. It provides relevant information with slight redundancy by discussing therapeutic implications rather than focusing solely on SERCA's role as the calcium pump.\", \"match\": true}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA.", "model_support": "Supporting sentence: Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.  \nThis sentence explicitly identifies SERCA as the calcium pump being discussed in the context of sarcoplasmic reticulum function.", "retries": 1}
{"idx": 309, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'SECIS element' matches the gold standard 'SECIS' closely, with only a minor difference in phrasing (adding 'element'). The supporting sentence is relevant and introduces the concept of SECIS elements accurately. However, it is slightly verbose and does not directly mention the 3' untranslated region or the stem-loop structure as specifically as the gold supporting sentence. Overall, it provides logical support but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Two functional SECIS elements were identified in the 3' untranslated region of the rat selenoprotein P mRNA, with predicted stem-loops and critical nucleotides similar to those in the SECIS elements in the type I iodothyronine 5' deiodinase (5'DI) and glutathione peroxidase selenoprotein mRNAs.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons.  \n\nThis sentence explicitly identifies \"SECIS elements\" as the stem-loop structures involved in selenocysteine insertion, which are located in the 3' end of selenoprotein genes. The context further confirms their role in eukaryotic selenoprotein mRNAs.", "retries": 1}
{"idx": 310, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK gene' is equivalent to 'XK'). The supporting sentence is relevant and covers the answer, but it includes additional information about the lack of hematologic, neuromuscular, or cerebral involvement, which is not necessary for directly supporting the answer. This makes it slightly verbose compared to the gold supporting sentence, which is more concise and directly mentions the mutation in the XK gene.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.", "retries": 1}
{"idx": 311, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Myelosuppression, predominantly neutropenia and leucopenia,' does not match the gold standard 'Cardiotoxicity,' but it is mentioned in the context as a significant toxicity (dose-limiting toxicity). However, it is not identified as the major adverse effect. The supporting sentence focuses on myelosuppression and other frequent toxicities, which are relevant but do not cover the gold answer or its reasoning related to cardiotoxicity. Therefore, while relevant, the supporting sentence fails to address the major adverse effect described in the gold standard.\", \"match\": false}", "gold_answer": "Cardiotoxicity", "gold_support": "Cardiotoxicity is a major adverse effect of the anthracycline antibiotics and can be acute or chronic; in the acute setting, electrocardiographic abnormalities may be seen, including ST-T elevations and arrhythmias, but chronic cardiotoxicity represents a serious adverse effect that may be lethal due to the development of irreversible, cumulative dose-dependent, congestive cardiomyopathy.", "model_answer": "Answer: Myelosuppression, predominantly neutropenia and leucopenia.", "model_support": "Supporting sentence: \"Myelosuppression, predominantly neutropenia and leucopenia, is the dose-limiting toxicity; in addition to this, mucositis, nausea, vomiting and alopecia are frequent, whereas hepatopathy, characterised by elevated bilirubin concentrations, occurs less frequently.\"", "retries": 1}
{"idx": 312, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about ecallantide but does not explicitly mention DX-88, which is part of the gold supporting sentence. The logic is strong, but slight redundancy exists as it focuses on the mechanism rather than directly linking to the investigational name.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.", "model_answer": "Answer: Ecallantide", "model_support": "Supporting sentence: Ecallantide, a novel plasma kallikrein inhibitor, inhibits production of bradykinin, the key mediator of these angioedema attacks.  \n\n(Note: The context provided does not explicitly mention \"DX-88\" as an investigational name. However, based on the answer \"Ecallantide\" and the context's focus on ecallantide as a drug for HAE, the sentence introducing ecallantide is the most relevant. If \"DX-88\" is a typo or misstatement, the answer aligns with the text's reference to ecallantide as a novel plasma kallikrein inhibitor.)", "retries": 1}
{"idx": 313, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('JNK'), and the supporting sentence is relevant, referencing the mitogen-activated protein kinase pathways, which include JNK. However, the supporting sentence does not explicitly mention JNK as the specific MAP kinase responsible for phosphorylating c-jun, making it slightly less direct than the gold supporting sentence. The reasoning is sound but could be more precise.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "The expressions of Bcl-2, Bax, caspase-3, extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal protein kinases (JNK), and p38 were evaluated by Western blot.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: The mechanisms of apoptosis might be associated with the activation of the mitochondria-initiated and the mitogen-activated protein kinase pathways.  \n\n**Note:** While the context does not explicitly name *JNK (c-Jun N-terminal kinase)*, it references \"mitogen-activated protein kinase pathways,\" which include JNK as a known member. The answer relies on general knowledge of MAP kinase families, as the context does not directly specify JNK.", "retries": 1}
{"idx": 314, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Na+-Ca2+ exchanger' is equivalent to the gold standard 'NCX' as NCX is an abbreviation for the Na+-Ca2+ exchanger. The supporting sentence is concise, directly relevant, and logically explains that SEA0400 is a specific inhibitor of the Na+-Ca2+ exchanger, aligning well with the gold supporting sentence. Minor extra details in the supporting sentence are acceptable since they do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "Using SEA0400, a potent and selective inhibitor of the Na+-Ca2+ exchanger (NCX), we examined whether NCX is involved in nitric oxide (NO)-induced disturbance of endoplasmic reticulum (ER) Ca2+ homeostasis followed by apoptosis in cultured rat microglia.", "model_answer": "Answer: Na+-Ca2+ exchanger", "model_support": "Supporting sentence: SEA0400, a specific inhibitor of the Na+-Ca2+ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia.", "retries": 1}
{"idx": 315, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('nestin'), but the supporting sentence provided by the model does not directly come from the context. Instead, the model seems to rely on external knowledge, which is not reflected in the given text. The gold supporting sentence is present in the context and directly supports the answer with clear relevance. However, the model's attempt to explain the absence of support in the provided context leads to verbosity without fully utilizing the available information.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "In the subventricular zone, this effect was exerted selectively on a precursor subpopulation expressing nestin but not neuronal or glial cell-specific proteins.", "model_answer": "Answer: Nestin", "model_support": "The context provided does not mention **Nestin** or any specific intermediate filament (IF) protein as a marker for neuronal precursor cells in the subventricular zone. Therefore, **no sentence in the given context supports the answer**. \n\nHowever, if the answer is expected to be **Nestin** based on external knowledge (as Nestin is a well-established marker for neural stem/progenitor cells), the context here does not include this information. The question may be based on a different or incomplete context. \n\n**Supporting sentence (if available in a correct context):**  \n*\"Nestin is a well-characterized intermediate filament protein expressed in neural stem cells and progenitors, making it a non-specific marker for neuronal precursor cells in the subventricular zone.\"*  \n\nBut this sentence is not present in the provided text.", "retries": 1}
{"idx": 316, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antioxidant') in essence, though it includes the word 'enzyme,' which is implied but not explicitly required by the question. The supporting sentence provides relevant context and aligns with the gold supporting sentence by referencing PRDX2 as an antioxidant enzyme tied to Srx-dependent modification. However, the supporting sentence is slightly verbose and draws broader contextual reasoning rather than directly quoting the concise gold supporting sentence. This makes the logic sound but less direct.\",\n  \"match\": true\n}", "gold_answer": "antioxidant", "gold_support": "The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats.", "model_answer": "Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme.", "model_support": "Supporting sentence: \"Gene expression of PRDX2, identified as an Srx-dependent modified enzyme, was stimulated by gonadotropins.\"  \nAlthough the text does not explicitly state that PRDX2 is an antioxidant enzyme, the context focuses on antioxidant systems (e.g., reactive oxygen species, sulfiredoxin [Srx], and hydrogen peroxide regulation). The term \"peroxiredoxin\" in the title and the association of PRDX2 with Srx-dependent modification (a process linked to antioxidant pathways) imply its role as an antioxidant enzyme. Additionally, the study's emphasis on ROS and antioxidant mechanisms reinforces this classification.", "retries": 1}
{"idx": 317, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Eukarya', does not match the gold standard, 'Fungi'. Although 'Eukarya' is a correct higher-level classification, it is too broad and does not address the specific question about the current classification scheme linking Microsporidia to Fungi. The supporting sentence mentions that Microsporidia are eukaryotic parasites but does not provide any information connecting them specifically to Fungi, which is required to support the gold answer. Thus, while relevant, the supporting sentence does not fully cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "Fungi", "gold_support": "Phylogenetic analysis indicates a relationship between the Microsporidia and the Fungi.", "model_answer": "Answer: Eukarya", "model_support": "Supporting sentence: Microsporidia are a group of obligate intracellular eukaryotic parasites that infect a wide variety of species, including humans.", "retries": 1}
{"idx": 318, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that pridopidine treatment was studied in the context of Huntington disease.\",\n  \"match\": true\n}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 319, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('parallel') does not match the gold standard ('antiparallel'). The supporting sentence provided by the model discusses electrostatic interactions and complementary potentials but misinterprets these as evidence for a parallel orientation. While the sentence is relevant to spectrin dimerization, it does not logically support the gold answer ('antiparallel'), which is explicitly stated in the context as the correct orientation of the heterodimer. The misunderstanding of the interaction described leads to an incorrect conclusion.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "The spectrin heterodimer is formed by the antiparallel lateral association of an alpha and a beta subunit, each of which comprises largely a series of homologous triple-helical motifs.", "model_answer": "Answer: Parallel", "model_support": "Supporting sentence: \"Modeling of the electrostatic potential on the surface of the alpha20 and beta2 motifs showed that the side of the motifs comprising the A and B helices is the most favorable for association, with an area of positive electrostatic potential on the AB face of the beta2 motif opposite negative potential on the AB face of the alpha20 motif and vice versa.\"  \n\nThis sentence describes complementary electrostatic interactions between the AB faces of the alpha20 and beta2 motifs, which implies a **parallel** orientation. The \"opposite\" alignment of positive and negative potentials on corresponding AB faces indicates that the motifs are aligned in the same direction (parallel) to facilitate charge complementarity, rather than antiparallel. Additionally, the text emphasizes that \"correct pairing of motifs, i.e., alpha21-beta1 and alpha20-beta2\" is initiated by these interactions, further supporting a parallel arrangement.", "retries": 1}
{"idx": 320, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer is incorrect as the context does contain the synonym for lubag disease, which is 'X-linked dystonia-Parkinsonism.' The supporting sentence acknowledges that the context doesn't explicitly mention a synonym but incorrectly concludes the question is unanswerable. While the supporting sentence is relevant in pointing out the lack of direct mention, it fails to identify the synonym provided in the context, leading to a lower score.\", \"match\": false}", "gold_answer": "X-linked dystonia-Parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The question is not answerable with the given context.", "model_support": "Supporting sentence: The context does not mention \"lubag disease\" or any synonym for it.  \nExplanation: The provided context discusses \"lingual dystonia\" and \"botulinum toxin injection,\" but there is no reference to \"lubag disease\" or its synonym. The question cannot be answered with the given information.", "retries": 1}
{"idx": 321, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'NCX (sodium-calcium exchanger)' is equivalent to the gold answer 'NCX'. The supporting sentence provided by the model is relevant and explains the context of NCX inhibition by SEA0400, though it is slightly more verbose than necessary compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: Thus, we examined the effect of SEA0400 on NCX currents and I/R induced intracellular Ca²+ overload in mouse ventricular myocytes using patch clamp techniques and fluorescence measurements.", "retries": 1}
{"idx": 322, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is equivalent to '5-HT2A'). The supporting sentence is concise, directly relevant, and clearly supports the answer by logically connecting [18F]altanserin with its use in studying 5-HT2A receptors. Minor extra details do not detract from the strong logical reasoning.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"the development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 323, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('No hormone abnormalities are characteristic to Pendred syndrome') does not match the gold standard ('thyroid'), which indicates that thyroid-related issues are characteristic. The supporting sentence correctly highlights normal TSH levels, but it does not cover the gold answer or fully explain the characteristic thyroid abnormalities (e.g., goiter) associated with Pendred syndrome. Therefore, while the supporting sentence is relevant, it fails to address the gold answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter.", "model_answer": "Answer: No hormone abnormalities are characteristic to Pendred syndrome.", "model_support": "Supporting sentence: \"serum thyrotropin (TSH) levels and iodine organification (examined by the perchrolate or thiocyanate discharge test) remained normal.\"  \n\nThis sentence directly states that TSH (a hormone) levels were normal in the patient, supporting the conclusion that **no hormone abnormalities are characteristic** of Pendred syndrome.", "retries": 1}
{"idx": 324, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying the role of EWS/FLI1 in regulating EYA3, which aligns with the context provided. Minor extra details are acceptable as they enhance clarity without detracting from the main point.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "Answer: EWS/FLI1", "model_support": "Supporting sentence: EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.", "retries": 1}
{"idx": 325, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 326, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about medicarpin biosynthesis, but it is slightly more detailed than necessary and does not directly state that medicarpin is the major phytoalexin in alfalfa, as the gold supporting sentence does. This makes it somewhat less concise and direct, though still logical and supportive.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: One of the final steps of medicarpin biosynthesis, from vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, is catalyzed by vestitone reductase.", "retries": 1}
{"idx": 327, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and is correct in context. The supporting sentence is relevant and supports the answer well, but it is slightly more detailed than necessary compared to the concise gold supporting sentence. The additional detail about differentiating stroke from mimics adds some redundancy.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 328, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the supporting sentence is slightly truncated compared to the gold supporting sentence, it retains all essential information needed to logically support the answer without introducing any redundancy.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.\"", "retries": 1}
{"idx": 329, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence is incorrect. The provided context does contain relevant information in the gold supporting sentence (the higher number of women in the study, n=225 vs. men, n=67), which implies a higher prevalence in women. However, the model incorrectly claims that the context does not provide explicit information about prevalence and relies on external knowledge. This makes the supporting sentence irrelevant to the context.\", \"match\": true}", "gold_answer": "women", "gold_support": "RESULTS: At baseline, men (n = 67) and women (n = 225) had similar disease activity and radiographic damage; men, however, had significantly worse erosion, while women had worse joint space narrowing.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "The context does not provide explicit information about the prevalence of Rheumatoid Arthritis (RA) in men versus women. The study focuses on disease characteristics, treatment responses, and gender differences in outcomes, but it does not mention or quantify the incidence or prevalence of RA in either gender. The conclusion notes that women had worse disease progression despite similar treatment, but this refers to disease progression, not the likelihood of developing RA. \n\n**Supporting sentence**: None. The context does not contain a sentence stating that RA is more common in women. The answer relies on external knowledge rather than the provided text.", "retries": 1}
{"idx": 330, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard, as it identifies thyroid hormone abnormalities as common in Williams syndrome. The supporting sentence is relevant and directly supports the answer by referencing congenital hypothyroidism in a patient with Williams syndrome. However, the supporting sentence contains slight redundancy ('important thyroid hypoplasia') compared to the concise gold supporting sentence. Overall, the logic is strong, but minor verbosity lowers the score.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Answer: Thyroid hormone abnormalities, such as congenital hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 331, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer by indicating Hsp70's involvement during Hsp90 inhibition. However, it does not explicitly mention 'upregulation' as clearly as the gold supporting sentence, which directly states that Hsp90 inhibition upregulates Hsp70 expression. The model's supporting sentence is slightly less direct but still logically connects to the answer.\", \"match\": true}", "gold_answer": "Hsp70", "gold_support": "Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation.", "model_answer": "Answer: Hsp70 is found to be upregulated during Hsp90 inhibition.", "model_support": "Supporting sentence: Silencing Hsp70 prevented Hsp90 inhibitor-mediated degradation of Nox5.  \n\nThis sentence indicates that Hsp70 is involved in the degradation process triggered by Hsp90 inhibition, implying that Hsp70's activity is upregulated or becomes critical under these conditions. While the text does not explicitly state \"upregulated,\" the context suggests Hsp70's role is heightened during Hsp90 inhibition, aligning with the answer.", "retries": 1}
{"idx": 332, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to extract the specific detail about peroxiredoxin 2 being an antioxidant enzyme from the context.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, was the most upregulated while tribbles homolog 3 (TRB3), a pro-apoptotic protein, was the most downregulated, implying a beneficial effect of lithium on neuronal cells.", "model_answer": "The context does not provide information about the type of enzyme peroxiredoxin 2 (PRDX2).", "model_support": "Supporting sentence: The context does not provide information about the type of enzyme peroxiredoxin 2 (PRDX2).  \n\nExplanation: The context explicitly discusses genes and pathways related to lithium's effects on human neuronal cells (e.g., *PIP5K2A*, *WIPI49*, *TRB3*, *SNX14*, *PKC*, and the MAPK pathway), but it does not mention *PRDX2* (peroxiredoxin 2) or its enzymatic classification. The absence of any reference to *PRDX2* in the text directly supports the conclusion that the context lacks information about this specific enzyme.", "retries": 1}
{"idx": 333, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.", "model_answer": "Answer: Inhibitor 1 (I-1)", "model_support": "Supporting sentence: Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.", "retries": 1}
{"idx": 334, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about alpha-synuclein being deposited abnormally, which aligns with the gold answer. However, it is slightly more general and does not specifically mention Lewy bodies or their main component as directly as the gold supporting sentence. This makes it somewhat less precise but still logically supportive.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\nThis sentence establishes that alpha-synuclein is the central component of the pathological deposits (including Lewy bodies, which are a type of neuronal inclusion) in alpha-synucleinopathies, even though the term \"Lewy bodies\" is not explicitly mentioned in the context.", "retries": 1}
{"idx": 335, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' differing only in specificity. The supporting sentence is relevant and directly supports the answer by summarizing the purpose of the ROSIER scale, though it repeats some information unnecessarily ('in the emergency room'). Overall, it provides logical support but could be slightly more concise.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 336, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('FSHD' and 'Facioscapulohumeral muscular dystrophy (FSHD)' are equivalent). The supporting sentence is concise, directly relevant, and logically explains the connection between DUX4 production and FSHD. It effectively covers the gold answer without unnecessary verbosity or irrelevant details.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: \"Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.\"  \n\nThis sentence directly links the D4Z4 array (which regulates DUX4 production) to Facioscapulohumeral muscular dystrophy (FSHD), establishing the disease association.", "retries": 1}
{"idx": 337, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'DYT1 dystonia' does not match the gold standard 'X-linked dystonia-parkinsonism,' but it is a plausible association based on external knowledge. The supporting sentence mentions misdiagnosis but does not directly connect Lubag to DYT1 dystonia or the gold answer. It fails to cover the correct relationship between Lubag and X-linked dystonia-parkinsonism as stated in the context.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism.", "model_answer": "Answer: DYT1 dystonia", "model_support": "Supporting sentence: Lubag patients are commonly misdiagnosed as idiopathic dystonia, essential tremor, Parkinson's disease, or Parkinson's-plus syndromes.  \n\n**Note**: The context does not explicitly state that \"Lubag\" is a synonym for \"DYT1 dystonia.\" The answer \"DYT1 dystonia\" may reflect external medical knowledge (e.g., Lubag is associated with DYT1 mutations), but the provided context only mentions misdiagnosis with \"idiopathic dystonia,\" not DYT1 specifically. The supporting sentence above is the closest reference, but it does not directly equate Lubag to DYT1 dystonia.", "retries": 1}
{"idx": 338, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively ties the degradation of Bach1 to its role as a repressor of HO-1, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a mammalian transcriptional repressor of HO-1.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.  \n\nThis sentence directly connects the degradation of Bach1 (repressor) to the up-regulation of HO-1, implying Bach1 functions as a repressor by inhibiting HO-1 expression under normal conditions.", "retries": 1}
{"idx": 339, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is logical, but it is slightly more detailed than necessary. The gold supporting sentence is more concise while still providing sufficient context.\", \"match\": true}", "gold_answer": "XK", "gold_support": "A spontaneous novel XK gene mutation in a patient with McLeod syndrome.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK protein of 313 amino acids, compared with 444 amino acids in the normal XK protein.", "retries": 1}
{"idx": 340, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.", "retries": 1}
{"idx": 341, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Xa factor' is correct but not directly supported by the given context. The supporting sentence provided by the model is inaccurate because it states there is no mention of betrixaban in the context, whereas the gold supporting sentence shows that betrixaban is indeed mentioned as a factor Xa inhibitor. The supporting sentence should have pointed out this information instead of claiming its absence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Xa factor", "model_support": "The context does not mention betrixaban or its mechanism of action. The only anticoagulant explicitly discussed is **dabigatran**, which is described as a \"direct thrombin antagonist.\" There is no reference to betrixaban or the Xa factor in the provided text.  \n\n**Supporting sentence**: None. The context does not contain information about betrixaban or its target clotting factor.  \n\n**Note**: The answer \"Xa factor\" is correct for betrixaban (a factor Xa inhibitor), but this detail is not supported by the given context. The context only discusses dabigatran, not betrixaban.", "retries": 1}
{"idx": 342, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically ties the synonym 'X-linked dystonia-parkinsonism (XDP)' to 'lubag disease' as stated in the context. Minor extra details in the supporting sentence do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-linked dystonia-parkinsonism (XDP) or \"lubag\" is an X-linked recessive disorder that afflicts Filipino men, and rarely, women.", "model_answer": "The synonym of the lubag disease is X-linked dystonia-parkinsonism (XDP).", "model_support": "Supporting sentence: Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (\"lubag\") in women.", "retries": 1}
{"idx": 343, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It identifies SERCA as the ER Ca²⁺-ATPase, which aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA.", "model_support": "Supporting sentence: Seipin promotes adipose tissue fat storage through the ER Ca²⁺-ATPase SERCA.  \nThis sentence explicitly identifies SERCA as the \"ER Ca²⁺-ATPase,\" which is the primary calcium pump responsible for transporting calcium into the sarcoplasmic reticulum (ER). The term \"sarcoplasmic reticulum\" is encompassed within the broader \"endoplasmic reticulum\" (ER) in this context.", "retries": 1}
{"idx": 344, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naive to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.\"", "retries": 1}
{"idx": 345, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard. The supporting sentence is relevant and provides context that microsporidia belong to the fungal tree of life, but it introduces unnecessary details about debates on their precise position, which adds slight redundancy. The gold supporting sentence is more concise and directly supports the answer.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: \"Microsporidia is one of the taxa that have experienced the most dramatic taxonomic reclassifications. However, the specific position of microsporidia within the fungal tree of life is still debated.\"  \n\nThis sentence explicitly states that microsporidia are discussed \"within the fungal tree of life,\" confirming their classification in the kingdom **Fungi** despite ongoing debates about their precise phylogenetic position.", "retries": 1}
{"idx": 346, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is close to the gold standard and captures the essence of an autoimmune mechanism, though it does not mention the environmental trigger or genetic susceptibility specifically. The supporting sentence aligns well with the gold supporting sentence but lacks the detail about the environmental trigger and genetic factors. It is relevant and supports the answer logically, though it could be more precise.\", \"match\": false}", "gold_answer": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "gold_support": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "model_answer": "Answer: The exact reason is not yet known, but the association suggests a possible autoimmune mechanism.", "model_support": "Supporting sentence: The pathological explanation of this association and narcolepsy is likely autoimmune, although supportive evidence is lacking.", "retries": 1}
{"idx": 347, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but has slight redundancy. The model's supporting sentence specifies details about variants in XK, which is accurate but slightly narrower in scope compared to the gold supporting sentence, which provides a broader context of the mutation screen. Overall, the logic is sound and directly supports the answer.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.", "retries": 1}
{"idx": 348, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as the context provided does not mention SEA0400 at all. The supporting sentence also fails to provide any relevant information about SEA0400, and instead discusses PPADS, which is unrelated to the gold answer. Both the answer and supporting sentence are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: The small molecule SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger.", "model_support": "The context does not mention \"SEA0400\" at all. The provided text discusses **PPADS** as an inhibitor of the Na⁺/Ca²⁺ exchanger (NCX) reverse mode, but there is **no reference to SEA0400** in the context. \n\n**Supporting sentence**: None (the context does not mention SEA0400). \n\nThe answer provided (\"SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger\") is **incorrect** based on the given context. The context only discusses **PPADS** as a NCX(REV) inhibitor. If the question intended to ask about **PPADS**, the supporting sentence would be:  \n*\"We found that PPADS, a P2X receptor antagonist, acts as a NCX(REV) inhibitor in guinea pig tracheal myocytes.\"*", "retries": 1}
{"idx": 349, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides an accurate context by linking 'Lubag' to 'X-linked dystonia-parkinsonism'.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "\"Lubag\" or X-linked dystonia-parkinsonism (XDP) is a genetic syndrome afflicting Filipino men.", "model_answer": "Synonym of Lubag disease is X-linked dystonia-parkinsonism.", "model_support": "Supporting sentence: First case of X-linked dystonia-parkinsonism (\"Lubag\") to demonstrate a response to bilateral pallidal stimulation.", "retries": 1}
{"idx": 350, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer refers to the localization of CENPC rather than CENPA, which is incorrect given the context. The supporting sentence discusses CENPC's localization at the inner kinetochore plate, which does not match the gold standard or logically support the correct answer regarding CENPA's localization at centromeres. While the model answer is present in the context (for CENPC), it fails to address the correct protein (CENPA) and therefore does not align with the gold answer.\", \"match\": false}", "gold_answer": "centromeres", "gold_support": "CENPA is a member of the histone H3-like proteins and is thought to replace histone H3 in centromeric nucleosomes.", "model_answer": "Answer: At the inner kinetochore plate of active mammalian centromeres.", "model_support": "Supporting sentence: CENPC is a DNA-binding protein that is located at the inner kinetochore plate of active mammalian centromeres. \n\n**Note**: The context explicitly states the localization of **CENPC**, not **CENPA**. However, the answer provided refers to **CENPA**, which may indicate a discrepancy. If the question intended to ask about **CENPC**, the sentence above directly supports the answer. If the question is correctly about **CENPA**, the context does not explicitly state its localization.", "retries": 1}
{"idx": 351, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and directly mentions Evolocumab as an inhibitor of proprotein convertase subtilisin/kexin type 9, but it does not include details about its mechanism of action (binding to LDL receptor and preventing recycling). Hence, there is slight verbosity without full coverage of the gold supporting sentence's depth.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab (AMG145) is a monoclonal antibody inhibiting the proprotein convertase subtilisin/kexin type 9 that binds to the liver LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Answer: Proprotein convertase subtilisin/kexin type 9 (PCSK9)", "model_support": "Supporting sentence: Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.", "retries": 1}
{"idx": 352, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. It provides a broader context rather than focusing specifically on Lewy bodies as the gold sentence does.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.", "retries": 1}
{"idx": 353, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it claims the text does not specify the localization of APOBEC3B, while the gold answer identifies it as nuclear. The supporting sentence is also incorrect because the context explicitly states that APOBEC3B is predominantly nuclear. Both the answer and supporting sentence fail to capture the correct information and reasoning.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "Answer: The text does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.", "model_support": "Supporting sentence: The text does not specify whether APOBEC3B is predominantly cytoplasmic or nuclear.  \n\n**Note**: The context provided does not include any explicit statement about the subcellular localization (cytoplasmic or nuclear) of APOBEC3B. The answer is derived from the absence of such information in the text.", "retries": 1}
{"idx": 354, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies tofacitinib as a Janus kinase inhibitor and connects it to rheumatoid arthritis, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).\" \n\nThis sentence explicitly identifies **tofacitinib** as a **Janus kinase (JAK) inhibitor** and connects it to both preclinical and clinical contexts for rheumatoid arthritis, supporting its approval as a JAK inhibitor for RA.", "retries": 1}
{"idx": 355, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Cytoplasmic') does not match the gold standard ('nuclear'), but it is present in the context as a characteristic of APOBEC3G, which the model incorrectly inferred for APOBEC3B. The supporting sentence discusses APOBEC3G's cytoplasmic localization, which is relevant to the context but does not cover the gold answer regarding APOBEC3B's nuclear localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "Answer: Cytoplasmic", "model_support": "Supporting sentence: APOBEC3G localizes predominantly to the cytoplasm of cells, which is consistent with a model wherein cytosolic APOBEC3G packages into assembling virions...  \n\n**Note**: The context explicitly states that *APOBEC3G* is cytoplasmic, but the question asks about *APOBEC3B*. While the context does not directly describe APOBEC3B's localization, the answer \"Cytoplasmic\" may be inferred from the shared localization determinant (first 60 residues) between APOBEC3G and APOBEC3B. However, the provided context does not explicitly confirm APOBEC3B's localization. The supporting sentence above refers to APOBEC3G, not APOBEC3B, highlighting a potential ambiguity in the question.", "retries": 1}
{"idx": 356, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NF1'). The supporting sentence is relevant and identifies the 'neurofibromatosis type 1 gene' which maps to NF1, but it contains slight redundancy by referencing acute myelogenous leukemia, which is not directly needed to answer the question. While logical, the supporting sentence could be more concise by focusing solely on the NF1 gene without introducing additional context about its analysis in leukemia.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) gene is a tumor suppressor gene, and the NF1 gene product, neurofibromin, can downregulate the N-ras gene.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.  \n\nThis sentence explicitly identifies \"neurofibromatosis type 1 gene\" as the gene under investigation, which is abbreviated as **NF1** in the context (e.g., \"mutations in the FLR exon of the NF1 gene\"). The question directly asks for the gene mutated in type 1 neurofibromatosis, and this sentence establishes the connection between \"neurofibromatosis type 1 gene\" and the NF1 designation.", "retries": 1}
{"idx": 357, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (JNK). However, the supporting sentence is missing in the model's response. While the context provided does not explicitly highlight JNK's role in phosphorylating c-jun, the gold supporting sentence shows that JNK is indeed mentioned as one of the activated MAP kinases. The lack of a concise supporting sentence in the model's output slightly lowers the score despite the correct answer.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "It also reduced the expressions of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and increases the expressions of reversion-inducing cysteine-rich protein with kazal motifs (RECK), as well as tissue inhibitor of metalloproteinase (TIMP) via inhibiting STAT3 by activating the mitogen-activated protein (MAP) kinases (the c-Jun N-terminal kinase (JNK), the p38 and extracellular signal-regulated kinase (ERK)) in A549 cells treated with RY10-4.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "The context does not mention JNK (c-Jun N-terminal kinase) or the phosphorylation of c-jun. The supporting sentence for the answer is **not present** in the provided text. The context focuses on ERK and p38 pathways, not JNK. \n\n**Answer:** No supporting sentence is found in the context. The answer (JNK) is not directly addressed in the text.", "retries": 1}
{"idx": 358, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'), but the supporting sentence focuses on the structure of R16 (antiparallel alpha-helices) rather than explicitly stating that alpha- and beta-spectrin form an antiparallel heterodimer. While the provided sentence is relevant and logically supports the concept of antiparallel arrangement, it does not directly reference the heterodimer formation as clearly as the gold supporting sentence. Therefore, it contains slight redundancy and misses direct alignment with the gold standard.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "Supporting sentence: \"R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.\"  \n\nThis sentence directly states that the spectrin repeat (R16) consists of antiparallel alpha-helices, which aligns with the formation of antiparallel heterodimers between alpha-spectrin and beta-spectrin subunits via their coiled-coil interactions.", "retries": 1}
{"idx": 359, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides useful context about the Ca(2+)/calcineurin/NFAT pathway, but it includes additional details about SCID syndrome that are not directly necessary to support the answer, making it slightly redundant compared to the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: The importance of the Ca(2+)/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca(2+) entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence.", "retries": 1}
{"idx": 360, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly supports the answer by identifying BACH1 as a transcriptional repressor. Minor extra details are acceptable, and the logic is strong.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "BACH1 is a repressor.", "model_support": "Supporting sentence: \"induction of the transcriptional repressor BACH1 by Nrf2.\"", "retries": 1}
{"idx": 361, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('ZEB2') is correct based on external knowledge but does not match the gold standard ('ZFHX1B') from the provided context. The supporting sentence acknowledges that the context does not support the model's answer, which is accurate since the context specifically mentions 'ZFHX1B'. However, the supporting sentence does not directly cover the gold answer, leading to a lower score.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype.", "model_answer": "Answer: The ZEB2 gene.", "model_support": "The context provided does not mention the ZEB2 gene or any specific gene associated with Mowat-Wilson syndrome. Therefore, there is no supporting sentence in the given context to confirm the answer. \n\n**Note:** While Mowat-Wilson syndrome is indeed caused by mutations in the **ZEB2** gene (as per external knowledge), this information is not included in the provided context.", "retries": 1}
{"idx": 362, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that BACH1 is a transcriptional repressor whose inactivation is required for NRF2-mediated induction.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "Answer: repressor", "model_support": "Supporting sentence: \"Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.\"", "retries": 1}
{"idx": 363, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and highlights the efficacy of Tofacitinib, which indirectly supports its role as a treatment for rheumatoid arthritis. However, it does not explicitly mention that Tofacitinib is a JAK inhibitor, which is a key detail in the gold supporting sentence. This omission makes the supporting sentence slightly less precise, though it still provides reasonable support.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: Tofacitinib demonstrated efficacy and safety comparable to other disease-modifying antirheumatic drugs (DMARDs).  \n\n**Note**: While the context does not explicitly state that Tofacitinib is a JAK inhibitor, it is widely recognized in medical literature as a JAK inhibitor approved for RA. The sentence above highlights its classification as a DMARD, which includes JAK inhibitors. However, the context provided does not directly mention \"JAK inhibitor,\" making this inference based on external knowledge. If strict adherence to the text is required, the context lacks an explicit statement.", "retries": 1}
{"idx": 364, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It explicitly states that rindopepimut targets EGFRvIII, which aligns perfectly with the gold answer and supporting sentence.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.  \n\nThis sentence explicitly states that rindopepimut is a vaccine targeting **EGFRvIII**, which directly supports the answer. While EGFRvIII is a mutated form of the epidermal growth factor receptor (EGFR), the context specifically refers to it as the target, making **EGFRvIII** the correct answer based on the provided text.", "retries": 1}
{"idx": 365, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard exactly. The supporting sentence provides relevant information and covers the answer logically, but it includes additional details about flavopiridol that are not necessary to directly support the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common.", "model_answer": "Answer: Bcr-Abl", "model_support": "Supporting sentence: \"Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor, down-regulates short-lived anti-apoptotic proteins via inhibition of transcription. In preclinical studies, flavopiridol synergizes with imatinib to induce apoptosis. We investigated this novel combination regimen in patients with Bcr-Abl(+) malignancies.\"  \n\nAdditionally, the conclusion explicitly states: \"Bcr-Abl tyrosine kinase inhibitors (TKIs).\" This confirms that Imatinib targets Bcr-Abl.", "retries": 1}
{"idx": 366, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly (both 'IL-17A' and 'interleukin-17A' are correct and interchangeable in this context); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.", "model_answer": "Answer: IL-17A", "model_support": "Supporting sentence: \"Blockade of IL-17A by secukinumab does not appear to interfere with efficacy of influenza and meningococcal vaccinations...\"", "retries": 1}
{"idx": 367, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by explaining the construction and purpose of LepChorionDB, which supports the answer effectively.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 368, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('NOTCH3'). Although the model notes that there is no direct supporting sentence in the provided context, this observation aligns with the fact that the context indeed does not explicitly restate the gene's involvement within the text body itself (other than the objective section). The logic is sound and acknowledges the dependency on external knowledge while remaining accurate.\", \"match\": true}", "gold_answer": "NOTCH3 gene", "gold_support": "OBJECTIVE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 gene.", "model_answer": "Answer: NOTCH3", "model_support": "The context provided does not explicitly mention the gene involved in CADASIL. However, based on external knowledge, CADASIL is caused by mutations in the **NOTCH3** gene. Since the context does not include this information, there is **no supporting sentence** within the given text to confirm the answer. \n\nIf the question assumes prior knowledge (outside the context), the answer is **NOTCH3**, but this is not derived from the provided text. \n\n**Supporting sentence (if available in the context):** None.", "retries": 1}
{"idx": 369, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about other proteins (DNMT3a, DNMT3b, and G9a), which are not directly necessary to support the answer. The logic is clear but slightly verbose.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: Coimmunoprecipitation experiments demonstrate that both UHRF1 and UHRF2 interact with DNMT1, DNMT3a, DNMT3b and G9a.", "retries": 1}
{"idx": 370, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard. The supporting sentence is relevant and supports the answer, but it is slightly more specific than necessary, focusing on how ortholog families were grouped by their proximity to origins rather than broadly stating that some archaeal genomes contain multiple origins of replication. This makes it less concise compared to the gold supporting sentence, which provides a clearer and broader rationale.\",\n  \"match\": true\n}", "gold_answer": "multiple", "gold_support": "However, because some archaeal genomes contain multiple origins of replication, bias in gene dosage caused by delayed replication should be minimized and hence the substitution rate of genes should associate less with chromosome position.", "model_answer": "Answer: Multiple origins of replication.", "model_support": "Supporting sentence: Ortholog families were grouped by their consensus position and designated by their proximity to one of the three origins (O1, O2, O3).", "retries": 1}
{"idx": 371, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the specific transporter is not explicitly mentioned in the provided context. However, the supporting sentence focuses on TH receptor beta gene mutations rather than addressing thyroid hormone transporters, which makes it less relevant to the gold answer. The supporting sentence should have highlighted the part of the context discussing 'cell-membrane transporter of TH, MCT8,' which directly supports the gold answer.\", \"match\": false}", "gold_answer": "MCT8", "gold_support": "One, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8;", "model_answer": "Answer: The thyroid hormone transporter implicated in thyroid hormone resistance syndrome is not explicitly mentioned in the context.", "model_support": "Supporting sentence: \"Mutations interfering with three of these steps have been so far identified. The first recognized defect, which causes resistance to TH, involves the TH receptor beta gene...\"  \n**Note**: The context does not explicitly name a specific thyroid hormone transporter gene. It only mentions \"cell transporters\" generally as one of the steps affected by mutations, but no specific transporter (e.g., *SLC16A10* or *SLC16A2*) is identified. The answer is correct because the context does not provide the name of a specific transporter.", "retries": 1}
{"idx": 372, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and correctly identifies the target of the inhibitors as factor Xa. However, it does not specifically mention betrixaban, which is part of the gold supporting sentence, leading to slight redundancy and less precision compared to the gold standard.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin.\"  \nThis sentence directly identifies \"factor Xa\" as the target of the inhibitors discussed, even though the specific drug \"betrixaban\" is not mentioned in the context. The question's answer (Factor Xa) aligns with the general mechanism described for this class of drugs.", "retries": 1}
{"idx": 373, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'AIP gene', matches the gold standard conceptually, as AIP refers to aryl hydrocarbon receptor interacting protein. However, it is less precise than the gold answer, which specifies the full name of the protein. The supporting sentence is relevant and correct but slightly indirect, as it mentions AIP mutations in parathyroid adenomas rather than directly linking AIP to familial isolated pituitary adenoma. This creates a minor disconnect from the gold supporting sentence, which explicitly ties AIP to pituitary adenoma pathogenesis. Overall, the logic is sound, but the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.  \n\n**Note:** While the context focuses on parathyroid adenomas, the AIP gene is well-established in the literature as being implicated in familial isolated pituitary adenoma. The provided context indirectly supports the answer by mentioning AIP mutations in the context of genetic alterations, even though the specific link to pituitary adenoma is not explicitly stated here.", "retries": 1}
{"idx": 374, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but it includes additional details about glycemia and inflammation that are not necessary for answering the question. The logic is sound, but slight redundancy reduces conciseness.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.", "retries": 1}
{"idx": 375, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer 'NF1 gene' is equivalent to the gold answer 'NF1,' and the supporting sentence provides context about the NF1 gene being studied in relation to neurofibromatosis type 1, although it includes additional details that are not strictly necessary.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.", "model_answer": "Answer: NF1 gene", "model_support": "Supporting sentence: In the present study, we used the polymerase chain reaction (PCR) and DNA sequencing analysis to characterize the NF1 gene in a 53-year-old Japanese patient with NF1 who suffered from neurofibroma, pheochromocytoma, and gastrointestinal stromal tumor (GIST).  \n\nThis sentence directly states that the NF1 gene was the focus of the study and identifies it as the gene associated with type 1 neurofibromatosis (NF1). Additionally, the subsequent description of a mutation in the NF1 allele further confirms this.", "retries": 1}
{"idx": 376, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Factor Xa' is correct based on general knowledge (not the provided context), but the supporting sentence fails to reference the gold supporting sentence or directly mention betrixaban. The context does not explicitly state that betrixaban inhibits Factor Xa, even though it lists it among other Factor Xa inhibitors. Therefore, while the answer matches the gold standard, the lack of proper support and reliance on external knowledge reduces the score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or its mechanism of action. The only anticoagulant explicitly discussed is **dabigatran**, which is described as a \"direct thrombin antagonist.\" There is no reference to betrixaban or the clotting factor it inhibits. \n\n**Supporting sentence**: None. The context does not contain information about betrixaban. \n\n**Note**: The answer \"Factor Xa\" would be correct for drugs like rivaroxaban or apixaban, but since betrixaban is not mentioned in the provided text, the question and answer cannot be supported by the given context.", "retries": 1}
{"idx": 377, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about JNK but does not explicitly state that JNK phosphorylates c-Jun. It mentions the broader role of JNK in phosphorylating other transcription factors, which is slightly indirect but still logically connected.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "JNK phosphorylates and regulates the activity of transcription factors other than c-Jun, including ATF2, Elk-1, p53 and c-Myc and non-transcription factors, such as members of the Bcl-2 family.", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family and are activated by environmental stress.  \n\nThis sentence directly identifies JNK (c-Jun N-terminal kinase) as the MAP kinase associated with c-Jun, answering the question about which kinase phosphorylates the transcription factor c-Jun.", "retries": 1}
{"idx": 378, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 379, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but does not explicitly state that medulloblastoma is the 'most common' pediatric cerebellar tumor, which is critical for fully supporting the answer. The provided sentence focuses on p18Ink4c as a tumor suppressor without directly addressing the frequency or origin of medulloblastoma as the gold supporting sentence does. Slight redundancy exists in the model's choice of supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "Supporting sentence: The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.  \n\n**Note**: While the context does not explicitly state that medulloblastoma is the \"most common\" pediatric cerebellar tumor, the entire passage focuses on medulloblastoma as the subject of the study (e.g., genetic alterations, tumor suppression mechanisms, and clinical relevance). The answer is inferred from the context's exclusive discussion of medulloblastoma.", "retries": 1}
{"idx": 380, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but adds extra details ('male gender and left hemisphere involvement') that are not strictly necessary for matching the gold answer ('cerebral hemiatrophy'). The supporting sentence is somewhat lengthy and includes additional information about frequency, which is not directly required by the gold supporting sentence. However, the logic connecting the answer to the context is reasonable.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "Left hemisphere and male sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson Syndrome).", "model_answer": "Answer: Male gender and left hemisphere involvement.", "model_support": "Supporting sentence: We conclude that male gender and left side involvement are frequent in cerebral hemiatrophy disease.", "retries": 1}
{"idx": 381, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and contains accurate information regarding S-adenosylmethionine (AdoMet) as a methyl donor. However, it introduces additional details about the SMM cycle that are not directly necessary to support the answer, leading to slight redundancy. The logic connecting AdoMet to its role as a methyl donor is clear but could be more concise.\", \"match\": true}", "gold_answer": "S-adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "Answer: S-adenosylmethionine (AdoMet)", "model_support": "Supporting sentence: Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).  \n\nThis sentence establishes that **S-adenosylmethionine (AdoMet)** is the methyl donor for the SMM cycle, which is directly relevant to the broader role of methyl donors in methyltransferase reactions (including histone methyltransferases, even though the context focuses on plant enzymes). The mention of AdoMet as the precursor for SMM aligns with its canonical role as a methyl donor in biological systems.", "retries": 1}
{"idx": 382, "gptscore_json": "{\"score\": 3, \"reason\": \"The model answer 'Acetylation' is very close to the gold standard 'acetylated lysines,' capturing the key concept of acetylation but not specifying the exact target (lysines). The supporting sentence discusses the general role of bromodomain regulators in chromatin regulation and gene expression but does not explicitly mention acetylated lysines or directly support the specific histone modification recognized by bromodomains. While the logic connecting bromodomains to acetylation is reasonable, the supporting sentence could be more concise and directly relevant.\", \"match\": false}", "gold_answer": "acetylated lysines", "gold_support": "Double bromodomain proteins bind to acetylated lysines in histones, bringing associated histone modification and nucleosome remodeling activity to chromatin.", "model_answer": "Answer: Acetylation", "model_support": "Supporting sentence: The ability of bromodomain regulators to alter chromatin status and control gene expression has long been appreciated to be important in the development of certain human cancers.  \n\n**Note**: While the context does not explicitly mention \"acetylation,\" bromodomains are well-known in biomedical literature for recognizing acetylated lysine residues on histones. The sentence provided reflects the general role of bromodomains in chromatin regulation, which is mechanistically linked to acetylation. However, the context itself does not explicitly state the histone modification.", "retries": 1}
{"idx": 383, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('factor Xa') matches the gold standard ('xa'), but the supporting sentence is incorrect because it does not come from the provided context. The context does not mention betrixaban or its specific target, and therefore, no supporting sentence can be derived from it. However, the answer itself is correct based on external knowledge.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context does not mention betrixaban or its specific target clotting factor. Therefore, there is no supporting sentence in the provided text to answer the question about which clotting factor betrixaban inhibits. \n\n**Note:** While betrixaban is known in real-world pharmacology to inhibit factor Xa, this information is not included in the given context.", "retries": 1}
{"idx": 384, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it focuses on a specific detail about the methylation process rather than directly stating that medicarpin is the major phytoalexin in alfalfa. This makes it slightly less concise and direct compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.  \n\nThis sentence identifies **medicarpin** as a key compound in the context of alfalfa's phytoalexin biosynthesis, directly addressing its role and relevance as the major phytoalexin.", "retries": 1}
{"idx": 385, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'Velcade (bortezomib) is not mentioned' when the context clearly identifies bortezomib as a treatment for multiple myeloma. The supporting sentence does not logically support the gold answer and incorrectly emphasizes the absence of Velcade rather than its use in multiple myeloma. This leads to an irrelevant response.\", \"match\": false}", "gold_answer": "multiple myeloma", "gold_support": "INTRODUCTION: Over the past decade, the novel agents thalidomide, lenalidomide, and bortezomib have emerged as effective treatment in patients with multiple myeloma (MM).", "model_answer": "Velcade (bortezomib) is not mentioned in the context provided.", "model_support": "Supporting sentence: The context does not mention Velcade (bortezomib) at all.  \n**Note**: The answer is correct because the context explicitly discusses thalidomide, lenalidomide, and dexamethasone for multiple myeloma but never references Velcade (bortezomib). However, there is no direct sentence in the context that explicitly states \"Velcade is not mentioned,\" as the answer implies. The absence of any mention of Velcade in the text is the basis for the answer.", "retries": 1}
{"idx": 386, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and covers the answer but contains slight redundancy by including additional details about the study methods rather than focusing directly on the enzyme's role.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on CYP17A1 enzymatic activity, steroid production in monkey adrenal cells and human adrenal tumor cells...\"", "retries": 1}
{"idx": 387, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context as Pendred syndrome relates to thyroid hormone abnormalities. However, the supporting sentence does not cover the gold answer effectively and focuses on the lack of direct mention of Pendred syndrome rather than linking it to dyshormonogenesis or thyroid-related issues. It acknowledges missing information without adequately addressing the gold answer.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "Answer: Pendred syndrome is not directly mentioned in the context, but it is a genetic disorder associated with congenital hypothyroidism and hearing loss. The hormone abnormalities characteristic of Pendred syndrome include congenital hypothyroidism due to dyshormonogenesis.", "model_support": "Supporting sentence: The context does not explicitly mention Pendred syndrome or its hormone abnormalities. The provided text discusses congenital hypothyroidism's genetic causes, including dyshormonogenesis, but does not reference Pendred syndrome directly. \n\n**Note:** The answer provided in the question relies on external knowledge (Pendred syndrome's association with dyshormonogenesis and hearing loss), as the context itself does not mention Pendred syndrome.", "retries": 1}
{"idx": 388, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer correctly identifies 'the transcribed strand' as the target of transcription-coupled repair (TCR), matching the gold answer. However, the supporting sentence chosen by the model is less direct and includes details about the methodology of strand-specific repair rather than explicitly stating the preference of TCR for the transcribed strand. While it provides indirect support, the gold supporting sentence more clearly and concisely conveys the key information.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "TCR can preferentially remove the bulky DNA lesions located at the transcribed strand of a transcriptional active gene more rapidly than those at the untranscribed strand or overall genomic DNA.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: Strand-specific repair in a suitable restriction fragment is usually determined by alkaline gel electrophoresis followed by Southern blotting transfer and hybridization with an indirect end-labeled single-stranded probe.  \n**Reasoning**: The context describes TCR as a \"strand-specific\" repair process, which inherently targets the transcribed strand (the DNA strand being actively transcribed into RNA). While the text does not explicitly state \"transcribed strand,\" the term \"strand-specific repair\" directly implies that TCR acts on the specific DNA strand involved in transcription. This aligns with the general understanding of TCR, which is coupled to transcription and repairs damage on the transcribed strand. The sentence about strand-specific repair methodology supports this conclusion.", "retries": 1}
{"idx": 389, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The model's supporting sentence focuses on BCR-ABL mRNA overexpression in minimal residual disease, which is indirectly related to Imatinib's target but does not explicitly mention the constitutively active tyrosine kinase encoded by BCR-ABL. While logical, it is less direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: BCR-ABL mRNA is overexpressed in the minimal residual disease (MRD), known as an early sign of relapse.  \n**Explanation**: While the context does not explicitly state that Imatinib targets BCR-ABL, the mention of BCR-ABL mRNA overexpression in MRD (a key feature of Philadelphia-chromosome-positive CML) directly ties the tyrosine kinase BCR-ABL to the disease context. Imatinib's mechanism in CML is well-established in medical literature to inhibit BCR-ABL, and the context implicitly supports this by linking BCR-ABL mRNA to disease monitoring and Imatinib's efficacy in controlling tyrosyl phosphorylation (a hallmark of BCR-ABL activity).", "retries": 1}
{"idx": 390, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly mention the mode of inheritance, the gold supporting sentence confirms that the context does indeed contain this information. Despite this, the model correctly identifies the mode of inheritance as autosomal dominant, and the logic behind the answer is strong. The supporting sentence from the gold standard directly validates the model's response.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "This family showed typical features of this syndrome with QT prolongation, torsades de pointes ventricular tachycardia, sudden death and an autosomal dominant inheritance pattern.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context provided does not explicitly mention the mode of inheritance of Romano-Ward long QT syndrome. While Romano-Ward syndrome is historically known to follow an **autosomal dominant** pattern in real-world medical knowledge, the given context lacks a direct statement or supporting sentence about inheritance. \n\n**Supporting sentence:** None explicitly stated in the context.  \n**Note:** The answer relies on external medical knowledge, as the context does not contain information about inheritance patterns.", "retries": 1}
{"idx": 391, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate, referencing KN-93 as an inhibitor of CaM kinase II, which aligns with the context. However, it introduces slight redundancy by discussing a hypothetical sentence that isn't strictly necessary for supporting the answer. The gold supporting sentence is more concise and directly ties KN-93 to the inhibition of CaM kinase II within the given context.\",\n  \"match\": true\n}", "gold_answer": "CaM kinase II", "gold_support": "NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide.", "model_answer": "Answer: CaM kinase II", "model_support": "The context provided does not explicitly mention the small molecule KN-93 or its target kinase. However, based on general knowledge, KN-93 is a well-established inhibitor of **CaM kinase II**. If the context were to include a sentence like:  \n**\"Contribution of Ca²⁺/calmodulin-dependent kinase II (CaMKII) was assessed by KN-93...\"**, this would directly support the answer.  \n\nSince the provided context does not contain this specific sentence, the answer cannot be directly supported by the text. However, the answer **\"CaM kinase II\"** is biologically accurate, as KN-93 is a known inhibitor of this kinase.  \n\nIf the context had included the sentence:  \n**\"Contribution of Ca²⁺/calmodulin-dependent kinase II (CaMKII) was assessed by KN-93...\"**, that would be the supporting sentence.", "retries": 1}
{"idx": 392, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence discusses the suppression of androgen levels and shrinkage of androgen-dependent organs, which indirectly supports the role of CYP17A1 inhibition without explicitly mentioning it. While this provides logical support, it is less direct than the gold supporting sentence, which specifically names the enzyme and its function.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: Preclinical studies demonstrate that orteronel treatment suppresses androgen levels and causes shrinkage of androgen-dependent organs, such as the prostate gland.  \n\n**Note**: While the context does not explicitly name *CYP17A1*, the suppression of androgen levels by orteronel aligns with the mechanism of CYP17A1 inhibitors, which block androgen synthesis. The answer is inferred from the described effect (androgen suppression) and contextual knowledge of hormonal therapies for prostate cancer.", "retries": 1}
{"idx": 393, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model correctly identifies the XK gene as the cause of McLeod syndrome and provides a brief explanation that aligns well with the context and gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: The context does not explicitly mention the gene associated with McLeod syndrome. However, based on external knowledge, McLeod syndrome is caused by mutations in the **XK gene**. \n\n**Note**: The provided context mentions \"McLeod phenotype\" but does not directly state the gene name. The answer relies on established medical knowledge rather than the given text.", "retries": 1}
{"idx": 394, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly linking pridopidine to Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 395, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Cortisol deficiency' does not match the gold standard 'growth hormone,' but it is mentioned in the context. The supporting sentence is relevant to cortisol deficiency but does not cover the gold answer related to growth hormone deficiency. Therefore, while the information is present in the context, it fails to correctly address the question.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "We describe an 18-month-old boy with Costello syndrome (CS) with proven partial growth hormone (GH) deficiency and hypoglycemic episodes.", "model_answer": "Answer: Cortisol deficiency", "model_support": "Supporting sentence: The hypoglycemia is deemed to be due to cortisol deficiency.", "retries": 1}
{"idx": 396, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, using a slightly different but acceptable synonym ('Small cell lung cancer' vs. 'small-cell lung cancer'). The supporting sentence is relevant and provides context for the association between SCLC and Lambert-Eaton syndrome; however, it includes some extra details about the experimental technique (patch-clamp) that are not essential to directly support the answer. This makes it slightly more verbose than necessary.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Human small-cell lung cancer (SCLC) cells are believed to express the antigens responsible for the production of pathological antibodies in the Lambert-Eaton syndrome (LES), a Ca2+ channel disorder in which quantal transmitter release from the motor nerve terminal is impaired.", "model_answer": "Answer: Small cell lung cancer (SCLC)", "model_support": "Supporting sentence: Whole-cell patch-clamp techniques were used to study the voltage-dependent Ca2+ channels expressed by H146 SCLC cells and the effects of LES antibodies on these channels.  \n\nThis sentence explicitly identifies \"SCLC\" (Small Cell Lung Cancer) as the type of lung cancer studied, which is directly associated with Lambert-Eaton syndrome (LES) in the context.", "retries": 1}
{"idx": 397, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes additional information ('hemiatrophy of the body') which is not part of the gold answer. The supporting sentence mentions relevant clinical features but does not directly focus on the imaging findings that confirm 'cerebral hemiatrophy,' making it somewhat less precise compared to the gold supporting sentence.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "MRI brain revealed characteristic features diagnostic of congenital type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is hemiatrophy of the brain and body.", "model_support": "Supporting sentence: A 15-year-old female presented with seizures, right-sided hemiparesis, hemiatrophy of the right side of the body and mental retardation.", "retries": 1}
{"idx": 398, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('Xa' and 'Factor Xa' are equivalent in this context). However, the supporting sentence, while relevant, is more verbose than necessary. It introduces additional information about a factor Xa decoy (PRT4445) which is not directly needed to support the answer. The gold supporting sentence is more concise and directly relevant.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.", "retries": 1}
{"idx": 399, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Cytoplasmic') does not match the gold standard ('nuclear'), but the context contains information about APOBEC3B being predominantly nuclear. The supporting sentence discusses APOBEC3G's cytoplasmic localization, which is relevant to the context but does not support the gold answer regarding APOBEC3B. Thus, while the supporting sentence is accurate for APOBEC3G, it fails to address the correct protein (APOBEC3B) and its nuclear localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "Answer: Cytoplasmic", "model_support": "Supporting sentence: APOBEC3G localizes predominantly to the cytoplasm of cells, which is consistent with a model wherein cytosolic APOBEC3G packages into assembling virions, where it exerts its antiviral effect by deaminating viral cDNA cytosines during reverse transcription.  \n\n**Note**: While the context explicitly describes APOBEC3G's cytoplasmic localization, it does not directly state APOBEC3B's subcellular localization. The answer assumes APOBEC3B shares similar properties due to the chimeric protein analysis, but the supporting sentence provided refers to APOBEC3G. If the question intended to ask about APOBEC3G, the sentence above is correct. For APOBEC3B, the context lacks explicit information.", "retries": 1}
{"idx": 400, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant and not as concise as it could be. While it mentions the ZEB2 gene, it does not directly explain its role in causing Mowat-Wilson syndrome, unlike the gold supporting sentence which clearly states the haploinsufficiency and its relevance.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2 gene", "model_support": "Supporting sentence: Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.", "retries": 1}
{"idx": 401, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The supporting sentence effectively highlights the reliability of [18F]altanserin PET for quantifying 5-HT2A receptors, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2A receptor availability in albino rats.", "retries": 1}
{"idx": 402, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('stroke'). The supporting sentence is relevant and provides information about the instrument's validation for stroke recognition, which logically supports the answer. However, it does not explicitly mention the ROSIER scale by name and contains slight redundancy by focusing on the validation process rather than directly stating its purpose for stroke recognition. This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: The instrument was assessed using the baseline 1-year dataset and then prospectively validated in a new cohort of ER patients admitted over a 9-month period.  \n**Note:** The context does not explicitly mention the \"ROSIER scale.\" The provided answer (\"stroke\") aligns with the instrument's purpose, but the specific name \"ROSIER scale\" is not referenced in the text. The supporting sentence above highlights the instrument's application for stroke recognition, which justifies the answer despite the absence of the exact term \"ROSIER scale\" in the context.", "retries": 1}
{"idx": 403, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Na(+)/Ca(2+) exchanger' matches the gold standard 'NCX,' as NCX is an abbreviation for the Na(+)/Ca(2+) exchanger. However, the supporting sentence provided by the model, while relevant and concise, does not directly reference SEA0400, which is a key part of the question. Instead, it broadly mentions inhibition of the Na(+)/Ca(2+) exchanger without linking it to the specific molecule (SEA0400) mentioned in the gold supporting sentence. Despite this, the logic connecting the answer to the supporting sentence is strong, though slightly less precise than the gold standard.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400 (1 μM), a pharmacological inhibitor of NCX, significantly shortened the MAP duration (P < .01) and reduced dispersion (P < .05).", "model_answer": "Answer: Na(+)/Ca(2+) exchanger", "model_support": "Supporting sentence: Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.  \n\n**Note**: The context does not explicitly mention \"SEA0400,\" but the answer refers to the Na(+)/Ca(2+) exchanger (NCX), which is directly discussed in the first sentence. The question may contain a discrepancy (SEA0400 is not mentioned in the text), but the supporting sentence for the answer \"Na(+)/Ca(2+) exchanger\" is the one explicitly stating \"Na(+)/Ca(2+) exchanger\" inhibition.", "retries": 1}
{"idx": 404, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, S-methylmethionine (SMM), does not match the gold standard, S-adenosylmethionine. However, SMM is mentioned in the context as a methyl donor in a different process, which makes it relevant but incorrect for this specific question. The supporting sentence is relevant to SMM's role as a methyl donor but does not support the gold answer regarding S-adenosylmethionine.\", \"match\": false}", "gold_answer": "S-adenosylmethionine", "gold_support": "Angiosperms synthesize S-methylmethionine (SMM) from methionine (Met) and S-adenosylmethionine (AdoMet) in a unique reaction catalyzed by Met S-methyltransferase (MMT).", "model_answer": "Answer: S-methylmethionine (SMM)", "model_support": "Supporting sentence: SMM serves as methyl donor for Met synthesis from homocysteine, catalyzed by homocysteine S-methyltransferase (HMT).", "retries": 1}
{"idx": 405, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence is concise, directly relevant, and logically explains the association between McLeod syndrome and the XK gene mutation, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: We describe a family with a novel point mutation in the XK gene consisting of a C to T base transition at nucleotide position 977, introducing a stop codon.", "retries": 1}
{"idx": 406, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "retries": 1}
{"idx": 407, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. The model's supporting sentence focuses on a fragment upstream of the SET domain, which is indirectly related but not as concise or directly supportive as the gold sentence.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Data base analysis indicates that human Set1A protein shares 39% identity with an uncharacterized SET domain protein, KIAA1076, hereafter denoted Set1B.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: A 123-amino acid fragment upstream of the Set1A SET domain is necessary for interaction with CFP1, Ash2, Rbbp5, and Wdr5.", "retries": 1}
{"idx": 408, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is missing and replaced with a note explaining that 'H3K4' is based on external knowledge rather than the text. While this acknowledgment is accurate, it does not fulfill the requirement for a concise supporting sentence directly derived from the context. The gold supporting sentence clearly identifies H3K4 methylation in the context of MDR1 activation, making it more appropriate. Thus, the score reflects correct identification but lacks proper textual support.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "It has also been shown that MDR1 activation is accompanied by increased methylation on lysine 4 of histone H3 (H3K4).", "model_answer": "Answer: H3K4", "model_support": "The context does not explicitly mention the specific histone residue methylated by MLL1. While the answer \"H3K4\" is biologically accurate (as MLL1 is a well-known H3K4 methyltransferase), the provided text does not include a sentence directly stating this. The closest relevant information is the mention of MLL1 as a \"histone methyltransferase\" and its role in regulating MDR1 transcription, but no specific residue is named. \n\n**Supporting sentence:** None explicitly stated in the context.  \n**Note:** The answer \"H3K4\" is based on external biological knowledge, not the provided text.", "retries": 1}
{"idx": 409, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by including other pathways (PKC, ERK1/2, PI3K/Akt) that are not directly necessary to support the role of mTOR as the molecular target of rapamycin. The sentence could be more concise by focusing only on mTOR.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "L-Leucine also increased the levels of phosphorylated molecular target of rapamycin (mTOR) and two of its targets, ribosomal protein S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1); furthermore, rapamycin (an mTOR inhibitor) blocked all of the mitogenic effects of L-leucine.", "model_answer": "Answer: mTOR", "model_support": "Supporting sentence: In conclusion, L-leucine stimulated DNA synthesis and promoted cell cycle progression in primary cultured chicken hepatocytes through PKC, ERK1/2, PI3K/Akt, and mTOR.", "retries": 1}
{"idx": 410, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Thyroid dysfunction,' is very close to the gold answer, 'thyroid,' though it could be more concise. The supporting sentence mentions mild thyroid dysfunction and relates it to Pendred syndrome, which shows relevance but includes extra context about hearing impairment that isn't necessary for supporting the answer directly. It mixes relevant content with some verbosity, making it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect.", "model_answer": "Answer: Thyroid dysfunction.", "model_support": "Supporting sentence: The mild thyroid dysfunction in these patients suggests that PS should be considered in all patients with congenital or early-onset hearing impairment.", "retries": 1}
{"idx": 411, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about NF1 and neurofibromin, but it introduces unnecessary details about mitochondria that are not directly related to confirming the gene mutated in type 1 neurofibromatosis. The logic is sound but slightly indirect compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: \"Because of their co-localization with the tumor suppressor protein neurofibromin, which is mutated in NF1, mitochondria were particular attractive candidates for investigation.\"", "retries": 1}
{"idx": 412, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but specifies 'congenital hypothyroidism' rather than just 'thyroid,' which makes it more detailed than necessary. The supporting sentence is relevant and supports the answer but includes extra details about the case of an infant, making it somewhat lengthy. The logic is reasonable, but it could be more concise.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Common hormone abnormalities in Williams syndrome include congenital hypothyroidism.", "model_support": "Supporting sentence: \"we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"", "retries": 1}
{"idx": 413, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'). The supporting sentence is relevant and supports the answer by referencing anti-Xa activity in relation to betrixaban. However, it includes additional information about PRT4445, which is not necessary to directly support the answer, making it slightly verbose. The logic connecting the supporting sentence to the answer is reasonable but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban inhibits factor Xa, as PRT4445 is described as a reversal agent for anticoagulants with anti-Xa activity, suggesting betrixaban targets factor Xa.", "retries": 1}
{"idx": 414, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less specific than the gold supporting sentence. The model's supporting sentence highlights the intrigue and unusual composition of Selenoprotein P, which aligns with the context, but it does not explicitly mention the number of selenocysteine residues as the gold supporting sentence does. This makes it somewhat less precise while still being logical and relevant.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Whereas most selenoproteins contain a single selenocysteine residue, the human, bovine and rodent selenoprotein P genes encode proteins containing 10-12 selenocysteines.", "model_answer": "Answer: Selenoprotein P", "model_support": "Supporting sentence: Selenoprotein P is a protein of considerable intrigue, due to its unusual composition and requirements for its biosynthesis.  \n\nThis sentence identifies **Selenoprotein P** as the human selenoprotein discussed in the context, even though the detailed characterization of selenocysteine residues (17 Se-Cys codons) is described in the zebrafish context. The question specifically asks for the human selenoprotein, and the background explicitly names *Selenoprotein P* as the subject of intrigue, aligning with the answer.", "retries": 1}
{"idx": 415, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard (1,4-benzothiazepine), but the supporting sentence does not cover the chemical classification of JTV519 as a 1,4-benzothiazepine derivative. Instead, it provides information about K201 as a multi-channel blocker, which is relevant to its function but does not logically support the specific chemical group. The correct supporting sentence should have explicitly mentioned that K201 (JTV519) is a 1,4-benzothiazepine derivative.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.  \n\n**Note**: The context provided does not explicitly mention \"1,4-benzothiazepine\" as the chemical group for JTV519/K201. However, based on prior knowledge (e.g., the example context where JTV519 is explicitly labeled as a \"1,4-benzothiazepine derivative\"), the answer assumes K201 and JTV519 are the same compound. The supporting sentence in the current context only identifies K201 as a \"multi-channel blocker,\" not its chemical classification. If strictly adhering to the given context, there is no direct mention of \"1,4-benzothiazepine.\"", "retries": 1}
{"idx": 416, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'impaired visuospatial functions,' does not match the gold standard 'cerebral hemiatrophy.' However, it is mentioned in the context as a feature of the syndrome. The supporting sentence is relevant but does not cover the gold answer, focusing instead on cognitive impairments rather than the defining anatomical characteristic of cerebral hemiatrophy.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The purpose of this study was to retrospectively evaluate the cognitive and electroclinical characteristics of right cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome [DDMS]).", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is impaired visuospatial functions.", "model_support": "Supporting sentence: Neuropsychological assessments demonstrated consistent impairments in tasks that have a spatial component (spatial processing and orientation discrimination), whereas attention, executive functions and verbal memory domains were variably impaired.", "retries": 1}
{"idx": 417, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly more verbose than necessary. The gold supporting sentence is more concise while still covering the essential point.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DNA methyltransferase 1 (Dnmt1) mutation affects Snrpn imprinting in the mouse male germ line.", "model_answer": "Answer: DNMT1", "model_support": "Supporting sentence: This defect does not appear in mouse models with mutations in Dnmt3a and Mthfr genes and, therefore, it is specific for the Dnmt1 gene and is suggestive of a role of DNMT1 in imprint resetting or maintenance in the male germ line.", "retries": 1}
{"idx": 418, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer '1,4-benzothiazepine' is consistent with the gold answer 'benzothiazepine,' and although the supporting sentence doesn't explicitly state the chemical classification, it implies JTV519's protective effect, which aligns indirectly with its therapeutic role mentioned in the gold supporting sentence.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: JTV519 is known to have a protective effect against Ca²⁺ overload-induced myocardial injury.  \n\n**Note:** The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. The answer \"1,4-benzothiazepine\" appears to be based on prior knowledge or a different context (e.g., the earlier example in the user's history). In the given text, the chemical classification of JTV519 is not mentioned.", "retries": 1}
{"idx": 419, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '1,4-benzothiazepine,' closely matches the gold standard 'benzothiazepine,' with only a minor difference in specificity (adding '1,4-' as a prefix). The supporting sentence is relevant and correctly references prior knowledge of JTV519 being a benzothiazepine derivative. However, it introduces slight redundancy by mentioning 'multi-channel blocker' and 'stabilizes RyR2s,' which are not necessary to support the answer. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The context does not explicitly mention the chemical group of JTV519. However, based on prior knowledge from the previous example, the answer is derived from the sentence: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" \n\n**Note**: The provided context in this query does not include the specific sentence about 1,4-benzothiazepine. The supporting sentence is inferred from the prior example, as the current context lacks this information.", "retries": 1}
{"idx": 420, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and explains that the context does not explicitly mention the number 15, which aligns with the instructions. However, the gold supporting sentence clearly establishes the source of the answer in the context, making the model's explanation accurate and logically sound.\", \"match\": true}", "gold_answer": "15", "gold_support": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains 15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4.", "model_answer": "Answer: 15", "model_support": "The context does not explicitly mention the number 15 or provide a direct statement about the total number of tissue kallikrein genes in the human genome. The answer \"15\" is a factual reference to the human kallikrein gene family (which includes 15 members), but this specific number is not stated or implied in the provided text. \n\n**Supporting sentence**: None.  \nThe context discusses kallikrein 13 and references PSA (kallikrein 3) but does not specify the total number of tissue kallikrein genes. The answer \"15\" is not supported by the given text.", "retries": 1}
{"idx": 421, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's supporting sentence highlights the limitation of Dnmt1, which indirectly supports its role in maintenance methylation, though it could be more direct like the gold supporting sentence.\", \"match\": true}", "gold_answer": "Dnmt1", "gold_support": "It is generally accepted that DNA methyltransferases carry out specific and non-overlapping functions, Dnmt3a and Dnmt3b being responsible for the establishment of methylation around the time of implantation and Dnmt1 ensuring that methylation is faithfully copied to daughter cells via what has come to be known as \"maintenance methylation.\"", "model_answer": "Answer: Dnmt1", "model_support": "Supporting sentence: \"This longstanding view has been challenged over the years with the observation that Dnmt1 alone is incapable of perfect maintenance methylation.\"", "retries": 1}
{"idx": 422, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer includes both 'stroke' and 'transient ischaemic attack (TIA),' while the gold answer specifies only 'stroke.' Although TIA is mentioned in the context, the ROSIER scale is specifically used for diagnosing stroke. The supporting sentence is somewhat relevant but unnecessarily lengthy and does not directly focus on the ROSIER scale’s purpose of identifying stroke, mixing general study information instead.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke and transient ischaemic attack (TIA)", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.", "retries": 1}
{"idx": 423, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale was used as a stroke recognition tool, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 424, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Distinctive histopathology was revealed with alpha-synuclein immunostaining, including pleomorphic Lewy bodies, synuclein-positive glial inclusions and widespread, severe neuritic dystrophy.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.\"  \n\nThis sentence explicitly states that the antibodies used for immunostaining (to reveal neuropathology) are directed against **alpha-synuclein**, which is the protein in question.", "retries": 1}
{"idx": 425, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although it does not explicitly mention that pridopidine is in development for Huntington disease, it still logically supports the answer by referencing the treatment context of Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 426, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'Xa'. The supporting sentence is relevant and aligns with the context, but it does not explicitly mention betrixaban, which makes it slightly less precise compared to the gold supporting sentence that directly lists betrixaban as an example of a Factor Xa inhibitor. Some redundancy exists in the broader categorization, but the logic remains strong.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.\"  \n\nAlthough betrixaban is not explicitly mentioned in the context, the question's answer (\"Factor Xa\") aligns with the broader classification of \"factor Xa inhibitors\" discussed in the text. The sentence directly identifies Factor Xa as a target of the drugs described, which includes newer anticoagulants like betrixaban (implied by the context's focus on Factor Xa inhibitors).", "retries": 1}
{"idx": 427, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer, but it is slightly less detailed compared to the gold supporting sentence. It captures the key relationship between gevokizumab and IL-1β but lacks mention of 'allosteric anti-IL-1β antibody,' which provides additional context.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.", "retries": 1}
{"idx": 428, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('epidural blood patch' and 'autologous epidural blood patch' are effectively synonymous in this context). However, the supporting sentence includes additional details about the volume of blood and rarity of complications, which, while relevant, are not necessary to directly support the answer. The gold supporting sentence is more concise and directly tied to the treatment recommendation. Thus, the supporting sentence has slight redundancy.\", \"match\": true}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients (e.g. age < 50 years, post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch.", "model_answer": "Answer: Autologous epidural blood patch.", "model_support": "Supporting sentence: The optimum volume of blood has been shown to be 12-20 ml for adult patients. Complications of autologous epidural blood patch are rare. \n\nThis sentence identifies \"autologous epidural blood patch\" as the treatment method, with the preceding statement about blood volume providing context for its application. The mention of the procedure directly answers the question.", "retries": 1}
{"idx": 429, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'Bcr-Abl tyrosine kinase' is effectively equivalent to 'Bcr-Abl' in this context. The supporting sentence is relevant and supports the answer logically, but it contains slight redundancy by specifying 'necessary and sufficient for the transformed phenotype,' which is not directly required to justify the answer. A more concise explanation could have been used.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib mesylate is a new drug that can inhibit the tyrosine kinase activity of Bcr-Abl, the receptors for platelet-derived growth factor receptor(PDGF) and stem cell factor, or c-kit.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "Supporting sentence: The expression of Bcr-Abl tyrosine kinase has been shown to be necessary and sufficient for the transformed phenotype of CML cells.", "retries": 1}
{"idx": 430, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('AIP gene') is biologically correct but does not match the gold standard ('aryl hydrocarbon receptor interacting protein'). The supporting sentence highlights that the context does not explicitly mention the AIP gene or any specific gene related to familial isolated pituitary adenoma, which is accurate. However, the supporting sentence fails to cover the gold answer and instead focuses on the absence of relevant information in the context, making it less relevant to the gold answer.\", \"match\": false}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: The context does not explicitly mention the AIP gene or any specific gene mutation related to familial isolated pituitary adenoma. The provided text discusses general challenges in understanding pituitary tumourigenesis but does not identify the gene implicated in familial isolated pituitary adenoma.  \n\n**Note**: The answer \"AIP gene\" is biologically accurate (mutations in the *AIP* gene are associated with familial isolated pituitary adenoma), but this specific information is not present in the given context. The context lacks a direct statement linking a gene mutation to this condition.", "retries": 1}
{"idx": 431, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard, as 'Growth hormone (GH) deficiency' is equivalent to 'Growth hormone' in this context. The supporting sentence is relevant and covers the answer but includes additional information ('to our knowledge, these are the only patients...') that slightly increases verbosity without being necessary for supporting the answer.\", \"match\": true}", "gold_answer": "Growth hormone", "gold_support": "Growth hormone deficiency in Costello syndrome.", "model_answer": "Answer: Growth hormone (GH) deficiency", "model_support": "Supporting sentence: \"To our knowledge, these are the only patients with Costello syndrome who have been successfully treated for GH deficiency.\"", "retries": 1}
{"idx": 432, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('three') but is present in the context as a plausible yet incorrect response. The supporting sentence correctly identifies that the context does not provide evidence for '4 genera,' but it fails to directly reference or extract the relevant sentence from the context that specifies 'three genera.' Therefore, while the supporting sentence acknowledges the lack of support for the model's answer, it does not cover the gold answer adequately.\", \"match\": false}", "gold_answer": "three", "gold_support": "Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV).", "model_answer": "The Flaviviridae family comprises 4 genera.", "model_support": "The context does not mention the number of genera in the Flaviviridae family. The supporting sentence for the answer is not present in the provided text.  \n\n**Answer:** The context does not contain a sentence that specifies the number of genera in the Flaviviridae family. The claim about 4 genera is not supported by the given information.", "retries": 1}
{"idx": 433, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by specifying the deletion involving the ZEB2 gene, which aligns with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "Individuals with Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene.", "model_answer": "Answer: ZEB2", "model_support": "Supporting sentence: High resolution microarray analysis revealed 0.9 Mb deletion of 2q22.3 involving two genes: ZEB2 and GTDC1.", "retries": 1}
{"idx": 434, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence, while relevant and covering the answer, is slightly indirect and could be seen as not fully concise because it discusses modulation of SERCA activity in a therapeutic context rather than directly stating that SERCA is the calcium pump crucial for calcium homeostasis. Some redundancy exists compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA.", "model_support": "Supporting sentence: \"Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.\"  \n\nThis sentence explicitly identifies SERCA as the primary calcium pump (Ca²⁺-ATPase) of the sarcoplasmic reticulum, as it refers to \"SERCA activity\" in the context of modulating calcium transport.", "retries": 1}
{"idx": 435, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the interaction between FANCA and BRG1 within the SWI/SNF complex. Although additional details were provided in the model's explanation, the primary supporting sentence aligns well with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: FANCA was demonstrated to associate with the endogenous SWI/SNF complex.  \n\nAdditionally, the sentence \"we demonstrated co-localization in the nucleus between transfected FANCA and BRG1\" directly links FANCA to BRG1, confirming BRG1 as the interacting subunit. However, the primary supporting sentence explicitly stating the interaction with the SWI/SNF complex (which includes BRG1) is:  \n**\"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"**", "retries": 1}
{"idx": 436, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model’s supporting sentence highlights the correct mechanism (kinase mutations or increased BCR-ABL expression), aligning well with the gold standard.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Imatinib mesylate (IM) binds to the BCR-ABL protein, inhibiting its kinase activity and effectively controlling diseases driven by this kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"IM resistance has been associated with kinase mutations or increased BCR-ABL expression.\"  \n\nThis sentence explicitly identifies **BCR-ABL** as the tyrosine kinase targeted by imatinib, as resistance mechanisms involve mutations in the kinase or elevated BCR-ABL expression.", "retries": 1}
{"idx": 437, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence mentions 'all 5 N-terminal isoforms,' which is irrelevant to the question about TAp73 isoforms specifically and fails to address the correct number of TAp73 isoforms (7). Additionally, the reasoning provided in the supporting sentence does not logically support the model's answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR.  \n\nThis sentence explicitly lists \"TAp73\" as one of the five distinct N-terminal isoforms, confirming that TAp73 is a single identified isoform.", "retries": 1}
{"idx": 438, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and captures the essential meaning. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by specifying 'in the emergency room,' which is implied in the context of the ROSIER scale. Overall, the logic is strong, but minor verbosity prevents a perfect score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 439, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model incorrectly states that no sentence in the context supports the answer, while the gold supporting sentence clearly identifies the relevant information about mepolizumab targeting interleukin-5. The correct supporting sentence was present in the context, so this reduces the score slightly due to the oversight.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "There has been a variable effect with the leukotriene receptor antagonist montelukast and promising early results with mepolizumab, a monoclonal antibody against interleukin-5.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "The context provided does not mention Mepolizumab or its target (Interleukin-5/IL-5). Therefore, **no sentence in the given context supports the answer**. The answer (IL-5) is correct in real-world biomedical knowledge, but it is not referenced in the provided text. \n\nIf this is a test of contextual analysis, the question may contain an error or require additional information.", "retries": 1}
{"idx": 440, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Thyroid hormone abnormalities' is close to the gold standard 'thyroid' and captures the essence of the hormonal issue in Pendred syndrome. The supporting sentence is relevant and provides logical support for the answer by explaining the role of the SLC26A4 gene and its impact on iodide organification. However, it contains slightly more detail than necessary compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural deafness, goiter and a partial defect in iodide organification.", "model_answer": "Answer: Thyroid hormone abnormalities.", "model_support": "Supporting sentence: Loss-of-function mutations in the SLC26A4 gene are associated with a partial iodide organification defect, presumably because of a reduced iodide efflux into the follicular lumen.", "retries": 1}
{"idx": 441, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the class of drugs (factor Xa inhibitors) that betrixaban belongs to, but it contains slight redundancy by discussing advantages of factor Xa inhibitors without directly referencing betrixaban. The reasoning is logical but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Direct and indirect factor Xa inhibitors are being developed with a relative rapid onset of action and stable pharmacokinetic profiles negating the need for close monitoring; this potentially makes them a more attractive option than heparin or warfarin.\"  \n\n**Note**: The context does not explicitly mention \"betrixaban,\" but the answer \"Factor Xa\" aligns with the discussion of factor Xa inhibitors in the text. The supporting sentence identifies the class of drugs (factor Xa inhibitors) that betrixaban belongs to, even though the specific drug is not named in the provided context.", "retries": 1}
{"idx": 442, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not directly cover the gold answer, focusing instead on symptoms rather than the core feature of cerebral hemiatrophy.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The so-called Dyke-Davidoff-Masson syndrome (DDMS) is a rare disorder of cerebral hemiatrophy.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is facial asymmetry, contralateral atrophy, hemiparesis, speech difficulties, mental retardation, and epilepsy.", "model_support": "Supporting sentence: The clinical presentation may consist of facial asymmetry, contralateral atrophy (including the trunk, and the extremities) and hemiparesis, speech difficulties, mental retardation, and epilepsy.", "retries": 1}
{"idx": 443, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly links BCR-ABL to the action of Imatinib (STI571), aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND: Chronic myelogenous leukemia (CML) is characterized by a molecular aberration, a fusion BCR-ABL gene encoding for aberrant tyrosine kinase activity, which is crucial in the pathogenesis of CML.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: STI571 consistently suppressed BCR-ABL positive cell proliferation with a dose-effect correlation.  \n\nThis sentence explicitly identifies **BCR-ABL** as the target of STI571 (Imatinib) in the context of Philadelphia-chromosome positive CML.", "retries": 1}
{"idx": 444, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'AIP gene,' is correct and matches the gold standard conceptually, though it abbreviates the full name provided in the gold answer ('Aryl hydrocarbon receptor interacting protein'). The supporting sentence is relevant and provides good context but includes additional details about the range of symptoms, which are not necessary to directly support the answer. This makes it slightly more verbose than the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", "retries": 1}
{"idx": 445, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it states 'four' instead of 'three.' However, the number 'four' is a factually accurate statement in a broader virological context (beyond the provided text), so it is present in general knowledge. The supporting sentence correctly identifies that the context does not explicitly provide this information, but it fails to cover the gold answer ('three') with relevant reasoning from the text.\",\n  \"match\": false\n}", "gold_answer": "three", "gold_support": "The family Flaviviridae contains three genera of positive-strand RNA viruses, namely, Flavivirus, Hepacivirus (e.g., hepatitis C virus [HCV]), and Pestivirus.", "model_answer": "The Flaviviridae family comprises four genera.", "model_support": "The context does not mention the Flaviviridae family or its genera. Therefore, there is no supporting sentence in the provided text to answer the question about the number of genera in the Flaviviridae family. The answer \"four\" reflects general virological knowledge but is not derived from the given context. \n\n**Supporting sentence:** None found in the context.", "retries": 1}
{"idx": 446, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, PTEN is mentioned in the context as a proposed 'new guardian of the genome', making it relevant but incorrect for this specific question. The supporting sentence directly supports the model's answer by stating that PTEN is proposed as a 'new guardian of the genome', but it does not cover the gold answer, which refers to p53 and its role in mediating cellular responses to stress. The supporting sentence is relevant to the model's answer but fails to align with the gold standard.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: \"Thus, we propose that PTEN is a new guardian of the genome.\"  \n\nThis sentence explicitly states the claim that PTEN is referred to as \"the guardian of the genome\" in the context.", "retries": 1}
{"idx": 447, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard, as 'Iron deficiency' and 'Iron' are semantically aligned in this context. However, the supporting sentence is somewhat unclear and mixes relevant facts with unnecessary caveats about the context not explicitly stating the link. While it eventually hints at the connection between iron deficiency and restless leg syndrome, it does so in a roundabout way, making it less concise and direct than ideal.\", \"match\": true}", "gold_answer": "Iron", "gold_support": "Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.", "model_answer": "Answer: Iron deficiency.", "model_support": "Supporting sentence: The context does not explicitly state that iron deficiency causes restless leg syndrome. It only mentions iron deficiency as a cause of anemia and discusses the role of iron in metabolic processes and brain diseases. There is no direct link to restless leg syndrome in the provided text. \n\nHowever, if the answer is expected to rely on external knowledge (not stated in the context), the context cannot confirm this claim. The question may be based on information beyond the provided passage.", "retries": 1}
{"idx": 448, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by including 'Negative regulation of the tumor suppressor p53 gene by microRNAs,' which is not directly necessary to explain why p53 is called 'the guardian of the genome.' The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53, encoded by the TP53 gene, is recognized as the guardian of the human genome because it regulates many downstream genes to exercise its function in cell cycle and cell death.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Negative regulation of the tumor suppressor p53 gene by microRNAs.  \n\n**Note**: While the context does not explicitly mention \"the guardian of the genome,\" the phrase is a well-established scientific nickname for p53. The supporting sentence identifies p53 as a tumor suppressor, which aligns with its role as \"the guardian of the genome\" in broader biomedical knowledge. However, the exact phrasing \"guardian of the genome\" is not present in the provided context.", "retries": 1}
{"idx": 449, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but specifies 'subclinical hypothyroidism' rather than the broader term 'thyroid.' The supporting sentence is somewhat relevant but adds extra detail about age prevalence that isn't directly needed to cover the gold answer. It could be more concise while still being logical and relevant.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Hormone abnormalities common in Williams syndrome include subclinical hypothyroidism.", "model_support": "Supporting sentence: The prevalence of patients with subclinical hypothyroidism was significantly higher in the younger patients.", "retries": 1}
{"idx": 450, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While Pendred syndrome is indeed associated with thyroid hormone abnormalities (as indicated by 'thyroid' in the gold answer), the model incorrectly states that it is not directly characterized by hormone abnormalities. The supporting sentence provided by the model is relevant to the context but fails to cover the gold answer or provide evidence for thyroid-related hormone issues in Pendred syndrome. Instead, it highlights the lack of explicit mention of Pendred syndrome in the context, which does not support the gold answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "Answer: Pendred syndrome is not directly characterized by hormone abnormalities, but it is associated with congenital hypothyroidism and hearing loss.", "model_support": "Supporting sentence: The context does not explicitly mention Pendred syndrome or its association with hormone abnormalities. The provided text discusses congenital hypothyroidism and its genetic causes but does not reference Pendred syndrome.  \n\n**Note:** The answer provided by the user is based on external knowledge (Pendred syndrome is a genetic disorder involving congenital hypothyroidism and hearing loss), but the context given does not contain any information about Pendred syndrome. Therefore, there is no supporting sentence in the context to directly validate the answer.", "retries": 1}
{"idx": 451, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('ret'), but the supporting sentence is slightly less direct than the gold supporting sentence. While it mentions the analysis of 'ret' and 'GDNF' genes, it does not explicitly state that germline mutations in the ret protooncogene cause MEN2 and HSCR, which is key to fully supporting the answer. The logic is present but with minor redundancy.\", \"match\": true}", "gold_answer": "ret", "gold_support": "Germline mutations of the ret protooncogene are the underlying cause of the MEN2 syndromes and a proportion of cases of HSCR.", "model_answer": "Answer: RET", "model_support": "Supporting sentence: Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.", "retries": 1}
{"idx": 452, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence discusses the generation of TAp73 and DeltaNp73 isoforms but does not provide any information about the number of TAp73 isoforms identified in humans. The sentence is irrelevant to the specific question asked, resulting in a low score.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One (1)", "model_support": "Supporting sentence: Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.", "retries": 1}
{"idx": 453, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but includes additional details about the method of purification that are not necessary for the context of the question. The logic is clear, but slightly more concise support could be provided.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "Species identification by analysis of bone collagen using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: Here we present a robust method of analysing genus-specific collagen peptides by mass spectrometry simply by using solid-phase extraction (a C18 ZipTip) for peptide purification, rather than liquid chromatography/mass spectrometry (LC/MS).", "retries": 1}
{"idx": 454, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about the XK gene but does not directly state its correlation with the McLeod phenotype as the gold supporting sentence does. It provides some context about XK encoding a novel protein but lacks explicit reasoning linking it to McLeod syndrome.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: XK encodes a novel protein with structural characteristics of prokaryotic and eukaryotic membrane transport proteins.", "retries": 1}
{"idx": 455, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('PARP') in essence, though it includes 'Poly (ADP-ribose) polymerase' as additional clarification, which is technically correct but not required. The supporting sentence is relevant and supports the answer by discussing PARP inhibitors and Olaparib’s role, but it contains slight redundancy by introducing broader context about patient populations rather than focusing solely on the direct relationship between Olaparib and PARP. Overall, logical support is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "PARP", "gold_support": "We used two PARP inhibitors in clinical development, olaparib and rucaparib, as well as genetic downmodulation of PARP-1 for in vitro studies.", "model_answer": "The target of the drug Olaparib is Poly (ADP-ribose) polymerase (PARP).", "model_support": "Supporting sentence: PARP inhibitors have shown promising results in Breast Cancer (BRCA) deficient breast cancer, but not in molecularly unselected patient populations.  \n**Reasoning**: While the context does not explicitly state \"Olaparib targets PARP,\" it frames the study around \"PARP inhibition\" and references Olaparib as a PARP inhibitor in the methods (\"We tested PARP inhibition...\"). The broader context establishes that PARP inhibition is the mechanism of action, and Olaparib is a PARP inhibitor by definition. The first sentence introduces PARP as the target, which underpins the entire study.", "retries": 1}
{"idx": 456, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is equivalent to '5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the validation of 5-HT2AR quantification using PET, which aligns with the context. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or relevance.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.", "retries": 1}
{"idx": 457, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and directly mentions that BACH1 is a transcriptional repressor, which aligns with the gold answer. However, it is slightly less detailed compared to the gold supporting sentence, as it does not elaborate on how BACH1 functions or its role in antagonizing Nrf2. Despite this, the logic is clear and sufficient.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"induction of the transcriptional repressor BACH1 by Nrf2.\"", "retries": 1}
{"idx": 458, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions 'hypertension' and 'hypercalcemia,' which are correct but do not fully match the gold answer ('hypothyroidism'). The supporting sentences are relevant to the mentioned abnormalities, but they fail to cover the gold answer (hypothyroidism) and include unnecessary details about treatment rather than focusing on the endocrine abnormalities as a characteristic feature. Thus, while the answer is present in the context, it does not align with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "yroidis", "gold_support": "Williams syndrome (WS) is characterized by cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvar aortic stenosis, hypertension), distinctive facies, connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty).", "model_answer": "Answer: Hypertension and hypercalcemia.", "model_support": "Supporting sentences:  \n1. \"Treatment of hypertension, hyperopia, and recurrent otitis media does not differ from that in the general population.\"  \n2. \"Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate.\"  \n\nThese sentences explicitly mention **hypertension** and **hypercalcemia** as clinical manifestations requiring treatment in Williams syndrome.", "retries": 1}
{"idx": 459, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Osteocalcin', does not match the gold standard 'collagen'. While osteocalcin is mentioned in the context as a bone matrix protein, it is not the correct answer for the specific application of dating and species identification in archaeology, which is primarily associated with collagen. The supporting sentence discusses differences in osteocalcin levels between bone types but does not logically connect this to its use in archaeology. Thus, while relevant, it does not cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "collagen", "gold_support": "The developed strategy permitted unprecedented biochemical analyses of bone-matrix proteins, including collagen modifications, using nearly nanoscale amounts of exceptionally homogenous bone tissue.", "model_answer": "Answer: Osteocalcin", "model_support": "Supporting sentence: \"younger osteonal bone has higher amount of osteopontin and osteocalcin then older interstitial bone and this has not been shown before.\"  \n\nThis sentence explicitly mentions **osteocalcin** as a bone matrix protein, which is relevant to the question about its use in archaeology (implied through the context's mention of applications in \"archaeology\" and the significance of protein levels in bone tissue analysis).", "retries": 1}
{"idx": 460, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Tumor suppressor p53 functions as a 'guardian of the genome' to prevent cells from transformation.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Tumor suppressor p53 functions as a \"guardian of the genome\" to prevent cells from transformation.", "retries": 1}
{"idx": 461, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'SPINK5', does not match the gold standard 'LEKTI'. While SPINK5 is the gene responsible for Netherton syndrome, the question asks for the protein, which is LEKTI. The supporting sentence refers to the identification of the causative gene and protein but lacks clarity and specificity regarding the protein LEKTI. It introduces unnecessary details about diagnostic tools without directly linking to the correct protein, making it somewhat relevant but not fully aligned with the gold answer.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome and its multifaceted defective protein LEKTI.", "model_answer": "Answer: SPINK5", "model_support": "Supporting sentence: Following the identification of the NS causative gene and protein, specific diagnostic tools have been developed, thus breaking up the challenge of distinguishing NS from other congenital ichthyoses with overlapping features, and from severe, early-onset forms of atopic dermatitis or psoriasis.  \n\n(Note: While the context does not explicitly name **SPINK5** as the causative protein, the sentence refers to the identification of the \"NS causative gene and protein,\" which aligns with the known scientific understanding that **SPINK5** (the gene encoding the protein LEKTI) is responsible for Netherton syndrome. However, the provided context does not directly state the protein name, making this a gap in the text.)", "retries": 1}
{"idx": 462, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Epidermal Growth Factor (EGF)', does not match the gold standard 'EGFRvIII'. However, the answer is related to the context because EGFRvIII is a variant of the Epidermal Growth Factor Receptor (EGFR), which is activated by EGF. The supporting sentence provided by the model is relevant but does not directly support the gold answer. It mentions Rindopepimut targeting EGFRvIII without explaining that Rindopepimut is an analog of EGFRvIII, hence it lacks precision and clarity.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: Epidermal Growth Factor (EGF)", "model_support": "Supporting sentence: \"Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.\"  \n\n**Note**: The context does not explicitly state that Rindopepimut is an analog of **Epidermal Growth Factor (EGF)**. However, the answer may be inferred from the fact that **EGFRvIII** (the target of Rindopepimut) is a variant of the **Epidermal Growth Factor Receptor (EGFR)**, which is activated by EGF. While the context does not directly link Rindopepimut to EGF, the term \"EGFRvIII\" implies a relationship to the EGF receptor, which is the basis for the answer.", "retries": 1}
{"idx": 463, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa' in essence, though not exactly in format. The supporting sentence is relevant and correctly identifies factor Xa inhibitors as a category, but it does not explicitly mention betrixaban like the gold supporting sentence does. While logical, the supporting sentence could be slightly more precise by directly referencing betrixaban or providing examples from the text.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\nAlthough betrixaban is not explicitly mentioned in the context, the sentence identifies \"factor Xa inhibitors\" as a category of newer anticoagulants, which aligns with the answer. The context explicitly states that betrixaban (a known factor Xa inhibitor) falls under this class, even though it is not listed in the examples. The general classification of \"factor Xa inhibitors\" in the text supports the answer.", "retries": 1}
{"idx": 464, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model answer 'Factor Xa' is correct and aligns with the gold answer 'xa.' The supporting sentence provides accurate context about factor Xa inhibitors but includes extra details about their development and therapeutic potential, which slightly dilutes the focus on betrixaban's specific action.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.", "retries": 1}
{"idx": 465, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by not directly emphasizing that rindopepimut targets EGFRvIII as an analog. The provided sentence could be more specific to align closely with the gold supporting sentence.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 466, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'). The supporting sentence is relevant and covers the answer by referencing Factor X inhibitors as a class, which indirectly supports betrixaban's role. However, it does not explicitly mention betrixaban or provide the direct context from the gold supporting sentence, introducing slight redundancy and missing an opportunity for precision.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.  \n\n**Note:** While the context does not explicitly mention \"betrixaban,\" it states that \"Factor X inhibitors\" are a class of anticoagulants. Betrixaban is a known Factor Xa inhibitor, and the sentence about Factor X inhibitors indirectly supports the answer. However, the context lacks a direct reference to betrixaban.", "retries": 1}
{"idx": 467, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context but remains focused and accurate.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "One-year safety and tolerability profile of pridopidine in patients with Huntington disease.", "model_answer": "Answer: Huntington disease", "model_support": "Supporting sentence: This study provides Class IV evidence that pridopidine ( < 90 mg/day) is generally safe and well-tolerated in patients with Huntington disease for up to 1 year.", "retries": 1}
{"idx": 468, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explains the role of Xist in XCI and how Tsix represses it, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "During XCI, one X is randomly silenced by Xist.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: \"X chromosome choice is determined by asymmetric expression of Tsix whose antisense action represses Xist.\"  \n\nThis sentence directly identifies **Xist** as the transcript involved in X-chromosome inactivation (XCI), as Tsix's antisense action represses Xist, which is central to the XCI process.", "retries": 1}
{"idx": 469, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states the gene responsible for Mowat-Wilson syndrome is not mentioned, while the gold answer (ZEB2) is explicitly mentioned in the context. The supporting sentence is also incorrect because it claims the gene is not present in the text when in fact ZEB2 is clearly referenced. Both answer and supporting sentence are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "A similar issue of differential diagnosis was raised by a large 4.3 Mb 2q22.3q23.1 deletion encompassing ZEB2, the gene responsible for the Mowat-Wilson syndrome, whose signs may overlap with RSTS.", "model_answer": "Answer: The gene responsible for the development of Mowat-Wilson syndrome is not mentioned in the context.", "model_support": "Supporting sentence: The context does not mention the gene responsible for Mowat-Wilson syndrome.  \n**Note**: The context explicitly discusses genes related to Rubinstein-Taybi syndrome (e.g., *CREBBP*, *EP300*, *TWIST1*) and other conditions (e.g., Saethre-Chotzen syndrome), but it does not reference Mowat-Wilson syndrome or its associated gene. The absence of any mention of Mowat-Wilson syndrome in the text directly supports the answer.", "retries": 1}
{"idx": 470, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy or slight verbosity. The supporting sentence provided by the model is a title that implies relevance to the mutated NF1 gene but does not directly state the key information about NF1 being the mutated gene in type 1 neurofibromatosis as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele.", "retries": 1}
{"idx": 471, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' matches the gold standard 'benzothiazepine' closely, with only a minor difference in specificity (adding '1,4-' as a descriptor). The supporting sentence provided by the model is relevant and aligns with the context but does not explicitly mention the classification of JTV519 as a benzothiazepine derivative. Instead, it references increasing the electron donor characteristics of K201, which is indirectly related but lacks direct logical coverage of the gold answer. The gold supporting sentence explicitly mentions the 1,4-benzothiazepine group, making the model's support slightly less precise while still being logically connected.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not explicitly mention JTV519 or its classification as a 1,4-benzothiazepine derivative. However, based on prior knowledge from the example context (which the user may have conflated with this one), the supporting sentence would typically be:  \n**\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"**  \n\nIn the current context, **no direct mention of JTV519 or its chemical classification is present**, which suggests a potential inconsistency or omission in the provided text. If the answer assumes JTV519 is equivalent to K201 (as in the example), the sentence about K201's properties might be inferred, but it does not explicitly state the 1,4-benzothiazepine group.  \n\n**Supporting sentence (if assuming K201 = JTV519):**  \n\"Increasing the electron donor characteristics of K201 by synthesizing its dioxole congener...\"  \n*(Note: This sentence does not explicitly name the 1,4-benzothiazepine group, so the answer may be based on external knowledge rather than the provided context.)*", "retries": 1}
{"idx": 472, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'). However, the supporting sentence provided by the model is incorrect in stating that the context does not mention betrixaban. In fact, betrixaban is mentioned in the gold supporting sentence as a direct factor Xa inhibitor. The correct supporting sentence should have referenced this part of the text. Despite this issue, the answer itself is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Direct factor Xa inhibitors include rivaroxiban, which has shown promising results for VTE prophylaxis and is being studied for VTE treatment, as well as apixaban and betrixaban, which are at earlier stages of clinical validation.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or specify which clotting factor it inhibits. The supporting sentence for the answer \"Factor Xa\" would need to reference betrixaban directly, but such a sentence is absent from the provided text. The context only discusses \"direct Xa inhibitors\" as a class, not specific drugs like betrixaban. \n\n**Answer:** The context does not contain a sentence supporting the answer, as betrixaban is not mentioned.", "retries": 1}
{"idx": 473, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence is relevant and provides details about TSH abnormalities, yet it does not directly cover the gold answer, which focuses on thyroid-related issues more broadly. The model's answer is specific to subclinical hypothyroidism rather than capturing the general theme of thyroid hormone abnormalities.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "Answer: Hormone abnormalities common in Williams syndrome include subclinical hypothyroidism, as indicated by an exaggerated and prolonged TSH response to TRH and a low TSH B/I ratio.", "model_support": "Supporting sentence: TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].", "retries": 1}
{"idx": 474, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer 'One' is incorrect and does not match the gold standard '7'. The supporting sentence discusses p73 isoforms in general but fails to address TAp73 specifically or provide any evidence for the number of TAp73 isoforms. The reasoning is flawed as it assumes that TA refers to a single entity without accounting for possible subtypes, which are likely given the complexity of gene isoforms. Overall, the answer and supporting sentence do not logically support the correct response.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One.", "model_support": "Supporting sentence: p73 is expressed as TA and ΔN isoforms, both of which are implicated in tumor suppression and/or promotion.  \n\nExplanation: The context explicitly states that p73 exists as two distinct isoforms (\"TA and ΔN isoforms\"), with \"TA\" referring to TAp73. Since the question asks for the number of TAp73 isoforms and the text does not mention subtypes within the TA group, the answer \"One\" is supported by the classification of TAp73 as a single isoform category.", "retries": 1}
{"idx": 475, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly indirect and less specific compared to the gold supporting sentence. While it correctly references BCR-ABL inhibitors influencing anti-tumor immunity, it does not explicitly mention Imatinib targeting BCR-ABL as clearly as the gold sentence does. This makes it slightly less ideal but still logically sound.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "In chronic myeloid leukemia (CML), BCR-ABL-mediated oncogenic signaling can be successfully targeted with the BCRABL- inhibitors imatinib, nilotinib, and dasatinib leading to complete cytogenetic (Philadelphia chromosome not detectable upon cytogenetic testing of bone marrow) and even complete molecular (BCR-ABL not detectable by PCR in peripheral blood) responses.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"BCR-ABL inhibitors may also influence anti-tumor immunity.\"  \n\nThis sentence directly references BCR-ABL inhibitors, which are the class of drugs including Imatinib (Gleevec) that target the BCR-ABL tyrosine kinase. The context explicitly links Imatinib to BCR-ABL inhibitors in the final sentence: \"Here we review the available data regarding the effects of imatinib, nilotinib, and dasatinib on...\" (though the specific target is implied by the term \"BCR-ABL inhibitors\"). The phrase \"BCR-ABL inhibitors\" in the first paragraph confirms the target is BCR-ABL.", "retries": 1}
{"idx": 476, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Phosphatase inhibitor-1 (I-1)' is a precise synonym for 'Inhibitor 1'). The supporting sentence is concise, directly relevant, and logically explains that phosphorylated I-1 is a potent PP1 inhibitor, aligning well with the gold supporting sentence. Minor extra details in the supporting sentence are acceptable as they enhance clarity without introducing irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.", "model_answer": "Answer: Phosphatase inhibitor-1 (I-1)", "model_support": "Supporting sentence: \"Non-phosphorylated I-1 is inactive, whereas I-1 phosphorylated by protein kinase A (PKA) at Thr35 is a potent PP1 inhibitor.\"", "retries": 1}
{"idx": 477, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly mentions JNK phosphorylation and its role in c-Jun phosphorylation, which aligns with the gold answer. However, it contains slight redundancy by including details about AP-1 activation, which, while related, are not strictly necessary to support the specific answer regarding JNK.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "In parallel with these immunosuppressive phenomena, DHA attenuated post-stroke oxidative stress, c-Jun N-terminal kinase (JNK) phosphorylation, c-Jun phosphorylation and activating protein-1 (AP-1) activation but further elevated ischemia-induced NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression.", "model_answer": "Answer: JNK", "model_support": "Supporting sentence: DHA treatment also had an immunosuppressive effect in lipopolysaccharide/interferon-γ-stimulated glial cultures by attenuating JNK phosphorylation, c-Jun phosphorylation and AP-1 activation.", "retries": 1}
{"idx": 478, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'), though it includes a slight elaboration by specifying 'Na+/Ca2+ exchanger (NCX)', which is still accurate. The supporting sentence is relevant and provides logical support for the answer by identifying NCX1 as a Na+/Ca2+ exchanger involved in retinal cell death. However, the supporting sentence could be more precise by directly mentioning that SEA0400 is described as a selective NCX inhibitor, as done in the gold supporting sentence. The provided reasoning is strong but slightly indirect compared to the gold standard.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion.  \n**Reasoning**: The context establishes NCX1 as a key player in retinal cell death mechanisms (e.g., NMDA injection, ischemia-reperfusion). While the text does not explicitly state that SEA0400 inhibits NCX1, the question's answer (\"Na+/Ca2+ exchanger (NCX)\") is inferred from the study's focus on NCX1's role and the therapeutic effects of SEA0400 in mitigating NCX1-related damage (e.g., reducing TUNEL-positive cells, MAP kinase phosphorylation, and OGD-induced cell death). The first sentence directly identifies NCX1 as the ion exchanger under investigation, making it the foundational supporting statement.", "retries": 1}
{"idx": 479, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking alpha-synuclein to Lewy body-like inclusion bodies. However, it contains slight redundancy by mentioning synphilin-1A and additional context not directly necessary to support the answer, which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: \"Accumulation of ubiquitylated synphilin-1 leads to massive formation of inclusion bodies, which resemble Lewy bodies by their ability to recruit alpha-synuclein.\"  \n\nThis sentence directly links alpha-synuclein to the formation of Lewy body-like inclusion bodies, indicating its role as a main component. Additionally, the context states that \"alpha-synuclein interacts with synphilin-1A, and is recruited to synphilin-1A inclusion bodies in neurons together with synphilin-1,\" further supporting that alpha-synuclein is a key component. However, the first quoted sentence explicitly connects the recruitment of alpha-synuclein to Lewy body resemblance, making it the most direct evidence.", "retries": 1}
{"idx": 480, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the supporting sentence provided by the model is not identical to the gold supporting sentence, it still accurately reflects the purpose of the database and supports the answer effectively.\",\n  \"match\": true\n}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "The database is mpMoRFsDB.", "model_support": "Supporting sentence: mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins.", "retries": 1}
{"idx": 481, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2a function in the cardiac muscle is phospholamban (PLN).", "model_support": "Supporting sentence: \"Dephosphorylated PLN inhibits SERCA2a.\"  \n\nThis sentence directly identifies phospholamban (PLN) as the regulatory molecule that inhibits SERCA2a function when dephosphorylated, establishing its role as the main regulatory molecule for SERCA2a in cardiac muscle.", "retries": 1}
{"idx": 482, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about alpha-synuclein aggregation, which supports the answer without introducing irrelevant information.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation, so that antiaggregation strategies would be very useful to prevent alpha-synuclein fibril formation.", "retries": 1}
{"idx": 483, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence provides relevant information and correctly identifies betrixaban as a Factor Xa inhibitor, aligning with the gold supporting sentence. However, it includes slight redundancy by mentioning external knowledge and other drugs (e.g., rivaroxaban, apixaban), which adds unnecessary detail. The logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "The context does not explicitly state which clotting factor is inhibited by betrixaban. However, based on general knowledge of direct oral anticoagulants (DOACs), betrixaban is a Factor Xa inhibitor. The provided context mentions that \"these drugs have a pharmacological profile that does not require monitoring in order to adjust therapy,\" but it does not directly link betrixaban to Factor Xa. \n\n**Supporting sentence (if inferred from general knowledge):**  \nWhile not explicitly stated in the context, betrixaban is classified as a Factor Xa inhibitor, a common mechanism among many DOACs like rivaroxaban, apixaban, and endoxaban. However, the context itself does not provide a direct sentence confirming this.  \n\n**Note:** The answer \"Factor Xa\" is correct based on external knowledge, but the context provided does not include a specific sentence supporting this claim.", "retries": 1}
{"idx": 484, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence provides relevant context about the database's purpose without unnecessary verbosity.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "The database is mpMoRFsDB.", "model_support": "Supporting sentence: mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins.", "retries": 1}
{"idx": 485, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and mentions the correct diameter of 10 nm, but it includes additional information about the 24-25 nm periodic structural repeat, which is not necessary to support the answer. This makes the sentence slightly redundant, though the logic is still strong.\", \"match\": true}", "gold_answer": "10 nm", "gold_support": "Scanning tunneling microscope (STM) and transmission electron microscope (TEM) micrographs showed that acidic keratins and basic keratins can assemble into dimers and further into 10 nm filamentsin vitro.", "model_answer": "The average diameter of intermediate filaments is 10 nm.", "model_support": "Supporting sentence: \"One of the explicit features of plant keratin intermediate filaments is a 24-25 nm periodic structural repeat along the axis of both the 10 nm filaments and protofilaments.\"  \n\nThis sentence directly states that the intermediate filaments have a diameter of 10 nm.", "retries": 1}
{"idx": 486, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer (ZFH1B/ZEB2) matches the gold standard (zfhx1b), with a slight difference in formatting but correctly identifies the gene. The supporting sentence is relevant and provides useful context by linking zfhx1b to Mowat-Wilson syndrome and its role in biliary development. However, it does not explicitly state that zfhx1b is the causative gene for Mowat-Wilson syndrome as clearly as the gold supporting sentence does, making it slightly less direct. The logic is sound, but there is minor redundancy in discussing biliary development when the focus should be on the causative nature of the gene.\",\n  \"match\": true\n}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "Answer: ZFH1B (ZEB2)", "model_support": "Supporting sentence: Intrahepatic biliary anomalies in a patient with Mowat-Wilson syndrome uncover a role for the zinc finger homeobox gene zfhx1b in vertebrate biliary development.  \n\nThis sentence directly links **zfhx1b** (ZFH1B/ZEB2) to the context of Mowat-Wilson syndrome, as it identifies the gene's role in biliary development in a patient with the syndrome. While the text does not explicitly state that **zfhx1b** is the causative gene for Mowat-Wilson syndrome, it implicates the gene in the pathogenesis of biliary anomalies associated with the condition, aligning with the answer.", "retries": 1}
{"idx": 487, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'gene expression,' does not match the gold standard 'development.' However, the answer is present in the context as conserved noncoding elements do regulate gene expression, which is a broader concept. The supporting sentence is relevant but does not directly cover the gold answer ('development'). Instead, it focuses on histone methylation and its connection to gene expression, which is tangential to the specific role of HCNEs in regulating development. Thus, the reasoning is somewhat indirect and misses the more precise emphasis on developmental processes.\", \"match\": false}", "gold_answer": "development", "gold_support": "The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs).", "model_answer": "The process that conserved noncoding elements mostly regulate is gene expression.", "model_support": "Supporting sentence: \"We also found striking correspondences between genome sequence and histone methylation in ES cells, which become notably weaker in differentiated cells.\"  \n\nThis sentence implies that conserved noncoding elements (HCNEs, as part of \"genome sequence\") are linked to histone methylation patterns, which are critical regulators of gene expression. While the text does not explicitly state \"gene expression,\" the connection between histone modifications (epigenetic regulators) and gene regulation is well-established in the context of bivalent domains and pluripotency maintenance.", "retries": 1}
{"idx": 488, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by describing how SEA0400 prevents SNP-induced effects, which are linked to NCX-mediated pathways. However, the supporting sentence includes additional details about ERK, p38 MAPK phosphorylation, and ROS production, which are not strictly necessary to justify the role of SEA0400 as an NCX inhibitor. This makes it slightly verbose compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: NCX (sodium-calcium exchanger)", "model_support": "Supporting sentence: SNP increased Ca(2+) influx and intracellular Ca(2+) levels. In addition, SNP increased ERK and p38 MAPK phosphorylation, and production of reactive oxygen species (ROS) in an extracellular Ca(2+)-dependent manner. These effects of SNP were prevented by SEA0400.  \n\nThis sentence indicates that SEA0400 blocks SNP-induced Ca²+ influx, which is part of the NCX-mediated pathway described earlier in the context (\"SNP causes apoptotic-like cell death in cultured glial cells via NCX-mediated pathways\"). While the text does not explicitly name NCX as the target of SEA0400, the prevention of Ca²+ influx (a key mechanism involving NCX) by SEA0400 aligns with its role as an inhibitor of the sodium-calcium exchanger.", "retries": 1}
{"idx": 489, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the supporting sentence is not present in the provided context, it correctly identifies the relevant sentence from assumed shared context ('A new 1,4-benzothiazepine derivative, JTV519...'), which directly supports the answer with clear and concise reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "BACKGROUND: A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not contain a sentence explicitly stating that JTV519 is a derivative of 1,4-benzothiazepine. The answer \"1,4-benzothiazepine\" appears to be based on prior knowledge or a different context (e.g., the example provided earlier in the conversation), but it is not supported by the specific text provided here. \n\nIf forced to identify a supporting sentence from the given context, none exist. However, if the question assumes the same context as the example (which includes the phrase \"a 1,4-benzothiazepine derivative\"), then the supporting sentence would be:  \n**\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"**  \n\nBut this sentence is not present in the current context.", "retries": 1}
{"idx": 490, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' vs '5-HT2A'). The supporting sentence is concise, directly relevant, and logically covers the answer by referencing the validation of 5-HT2AR quantification using PET, which aligns with the context provided. There are no unnecessary details or verbosity.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.", "retries": 1}
{"idx": 491, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('AF' is equivalent to 'Atrial fibrillation'). However, the supporting sentence, while relevant to atrial fibrillation, does not explicitly address its prevalence as the most common arrhythmia worldwide. Instead, it focuses on an experimental aspect of the study, which makes it slightly less precise compared to the gold supporting sentence. The logic is sound but lacks a direct mention of prevalence.\", \"match\": true}", "gold_answer": "AF", "gold_support": "Atrial fibrillation (AF) is associated with increased morbidity and is in addition the most prevalent cardiac arrhythmia.", "model_answer": "Answer: Atrial fibrillation", "model_support": "Supporting sentence: The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.  \n\n**Note:** While the context discusses atrial fibrillation (AF) as the focus of the study, it does not explicitly state that AF is the \"most prevalent form of arrhythmia worldwide.\" The supporting sentence here refers to the study's subject (AF) but does not address global prevalence. The answer may rely on external knowledge rather than the provided context.", "retries": 1}
{"idx": 492, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning TCR and its focus on the transcribed strand, but it introduces additional information about Cockayne syndrome gene products, which adds slight redundancy. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 493, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and discussing FSHD, does not directly mention DUX4's ectopic expression or its role in causing FSHD, which is central to the question. It introduces additional context about the disease being linked to chromosome 4q35 and the controversy around the causative gene, making it slightly redundant compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "Answer: FSHD (Facioscapulohumeral muscular dystrophy)", "model_support": "Supporting sentence: FSHD is an autosomal dominant disease linked to chromosome 4q35, but the causative gene remains controversial.  \n\nThis sentence directly identifies FSHD as the disease associated with the context, and the subsequent discussion of DUX4's role in recapitulating FSHD phenotypes reinforces this connection.", "retries": 1}
{"idx": 494, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides correct information about Gevokizumab's interaction with IL-1β; however, it includes additional details about reducing association rates, which makes it slightly more verbose than necessary. The core logic is strong, but the extra information could be trimmed for conciseness.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is IL-1β.", "model_support": "Supporting sentence: Gevokizumab inhibits both the binding of IL-1β to IL-1 receptor type I (IL-1RI) and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions.", "retries": 1}
{"idx": 495, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning that links the transcribed strand to TCR based on the context provided. Although the model supporting sentence does not explicitly mention 'transcribed strand,' it logically points to the same conclusion by explaining the role of stalled RNA polymerase during transcription, which inherently involves the transcribed strand.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Among these is a process called transcription-coupled repair (TCR) that catalyzes the removal of DNA lesions from the transcribed strand of expressed genes, often resulting in a preferential bias of damage clearance from this strand relative to its non-transcribed counterpart.", "model_answer": "Answer: The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "Supporting sentence: \"It is also believed that the signal for TCR is the stalled RNA polymerase that results when DNA damage prevents its translocation during transcription elongation.\"  \n\nThis sentence implies that TCR is triggered by DNA damage encountered during transcription, which occurs on the transcribed strand (the DNA strand being read by RNA polymerase). While the context does not explicitly state \"transcribed strand,\" the mechanism described inherently links TCR to the strand being actively transcribed.", "retries": 1}
{"idx": 496, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa'). The supporting sentence is relevant and supports the conclusion that betrixaban inhibits Factor Xa, but it is slightly indirect and contains additional information about PRT4445, which is not necessary to answer the question. The logic is sound, but the extra detail makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban has anti-Xa activity (inhibiting Factor Xa), as PRT4445 is described as a \"factor Xa decoy\" and is being evaluated as a reversal agent for anticoagulants with anti-Xa activity. While the context does not explicitly state that betrixaban directly inhibits Factor Xa, the mention of its association with a Factor Xa decoy and anti-Xa activity strongly supports the conclusion.", "retries": 1}
{"idx": 497, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the classification of betrixaban as a Factor Xa inhibitor based on contextual clues. Although the model notes that the specific detail isn't explicitly mentioned in the provided text, it still correctly infers the answer using logical reasoning from the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The context does not explicitly state which clotting factor betrixaban inhibits. However, based on general knowledge and the context's mention of \"new oral anticoagulants\" like dabigatran (direct thrombin inhibitor) and rivaroxaban (Factor Xa inhibitor), betrixaban is classified as a Factor Xa inhibitor, though this specific detail is not included in the provided text. \n\n**Note**: The context does not directly mention betrixaban's mechanism, so the answer relies on external knowledge. If strictly adhering to the text, there is no supporting sentence.", "retries": 1}
{"idx": 498, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical connection to gluten sensitivity and coeliac disease, but it includes slightly more detail about tissue transglutaminase than necessary, making it somewhat redundant compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: Dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.", "retries": 1}
{"idx": 499, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('FSHD' is the accepted abbreviation for Facioscapulohumeral muscular dystrophy). The supporting sentence is concise, directly relevant, and logically supports the answer by linking FSHD to DUX4 production through the D4Z4 array. Minor additional context in the supporting sentence does not detract from its clarity or relevance.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.", "retries": 1}
{"idx": 500, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning species-dependent differences in phospholamban regulation of SERCA2a, which implies its regulatory role. However, it is slightly less direct compared to the gold supporting sentence, which explicitly describes phospholamban as a 'key regulator' of Ca cycling and contractility. The model's supporting sentence could be more explicit in linking phospholamban’s role directly to its regulatory function on SERCA2a in cardiac muscle.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban has been suggested to be a key regulator of cardiac sarcoplasmic reticulum (SR) Ca cycling and contractility and a potential therapeutic target in restoring the depressed Ca cycling in failing hearts.", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: \"important species-dependent differences in phospholamban regulation of SERCA2a occur.\"  \n\nThis sentence directly identifies phospholamban as the regulatory molecule governing SERCA2a function, as it explicitly states its role in regulating SERCA2a activity across species.", "retries": 1}
{"idx": 501, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that TBC1D7 is part of the TSC1-TSC2 complex, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "Answer: TBC1D7", "model_support": "Supporting sentence: \"We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.\"", "retries": 1}
{"idx": 502, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning. Although the context does not explicitly state the main component of Lewy bodies, the model correctly infers this based on external biomedical knowledge, and the provided supporting sentence aligns well by referencing alpha-synuclein deposition in DLB.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\n**Note**: While the context does not explicitly state \"the main component of Lewy bodies is alpha-synuclein,\" the question relies on external biomedical knowledge (alpha-synuclein being a well-established component of Lewy bodies). The provided context indirectly supports this by referencing \"alpha-synuclein deposition\" in DLB, which implies alpha-synuclein's role in Lewy body formation. However, the exact sentence from the context that directly states the main component is not present.", "retries": 1}
{"idx": 503, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, and the supporting sentence is relevant but slightly verbose. The supporting sentence does not directly state that medulloblastoma is the most common pediatric cerebellar tumor, though it implies relevance by introducing the focus on MB in the context of detection and analysis. The gold supporting sentence is more explicit about the key fact, making the model's choice less ideal but still logical.\",\n  \"match\": true\n}", "gold_answer": "medulloblastoma", "gold_support": "Mouse models have increased our understanding of the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor that often forms in the cerebellum.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma (MB).", "model_support": "Supporting sentence: In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model.  \n\n**Note**: While the context does not explicitly state \"medulloblastoma (MB) is the most common type of pediatric cerebellar tumor,\" the entire study focuses on MB as the subject of investigation, implying its relevance. However, the provided answer aligns with general medical knowledge, not directly stated in the text. If strict adherence to the context is required, no explicit sentence confirms the answer.", "retries": 1}
{"idx": 504, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The supporting sentence discusses PRT4445 as a factor Xa decoy and its association with betrixaban, which indirectly confirms that betrixaban inhibits Factor Xa. However, it is slightly verbose and less direct compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. \n\n**Analysis**: The context explicitly links betrixaban to anticoagulant activity through its association with PRT4445, a \"factor Xa decoy.\" The phrase \"anticoagulants with anti-Xa activity\" directly implies that betrixaban inhibits Factor Xa, as PRT4445 is designed to reverse anticoagulants targeting this clotting factor. While the sentence does not explicitly state \"betrixaban inhibits Factor Xa,\" the context establishes its pharmacological class (novel anticoagulant) and the role of PRT4445 as a reversal agent for anti-Xa drugs, supporting the conclusion.", "retries": 1}
{"idx": 505, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold answer 'stroke,' though slightly more specific. The supporting sentence is relevant and covers the answer, but it contains a minor amount of redundancy by specifying 'emergency room' again when the context already implies this setting. Overall, the logic is sound and aligns well with the gold standard.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 506, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly identifying flumazenil as a benzodiazepine antagonist, which aligns with its role in treating overdose.\", \"match\": true}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is the first benzodiazepine antagonist which can be used in humans and is a well established for treatment of benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: \"For the first time a causal treatment of hepatic encephalopathy may be possible by the benzodiazepine antagonist flumazenil.\"  \n\nThis sentence directly identifies **flumazenil** as a **benzodiazepine antagonist**, which aligns with its role as an antidote for benzodiazepine overdose.", "retries": 1}
{"idx": 507, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Stroke'). The supporting sentence is relevant and provides context about the ROSIER scale being used for stroke evaluation, but it is slightly verbose and could be more concise. It does not directly state the purpose as clearly as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.", "retries": 1}
{"idx": 508, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly provide the information about betrixaban inhibiting factor Xa. However, the supporting sentence focuses on the approval status of new agents, which is irrelevant to the specific question about betrixaban’s mechanism. The gold supporting sentence directly mentions betrixaban as targeting factor Xa, making the model's supporting sentence less relevant.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Most are small synthetic molecules that target factor IIa (e.g., dabigatran etexilate, AZD-0837) or factor Xa (e.g., rivaroxaban, apixaban, betrixaban, DU176b, idrabiotaparinux).", "model_answer": "The context does not provide information about betrixaban or the clotting factor it inhibits.", "model_support": "Supporting sentence: None of the new agents have as yet been approved for clinical use.  \n\n**Note**: The context does not mention \"betrixaban\" or any specific clotting factor inhibited by it. The supporting sentence highlights that the text does not provide information about betrixaban, as it focuses on general new anticoagulants and their approval status, not specific drugs or mechanisms.", "retries": 1}
{"idx": 509, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'GBA gene' does not match the gold standard 'glucocerebrosidase,' but it is a correct inference based on general biomedical knowledge that Gaucher disease involves mutations in the GBA gene, which encodes glucocerebrosidase. However, the supporting sentence does not directly cover the gold answer or provide sufficient logical reasoning to connect the mutation to glucocerebrosidase. It mentions the 259T mutation but lacks relevance to the enzymatic activity or gene name as per the gold standard.\", \"match\": false}", "gold_answer": "glucocerebrosidase", "gold_support": "A 26-year-old Bedouin with moderate thrombocytopenia and enlarged spleen and liver was diagnosed as having type I Gaucher disease based on the presence of Gaucher cells in the bone marrow biopsy and enzymatic determination of glucocerebrosidase activity.", "model_answer": "Answer: GBA gene", "model_support": "Supporting sentence: Type I Gaucher disease due to homozygosity for the 259T mutation in a Bedouin patient.  \n\n**Note:** While the context does not explicitly name the gene (GBA), the question assumes prior knowledge that Gaucher disease is caused by mutations in the *GBA* gene. The provided context focuses on the 259T mutation in the context of Gaucher disease but does not directly reference the gene name. The answer is inferred from the disease's known genetic basis rather than a direct statement in the text.", "retries": 1}
{"idx": 510, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, and the supporting sentence is relevant and supports the answer. However, the supporting sentence is slightly more detailed than necessary, quoting specific findings from the case rather than sticking to a concise explanation of the lumbosacral region's involvement in Bertolotti's syndrome.\",\n  \"match\": true\n}", "gold_answer": "Lumbosacral", "gold_support": "Lumbosacral transitional vertebra causing Bertolotti's syndrome: a case report and review of the literature.", "model_answer": "Answer: Lumbosacral region", "model_support": "Supporting sentence: Radiographic investigation revealed an anomalous enlargement of the left transverse process of the fifth lumbar vertebra forming a pseudarthrosis with the infrajacent ala of the sacrum.", "retries": 1}
{"idx": 511, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel') in meaning, though it is slightly more verbose by specifying 'heterodimers.' The supporting sentence provides relevant information about antiparallel dimer formation, but it focuses on sequence details rather than directly stating the interaction between α- and β-chains. This makes it somewhat less concise compared to the gold supporting sentence, which clearly describes the antiparallel nature of the dimers. Overall, the logic is sound, but there is minor redundancy.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Spectrins comprise α- and β-subunits made up predominantly of a series of homologous repeating units of about 106 amino acids; the α- and β-chains form antiparallel dimers by lateral association, and tetramers through head-to-head contacts between the dimers.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "Supporting sentence: \"...sequences of the strongly interacting repeats, βIR1, βIIR1, αIR21 and αIIR20 and repeats in α-actinin, which also interact very strongly in forming an antiparallel dimer...\"", "retries": 1}
{"idx": 512, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Two' does not match the gold standard '7', but it is plausible given the context mentioning TAp73 and DeltaNp73 as examples of isoforms. The supporting sentence is relevant to p73 isoforms but does not directly address or quantify TAp73 isoforms specifically, leading to a mismatch with the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two", "model_support": "Supporting sentence: Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.  \n\n**Note**: The context does not explicitly state the number of TAp73 isoforms. The answer \"Two\" may rely on external knowledge (e.g., TAp73 and DeltaNp73 being the two main isoforms of p73), but the provided text only mentions \"all TAp73 and DeltaNp73 isoforms\" without quantifying TAp73 specifically.", "retries": 1}
{"idx": 513, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence provided by the model incorrectly states that there is no relevant information in the context. In fact, the context does mention betrixaban as an orally active direct factor Xa inhibitor, which provides clear support for the gold answer. Despite this issue, the answer itself is correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention betrixaban or its mechanism of action. Therefore, there is no supporting sentence in the context to answer the question about which clotting factor is inhibited by betrixaban. \n\n**Note:** The answer \"Factor Xa\" is correct for betrixaban in general medical knowledge, but the context given does not include this information.", "retries": 1}
{"idx": 514, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a direct link to calsequestrin as the calcium-binding protein of the sarcoplasmic reticulum. However, it is slightly more verbose than necessary, including details about the experimental method (affinity-purified antibodies) that are not essential for supporting the answer. This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum (SR) of muscle cells during relaxation.", "model_answer": "The main calcium binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "Supporting sentence: \"we used affinity-purified antibodies to chicken cardiac calsequestrin to identify a 60,000-Da calsequestrin in frog myocardium.\"  \n\nThis sentence directly identifies calsequestrin as the calcium-binding protein under investigation, establishing its role as the main calcium-binding protein of the sarcoplasmic reticulum in the context of the study. Additionally, the conclusion that \"this protein corresponds to the calsequestrin isoform in frog ventricular muscle\" reinforces this assertion.", "retries": 1}
{"idx": 515, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about RANKL as a key regulator of bone resorption, but it does not directly mention Denosumab's action on RANKL. While the sentence is relevant and logical, it lacks the explicit connection to Denosumab that the gold supporting sentence provides.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Denosumab (AMG 162), a fully human monoclonal antibody to RANKL, shares the pharmacologic attributes of OPG but has a significantly longer half-life that allows less frequent administration.", "model_answer": "Answer: RANKL", "model_support": "Supporting sentence: \"Osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand (RANKL) are dominant regulators of bone resorption.\"  \n\nThis sentence identifies RANKL as the ligand for the receptor activator of nuclear factor-kappaB (RANK), which is the target of Denosumab (Prolia). Denosumab functions by binding to RANKL, inhibiting its activity. Although the context does not explicitly mention Denosumab, the role of RANKL as a ligand is directly stated, supporting the answer.", "retries": 1}
{"idx": 516, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.", "model_answer": "Answer: AIP gene", "model_support": "Supporting sentence: AIP mutations cause a low penetrance autosomal dominant disease with often a distinct phenotype characterized by young-onset, aggressive, large GH, mixed GH and PRL or PRL-secreting adenomas.", "retries": 1}
{"idx": 517, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, as 'EGFR gene' is equivalent to 'epidermal growth factor receptor (EGFR) gene.' The supporting sentence is relevant and provides context about the focus on EGFR mutations; however, it is slightly verbose and indirect compared to the concise gold supporting sentence. It does not explicitly link the mutations to the response to erlotinib and gefitinib, which makes it less precise than the gold standard.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the responses to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with non-small-cell lung cancer (NSCLC).", "model_answer": "Answer: EGFR gene", "model_support": "Supporting sentence: \"Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non-small-cell lung cancer.\"  \n\nThis sentence explicitly states the focus of the study on mutations in the *EGFR* gene, which is directly relevant to the question about mutations determining response to erlotinib and gefitinib. Additionally, the background and conclusion further reinforce this by emphasizing the detection of EGFR gene mutations and their clinical applicability.", "retries": 1}
{"idx": 518, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it discusses the effects of Bach1 ablation rather than directly stating its role as a repressor of the HO-1 gene. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.", "retries": 1}
{"idx": 519, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it discusses the trend of increasing diameter without providing the specific value mentioned in the gold supporting sentence.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.", "model_answer": "The context does not provide the average diameter of intermediate filaments.", "model_support": "Supporting sentence: As the temperature increased, both the average diameter and average length of particles in the supernatant increased.  \n\nExplanation: The context mentions that \"average diameter\" increased with temperature but does not provide a specific numerical value for the average diameter of intermediate filaments. Thus, the answer \"The context does not provide the average diameter of intermediate filaments\" is supported.", "retries": 1}
{"idx": 520, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Atrial fibrillation' matches the gold standard 'af' in meaning, though it is not abbreviated. The supporting sentence chosen by the model does not directly address the prevalence of atrial fibrillation worldwide and instead discusses its significance in athletes, which is tangential to the question. While the logic connecting AF as a frequent arrhythmia can be inferred from the broader context, the supporting sentence provided is not optimal, making the response somewhat less concise and relevant than ideal.\", \"match\": true}", "gold_answer": "af", "gold_support": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population.", "model_answer": "Answer: Atrial fibrillation", "model_support": "Supporting sentence: \"Atrial Fibrillation in athletes should always be considered as an abnormality which requires further investigation...\"  \n\nAlthough the context focuses on atrial fibrillation (AF) in athletes, the question about the *most prevalent form of arrhythmia worldwide* is implicitly supported by the context's emphasis on AF as a critical and frequent arrhythmia, particularly in the opening discussion of its paradoxical association with physical activity and its clinical significance. The sentence directly names AF as the subject of the entire text, aligning with its global prevalence as the answer.", "retries": 1}
{"idx": 521, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer does not match gold standard but is present in context; supporting sentence is relevant but does not cover gold answer. The model's answer is correct as '1,4-benzothiazepine,' but the supporting sentence provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine, which is critical to logically support the answer.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: JTV519 is known to have a protective effect against Ca2+ overload-induced myocardial injury.  \n\n**Note**: The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. The supporting sentence from the original example (which is not included in this context) would be required to confirm this. However, based on the user's answer and the example, the expected response is derived from prior knowledge rather than the given text.", "retries": 1}
{"idx": 522, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Tofacitinib' matches the gold standard and is correct based on external knowledge. However, the supporting sentence incorrectly states that the context does not provide information about approved JAK inhibitors for rheumatoid arthritis, when in fact the context explicitly mentions tofacitinib as being FDA-approved for RA. The supporting sentence fails to cover the gold answer with relevant context, leading to a lower score.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "After two decades of research and development activity focussed on orally active kinase inhibitors, the first such drug (the JAK inhibitor Xeljanz, tofacitinib) was approved by the FDA in November 2012 for the treatment of rheumatoid arthritis (RA).", "model_answer": "Answer: Tofacitinib", "model_support": "The context does not explicitly mention any specific JAK inhibitor that is approved for the treatment of rheumatoid arthritis. While it references ongoing research and clinical trials for JAK inhibitors and mentions \"fostamatinib\" as a Syk inhibitor in phase 3 trials, it does not name a JAK inhibitor (e.g., tofacitinib) that has been approved for rheumatoid arthritis. \n\n**Supporting sentence**: None. The context does not provide information about approved JAK inhibitors for rheumatoid arthritis. \n\n**Note**: The answer \"Tofacitinib\" is correct in real-world medical knowledge, but it is not supported by the provided context.", "retries": 1}
{"idx": 523, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 524, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model notes that the context does not explicitly state the mechanism, it correctly identifies the answer based on general knowledge, which aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The context does not explicitly state which clotting factor is inhibited by betrixaban. However, based on external knowledge, betrixaban is a Factor Xa inhibitor, but this is not mentioned in the provided text. \n\n**Note:** The context provided does not contain a direct statement about betrixaban's mechanism of action or the specific clotting factor it inhibits. The answer \"Factor Xa\" is inferred from general knowledge of anticoagulants but is not supported by the given text.", "retries": 1}
{"idx": 525, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions that p73 is expressed as TA and ΔN isoforms, which is relevant to the broader topic of p73 isoforms but does not cover the gold answer of '7 TAp73 isoforms.' The explanation provided by the model conflates the number of overall p73 isoforms with TAp73 specifically, leading to an incorrect conclusion.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One.", "model_support": "Supporting sentence: The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and ΔN isoforms.  \n\n**Explanation**: The context explicitly states that the p73 gene produces two main isoforms: TA (transactivation domain-containing) and ΔN (delta N-terminal). While the question asks about \"TAp73 isoforms,\" the text does not mention multiple sub-isoforms of TAp73 itself. Instead, it refers to TAp73 as a single functional isoform (distinct from ΔNp73). The answer \"One\" aligns with the idea that TAp73 is a single isoform, not multiple variants, even though the p73 gene as a whole has two major isoforms (TA and ΔN). The sentence about the p73 gene's expression as TA and ΔN isoforms indirectly supports the conclusion that TAp73 (as a specific isoform) is singular.", "retries": 1}
{"idx": 526, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 527, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by including an additional sentence that, while correct, isn't strictly necessary for supporting the answer. The logic is strong, but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "Answer: alpha-Synuclein", "model_support": "Supporting sentence: \"alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.\"  \n\nAdditionally, the text explicitly states: \"alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles,\" which confirms the antibody targets alpha-synuclein.", "retries": 1}
{"idx": 528, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context ('cardiovascular causes' is a broad category that includes hypertrophic cardiomyopathy). However, it lacks specificity and fails to identify hypertrophic cardiomyopathy as the most common cause. The supporting sentence mentions cardiovascular causes but does not provide specific information about hypertrophic cardiomyopathy being the leading cause, thus failing to cover the gold answer adequately.\", \"match\": false}", "gold_answer": "hypertrophic cardiomyopathy", "gold_support": "The most common cause of death was hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).", "model_answer": "Answer: The most common cause of sudden cardiac death in young athletes is cardiovascular causes, though specific conditions are not detailed in the context.", "model_support": "Supporting sentence: A total of 69 individuals 11-30 years of age (mean 17 ± 5 years) died suddenly of cardiovascular causes while participating in 15 different organized sports and a variety of nonorganized physical activities.", "retries": 1}
{"idx": 529, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and contains important information about the Ca(2+)/calcineurin/NFAT pathway, but it is slightly verbose and includes details about SCID syndrome that are not directly necessary to support the answer. Despite this, the logic connecting calcineurin to NFAT activation is clear.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: The importance of the Ca(2+)/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca(2+) entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence.", "retries": 1}
{"idx": 530, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise and directly relevant, clearly stating that [18F]altanserin is a ligand for the 5-HT2A receptor and aligns with the context of identifying its target receptors. Minor extra details are acceptable as they do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.", "retries": 1}
{"idx": 531, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it contains slight redundancy by mentioning 'heme-dependent up-regulation,' which is not directly necessary to establish Bach1 as a repressor. The logic is clear but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.", "retries": 1}
{"idx": 532, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly verbose and does not explicitly mention Lewy bodies. The chosen sentence broadly discusses alpha-synuclein deposition in alpha-synucleinopathies rather than directly focusing on Lewy bodies as the main component.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\nThis sentence directly states that alpha-synuclein is the central abnormal deposit in alpha-synucleinopathies, which includes Lewy bodies (implied as neuronal inclusions in the context).", "retries": 1}
{"idx": 533, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('beta-Trcp'), but the supporting sentence is somewhat indirect and mixes relevant with less relevant content. While it correctly implies beta-Trcp's role in IFNAR1 degradation by discussing Tyk2 stabilization, it does not explicitly state that beta-Trcp mediates ubiquitination and degradation as clearly as the gold supporting sentence. The reasoning is reasonable but could be more concise and directly tied to the gold answer.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: The E3 ubiquitin ligase beta-Trcp mediates the ubiquitination and degradation of IFNAR1.", "model_support": "Supporting sentence: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"  \n\nThis sentence implies that beta-Trcp is involved in the ubiquitination/degradation of IFNAR1, as the stabilization by Tyk2 occurs independently of beta-Trcp, suggesting beta-Trcp normally mediates the degradation process.", "retries": 1}
{"idx": 534, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains how Mepolizumab targets interleukin-5 by blocking its binding to the receptor, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signalling.", "retries": 1}
{"idx": 535, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and explains the reasoning behind the answer by referencing general biological knowledge about p53 being known as 'the guardian of the genome,' which aligns with the gold supporting sentence. Although the context doesn't explicitly mention the nickname, the logic is clear and accurate.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "The context does not explicitly mention the phrase \"guardian of the genome\" or directly identify the tumor suppressor by this nickname. However, the answer \"p53\" is correct based on general biological knowledge, as p53 is widely recognized as \"the guardian of the genome.\" \n\n**Supporting sentence (if the context had included it):** *The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.*  \n**Note:** While the context discusses p53's function, it does not explicitly state the nickname \"guardian of the genome.\" The answer relies on external knowledge, not a direct quote from the provided text.", "retries": 1}
{"idx": 536, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the supporting sentence is relevant and accurate in the context of normal hormone analysis, it does not address the presence of thyroid goiter, which is characteristic of Pendred syndrome as per the gold answer. The failure to mention thyroid abnormalities lowers the score.\", \"match\": false}", "gold_answer": "Thyroid", "gold_support": "Thyroid goiter was found in 46.5% of cases.", "model_answer": "Answer: No hormone abnormalities are characteristic to Pendred syndrome.", "model_support": "Supporting sentence: Hormone analysis was normal and perchlorate test negative in all cases.", "retries": 1}
{"idx": 537, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing the combination of L-dopa with a peripheral decarboxylase inhibitor (PDI), which implies benserazide. However, it contains slight redundancy by elaborating on additional compounds like ALAAD, DA, etc., making it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "In a cross-sectional study blood was obtained, 2 h after dosing, from 104 patients with idiopathic parkinsonism, divided into four groups: no L-dopa treatment (group 1), L-dopa alone (group 2), L-dopa + benserazide (Madopar) (group 3) and L-dopa + carbidopa (Sinemet) (group 4).", "model_answer": "Answer: Levodopa (L-dopa)", "model_support": "Supporting sentence: The effect of levodopa (L-dopa), alone or in combination with a peripheral decarboxylase inhibitor (PDI), on plasma levels of aromatic-L-amino acid decarboxylase (ALAAD, = dopa decarboxylase), L-dopa, 3-O-methyl-dopa (3-OMD), dopamine (DA), noradrenaline, adrenaline and dopamine beta-hydroxylase has been studied.  \n\n**Note**: The context does not explicitly mention \"benserazide,\" but it refers to \"peripheral decarboxylase inhibitor (PDI)\" being co-administered with L-dopa. Benserazide is a known PDI, so the answer assumes this contextual link. The supporting sentence highlights the co-administration of L-dopa with a PDI.", "retries": 1}
{"idx": 538, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod syndrome resulting from a novel XK mutation.", "retries": 1}
{"idx": 539, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but includes additional details that slightly increase verbosity. The logic is clear and accurate, but the inclusion of the Gprk2 detail is not necessary for answering the question.\",\n  \"match\": true\n}", "gold_answer": "serine 129", "gold_support": "Alpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies.", "model_answer": "Answer: Ser129", "model_support": "Supporting sentence: \"Mutation of Ser129 to alanine to prevent phosphorylation completely suppresses dopaminergic neuronal loss produced by expression of human alpha-synuclein.\"  \n\nThis sentence directly identifies **Ser129** as the phosphorylated residue in alpha-synuclein, which is linked to neurotoxicity and inclusion formation in the context of Parkinson disease. Additionally, the sentence \"G protein-coupled receptor kinase 2 (Gprk2) phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity\" further confirms Ser129 as the site of phosphorylation.", "retries": 1}
{"idx": 540, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' exactly. The supporting sentence is concise, directly relevant, and logically explains that direct factor Xa inhibitors target Factor Xa, which aligns perfectly with the gold supporting sentence. Minor differences in wording do not detract from the strong logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.\" \n\n(Note: While the context does not explicitly mention \"betrixaban,\" the question's answer (\"Factor Xa\") is directly supported by the statement that \"direct factor Xa inhibitors\" target Factor Xa, which is the mechanism described for this class of drugs.)", "retries": 1}
{"idx": 541, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why p53 is referred to as 'the guardian of the genome' by linking its function to genomic integrity. Although it doesn't explicitly repeat the phrase 'guardian of the genome,' the reasoning is clear and aligns perfectly with the context.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: When p53 function is impaired, its ability to preserve genomic integrity is compromised.  \n\nThis sentence directly links p53 to the preservation of genomic integrity, which aligns with its widely recognized role as \"the guardian of the genome\" in biomedical literature, even though the exact phrase \"guardian of the genome\" is not explicitly stated in the context. The question assumes prior knowledge of p53's nickname, while the context provides the functional rationale for this designation.", "retries": 1}
{"idx": 542, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies that the text does not explicitly state the subcellular localization of APOBEC3B, but it fails to cover the gold answer ('nuclear') as the context indeed mentions that APOBEC3B appeared predominantly nuclear. Therefore, while the model's response is relevant, it does not fully support the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The text does not provide information about the subcellular localization of APOBEC3B protein.", "model_support": "Supporting sentence: The text does not provide information about the subcellular localization of APOBEC3B protein. \n\n**Note**: While the context does not explicitly state this, the answer is supported by the absence of any mention of APOBEC3B's subcellular localization in the provided text. The context focuses on APOBEC3B's role in inhibiting L1 retrotransposition and its deamination-independent mechanism but does not address its cellular compartmentalization.", "retries": 1}
{"idx": 543, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose. It includes additional details about the cloning and homology which are not strictly necessary to support the answer, but the logic is clear and the sentence still directly relates to selenoprotein P.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression.", "model_answer": "Answer: Selenoprotein P", "model_support": "Supporting sentence: \"a clone which seemed to encode a selenoprotein P-like protein was isolated. The coding nucleotide sequence of its cDNA insert displayed high homology to rat and human selenoprotein P cDNA...\"", "retries": 1}
{"idx": 544, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'Xa'), and the supporting sentence is relevant and supports the answer by discussing betrixaban within the context of Factor Xa inhibitors. However, the supporting sentence contains slight redundancy by introducing broader information about anticoagulants rather than focusing directly on betrixaban as a Factor Xa inhibitor.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.  \n**Reasoning**: The context explicitly categorizes betrixaban as a \"novel oral anticoagulant\" and mentions that \"factor Xa inhibitors\" are one of the two new classes of anticoagulants. While the text does not directly state that betrixaban inhibits Factor Xa, it is implied by its classification as a novel anticoagulant within the broader context of Factor Xa inhibitors. The mention of \"factor Xa decoy\" (PRT4445) in conjunction with betrixaban further contextualizes the relevance of Factor Xa in its mechanism, even if not explicitly stated.", "retries": 1}
{"idx": 545, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically. However, it includes additional details about leukemia stem cells (LSCs) that are not necessary to directly support the answer, introducing slight redundancy.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "CML is induced by the BCR-ABL oncogene, whose gene product is a BCR-ABL tyrosine kinase.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"the inability of BCR-ABL kinase inhibitors to completely kill leukemia stem cells (LSCs) indicates that these kinase inhibitors are unlikely to cure CML.\"  \n\nThis sentence explicitly identifies **BCR-ABL** as the tyrosine kinase target of inhibitors like Imatinib (Gleevec) in Philadelphia-chromosome positive CML.", "retries": 1}
{"idx": 546, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (IXa) does not match the gold standard (xa), but the context includes information about betrixaban being a factor Xa inhibitor. The supporting sentence acknowledges that the provided text does not explicitly mention betrixaban's mechanism of action, which is correct but fails to leverage the available implicit information from the context about factor Xa inhibitors. Therefore, the answer is incorrect, yet the supporting sentence is relevant but incomplete.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Answer: IXa", "model_support": "The context does not mention betrixaban or its mechanism of action. Therefore, there is no supporting sentence in the provided text to answer the question about which clotting factor is inhibited by betrixaban. The context only discusses dabigatran as a direct thrombin antagonist and does not reference betrixaban. \n\n**Answer:** The context does not provide information about betrixaban or its target clotting factor.", "retries": 1}
{"idx": 547, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence, while relevant, is more focused on specific risks faced by women with RA rather than directly addressing the prevalence. It does not mention the key statistic from the gold supporting sentence (5.2 women per man), which would have provided stronger and more concise support. The chosen sentence is somewhat indirect and contains additional details that do not fully align with the main point about prevalence.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "Supporting sentence: Colombian women with RA are more at risk of having an early age at onset and developing polyautoimmunity and abdominal obesity, and they perform more household duties than their male counterparts.  \n\n**Note:** While the context does not explicitly state that RA is more common in women, the sentence highlights that women are at higher risk for certain disease characteristics (e.g., earlier onset, polyautoimmunity, and abdominal obesity), which may indirectly suggest a higher prevalence or susceptibility in women. However, the text does not provide direct data on the overall prevalence of RA in men vs. women.", "retries": 1}
{"idx": 548, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical connection to Alzheimer's disease by referencing the metals hypothesis, which is directly tied to the disorder in the context. However, it is slightly vague and lacks specific details about PBT2's clinical trial or its targeting of amyloid-beta-metal interactions, which would make it more precise and aligned with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "PBT2 has been tested for Alzheimer's disease.", "model_support": "Supporting sentence: Drug development based on the metals hypothesis of Alzheimer's disease.  \n\nThis sentence establishes the context that PBT2 and related compounds are part of drug development efforts targeting Alzheimer's disease, as the Metals Hypothesis is specifically tied to the pathogenesis of the disorder. While PBT2 is not explicitly named in the same sentence, the broader context of \"drug development based on the metals hypothesis of Alzheimer's disease\" directly supports the conclusion that PBT2 has been tested for this disorder.", "retries": 1}
{"idx": 549, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('factor Xa') is correct based on external knowledge and matches the gold standard ('xa'). However, the supporting sentence provided by the model is accurate but does not directly confirm the specific action of betrixaban, as betrixaban itself is not mentioned in the context. The gold supporting sentence indirectly refers to FXa inhibitors as a class but does not specifically address betrixaban. Thus, while the answer is correct, the lack of direct support from the context lowers the score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Answer: Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban or its target clotting factor. Therefore, there is no supporting sentence in the given text to confirm that \"betrixaban inhibits factor Xa.\" The answer may be correct based on external knowledge, but it is not derived from the provided context. \n\n**Supporting sentence:** None (betrixaban is not mentioned in the context).", "retries": 1}
{"idx": 550, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('memory loss'), as it claims that memory problems are not specified in the context. However, the gold supporting sentence clearly identifies 'memory loss/lack of concentration' as one of the strongest associations reported by Gulf War veterans. The model's supporting sentence is relevant but fails to cover the gold answer, as it discusses general symptom reporting without referencing memory loss specifically.\", \"match\": false}", "gold_answer": "memory loss", "gold_support": "The strongest associations were for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8), night sweats (OR 9.9, 95% CI 6.5-15.2), general fatigue (OR 9.6, 95% CI 8.3-11.1) and sexual dysfunction (OR 4.6, 95%CI 3.2-6.6).", "model_answer": "The context does not specify particular memory problems reported in Gulf War syndrome. It mentions that veterans who believed they had Gulf War syndrome reported the highest number of symptoms, but it does not detail specific memory issues.", "model_support": "Supporting sentence: \"6% of GWV believed they had Gulf War syndrome (GWS), and this was associated with the highest symptom reporting.\"  \n\nThis sentence indicates that veterans who believed they had Gulf War syndrome reported the highest number of symptoms, but it does not specify any particular symptoms (including memory problems). The context explicitly avoids detailing specific health issues, aligning with the answer that memory problems are not mentioned.", "retries": 1}
{"idx": 551, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and is logical, but it focuses on describing Factor Xa's role in the coagulation cascade rather than explicitly linking betrixaban to FXa inhibition. The gold supporting sentence more directly connects betrixaban to FXa inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "EXPERT OPINION: A large body of Phase II and Phase III data is now available for FXa inhibitors such as rivaroxaban, apixaban, edoxaban and betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Factor Xa (FXa) is a critical enzyme in the coagulation cascade responsible for thrombin generation, the final enzyme that leads to fibrin clot formation.  \n\nExplanation: While the context does not explicitly mention \"betrixaban,\" it establishes that the review focuses on **Factor Xa (FXa) inhibitors** (e.g., rivaroxaban, apixaban, edoxaban) and describes FXa as the target enzyme in the coagulation cascade. The question assumes betrixaban falls under this class of FXa inhibitors, and the supporting sentence directly identifies FXa as the clotting factor inhibited by such drugs.", "retries": 1}
{"idx": 552, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard, though it omits the abbreviation '(CMA)' which is a minor discrepancy. The supporting sentence identifies key components of CMA (LAMP2A and Hsc70) but does not explicitly mention the KFERQ motif or directly state that CMA is triggered by it, which makes it slightly less precise compared to the gold supporting sentence. However, the logic connecting the components to CMA is still strong.\", \"match\": true}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.", "model_answer": "Answer: Chaperone-mediated autophagy", "model_support": "Supporting sentence: Lysosome-associated membrane protein type 2A (LAMP2A) and the heat-shock cognate protein 70 (Hsc70) constitute specific CMA components.  \n\nThis sentence directly identifies LAMP2A and Hsc70 as components of chaperone-mediated autophagy (CMA), which is the pathway triggered by the KFERQ motif (implied through the context of CMA's role in targeting proteins for lysosomal degradation).", "retries": 1}
{"idx": 553, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly identifies betrixaban as an inhibitor of Factor Xa. However, the supporting sentence is slightly verbose and could be more concise by focusing on the specific statement about betrixaban inhibiting Factor Xa rather than listing all the drugs.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"  \n\nThis sentence explicitly identifies betrixaban as a direct inhibitor of **Factor Xa**, as it lists it alongside other drugs (rivaroxaban, apixaban, edoxaban) that target Factor Xa.", "retries": 1}
{"idx": 554, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Parallel') does not match the gold standard ('antiparallel'), but the supporting sentence acknowledges that the context lacks explicit information about the orientation. The supporting sentence is relevant to spectrin dimerization and logical in its explanation; however, it does not support the incorrect answer and fails to cover the gold answer. The correct orientation (antiparallel) is explicitly stated in the context, making the model's inference from external knowledge inappropriate here.\",\n  \"match\": false\n}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Answer: Parallel", "model_support": "Supporting sentence: The text does not explicitly state whether alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers. However, the context describes the formation of \"high affinity heterodimers\" and notes that \"terminal nonhomologous domains do not contribute to dimer initiation nor are they required for formation of high affinity spectrin heterodimers in physiological buffers.\" While this implies that the core regions (motifs) are sufficient for dimerization, it does not directly address the orientation (parallel vs. antiparallel). The answer \"Parallel\" may rely on prior knowledge of spectrin structure, but the context itself does not provide a sentence confirming this. \n\n**Note:** The provided context does not contain a direct statement about the orientation (parallel/antiparallel) of alpha- and beta-spectrin subunits. The answer \"Parallel\" may be inferred from general biological knowledge of spectrin's coiled-coil structure, but no sentence in the context explicitly supports this.", "retries": 1}
{"idx": 555, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('stroke'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that the ROSIER scale was used as a stroke recognition tool. Minor extra details are acceptable and do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 556, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('congenital hypothyroidism') is closely related to the gold standard ('thyroid'), though it is more specific. The supporting sentence is relevant and supports the answer by highlighting thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome. However, the supporting sentence could be slightly more concise, as it includes extra details like 'an important thyroid hypoplasia,' which are not strictly necessary to support the answer.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Common hormone abnormalities in Williams syndrome include congenital hypothyroidism.", "model_support": "Supporting sentence: \"We describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"", "retries": 1}
{"idx": 557, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence explains the role of LEKTI in the pituitary gland and its connection to growth hormone processing, which is relevant but not as concise as the gold supporting sentence.\", \"match\": true}", "gold_answer": "LEKTI", "gold_support": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.", "model_answer": "Answer: LEKTI", "model_support": "Supporting sentence: It is proposed that a lack of inhibition of proteases due to a deficiency of LEKTI in the pituitary gland leads to the overprocessing of human GH in NS.", "retries": 1}
{"idx": 558, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is not as directly relevant or concise as it could be. While it introduces Lewy bodies in DLB, it does not explicitly state that alpha-synuclein is the main component of Lewy bodies, which is critical for fully supporting the answer. The gold supporting sentence more clearly and directly links alpha-synuclein to Lewy bodies. Thus, the answer is correct, but the supporting sentence has minor deficiencies in precision and relevance.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.  \n\n**Note**: While the context does not explicitly state that alpha-synuclein is the main component of Lewy bodies, the study focuses on alpha-synuclein isoforms in DLB, which is a well-established pathological feature of Lewy bodies. The supporting sentence here is the first sentence, as it introduces the association between DLB and Lewy bodies, even though the specific component is not directly mentioned.", "retries": 1}
{"idx": 559, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by identifying p53 as the major tumor suppressor protein, which aligns with its widely recognized role as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "Often referred to as the Guardian of the Genome, the list of known functions of p53 include regulatory roles in cell cycle arrest, apoptosis, angiogenesis, DNA repair and cell senescence.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The major tumour suppressor protein, p53, is one of the most well-studied proteins in cell biology.  \n\n**Note:** While the context does not explicitly use the phrase \"guardian of the genome,\" p53 is universally recognized as this title in scientific literature. The sentence identifying p53 as the \"major tumour suppressor protein\" directly supports the answer, as it establishes p53 as the tumor suppressor referenced in the question.", "retries": 1}
{"idx": 560, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states 'One (TAp73)' when the gold answer clearly indicates there are 7 TAp73 isoforms. The supporting sentence focuses on describing the p73 gene and its ability to encode TAp73 and DeltaNp73 but does not provide any information about the number of TAp73 isoforms. Therefore, both the answer and supporting sentence fail to address the gold standard or provide relevant support.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One (TAp73)", "model_support": "Supporting sentence: The p73 gene is able to encode transcriptionally active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms.  \n\nThis sentence explicitly identifies **TAp73** as one of the transcript isoforms encoded by the *p73* gene, directly supporting the answer that **one TAp73 isoform** (TAp73) has been identified. The phrasing \"transcriptionally active TAp73\" and \"DeltaNp73 transcript isoforms\" confirms that TAp73 is a single, distinct isoform.", "retries": 1}
{"idx": 561, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly provide a direct answer to the question. However, the gold answer (beta-TrCP) can be reasonably inferred from the context provided. The supporting sentence acknowledges the lack of explicit information but fails to cover the gold answer, as it does not mention beta-TrCP or utilize the partial information given about it in the context.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involved in IkappaB-alpha degradation.", "model_answer": "The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: The question cannot be answered based on the provided context.  \n\n**Note**: While the context discusses clusterin (CLU) and its interaction with the NF-κB pathway, it does not explicitly mention the E3 ubiquitin ligase responsible for ubiquitinating IκB. The answer is derived from the absence of relevant information in the text.", "retries": 1}
{"idx": 562, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying the 'SET domain' as the characteristic domain of histone methyltransferases. The supporting sentence provided by the model is concise and directly references the relevant part of the context, despite noting that the SET domain isn't explicitly mentioned in the immediate surrounding text. It accurately explains the connection between the catalytic activity and the SET domain, aligning well with the gold supporting sentence. The logic is clear and covers the necessary information without excessive verbosity.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity.", "model_answer": "Answer: The characteristic domain of histone methyltransferases is the SET domain.", "model_support": "Supporting sentence: The context does not explicitly mention the SET domain as the characteristic domain of histone methyltransferases. The provided text describes SUV39H1 and Suv39h1 as histone H3-specific methyltransferases but does not reference the \"SET domain\" or any specific protein domain. The answer \"SET domain\" is based on external knowledge rather than the given context. \n\nHowever, if forced to identify a sentence related to the methyltransferase activity, the following could be considered relevant:  \n\"Human SUV39H1 and murine Suv39h1--mammalian homologues of Drosophila Su(var)3-9 and of Schizosaccharomyces pombe clr4--encode histone H3-specific methyltransferases that selectively methylate lysine 9 of the amino terminus of histone H3 in vitro.\"  \nThis sentence highlights their role as methyltransferases but does not specify the SET domain.", "retries": 1}
{"idx": 563, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and logically explains that BACH1 represses HO-1 transcription based on evidence from the context. It clearly links the absence of BACH1 to reduced down-regulation of HO-1, making the reasoning strong and aligned with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "This study was undertaken to clarify the effects of HO-1 and its repressor Bach1 in osteoclastogenesis.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Transcription of HO-1 was down-regulated by stimulation with RANKL in the early stage of OC differentiation. Bach1(-/-) mouse bone marrow-derived macrophages were partially resistant to the RANKL-dependent HO-1 reduction.\"  \n\nThis sentence indicates that BACH1 is involved in the repression of HO-1 transcription, as its absence (Bach1-deficiency) reduces the RANKL-induced down-regulation of HO-1. This suggests BACH1 acts as a repressor of HO-1, aligning with the conclusion that BACH1 regulates osteoclastogenesis via repressive mechanisms.", "retries": 1}
{"idx": 564, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' (shorthand for Factor Xa). The supporting sentence is concise, directly relevant, and logically covers the answer by referencing that some drugs target factor Xa. Despite the incomplete context, the provided sentence aligns well with the gold standard.\", \"match\": true}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. These drugs...  \n\nNote: The context appears to be incomplete (the example after \"factor Xa\" is cut off), but the sentence explicitly mentions \"factor Xa\" as a target for some drugs, which aligns with the answer. While betrixaban is not mentioned in the provided text, the question may contain an error, as the context only discusses dabigatran etexilate (a thrombin inhibitor) and references factor Xa inhibitors without naming specific drugs.", "retries": 1}
{"idx": 565, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about proliferation, self-renewal, and multipotentiality, which are not necessary to directly support the gold answer. This makes it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Nestin", "gold_support": "A small subset of Prominin-1(+) cells coexpressed the nonspecific precursor cell marker Nestin as well as GFAP and Sox2.", "model_answer": "Answer: Nestin", "model_support": "Supporting sentence: Upon fluorescence-activated cell sorting, only Prominin-1/Nestin double-positive cells fulfilled the defining stem cell criteria of proliferation, self-renewal, and multipotentiality as assessed by a neurosphere assay.", "retries": 1}
{"idx": 566, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('iron') semantically, though it uses 'Iron deficiency' instead of just 'iron.' The supporting sentence is relevant and provides logical support by linking iron depletion to restless legs syndrome (RLS). However, it includes slightly more detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "iron", "gold_support": "High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.", "model_answer": "Answer: Iron deficiency.", "model_support": "Supporting sentence: The objective of the study was to investigate the frequency and severity of iron depletion in regular blood donors and whether IV iron is more effective than oral to avoid iron depletion and symptoms thereof, especially restless legs syndrome (RLS).  \n\nThis sentence explicitly states that restless legs syndrome (RLS) is a symptom associated with iron depletion, directly linking the deficiency to the condition.", "retries": 1}
{"idx": 567, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of Knudson's two-hit hypothesis further strengthens the relevance to autosomal dominant inheritance.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Li-Fraumeni syndrome (LFS) is a highly penetrant, autosomal dominant, human familial cancer predisposition.", "model_answer": "Answer: Autosomal dominant.", "model_support": "Supporting sentence: \"This report of LOH indicates that Knudson's two-hit hypothesis, a hallmark of human autosomal dominant cancer syndromes, can be modeled in zebrafish.\"  \n\nThis sentence explicitly links the observed loss of heterozygosity (LOH) in the zebrafish model to Knudson's two-hit hypothesis, which is a defining feature of **autosomal dominant** inheritance in cancer syndromes like Li-Fraumeni syndrome.", "retries": 1}
{"idx": 568, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs 'xa'). However, the supporting sentence provided by the model is incorrect in stating that there is no relevant information in the context. The gold supporting sentence clearly identifies betrixaban as an inhibitor of Factor Xa in a list of other Factor Xa inhibitors. While the model's answer is correct, its reasoning for the supporting sentence is flawed because it failed to extract the relevant information from the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Answer: Factor Xa", "model_support": "The context provided does not mention betrixaban or specifically state which clotting factor it inhibits. The only relevant sentence is: \"Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.\" However, this sentence does not reference betrixaban or explicitly name Factor Xa as the target. \n\n**Supporting sentence:** None. The context does not contain information about betrixaban or its mechanism of action.", "retries": 1}
{"idx": 569, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by specifying that the ROSIER scale is used as a stroke recognition tool, which aligns perfectly with the gold answer and supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 570, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically establishes the role of Xist in X chromosome inactivation, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Expression of the X inactive-specific transcript (Xist) is thought to be essential for the initiation of X chromosome inactivation and dosage compensation during female embryo development.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "Supporting sentence: X inactive-specific transcript (Xist) expression and X chromosome inactivation in the preattachment bovine embryo.  \n\nThis sentence directly states the relationship between Xist transcript expression and X chromosome inactivation, establishing Xist as the transcript responsible for the process.", "retries": 1}
{"idx": 571, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces evolutionary studies, which is not directly necessary to support the answer about XIST's role in X-chromosome inactivation. The gold supporting sentence is more concise and directly explains why XIST is a candidate for X chromosome inactivation.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "The human XIST gene, a candidate for a role in X chromosome inactivation, has recently been cloned and sequenced, yielding a 17 kb cDNA with no apparent significant, conserved open reading frame.", "model_answer": "Answer: XIST", "model_support": "Supporting sentence: \"In the absence of a conserved open reading frame, we have turned to evolutionary studies as a first step toward elucidating a function for XIST in the process of X inactivation.\" \n\nThis sentence directly identifies **XIST** as the transcript implicated in X-chromosome inactivation, aligning with the answer.", "retries": 1}
{"idx": 572, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by showing that the absence of Bach1 leads to increased HO-1 expression, which supports the conclusion that BACH1 acts as a repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied.  \n\nThis sentence directly supports the conclusion that BACH1 is a repressor, as the absence of Bach1 (Bach1(-/-)) leads to elevated HO-1 expression, indicating that BACH1 normally suppresses HO-1 transcription.", "retries": 1}
{"idx": 573, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor, we have carried out structure-guided design, synthesis, and characterization of orthogonal vSET methyltransferase mutant/SAM analogue pairs using a 'bump-and-hole' strategy.", "model_answer": "Answer: S-adenosyl-l-methionine (SAM)", "model_support": "Supporting sentence: \"To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor...\"", "retries": 1}
{"idx": 574, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly explains that H3K4 is the residue methylated by MLL1, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: \"Thus, we identified a molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-kappaB-dependent gene induces its expression...\"  \n\nThis sentence explicitly states that the histone methyltransferase complex involved is specific for H3K4, which is the residue methylated by MLL1.", "retries": 1}
{"idx": 575, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence is missing in the model's response, which leads to a lack of direct context for betrixaban specifically. Although the context provided mentions rivaroxaban and other Factor Xa inhibitors, it indirectly supports the correct mechanism of action for betrixaban as well. The absence of an explicit supporting sentence reduces the score slightly, but the correct answer and general relevance of the context prevent a lower rating.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or the specific clotting factor it inhibits. The supporting sentence is missing from the provided text. The answer \"Factor Xa\" is correct for rivaroxaban (a drug mentioned in the context), but since the question refers to **betrixaban** (not mentioned in the context), there is no relevant sentence to support the answer. \n\n**Error Note:** The question contains a discrepancy. The context discusses **rivaroxaban** (a Factor Xa inhibitor) but not **betrixaban**. If the intended drug was rivaroxaban, the supporting sentence would be:  \n\"**Dabigatran and rivaroxaban have been the firsts of the new oral anticoagulants to be licensed...**\" (implying rivaroxaban's mechanism as a Factor Xa inhibitor). However, this is not explicitly stated in the text.", "retries": 1}
{"idx": 576, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it discusses repair of both strands rather than specifically addressing TCR targeting the transcribed strand.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: Both DNA strands.", "model_support": "Supporting sentence: Within active genes, however, both DNA strands continue to be proficiently repaired.", "retries": 1}
{"idx": 577, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is somewhat redundant and verbose as it explains the lack of context within the text, which is unnecessary since the correct information (autosomal recessive) can be inferred from general knowledge. The gold supporting sentence is more concise and directly relevant.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Inheritance seems most likely to be autosomal recessive.", "model_answer": "Answer: Autosomal recessive.", "model_support": "Supporting sentence: The context does not explicitly mention the mode of inheritance of Wilson's disease. However, based on general medical knowledge, Wilson's disease is inherited in an autosomal recessive manner. But since the context provided does not include this information, there is no supporting sentence within the text. \n\n**Note:** The answer \"Autosomal recessive\" is correct in real-world medical knowledge, but the context provided does not explicitly state this. The question may be based on external knowledge rather than the given text.", "retries": 1}
{"idx": 578, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence identifies p53 as the subject of discussion, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Note**: While the context does not explicitly mention \"the guardian of the genome,\" the question refers to p53 as a well-established tumor suppressor known by this nickname in scientific literature. The supporting sentence identifies p53 as the subject of the study, confirming it as the answer.", "retries": 1}
{"idx": 579, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'EGFR', is correct and matches the gold standard conceptually, though it is an abbreviation rather than the full name provided in the gold answer ('epidermal growth factor receptor (EGFR) gene'). The supporting sentence is relevant and explicitly connects EGFR mutations to sensitivity to both gefitinib and erlotinib, aligning well with the gold supporting sentence. However, it includes additional details about the sequencing results that are not strictly necessary for answering the question, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor.", "model_answer": "Answer: EGFR", "model_support": "Supporting sentence: We found from sequencing the EGFR TK domain that 7 of 10 gefitinib-sensitive tumors had similar types of alterations; no mutations were found in eight gefitinib-refractory tumors (P = 0.004). Five of seven tumors sensitive to erlotinib (Tarceva), a related kinase inhibitor for which the clinically relevant target is undocumented, had analogous somatic mutations, as opposed to none of 10 erlotinib-refractory tumors (P = 0.003).  \n\nThis sentence explicitly connects mutations in the **EGFR** gene (via sequencing of its TK domain) to responses (sensitivity or resistance) to both gefitinib and erlotinib, confirming the gene's role in determining drug efficacy.", "retries": 1}
{"idx": 580, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Recessive' is very close to the gold standard 'autosomal recessive,' though it omits the specificity of 'autosomal.' The supporting sentence discusses heterozygous carriers and their potential symptoms but does not directly state that JLNS is autosomal recessive. It mixes relevant information with some indirect reasoning and could be more concise in linking the concept of recessive inheritance to JLNS. The logic is reasonable but less direct than ideal.\", \"match\": false}", "gold_answer": "autosomal recessive", "gold_support": "Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait.", "model_answer": "Answer: Recessive.", "model_support": "Supporting sentence: Some heterozygous carriers of JLNS mutations in either gene may suffer from prolonged QTc and be symptomatic LQTS patients with a need for appropriate medical treatment to prevent life-threatening cardiac arrhythmia.  \n\n**Analysis**: The context states that heterozygous carriers (individuals with one mutant allele) of JLNS mutations may exhibit symptoms of LQTS. This implies that JLNS requires two mutant alleles (recessive inheritance) to manifest, as heterozygous carriers (who would have a dominant inheritance pattern for other conditions) are not typically affected by recessive disorders. The mention of heterozygous carriers developing LQTS symptoms indirectly supports that JLNS follows a recessive mode of inheritance.", "retries": 1}
{"idx": 581, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is missing in the model's output, while the context provided does contain a relevant sentence that directly supports the answer. The gold supporting sentence is concise and directly ties the bacterium to botulism, which the model failed to extract. Therefore, the answer is correct but loses points for not identifying the clear supporting sentence present in the context.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease is caused by exposure to toxins produced by Clostridium botulinum and other botulinum toxin-producing clostridia.", "model_answer": "Answer: Clostridium botulinum", "model_support": "The context does not explicitly mention the bacterium responsible for botulism (Clostridium botulinum). While the answer \"Clostridium botulinum\" is scientifically accurate, the provided text does not include a supporting sentence for this specific claim. \n\n**Supporting sentence:** None found in the context. \n\nThe context focuses on management, diagnosis, and prevention of botulism outbreaks but does not identify the causative bacterium.", "retries": 1}
{"idx": 582, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer, 'Protein phosphatase-1', matches the gold standard 'PP1' as PP1 is the widely recognized abbreviation for Protein phosphatase-1. The supporting sentence is concise, directly relevant, and logically explains the interaction between HSP20 and PP1, aligning with the gold supporting sentence. Minor differences in phrasing do not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "PP1", "gold_support": "Interestingly, the activity of type 1 protein phosphatase (PP1), a known regulator of PLN signaling, was significantly reduced by Hsp20 overexpression, suggesting that the Hsp20 stimulatory effects are partially mediated through the PP1-PLN axis.", "model_answer": "Answer: Protein phosphatase-1", "model_support": "Supporting sentence: Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling.", "retries": 1}
{"idx": 583, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer well, but it includes additional details about the drug's uses (CTEPH and PAH), which are not necessary to directly support the answer. This makes it slightly more verbose than the gold supporting sentence, which is more concise.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is riociguat.", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 584, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is close to the gold standard but includes additional information ('transient ischaemic attack (TIA)') that, while relevant in the broader context, is not part of the specific gold answer ('stroke'). The supporting sentence is relevant and provides a reasonable explanation, though it is slightly verbose and indirectly references the gold answer by summarizing the study's purpose rather than directly quoting the diagnostic focus on stroke. The logic is sound, but the extra detail lowers the precision.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: \"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"  \n\nThis sentence explicitly states the purpose of the study, which is to evaluate clinical scores (including the ROSIER scale) for the identification of stroke and TIA. Additionally, the objective in the context further confirms this: \"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"", "retries": 1}
{"idx": 585, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('l-DOPA'). However, the supporting sentence provided by the model discusses buspirone instead of benserazide, which is not directly relevant to the question. The gold supporting sentence correctly highlights that benserazide is co-administered with l-DOPA in the context. While the model’s answer is correct, its supporting sentence contains slight redundancy and focuses on a different drug (buspirone), hence a score of 4.\", \"match\": true}", "gold_answer": "l-DOPA", "gold_support": "In experiment 1, l-DOPA-primed rats were pre-treated with Vehicle (0.9% NaCl), various doses of the partial 5-HT(1A) agonist, buspirone (0.25, 1.0 or 2.5 mg/kg, ip) or buspirone (2.5 mg/kg, ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip).", "model_answer": "Answer: l-DOPA", "model_support": "The context does not mention benserazide at all. The drug discussed in the context is **buspirone**, which is co-administered with **l-DOPA**. However, the question refers to **benserazide**, a different drug not addressed in the provided text. \n\n**Supporting sentence (for buspirone, not benserazide):**  \n\"In experiment 2, l-DOPA-naïve rats received co-administration of l-DOPA+buspirone (1.0 or 2.5 mg/kg, ip) for 2 weeks.\"  \n\n**Note:** The answer \"l-DOPA\" is correct for benserazide in real-world pharmacology, but the context provided does not support this. The context only discusses buspirone, not benserazide.", "retries": 1}
{"idx": 586, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'BCR-ABL1' is very close to the gold standard 'BCR-ABL,' with only a minor difference in formatting (adding '1' at the end), which is commonly accepted in scientific literature. The supporting sentence provides relevant context about the translocation causing the Philadelphia chromosome but does not explicitly mention the BCR-ABL protein or its kinase activity, making it slightly less direct than the gold supporting sentence. It contains accurate information but lacks the specificity of the gold sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: Chronic myelogenous leukemia (CML) is a clonal hematopoietic disorder caused by the reciprocal translocation between chromosome 9 and 22.  \n\n**Note**: While the context does not explicitly mention \"BCR-ABL1,\" the reciprocal translocation between chromosomes 9 and 22 is the genetic basis of the Philadelphia chromosome, which generates the BCR-ABL1 fusion tyrosine kinase. The answer is inferred from the canonical molecular mechanism of CML, even though the specific term \"BCR-ABL1\" is not stated in the provided text.", "retries": 1}
{"idx": 587, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer includes 'mantle cell lymphoma,' which is not mentioned in the context and does not match the gold standard. However, 'multiple myeloma' is correct and present in the context. The supporting sentence is technically accurate in stating that the context does not explicitly mention Velcade but fails to utilize the available information about bortezomib's effectiveness against multiple myeloma. Therefore, while the answer partially matches the gold standard, the supporting sentence does not adequately cover the gold answer.\", \"match\": false}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, a dipeptidyl boronic acid and potent inhibitor of the 26S proteasome, is remarkably effective against multiple myeloma (MM) but not against solid tumors.", "model_answer": "Answer: Multiple myeloma and mantle cell lymphoma.", "model_support": "The context does not mention Velcade (bortezomib) or the specific diseases it is used for. Therefore, there is no supporting sentence in the provided context to answer the question about the disease(s) Velcade is mainly used for. \n\n**Answer:** The context does not contain a supporting sentence for the answer.", "retries": 1}
{"idx": 588, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'Factor Xa' aligns with the gold answer 'xa,' and the supporting sentence correctly identifies factor Xa inhibitors as a class. However, it does not explicitly mention betrixaban, which is present in the gold supporting sentence, leading to slight verbosity and less precision.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.\"  \n\nAlthough betrixaban is not explicitly mentioned in the context, the sentence identifies \"factor Xa inhibitors\" as a class of anticoagulants, which includes betrixaban (a known factor Xa inhibitor). The question's answer (\"Factor Xa\") aligns with this classification, even though the specific drug is not named in the provided text.", "retries": 1}
{"idx": 589, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer does not match gold standard but is present in context; supporting sentence is relevant but does not cover gold answer. The model's answer of 'One' conflicts with the plural 'isoforms' mentioned in the context. The supporting sentence discusses the promoters and isoforms but does not specify the number, making it insufficient to support the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One", "model_support": "Supporting sentence: p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.  \n\n**Note**: The context states \"TAp73 isoforms\" (plural), which would imply multiple TAp73 isoforms. However, the provided answer claims \"One,\" which may reflect a specific context or clarification not explicitly stated in the given text. The supporting sentence directly references the existence of TAp73 isoforms but does not specify their number.", "retries": 1}
{"idx": 590, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it includes slight redundancy by mentioning p38MAPK when the focus should solely be on JNK. The sentence is still concise and directly mentions JNK, which aligns with the gold answer.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "OBJECTIVE: To investigate the effects of antidepressant citalopram on the gene expressions of tumor necrosis factor-alpha (TNF-α) and interleukin 1 beta (IL-1β), and to discuss the impacts of citalopram on p38 and c-jun N-terminal kinase (JNK) of mitogen-activated protein kinase (MAPK) family in microglial cells.", "model_answer": "Answer: JNK", "model_support": "Supporting sentence: \"the effects of citalopram on the phosphorylation of p38MAPK and JNK were observed after pretreatment for 30 min.\"  \n\nThis sentence explicitly mentions JNK as a MAP kinase whose phosphorylation is analyzed in the study, aligning with the role of JNK in phosphorylating the transcription factor c-Jun.", "retries": 1}
{"idx": 591, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs 'xa'). The supporting sentence is relevant and supports the idea that betrixaban is a factor Xa inhibitor by association with other factor Xa inhibitors like rivaroxaban. However, the sentence contains slight redundancy by discussing dabigatran, which is not directly relevant to the question about betrixaban.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Another factor Xa inhibitor, edoxaban, is under evaluation in an ongoing phase III clinical trial and others such as AZD0837, betrixaban and darexaban are still in safety and tolerability phase II studies.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban and apixaban have proven, in large, multicenter, randomized, phase III, clinical studies, to be at least as efficient as warfarin in stroke prevention in patients with AF.  \n\n(Note: The context does not mention \"betrixaban\" but refers to \"rivaroxaban\" as a factor Xa inhibitor. Assuming a possible typo in the question, the answer \"Factor Xa\" is supported by the sentence above.)", "retries": 1}
{"idx": 592, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (SAM), as S-adenosylmethionine (SAMe) is the full name of SAM. The supporting sentence is relevant and aligns with the context by emphasizing SAMe's role in histone methylation, which indirectly supports its function as a methyl donor. However, the sentence is slightly verbose and includes additional details about SAMe's inhibitory effects, which are not directly necessary to justify the answer. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: S-adenosylmethionine (SAMe) inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation.  \n**Note**: While the context does not explicitly state that SAMe is the methyl donor for histone methyltransferases, the question's answer aligns with the well-established biological role of S-adenosylmethionine (SAM) as the primary methyl donor. The provided sentence highlights SAMe's involvement in histone methylation, which indirectly supports its role as the methyl donor. Additionally, the context mentions that SAMe converts to MTA and S-adenosylhomocysteine (SAH), which are downstream metabolites, reinforcing that SAMe is the precursor and likely the source of the methyl group.", "retries": 1}
{"idx": 593, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by including additional details about the receptors, which are not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is IL-1β.", "model_support": "Supporting sentence: Gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).", "retries": 1}
{"idx": 594, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Bone collagen' matches the gold standard 'collagen', but includes an extra word ('Bone') that is not necessary for the specific question asked. The supporting sentence is relevant and covers the answer, but it introduces additional information about dietary components which slightly increases verbosity. The logic is sound, but it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "In archaeological studies, the isotopic enrichment values of carbon and nitrogen in bone collagen give a degree of information on dietary composition.", "model_answer": "Answer: Bone collagen.", "model_support": "Supporting sentence: The isotopic enrichments of individual amino acids from bone collagen and dietary protein have the potential to provide more precise information about the components of diet.", "retries": 1}
{"idx": 595, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly explains the regulatory role of PLN over SERCA2a, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "Answer: Phospholamban (PLN)", "model_support": "Supporting sentence: \"Dephosphorylated PLN inhibits SERCA2a.\"  \n\nThis sentence directly identifies phospholamban (PLN) as the regulatory molecule that inhibits SERCA2a function when dephosphorylated, establishing its role as the main regulatory molecule for SERCA2a in cardiac muscle.", "retries": 1}
{"idx": 596, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis.", "model_answer": "Answer: Interleukin-5", "model_support": "Supporting sentence: Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.", "retries": 1}
{"idx": 597, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the use of flumazenil in benzodiazepine toxicity, but it includes some redundancy by mentioning continuous-infusion specifically, which is not necessary for the general context of the question. The logic is sound but slightly verbose compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: \"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.\"  \nAdditionally: \"consideration of continuous-infusion flumazenil is warranted\" in cases of benzodiazepine toxicity.", "retries": 1}
{"idx": 598, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'S-adenosylmethionine (SAM),' matches the gold standard ('adenosylmethionine') in essence, as SAM is the biologically correct methyl donor for histone methyltransferases. However, the supporting sentence provided by the model discusses methionine rather than S-adenosylmethionine, which introduces slight confusion. The gold supporting sentence explicitly mentions S-adenosylmethionine as the methyl donor, making it more accurate and directly relevant. Despite this discrepancy, the model's supporting sentence still refers to methylation in a related context, hence some logical connection remains. Overall, the answer is correct, but the supporting sentence contains minor inaccuracies.\", \"match\": true}", "gold_answer": "adenosylmethionine", "gold_support": "The purified cytochrome can act as a methyl acceptor for a methyltransferase activity in the cell extract that uses S-adenosylmethionine as methyl donor.", "model_answer": "Answer: S-adenosylmethionine (SAM)", "model_support": "Supporting sentence: The mitochondrial cytochrome c-557 of Crithidia oncopelti contains two lysine residues and an N-terminal proline residue that are methylated in vivo by the methyl group of methionine.  \n\n**Note:** While the answer provided (\"S-adenosylmethionine (SAM)\") is biologically accurate for histone methyltransferases, the context explicitly states that methionine is the methyl donor for the Crithidia cytochrome c methyltransferase. The supporting sentence in the context refers to **methionine**, not SAM. If the question were about the specific methyltransferase in the context, the answer would align with methionine. However, the user's answer (SAM) does not match the context.", "retries": 1}
{"idx": 599, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly more verbose than necessary. The model's supporting sentence discusses the effect of SET domain mutations on PRC2 histone methyltransferase activity, which indirectly supports the answer but includes additional details not critical to the core explanation.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: Analysis of mutant PRC2 complexes in vitro, and H3-K27 methylation in vivo, shows that each SET domain mutation disrupts PRC2 histone methyltransferase.", "retries": 1}
{"idx": 600, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly less direct compared to the gold supporting sentence, which explicitly highlights CYP17A1's role in androgen biosynthesis.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"we quantified the inhibitory activity and specificity of orteronel for testicular and adrenal androgen production by evaluating its effects on CYP17A1 enzymatic activity.\"", "retries": 1}
{"idx": 601, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While it does not explicitly mention '(-)-medicarpin,' this level of detail is unnecessary for full credit given the context and clarity of the support provided.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa is medicarpin.", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence directly identifies **medicarpin** as the phytoalexin synthesized through the pathway involving IFR, making it the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 602, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by explaining how LepChorionDB was constructed, which aligns well with the context and supports the answer effectively.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 603, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning 'sequence-specific polyamide-chlorambucil conjugate,' which is not necessary to explain the role of BCR-ABL as the target of Imatinib. The logic is strong, but the additional detail makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: \"Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate.\"  \nThis sentence directly identifies **BCR-ABL** as the target of therapeutic intervention in Philadelphia-chromosome positive CML, which aligns with the role of Imatinib (Gleevec) in targeting this tyrosine kinase. Additionally, the context explicitly references \"BCR-ABL positive cells\" and \"imatinib-resistant cells,\" reinforcing that BCR-ABL is the tyrosine kinase involved in this disease context.", "retries": 1}
{"idx": 604, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor difference in wording ('Maf recognition element' vs. 'MARE') does not affect the meaning or accuracy, as MARE is an abbreviation of the same term.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcription factor Bach1 heterodimerizes with small Maf proteins to repress MARE-dependent gene expression.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: The transcription factor Bach1 heterodimerizes with small Maf proteins to repress Maf recognition element (MARE)-dependent gene expression.", "retries": 1}
{"idx": 605, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for the role of alpha-synuclein in forming inclusions, though it focuses on multiple system atrophy rather than Parkinson's disease or Lewy body dementia. This introduces slight redundancy but still supports the answer reasonably well.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.  \n\nThis sentence directly links alpha-synuclein to the formation of neuronal inclusions, which are structurally and pathologically analogous to Lewy bodies (a defining feature of alpha-synucleinopathies like Parkinson's disease). While \"Lewy bodies\" are not explicitly named, the context establishes alpha-synuclein as the primary component of neuronal inclusions in alpha-synucleinopathies.", "retries": 1}
{"idx": 606, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is equivalent to '5-HT2A'). The supporting sentence is concise, directly relevant, and provides clear logical reasoning by referencing the study's purpose, which explicitly mentions the evaluation of 5-HT2A receptor availability. Minor additional context from the PURPOSE section does not detract from the strong alignment with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: \"Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.\"  \n\nAdditionally, the **PURPOSE** section explicitly states: \"determine 5-HT2A receptor availability in the rat brain,\" confirming the target receptor.", "retries": 1}
{"idx": 607, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('ultrasound'), as transvaginal ultrasound is a type of ultrasound. The supporting sentence provides relevant information about the use of transvaginal ultrasound for measuring bladder wall thickness, but it includes additional details about its sensitivity and application in diagnosing detrusor instability, which slightly extends beyond the concise gold supporting sentence. This makes the supporting sentence somewhat redundant but still logically connected to the answer.\",\n  \"match\": true\n}", "gold_answer": "ultrasound", "gold_support": "OBJECTIVE: To determine whether transvaginal ultrasound measurement of bladder wall thickness can be used as a screening test for detrusor instability in women with urinary symptoms.", "model_answer": "Bladder wall thickness is measured using transvaginal ultrasound.", "model_support": "Supporting sentence: The measurement of a mean bladder wall thickness greater than 5 mm with transvaginal ultrasound is a sensitive screening method for diagnosing detrusor instability in symptomatic women without outflow obstruction.", "retries": 1}
{"idx": 608, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides correct information about antiparallel spectrin dimers. However, it references different spectrin repeats (HEalpha1,2 and HEalpha2,3) rather than the specific repeats mentioned in the gold supporting sentence (HEalpha13,14 and HEbeta8,9), making it slightly less precise but still logical and accurate.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Two of the less stably folded fragments, human erythroid alpha-spectrin repeats 13 and 14 (HEalpha13,14) and human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel spectrin dimers.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: More stably folded fragments, human erythroid alpha-spectrin repeats 1 and 2 (HEalpha1,2) and human erythroid alpha-spectrin repeats 2 and 3 (HEalpha2,3), lie nearly opposite each other on antiparallel spectrin dimers of a tetramer.", "retries": 1}
{"idx": 609, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ZEB2 gene', does not match the gold standard 'SIP-1', but it is present in the context as an alternative name for the gene. The supporting sentence is relevant but overly focused on the analysis approach rather than directly stating the role of the ZEB2 gene (or SIP-1) in Mowat-Wilson syndrome, and it fails to cover the gold answer.\", \"match\": false}", "gold_answer": "SIP-1", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2 gene", "model_support": "Supporting sentence: Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.", "retries": 1}
{"idx": 610, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by mentioning collagen in the context of archaeological bones and dating, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "Collagen is the most suitable fraction and is the material normally used in radiocarbon dating.", "model_answer": "Answer: Collagen", "model_support": "Supporting sentence: A new procedure for extraction of collagen from modern and archaeological bones for 14C dating.", "retries": 1}
{"idx": 611, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence, as it correctly identifies thyroid hormone abnormalities as characteristic to Pendred syndrome. The supporting sentence is relevant and provides context regarding the measurement of thyroid hormone levels, but it is slightly less direct than the gold supporting sentence, which explicitly mentions the classical triad of symptoms and hypothyroidism. The model's supporting sentence does not cover the full reasoning behind the abnormalities (e.g., iodine organification defect), leading to a score of 4 rather than 5.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities are characteristic to Pendred syndrome.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured.", "retries": 1}
{"idx": 612, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is very close to the gold standard 'benzothiazepine,' with only a minor difference in specificity (adding '1,4'). The supporting sentence from the model references external context not provided here but aligns with the logic of the gold supporting sentence when considering the additional example. However, since the original context does not include this information, there is slight redundancy or assumption of external knowledge.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: None. The context provided does not mention the chemical group (1,4-benzothiazepine) that JTV519 is derived from. The answer appears to be based on external knowledge or a different context, as the given text does not include this information. \n\nHowever, if the question is tied to the example context (not the one provided here), the supporting sentence would be:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"  \n\n**Note**: The current context provided in the question does not contain the supporting sentence for the answer. The answer likely references a different source or context.", "retries": 1}
{"idx": 613, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence is identical to the gold supporting sentence, fulfilling all criteria for a perfect score.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.\"", "retries": 1}
{"idx": 614, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly captures the essence of the disease association with DUX4 expression as described in the context.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "Answer: FSHD", "model_support": "Supporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 615, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning despite not quoting the exact sentence from the context.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.  \n**Note**: While the context does not explicitly state that alpha-synuclein is the main component of Lewy bodies, the study focuses on alpha-synuclein isoforms in DLB, and the answer aligns with established biomedical knowledge. However, the provided context does not directly link alpha-synuclein to Lewy bodies. If strict adherence to the text is required, no sentence in the context explicitly states the main component of Lewy bodies.", "retries": 1}
{"idx": 616, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence is slightly less detailed than the gold standard but still clearly indicates that benserazide is co-administered with L-Dopa.\", \"match\": true}", "gold_answer": "L-Dopa", "gold_support": "They were injected subcutaneously (s.c.) with L-Dopa methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-Dopa/benserazide) alone or in combination with JL-18 (at the doses of 0.1, 0.3, or 0.9 mg/kg, s.c.).", "model_answer": "Answer: L-Dopa", "model_support": "Supporting sentence: \"L-Dopa/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\" \n\nThis sentence explicitly states that benserazide is co-administered with L-Dopa, as they are mentioned together as a combined treatment.", "retries": 1}
{"idx": 617, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that TCR targets the transcribed strand by describing how RNA polymerase mediates repair at damage sites on this strand. The reasoning aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "Supporting sentence: \"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage. The stalled RNA polymerase complex may then mediate recruitment of repair proteins to damage in the transcribed strand.\" \n\nThis sentence explicitly states that transcription-coupled repair (TCR) targets the **transcribed strand** of active genes, as it describes the repair process occurring at damage sites on this strand.", "retries": 1}
{"idx": 618, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is somewhat verbose and does not directly state the autosomal dominant inheritance but rather describes a study that aimed to investigate the disease's inheritance. While it implies relevance to inheritance, it lacks the concise clarity of the gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Dystrophic myotonia is a sufficiently rare disease inherited mainly by the autosomal dominant type.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "Supporting sentence: A clinical, genetic, and electromyographic study was carried out to elucidate the problem of this condition inheritance, its intra- and interfamilial clinical polymorphism, and effects of environmental factors on its course and outcomes.  \n\n**Note**: While the context mentions the study aimed to \"elucidate the problem of this condition inheritance,\" it does not explicitly state the inheritance pattern (autosomal dominant). The answer \"autosomal dominant\" is based on general knowledge of myotonic dystrophy, but the provided context does not include a direct statement confirming this.", "retries": 1}
{"idx": 619, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes extra details (specifying subclinical and overt hypothyroidism) that are not explicitly required by the gold answer. The supporting sentence is somewhat lengthy and provides specific statistics, which, while accurate, are not necessary to support the more general gold answer. Logic is reasonable but could be more concise.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Answer: Thyroid function abnormalities, including subclinical and overt hypothyroidism, are common in Williams syndrome.", "model_support": "Supporting sentence: Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).  \n\nThis directly states the prevalence of thyroid function abnormalities (subclinical and overt hypothyroidism) in Williams syndrome patients, which supports the answer.", "retries": 1}
{"idx": 620, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "Answer: Zfhx1b", "model_support": "Supporting sentence: Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.", "retries": 1}
{"idx": 621, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'CaN (calcineurin)' is equivalent to the gold answer 'phosphatase 2B' as calcineurin is another name for phosphatase 2B. The supporting sentence is relevant and covers the answer logically, but it is slightly less detailed compared to the gold supporting sentence, omitting the explicit mention of Ca(2+)/calmodulin dependency. However, the core idea is still conveyed effectively.\",\n  \"match\": true\n}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: CaN (calcineurin)", "model_support": "Supporting sentence: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 622, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence identifies medicarpin as the major product during elicitation, aligning perfectly with its role as the primary phytoalexin in alfalfa.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.\"  \n\nThis sentence directly identifies **medicarpin** as the major isoflavonoid synthesized during elicitation, which aligns with its role as the primary phytoalexin in alfalfa. Additionally, the subsequent mention of \"the phytoalexin could be released from a preformed conjugate\" implicitly ties medicarpin to the phytoalexin function.", "retries": 1}
{"idx": 623, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the symptoms listed in the model's answer are present in the context and associated with Dyke-Davidoff-Masson syndrome, they do not directly identify the characteristic feature, which is 'cerebral hemiatrophy.' The supporting sentence provides relevant information but focuses on symptoms rather than addressing the diagnostic feature found in the CT scan as required by the gold standard.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic features of Dyke-Davidoff-Masson syndrome include recurrent seizures, spastic hemiplegia, microcephaly, and developmental delay.", "model_support": "Supporting sentence: A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains.", "retries": 1}
{"idx": 624, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, but it does not explicitly mention 'transcribed strand,' which makes it slightly less precise compared to the gold supporting sentence. It discusses TCR in active genes, which implies the transcribed strand but lacks the direct clarity of the gold sentence.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Answer: The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "Supporting sentence: \"CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes.\"  \n\n**Analysis**: While the context does not explicitly state \"transcribed strand,\" the phrase \"transcription-coupled repair (TCR) of active genes\" implies that TCR targets the transcribed strand. Transcription-coupled repair is specifically activated during transcription, which occurs on the transcribed (non-template) strand of actively expressed genes. The mention of \"active genes\" in the context aligns with the biological mechanism of TCR, which repairs damage on the strand being transcribed.", "retries": 1}
{"idx": 625, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('autosomal dominant'). The supporting sentence accurately reflects that the context does not explicitly discuss inheritance but acknowledges the correctness of the answer as a general medical fact. While the model's supporting sentence is minimal, it appropriately notes the lack of explicit inheritance information in the provided text, aligning with the scoring criteria for conciseness and relevance.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "BACKGROUND: Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.", "model_answer": "Answer: Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The context provided does not include any information about the inheritance pattern of myotonic dystrophy. The answer \"autosomal dominant\" is a general medical fact but is not explicitly stated or implied in the given text. \n\n**Supporting sentence:** None. The context focuses on clinical, electrophysiologic, and pathologic findings but does not mention inheritance mechanisms.", "retries": 1}
{"idx": 626, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context, as it describes subclinical hypothyroidism related to Williams syndrome. The supporting sentence is relevant and provides details about TSH abnormalities but does not directly cover the gold answer ('thyroid'). It focuses more on subclinical hypothyroidism rather than the broader thyroid-related abnormalities implied by the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "Answer: Hormone abnormalities common in Williams syndrome include subclinical hypothyroidism, as indicated by an exaggerated and prolonged TSH response to TRH and a reduced TSH bioactivity to immunoreactivity ratio.", "model_support": "Supporting sentence: TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].", "retries": 1}
{"idx": 627, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by identifying tofacitinib as a Janus kinase inhibitor in the context of rheumatoid arthritis treatment.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: \"the preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).\"  \n\nThis sentence explicitly identifies **tofacitinib** as a **Janus kinase (JAK) inhibitor** and contextualizes its evaluation in both preclinical and clinical settings for rheumatoid arthritis, supporting the answer that it is the JAK inhibitor approved for RA treatment.", "retries": 1}
{"idx": 628, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence is concise and directly relevant, acknowledging that the context does not explicitly state betrixaban's mechanism but correctly infers it based on general knowledge. Although the model notes the lack of explicit information in the provided text, its logical inference aligns perfectly with the gold supporting sentence, which confirms betrixaban as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The context does not explicitly state which clotting factor is inhibited by betrixaban. However, based on general knowledge, betrixaban is a factor Xa inhibitor. But since the provided context does not include this information, there is no direct supporting sentence in the given text. \n\n**Note:** The context mentions \"new oral anticoagulants\" like dabigatran (direct thrombin inhibitor) and rivaroxaban (factor Xa inhibitor), but it does not specify betrixaban's mechanism. The answer \"Factor Xa\" is inferred from external knowledge, not explicitly stated in the provided text.", "retries": 1}
{"idx": 629, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable, but none are present here that detract from the clarity.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 630, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy by mentioning the chromodomain, which is not necessary to directly support the answer about the SET domain. The logic is correct but could be more concise.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "Deletion of the chromodomain or point mutation of the conserved amino acids, W64A or W67A, of SUV39H1 impaired enzyme activity despite the presence of an intact catalytic SET domain.", "model_answer": "Answer: SET domain", "model_support": "Supporting sentence: Thus, SUV39H1 utilizes both the chromodomain and the SET domain for catalysis.", "retries": 1}
{"idx": 631, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the context but does not cover the gold answer, as it focuses on the absence of information rather than identifying growth hormone deficiency explicitly mentioned in the text.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients.", "model_answer": "Answer: The context does not mention any hormone deficiency implicated in Costello syndrome.", "model_support": "Supporting sentence: The context does not mention any hormone deficiency implicated in Costello syndrome.  \n**Note**: The context explicitly focuses on genetic mutations (e.g., HRAS, BRAF, MEK1) and their roles in Costello and CFC syndromes, without referencing hormone deficiencies. The absence of any mention of hormones or deficiencies in the text directly supports the answer. However, since the context does not include a sentence explicitly stating \"no hormone deficiency is mentioned,\" the conclusion is drawn from the lack of relevant information in the provided text.", "retries": 1}
{"idx": 632, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Both the model's answer and supporting sentence are identical to the gold standard.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.\"", "retries": 1}
{"idx": 633, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence mentions five N-terminal isoforms but does not clarify that there are seven TAp73 isoforms in total, leading to a failure in addressing the question accurately. Additionally, the reasoning provided by the model incorrectly interprets the context, making both the answer and supporting sentence irrelevant.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: One.", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR.  \n\nThis sentence explicitly lists \"TAp73\" as one of the five distinct N-terminal isoforms, confirming that **one** TAp73 isoform has been identified.", "retries": 1}
{"idx": 634, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it introduces a comparison with Mahalanobis distance, which is not necessary for directly supporting the answer about delta-distance. This makes the sentence slightly redundant, though the logic remains sound.\", \"match\": true}", "gold_answer": "delta-distance", "gold_support": "The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.", "model_answer": "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is delta-distance.", "model_support": "Supporting sentence: We demonstrate that the Mahalanobis distance is better than the delta-distance at measuring genomic signature differences between plasmids and chromosomes of potential hosts.", "retries": 1}
{"idx": 635, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes slightly more reasoning than necessary, making it somewhat verbose compared to the concise gold supporting sentence. While the logic is strong, the extra explanation about SNP and calcium pathways is not required to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "Supporting sentence: \"These effects of SNP were prevented by SEA0400.\"  \nThis sentence indicates that SEA0400 blocks the effects of SNP, which include Ca²⁺ influx and intracellular Ca²⁺ elevation mediated by the Na⁺/Ca²⁺ exchanger (NCX). The context explicitly links these effects to NCX-mediated pathways, confirming SEA0400's role as an NCX inhibitor.", "retries": 1}
{"idx": 636, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence indirectly but effectively identifies the bacterium through its association with botulinum toxin, aligning well with the context.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "Botulism is a disease characterized by neuromuscular paralysis and is produced from botulinum neurotoxins (BoNTs) found within the Gram positive bacterium Clostridium botulinum.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: This bacteria produces the most deadliest toxin known, with lethal doses as low as 1 ng/kg.  \n\n**Note**: While the context does not explicitly name *Clostridium botulinum*, the reference to \"botulinum neurotoxin intoxication\" and the description of the bacterium producing the \"most deadliest toxin\" align with the well-established scientific understanding that *Clostridium botulinum* is the causative agent of botulism. The supporting sentence implicitly identifies the bacterium through its association with botulinum toxin.", "retries": 1}
{"idx": 637, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about medicarpin, referencing its methylation process. However, it does not directly state that medicarpin is the major phytoalexin in alfalfa, which makes it slightly less concise and specific compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein. \n\nThis sentence directly identifies **medicarpin** as the compound under discussion, which is the major phytoalexin in alfalfa, as the context focuses on its biosynthesis and related enzymatic processes.", "retries": 1}
{"idx": 638, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'beta-Trcp' is a correct but slightly abbreviated version of the gold answer 'SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)'. The supporting sentence provided by the model is relevant and supports the answer, but it focuses on the recruitment of beta-Trcp via serine residues rather than directly stating that SCFbeta-Trcp mediates ubiquitination and degradation. The logic is strong, but the supporting sentence could be more concise and directly aligned with the gold standard.\", \"match\": true}", "gold_answer": "SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: beta-Trcp", "model_support": "Supporting sentence: \"the integrity of two Ser residues at positions 535 and 539 within the specific destruction motif present in the cytoplasmic tail of IFNAR1 is essential for the ability of IFNAR1 to recruit beta-Trcp as well as to undergo efficient ubiquitination and degradation.\"", "retries": 1}
{"idx": 639, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively ties ZFHX1B to the clinical manifestations of Mowat-Wilson syndrome, aligning well with the context provided.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "ZFHX1B mutations cause a complex developmental phenotype characterized by severe mental retardation (MR) and multiple congenital defects.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the \"Mowat-Wilson\" syndrome.", "retries": 1}
{"idx": 640, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard in essence, as 'BCR-ABL tyrosine kinase' is a correct and closely related form of the gold answer 'BCR-ABL'. The supporting sentence is relevant and provides information about the reactivation of BCR-ABL signal transduction, which supports the role of BCR-ABL in resistance during advanced phases. However, it is slightly indirect compared to the gold supporting sentence, which directly explains the formation and role of BCR-ABL in CML. The model's supporting sentence contains some redundancy by focusing on treatment outcomes rather than being as concise as the gold standard.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is characterised by the occurrence of the Philadelphia (Ph) chromosome (9/22 translocation) and the formation of a fusion protein--the BCR-ABL transcript with constitutive activation of the BCR-ABL tyrosine kinase and consequent changes in the intracellular signal transduction, which is responsible for the deregulated myeloid cell proliferation.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: \"the results in the advanced phase are far less favourable, which is explained by the development of resistance owing to reactivation of the BCR-ABL signal transduction.\"", "retries": 1}
{"idx": 641, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it adds 'acute,' which is implied but not strictly necessary. The supporting sentence is relevant and supports the answer well, but it includes slight redundancy by specifying 'in the emergency room,' which is already implied by the ROSIER context. Overall, the logic is strong, but minor verbosity reduces the score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 642, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about it being a novel treatment are acceptable as they do not detract from the core relevance.\", \"match\": true}", "gold_answer": "sodium glucose co-transporter 2", "gold_support": "The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies.", "model_answer": "Answer: Sodium glucose co-transporter 2", "model_support": "Supporting sentence: Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM).", "retries": 1}
{"idx": 643, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Sporozoa,' does not match the gold standard, which is 'Fungi.' The supporting sentence mentions Sporozoa and formerly microsporidian metchnikovellids but fails to address the classification of Microsporidia within Fungi as stated in the gold supporting sentence. While the supporting sentence is relevant to the context of microbial classification, it does not logically support the correct gold answer.\",\n  \"match\": false\n}", "gold_answer": "Fungi", "gold_support": "The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.", "model_answer": "Answer: Sporozoa", "model_support": "Supporting sentence: Haplosporidia and the (formerly microsporidian) metchnikovellids are now both placed within the phylum Sporozoa.", "retries": 1}
{"idx": 644, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer (BCR-ABL1) is scientifically correct and aligns with the gold standard (BCR-ABL), differing only by the inclusion of '1,' which is a minor variation in nomenclature. The supporting sentence provides logical reasoning, correctly inferring the target based on the context of Philadelphia-chromosome positive CML and imatinib's mechanism. However, it acknowledges the absence of an explicit mention in the context, making it slightly less concise than ideal. The gold supporting sentence directly references BCR-ABL, whereas the model's supporting sentence relies on inference.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND/AIM: Imatinib mesylate, a tyrosine kinase inhibitor with specific activity against the breakpoint cluster region--Abelson murine leukemia (BCR-ABL) tyrosine kinase has been developed for treatment of chronic myelogenous leukemia (CML).", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The context does not explicitly state the target tyrosine kinase of imatinib. However, based on the context's mention of \"Philadelphia-chromosome positive chronic myelogenous leukemia\" and the well-established mechanism of imatinib, the answer (BCR-ABL1) is inferred. The context focuses on imatinib's efficacy in CML but does not directly reference BCR-ABL1. \n\n**Note**: While the answer is scientifically accurate, the provided context does not contain a direct sentence identifying BCR-ABL1 as the target. The supporting sentence would require explicit mention of the tyrosine kinase target, which is absent here.", "retries": 1}
{"idx": 645, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by identifying Jnk as part of the MAP kinase family, which aligns with its role in phosphorylating c-Jun. Minor extra details about dual phosphorylation are acceptable as they do not detract from the logic.\", \"match\": true}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "Answer: Jnk", "model_support": "Supporting sentence: Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group that is activated by dual phosphorylation at Tyr and Thr.  \n\nThis sentence identifies Jnk as a member of the MAP kinase family, which is consistent with its role in phosphorylating transcription factors like c-Jun, as described in the context. While the text does not explicitly state that Jnk phosphorylates c-Jun, the classification of Jnk as a MAP kinase (a family known to regulate such transcription factors) supports the answer.", "retries": 1}
{"idx": 646, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold standard 'stroke,' making it a match. The supporting sentence is concise, directly relevant, and explains the purpose of the ROSIER scale in differentiating acute stroke, aligning well with the gold supporting sentence while adding clear context.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 647, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy by mentioning TA-p73 and p63, which are not necessary to directly support the answer. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors.  \n\n**Note**: While the context does not explicitly use the phrase \"guardian of the genome,\" p53 is historically and widely recognized as \"the guardian of the genome\" in biomedical literature. The sentence above identifies p53 as a tumor suppressor, which aligns with its canonical role in genome stability.", "retries": 1}
{"idx": 648, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model correctly acknowledges that the context doesn't explicitly restate the enzyme but affirms the correctness of the answer. The gold supporting sentence directly validates this by defining Evolocumab as an inhibitor of PCSK9, ensuring logical consistency.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.", "model_answer": "Evolocumab targets proprotein convertase subtilisin/kexin type 9 (PCSK9).", "model_support": "The context provided does not explicitly mention the enzyme targeted by Evolocumab. While the answer \"Evolocumab targets proprotein convertase subtilisin/kexin type 9 (PCSK9)\" is scientifically accurate, the context does not include a sentence stating this. The text focuses on Evolocumab's effects on LDL-C reduction, apolipoprotein B100, lipoprotein(a), and adverse events but does not specify its molecular target. \n\n**Supporting sentence:** None. The context does not contain a sentence directly stating that Evolocumab targets PCSK9.", "retries": 1}
{"idx": 649, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' with only a minor difference in specificity. The supporting sentence is relevant and aligns well with the context, directly mentioning the ROSIER scale's effectiveness in differentiating stroke in the ER. However, it contains slight redundancy by specifying 'acute stroke' when 'stroke' alone would suffice for full alignment with the gold standard.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 650, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('JNK' is equivalent to 'c-Jun NH2-terminal kinase'). However, the supporting sentence contains a mix of relevant and irrelevant information. While it correctly identifies that the context does not explicitly mention JNK's role in phosphorylating c-jun, it also introduces unnecessary details about p38 MAPK and other elements that do not directly support the answer. The correct supporting sentence could have been more concise by focusing on the part of the context mentioning JNK.\", \"match\": true}", "gold_answer": "c-Jun NH2-terminal kinase", "gold_support": "E2 also attenuated the LPS activation of p38 mitogen-activated protein kinase (MAPK) but not that of extracellular-regulated protein kinase 1/2 (ERK1/2) and c-Jun NH2-terminal kinase (JNK).", "model_answer": "Answer: JNK (c-Jun N-terminal kinase)", "model_support": "Supporting sentence: The context does not explicitly mention JNK (c-Jun N-terminal kinase) or its role in phosphorylating c-jun. The text references p38 MAPK, NF-κB, and AP-1 but does not directly identify JNK as the kinase responsible for c-jun phosphorylation. \n\nHowever, based on general knowledge (not explicitly stated in the context), the answer is **JNK**. Since the context does not provide a sentence supporting this specific claim, the answer cannot be derived directly from the provided text. \n\n**Note**: The question relies on external biological knowledge rather than the context provided.", "retries": 1}
{"idx": 651, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Acute stroke' is very close to the gold standard 'stroke' and is contextually correct, though slightly more specific than necessary. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by specifying 'from stroke mimics,' which is not essential for answering the question directly. Overall, the logic is strong, but minor verbosity reduces the score.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 652, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the answer, but it is somewhat redundant as it repeats the title of the context rather than directly referencing the specific information about betrixaban inhibiting factor Xa. A more concise supporting sentence would improve the score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].  \n\nThis sentence explicitly identifies betrixaban as a \"direct inhibitor of factor Xa,\" aligning with the answer.", "retries": 1}
{"idx": 653, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).", "retries": 1}
{"idx": 654, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'XK gene' is very close to the gold standard 'XK', with only a minor difference in wording that does not affect correctness. The supporting sentence is relevant and supports the answer by mentioning the association of the McLeod phenotype with an XK missense mutation. However, it includes additional context (lack of hematologic, neuromuscular, or cerebral involvement) that, while accurate, is not directly necessary to justify the answer. This makes the sentence slightly more verbose than the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.", "retries": 1}
{"idx": 655, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although referencing external knowledge, is concise, directly relevant, and explains the answer with clear and logical reasoning. The use of external knowledge is appropriate since the context does not explicitly include the supporting sentence but aligns with the gold supporting sentence in meaning.\",\n  \"match\": true\n}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.", "model_answer": "Answer: Interleukin-17A (IL-17A)", "model_support": "The context provided does not explicitly state the molecular target of secukinumab. However, based on standard biomedical knowledge, secukinumab is a monoclonal antibody targeting **interleukin-17A (IL-17A)**, which is a well-established mechanism for its therapeutic effect in psoriasis. \n\n**Supporting sentence (from external knowledge, not explicitly stated in the provided context):**  \n\"Secukinumab is a human monoclonal antibody that selectively neutralizes interleukin-17A (IL-17A), a pro-inflammatory cytokine involved in the pathogenesis of psoriasis.\"\n\n**Note:** The provided context does not include this specific sentence, but the answer is derived from widely recognized scientific understanding of secukinumab's mechanism of action.", "retries": 1}
{"idx": 656, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer refers to a specific variant ('EAE+Cyclosporine') rather than the broader category of Experimental Autoimmune Encephalomyelitis (EAE), which is the gold standard. The supporting sentence mentions the robustness of this specific model but does not directly or fully cover the gold answer about EAE being the most widely used model for MS research. While the answer is present in the context, it does not align with the gold standard and lacks concise logical support.\", \"match\": false}", "gold_answer": "Experimental Autoimmune Encephalomyelitis (EAE)", "gold_support": "The aim of our study was to characterize the sensory abnormalities and in particular the clinical signs linked to persistent pain in two models of Experimental Autoimmune Encephalomyelitis (EAE) in the rat.", "model_answer": "Answer: The \"EAE+Cyclosporine\" model.", "model_support": "Supporting sentence: The second part of our study aimed at characterizing from a pharmacological point of view the most robust model (\"EAE+Cyclosporine\").", "retries": 1}
{"idx": 657, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, acknowledges the context does not explicitly define 'mTOR,' and provides logical reasoning by referencing general biomedical knowledge. Although the supporting sentence introduces some external clarification, it remains relevant and appropriate given the lack of explicit definition in the text.\",\n  \"match\": true\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.", "model_answer": "mTOR stands for mammalian target of rapamycin.", "model_support": "Supporting sentence: The context does not explicitly state the full form of \"mTOR.\" However, based on standard biomedical knowledge, \"mTOR\" stands for \"mammalian target of rapamycin.\" Since the context uses the acronym \"mTOR\" without expansion, there is no direct sentence in the provided text that defines it. \n\n**Note:** The answer is accurate based on general knowledge, but the context provided does not include a sentence explicitly stating the full form of \"mTOR.\"", "retries": 1}
{"idx": 658, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes slight redundancy by providing additional context about oats and gluten sensitivity, which is not directly necessary to support the answer. The sentence 'the rash in patients with dermatitis herpetiformis is not activated by eating oats' indirectly supports the answer but introduces extra details that could have been omitted for conciseness. Overall, the logic is sound, but the supporting sentence could be more direct.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: The study focuses on \"Tolerance to oats in dermatitis herpetiformis,\" and the context explicitly links dermatitis herpetiformis to gluten-related conditions, as the patients are described as having \"dermatitis herpetiformis\" and the research pertains to gluten-free diets and gluten sensitivity. While the text does not explicitly state \"the typical rash associated with gluten is dermatitis herpetiformis,\" the entire context revolves around dermatitis herpetiformis as the condition under investigation, which is a well-established gluten-related rash. The direct reference to the condition in the title and the study's focus on gluten-free diets implicitly supports this answer. \n\nHowever, if a more explicit sentence is required, the conclusion states: \"the rash in patients with dermatitis herpetiformis is not activated by eating oats,\" which indirectly confirms that dermatitis herpetiformis is the rash associated with gluten sensitivity. \n\n**Final Answer:**  \nSupporting sentence: \"the rash in patients with dermatitis herpetiformis is not activated by eating oats.\" (This implies that dermatitis herpetiformis is the rash associated with gluten sensitivity, as the study investigates its response to oats in a gluten-sensitive context.)", "retries": 1}
{"idx": 659, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the specific study on [18F]altanserin as a ligand for 5-HT2A receptors. There is no unnecessary verbosity or irrelevant information.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "Answer: 5-HT2A receptors.", "model_support": "Supporting sentence: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.", "retries": 1}
{"idx": 660, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about mTOR, but it contains slight redundancy by mentioning 'mTORC2' specifically when the question only asks for what 'mTOR' stands for. However, the logic connecting the answer to the supporting sentence is sound.\",\n  \"match\": true\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "The role of the distinct mammalian target of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation and survival in PAH and their therapeutic relevance are unknown.", "model_answer": "mTOR stands for mammalian target of rapamycin.", "model_support": "Supporting sentence: Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.", "retries": 1}
{"idx": 661, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although it does not explicitly mention that pridopidine is in development for Huntington disease, the context provided clearly supports the answer without unnecessary verbosity.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 662, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer logically. However, it introduces additional details about the nuclear import process and amino acid Val54, which are not necessary to answer the question directly. The gold supporting sentence is more concise and directly addresses the steady-state nuclear localization of A3B.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "Answer: Nuclear", "model_support": "Supporting sentence: A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase).", "retries": 1}
{"idx": 663, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The additional information provided by the model does not detract from the clarity or correctness of the primary supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.  \n\nAdditionally, the sentence \"LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB\" confirms its availability for identifying chorion proteins. However, the primary supporting sentence directly naming the database and its purpose is the first one.", "retries": 1}
{"idx": 664, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Nestin,' matches the gold standard. However, the supporting sentence states that the context does not mention Nestin, which is incorrect because the gold supporting sentence explicitly mentions Nestin as a marker protein for precursor cells in the subventricular zone. The supporting sentence fails to cover the gold answer and is therefore inadequate.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats.", "model_answer": "Answer: Nestin", "model_support": "The context provided does not mention **Nestin** or any intermediate filament protein as a marker for neuronal precursor cells in the subventricular zone. The text discusses **PSA-NCAM** (polysialated-neural cell adhesion molecules) and nuclear receptor ligands but does not reference **Nestin** or intermediate filaments. \n\n**Supporting sentence:** None.  \nThe answer \"Nestin\" is not supported by the given context.", "retries": 1}
{"idx": 665, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). However, the supporting sentence provided by the model is not fully accurate because it states that the context does not mention betrixaban or its mechanism of action, which is incorrect. The gold supporting sentence clearly lists betrixaban as an orally active direct factor Xa inhibitor within the provided context. Despite this, the model's supporting explanation is reasonable in attempting to link general knowledge to the answer, justifying a score of 4.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or its mechanism of action. Therefore, there is no supporting sentence in the provided text to answer the question. \n\nHowever, based on general knowledge, betrixaban is a Factor Xa inhibitor, but this information is not present in the given context. \n\nIf the question is strictly based on the context, the answer cannot be determined from the provided text.", "retries": 1}
{"idx": 666, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK') in essence by specifying 'the XK gene,' though it is slightly more verbose. The supporting sentence is relevant and directly points to a mutation in the XK gene, but it lacks the broader explanatory context provided in the gold supporting sentence, which mentions the function of the XK protein. The logic is sound, but the supporting sentence could be more comprehensive.\", \"match\": true}", "gold_answer": "XK", "gold_support": "It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function.", "model_answer": "Mutation of the XK gene is associated with McLeod syndrome.", "model_support": "Supporting sentence: \"a McLeod patient with a XK gene point mutation (C977T)\"", "retries": 1}
{"idx": 667, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why TCR targets the transcribed strand by highlighting the normal NER activity in the transcribed strand versus the lack of it in the non-transcribed strand. This aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of an active gene.", "model_support": "Supporting sentence: Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand. \n\nThis sentence indicates that transcription-coupled repair (TCR) targets the transcribed strand, as NER (a process involving TCR) remains functional in the transcribed strand despite elc1 deletion, while it fails in the non-transcribed strand. The context links TCR to the transcribed strand through the absence of repair in the non-transcribed strand and the presence of normal repair in the transcribed strand.", "retries": 1}
{"idx": 668, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence provides a clear explanation of how LepChorionDB was constructed, which aligns with its purpose as stated in the gold supporting sentence.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 669, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.", "retries": 1}
{"idx": 670, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about gevokizumab's interaction with IL-1β, but it includes additional details about receptor types that are not necessary to directly support the answer, making it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Answer: IL-1β", "model_support": "Supporting sentence: Gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).", "retries": 1}
{"idx": 671, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explaining the construction and purpose of LepChorionDB, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 672, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context for the answer, but it contains some redundancy by elaborating on test-retest variability, which is not directly necessary to support the specific answer about 5-HT2A receptors.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 673, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly state the inheritance pattern, the gold supporting sentence confirms that 'autosomal dominant' is indeed mentioned in the provided text. The supporting sentence from the gold standard directly and concisely supports the correct answer, fulfilling the criteria for a score of 5.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Myotonic dystrophy type 1 is a neuromuscular, degenerative and progressive disease, with an autosomal dominant pattern of inheritance, variable expressivity and incomplete penetrance.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The context does not explicitly state the inheritance pattern of myotonic dystrophy. While the answer \"autosomal dominant\" is biologically accurate for Myotonic Dystrophy Type 1 (DM1), the provided text does not include a sentence that directly addresses the inheritance mechanism. The context focuses on mutation size, transmission dynamics, and correlations with symptoms but does not mention \"autosomal dominant\" or similar terminology. \n\n**Supporting sentence:** None explicitly stated in the context.  \n**Note:** The answer relies on general biomedical knowledge rather than the provided text.", "retries": 1}
{"idx": 674, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is accurate in stating that the context does not explicitly mention the gene name HEXA but correctly implies that external knowledge supports the answer. While the model's supporting sentence is technically 'None,' this approach aligns with the instructions since the context indeed does not explicitly state the necessary information, making the evaluation consistent with the gold standard.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.", "model_answer": "Answer: HEXA", "model_support": "The context does not explicitly mention the gene most commonly mutated in Tay-Sachs disease (HEXA). While the text discusses mutations (e.g., G749T, C1351G) in the context of Tay-Sachs disease carriers, it does not name the specific gene. Therefore, **no sentence in the provided context directly supports the answer** \"HEXA.\" The answer relies on external biomedical knowledge about Tay-Sachs disease, which is caused by mutations in the *HEXA* gene, but this information is not included in the given text. \n\n**Supporting sentence:** None. The context does not reference the gene name *HEXA*.", "retries": 1}
{"idx": 675, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical basis for Bach1 being a repressor by discussing its heme-regulated nuclear export, which aligns with its role as a transcriptional repressor. However, it does not explicitly mention Bach1's direct repressive action on specific genes (e.g., heme oxygenase-1 and beta-globin), making it slightly less precise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1 and beta-globin genes, both of which are known to be transcriptionally induced by heme.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1.  \n**Reasoning**: The context describes heme's role in regulating gene expression through Bach1's nuclear export. If Bach1 is exported from the nucleus (where it likely exerts its regulatory function), its absence from the nucleus would suggest it acts as a repressor when localized there. The phrase \"regulates gene expression\" implies Bach1's involvement in controlling gene activity, and the mechanism of nuclear export (a common regulatory strategy for transcription factors) aligns with its role as a repressor. While the text does not explicitly state \"repressor,\" the functional context of heme-dependent nuclear export strongly implies this role.", "retries": 1}
{"idx": 676, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model answer '5-HT2A receptors' is slightly more verbose than the gold answer '5-HT2A,' but this difference is minor. The supporting sentence is relevant and explains the concept well but could be more concise to directly match the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 677, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard. The supporting sentence is relevant and provides context about microsporidia being part of the fungal kingdom, but it introduces unnecessary details about taxonomic debates, making it slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: \"Microsporidia is one of the taxa that have experienced the most dramatic taxonomic reclassifications. However, the specific position of microsporidia within the fungal tree of life is still debated.\"  \n\nThis sentence establishes that microsporidia are classified within the fungal kingdom (\"fungal tree of life\") despite ongoing debates about their precise phylogenetic position.", "retries": 1}
{"idx": 678, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence, though it is slightly more verbose by specifying 'thyroid hormone abnormalities.' The supporting sentence is relevant and provides context about thyroid hormone levels being measured, but it does not directly mention hypothyroidism or the functional disorders linked to Pendred syndrome as clearly as the gold supporting sentence. Slight redundancy exists in the supporting sentence, which prevents a perfect score.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Answer: Thyroid hormone abnormalities are characteristic to Pendred syndrome.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured.", "retries": 1}
{"idx": 679, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).", "retries": 1}
{"idx": 680, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs 'xa'). The supporting sentence is relevant and covers the answer by referencing the classification of betrixaban as a factor Xa inhibitor, but it includes some additional context about direct thrombin inhibitors that is not strictly necessary, introducing slight redundancy. Overall, the logic is solid, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states. \n\n**Explanation**: The context explicitly states that betrixaban is a \"novel oral anticoagulant\" and places it within the broader category of \"new classes of orally administered anticoagulants,\" which are described as \"direct thrombin and factor Xa inhibitors.\" While the text does not directly state that betrixaban inhibits Factor Xa, it is implied by its classification as part of the \"novel anticoagulants\" alongside factor Xa inhibitors. The mention of \"factor Xa decoy\" (PRT4445) in conjunction with betrixaban further reinforces that betrixaban belongs to the factor Xa inhibitor class, as the decoy would target the same pathway.", "retries": 1}
{"idx": 681, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly explains the relationship between [18F]altanserin and 5-HT2A receptors, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 682, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence is correct but less informative compared to the gold supporting sentence, which provides more context about the database's purpose and tools.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.", "retries": 1}
{"idx": 683, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: McLeod syndrome resulting from a novel XK mutation.", "retries": 1}
{"idx": 684, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not directly cover the gold answer (XK). It mentions the region where the gene is located but fails to specify the gene itself, which is critical for full accuracy.\", \"match\": false}", "gold_answer": "XK", "gold_support": "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.", "model_answer": "Answer: The gene associated with McLeod syndrome is not explicitly mentioned in the context.", "model_support": "Supporting sentence: \"The locus for this syndrome has been mapped, by deletion analysis, to a region between the loci for Duchenne muscular dystrophy (DMD) and chronic granulomatous disease (CGD).\"  \n\nThis sentence indicates that the genetic location (locus) of McLeod syndrome has been identified, but the specific gene responsible is not explicitly named in the context. Additionally, the text refers to \"candidate sites for the McLeod gene\" without providing the gene's name.", "retries": 1}
{"idx": 685, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('alpha-synuclein'). However, the supporting sentence relies on external knowledge rather than the provided context, which slightly reduces its score. While it correctly identifies α-synuclein as the target protein for Lewy body immunostaining based on general biomedical knowledge, the gold supporting sentence directly references a relevant sentence from the text ('Immunohistochemistry for alpha-synuclein revealed LBs...'), which is more precise and rooted in the given context. The model's supporting sentence introduces unnecessary ambiguity by implying the context does not explicitly mention the protein.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).", "model_answer": "Answer: α-synuclein", "model_support": "Supporting sentence: The context does not explicitly mention the antibody's target protein (α-synuclein). However, based on general biomedical knowledge, Lewy bodies are primarily composed of α-synuclein, which is a well-established marker for Lewy body diseases. The context refers to \"Lewy bodies (LBs)\" but does not directly state the protein targeted by the antibody. \n\n**Note**: The answer \"α-synuclein\" is correct in real-world context, but the provided text does not include a sentence explicitly stating this. The question may rely on external knowledge rather than the given text.", "retries": 1}
{"idx": 686, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it provides the full name instead of the acronym. The supporting sentence is relevant and directly links DUX4 dysregulation to FSHD; however, it includes additional information ('The DUX4-fl pathogenic transcript...') which, while correct, adds slight redundancy. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is facio-scapulo-humeral dystrophy (FSHD).", "model_support": "Supporting sentence: \"Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.\"  \nAdditionally: \"The DUX4-fl pathogenic transcript was detected in FSHD biopsies...\"  \n\nThese sentences directly link the ectopic expression of DUX4 (via the D4Z4 array dysregulation) to facio-scapulo-humeral dystrophy (FSHD).", "retries": 1}
{"idx": 687, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is incorrect as it states that thyroid hormone concentrations are not altered in AHDS, which contradicts the gold answer and context. The supporting sentence focuses on cases with normal thyroid hormone levels but ignores the key detail from the gold supporting sentence about 'altered TH levels, in particular, high serum T3 levels.' While the model's supporting sentence is relevant to its answer, it does not cover the gold answer logically or accurately.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels.", "model_answer": "Answer: Thyroid hormone concentrations are not altered in patients with Allan-Herndon-Dudley syndrome.", "model_support": "Supporting sentence: \"Phenotypic variability with the presence of normal serum T3 levels.\"  \nAdditionally: \"One of them presented normal thyroid hormone levels.\" and \"mutation was also detected, although in the heterozygous state, in three females showing thyroid hormone levels in the normal range.\"  \n\nThese sentences directly state that thyroid hormone (T3) concentrations remain normal in patients with AHDS despite the MCT8 mutation.", "retries": 1}
{"idx": 688, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect. It discusses a treatment approach for EAE without explicitly stating that EAE is the most widely used model for MS, which makes it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE) is an animal model for studying multiple sclerosis (MS).", "model_answer": "Answer: EAE (Experimental Autoimmune Encephalomyelitis)", "model_support": "Supporting sentence: To test this hypothesis, acute EAE Lewis rats were treated dose dependently with the calpain inhibitor calpeptin (50-250 microg/kg).  \n\nThis sentence explicitly identifies **EAE (Experimental Autoimmune Encephalomyelitis)** as the animal model used for studying multiple sclerosis (MS) in the context.", "retries": 1}
{"idx": 689, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Acute stroke' is effectively synonymous with the gold answer 'stroke,' making it a match. The supporting sentence is concise, directly relevant, and provides clear reasoning by stating that the ROSIER scale differentiates acute stroke from mimics in the ER, aligning well with the context.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 690, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains p53's role in preserving genomic integrity, which aligns with the reasoning behind its nickname 'the guardian of the genome.' Although the exact phrase is not used, the explanation is clear and accurate.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: When p53 function is impaired, its ability to preserve genomic integrity is compromised.  \n\nThis sentence directly links p53 to the maintenance of genomic integrity, which is the rationale behind its nickname \"the guardian of the genome.\" While the exact phrase \"guardian of the genome\" is not explicitly used in the context, the description of p53's role in preserving genomic integrity aligns with this established biological characterization.", "retries": 1}
{"idx": 691, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Two' does not match the gold standard '7', but it is present in the context as the text mentions TA and ΔN isoforms. The supporting sentence is relevant but does not cover the gold answer, which specifies seven isoforms rather than just two.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Two.", "model_support": "Supporting sentence: p73, a p53 family tumor suppressor, is expressed as TA and ΔN isoforms.", "retries": 1}
{"idx": 692, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less detailed than the gold supporting sentence. It establishes the association of calsequestrin with calcium signaling and its pathological implications, though it lacks specific mention of its location in the sarcoplasmic reticulum and high-capacity calcium-binding property.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.", "retries": 1}
{"idx": 693, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptors' is equivalent to '5-HT2A'). The supporting sentence is concise, directly relevant, and provides clear reasoning by linking [18F]altanserin with its purpose of determining 5-HT2A receptor availability. Minor additional context in the supporting sentence is acceptable as it does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.", "retries": 1}
{"idx": 694, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and covers the answer, but it contains slight redundancy by quoting the title of the context. Although accurate, it could be more concise by directly referencing betrixaban as a factor Xa inhibitor without repeating the list of other drugs in the explanation.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].  \nThis sentence explicitly states that betrixaban is a direct inhibitor of factor Xa, as it is listed alongside other drugs (rivaroxaban, apixaban, edoxaban) under the category of \"direct inhibitors of factor Xa.\"", "retries": 1}
{"idx": 695, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence is relevant and supports the answer by describing the mechanism of tetramer formation, which implies antiparallel alignment. However, it is slightly more verbose than necessary and does not directly state 'antiparallel heterodimer,' which makes it less concise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "Supporting sentence: These assemble a tetramer via a mechanism that relies on the completion of a single repeat by association of the partial repeats located at the C terminus of the beta-chain (two helices) and at the N terminus of the alpha-chain (one helix).  \n\nThis sentence implies that the interaction between the beta-chain (C terminus) and alpha-chain (N terminus) occurs in a way that requires antiparallel alignment to form the tetramer, as the \"completion of a single repeat\" suggests complementary, antiparallel associations between the subunits.", "retries": 1}
{"idx": 696, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe),' is correct and aligns with the gold standard abbreviation SAM. However, it does not use the exact abbreviation SAM as provided in the gold answer, which slightly reduces precision. The supporting sentence is relevant and supports the role of SAMe in methylation processes, but it includes additional details about its effects on TNFalpha expression that are not directly necessary for answering the question. This makes the sentence somewhat redundant while still maintaining logical relevance.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"S-adenosylmethionine (SAMe) and its metabolite methylthioadenosine (MTA) blocked lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNFalpha) expression in RAW (murine macrophage cell line) and Kupffer cells at the transcriptional level without affecting nuclear factor kappa B nuclear binding.\"  \n\n**Analysis**: While the context does not explicitly state that SAMe is the methyl donor for histone methyltransferases, the question's answer (\"S-adenosylmethionine (SAMe)\") aligns with the broader biochemical understanding that SAMe is the primary methyl donor in methylation reactions, including histone methylation. The context emphasizes SAMe's role in modulating histone methylation (e.g., \"inhibits... via modulation of histone methylation\") and its conversion to MTA, which indirectly supports SAMe's involvement as the precursor for methyl groups. The sentence above highlights SAMe's direct pharmacological effect on gene expression, which is tied to its role in methylation pathways.", "retries": 1}
{"idx": 697, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information about TCR being directed at the transcribed strand via the recognition of stalled RNA polymerase, which aligns with the gold answer. However, it contains slight redundancy by mentioning Cockayne syndrome gene products without directly referencing the 'transcribed strand of active genes,' making it less concise than the ideal supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 698, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'JNK isoforms,' is very close to the gold standard 'JNK' but adds slight specificity by mentioning 'isoforms,' which is not incorrect but more detailed than required. The supporting sentence is relevant and covers the interaction between DUSP8 and JNK, though it contains a bit more detail about the investigation with JIP proteins, making it slightly verbose compared to the gold supporting sentence. Overall, the logic is strong, but minor redundancy lowers the score from a perfect 5.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.", "model_answer": "Answer: JNK isoforms.", "model_support": "Supporting sentence: We have investigated the interaction of M3/6 with JNK isoforms, as well as scaffold proteins of the JNK interacting protein (JIP) family, in order to elucidate the contribution of M3/6 to the regulation of distinct JNK signaling modules.  \n\nThis sentence directly states that M3/6 (DUSP8) interacts with JNK isoforms, establishing their relationship as the protein(s) affected by DUSP8 activation.", "retries": 1}
{"idx": 699, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'BCR-ABL1' is technically correct and aligns with the gold standard 'BCR-ABL,' as both refer to the same tyrosine kinase target of Imatinib, with only a minor difference in formatting (BCR-ABL vs. BCR-ABL1). However, the supporting sentence relies on external knowledge rather than directly citing evidence from the provided context, which slightly weakens its precision. The gold supporting sentence explicitly mentions BCR-ABL kinase within the context, making it more concise and contextually grounded. The model’s supporting sentence is relevant but includes an explanatory note about the lack of explicit mention in the context, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "The discovery of targeted tyrosine kinase inhibition of BCR-ABL kinase dramatically changed the treatment of CML.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The context does not explicitly state the target of Imatinib (Gleevec) in Philadelphia-chromosome positive CML. However, based on general biomedical knowledge, Imatinib targets the BCR-ABL1 tyrosine kinase, which is a hallmark of Philadelphia-chromosome positive CML. The provided context focuses on the use of TKIs for CML but does not directly mention BCR-ABL1. \n\n**Note:** The answer \"BCR-ABL1\" is correct based on external knowledge, but the context provided does not include a direct statement supporting this.", "retries": 1}
{"idx": 700, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Flumazenil' matches the gold standard and is correct based on external knowledge. However, the supporting sentence provided by the model incorrectly states that no supporting information exists in the context, whereas the gold supporting sentence explicitly mentions flumazenil infusion as part of the treatment. The model's failure to extract this relevant sentence leads to a lower score despite the correct answer.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "A 54-y-old man ingested 2 g of bulk laboratory diazepam and was treated with activated charcoal, enhanced diuresis and flumazenil infusion.", "model_answer": "Answer: Flumazenil", "model_support": "The context does not explicitly mention Flumazenil or any specific antidote for benzodiazepine overdose. The supporting sentence for the answer \"Flumazenil\" is **not present** in the provided text. The context discusses treatment outcomes, side effects, and recommendations against re-administering benzodiazepines but does not identify an antidote. \n\nIf forced to infer based on external knowledge (not the context), Flumazenil is the correct antidote, but this is not supported by the given text. \n\n**Answer:** No supporting sentence is present in the context.", "retries": 1}
{"idx": 701, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence introduces additional context about abnormal calcium signaling and sudden cardiac death, which, while related, is not as concise or directly focused on defining calsequestrin's role as the gold supporting sentence.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.", "retries": 1}
{"idx": 702, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning the role of EWS/FLI1 in regulating EYA3, which is consistent with the gold supporting sentence. However, the model's supporting sentence includes additional information about miRNA-708 and chemoresistance, which, while correct, adds slight redundancy not present in the more focused gold supporting sentence.\", \"match\": true}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "Answer: EWS/FLI1", "model_support": "Supporting sentence: EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.", "retries": 1}
{"idx": 703, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Syk kinase' is essentially correct and matches the gold standard 'spleen tyrosine kinase' in meaning, as Syk is an accepted abbreviation. However, the supporting sentence, while relevant and concise, does not explicitly mention 'spleen tyrosine kinase,' which would have made it a perfect match to the gold standard. The logic is strong, but the omission of the full name slightly reduces precision.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "OBJECTIVE: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies.", "model_answer": "Answer: Syk kinase", "model_support": "Supporting sentence: \"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.\"  \n\nThis sentence explicitly states that the drug (R788) is a \"Syk kinase inhibitor,\" directly answering the question.", "retries": 1}
{"idx": 704, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is technically correct in stating that the context does not explicitly provide the origin of the NCI-H520 cell-line. However, the supporting sentence fails to cover the gold answer ('squamous cell carcinoma') and instead reiterates the absence of information, which doesn't align with the gold supporting sentence. The gold supporting sentence directly identifies NCI-H520 as a squamous cell carcinoma, making the model's response incomplete and less relevant.\", \"match\": false}", "gold_answer": "squamous cell carcinoma", "gold_support": "Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population.", "model_answer": "The context does not provide information about the origin of the NCI-H520 cell-line.", "model_support": "Supporting sentence: The context does not provide information about the origin of the NCI-H520 cell-line.  \n(Note: The context explicitly discusses Musashi1's role in lung cancer diagnostics and therapeutics but does not mention the NCI-H520 cell-line or its tissue origin. The answer is derived from the absence of relevant information in the provided text.)", "retries": 1}
{"idx": 705, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Calsequestrin' is correct and matches the gold standard conceptually (CASQ refers to calsequestrin). However, the supporting sentence, while relevant, is less specific compared to the gold supporting sentence. It mentions abnormal calcium signaling and links it to calsequestrin but does not explicitly highlight its role as a high-capacity calcium-binding protein in the sarcoplasmic reticulum. The reasoning is valid but slightly less precise.\", \"match\": true}", "gold_answer": "CASQ", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "Answer: Calsequestrin", "model_support": "Supporting sentence: Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.  \n\nThis sentence directly identifies calsequestrin as the calcium-binding protein linked to sarcoplasmic reticulum (SR) dysfunction, establishing its role as the primary calcium-binding protein in the SR.", "retries": 1}
{"idx": 706, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and covers the answer well, but it includes additional details about the conditions being treated, which makes it slightly more verbose than necessary. The core information directly supporting the answer is present, but the extra content reduces conciseness.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc. for the treatment of adult patients with inoperable or chronic/persistent chronic thromboembolic pulmonary hypertension (CTEPH) and for the treatment of adult patients with pulmonary arterial hypertension (PAH).", "retries": 1}
{"idx": 707, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence highlights p53's role in responding to genomic stress, which aligns perfectly with its designation as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "model_answer": "Answer: p53", "model_support": "Supporting sentence: In response to genomic stresses, p53 causes cell cycle arrest to allow time for genomic damage to be repaired before cell division or induces apoptosis to eliminate irreparably damaged cells.  \n\n**Note**: While the context does not explicitly use the phrase \"the guardian of the genome,\" p53 is widely recognized in biomedical literature as the \"guardian of the genome\" due to its critical role in maintaining genomic integrity. The supporting sentence highlights p53's function in responding to genomic stress, which aligns with its established role as the \"guardian of the genome.\"", "retries": 1}
{"idx": 708, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the symptoms listed in the model answer are indeed associated with Dyke-Davidoff-Masson syndrome, they do not capture the specific characteristic feature, which is cerebral hemiatrophy. The supporting sentence mentions clinical symptoms but does not focus on the diagnostic feature of cerebral hemiatrophy from the CT scan, as highlighted in the gold supporting sentence.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic features of Dyke-Davidoff-Masson syndrome include recurrent seizures, spastic hemiplegia, microcephaly, and developmental delay.", "model_support": "Supporting sentence: A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains.", "retries": 1}
{"idx": 709, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Both DNA strands') does not match the gold standard ('the transcribed strand'), but it is present in the context as a related concept. The supporting sentence refers to the repair of both strands, which is relevant but does not cover the gold answer, since transcription-coupled repair (TCR) specifically targets the transcribed strand. The logic is somewhat misleading because it conflates global repair mechanisms with TCR.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: Both DNA strands.", "model_support": "Supporting sentence: \"proficient repair of both DNA strands can occur in a part of a gene that the polymerase never reaches, and even if the translocation of RNAPII is blocked with transcription inhibitors.\"  \n\nThis sentence directly states that **both DNA strands** are repaired, even in regions not accessed by RNA polymerase II, supporting the claim that TCR targets both strands.", "retries": 1}
{"idx": 710, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by linking alpha-synuclein to Lewy body deposition, which aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\nThis sentence directly references **alpha-synuclein** as the key protein involved in the pathogenesis of Lewy bodies (DLB), which aligns with the answer that the main component of Lewy bodies is alpha-synuclein. While the context does not explicitly state \"main component,\" it explicitly ties alpha-synuclein to Lewy body formation through deposition, which is the critical link.", "retries": 1}
{"idx": 711, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "p16Ink4", "gold_support": "In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation.", "model_answer": "Answer: p16Ink4a", "model_support": "Supporting sentence: p16Ink4a deficiency partially reverses the self-renewal defect in Bmi-1-/- neural stem cells.", "retries": 1}
{"idx": 712, "gptscore_json": "{\"score\": 1, \"reason\": \"The answer 'chlorophyll' is incorrect and not supported by the context. Chlorophyll is a pigment, not a membrane protein, and the context explicitly states that LHCII is the most abundant membrane protein. The supporting sentence provided by the model is accurate in stating that the context does not support the answer 'chlorophyll,' but this further underscores the irrelevance and inaccuracy of the answer itself. The gold answer and supporting sentence directly align with the context, making the model's response clearly inadequate.\", \"match\": false}", "gold_answer": "Light-harvesting pigment-protein complex of Photosystem II", "gold_support": "Light-harvesting pigment-protein complex of Photosystem II (LHCII) is the largest photosynthetic antenna complex of plants and the most abundant membrane protein in the biosphere.", "model_answer": "Answer: The most abundant membrane protein on Earth is chlorophyll.", "model_support": "The context does not provide any information about the most abundant membrane protein on Earth. The text focuses on the isomerization of neoxanthin in LHCII complexes and its role in photoprotection, but it never mentions chlorophyll as a membrane protein or addresses the abundance of membrane proteins. \n\n**Supporting sentence:** None. The context does not contain a sentence that supports the answer \"chlorophyll\" for the question about the most abundant membrane protein. \n\n**Note:** The answer is scientifically inaccurate. The most abundant membrane protein on Earth is not chlorophyll (a pigment), but rather **chlorophyll-binding proteins** such as those in the Light Harvesting Complex II (LHCII), which are part of the photosynthetic machinery. However, this detail is not mentioned in the provided context.", "retries": 1}
{"idx": 713, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about the functional role of the TSC1-TSC2-TBC1D7 complex, which strengthens the explanation without being overly verbose.\", \"match\": true}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "Answer: TBC1D7", "model_support": "Supporting sentence: We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.", "retries": 1}
{"idx": 714, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies betrixaban as a direct inhibitor of factor Xa, aligning perfectly with the gold answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"  \n\nThis sentence explicitly identifies betrixaban as a direct inhibitor of factor Xa, aligning with the answer.", "retries": 1}
{"idx": 715, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, making it an excellent match.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 716, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by discussing in vitro reactions that do not directly support the identification of medicarpin as the major phytoalexin. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"the isoflavone-O-methyltransferase (IOMT), which is induced along with other enzymes involved in medicarpin biosynthesis, methylates the A-ring 7-hydroxyl group of daidzein in vitro, a reaction that probably does not occur in vivo.\"  \n\nThis sentence explicitly identifies **medicarpin** as the compound whose biosynthesis involves the IOMT enzyme, establishing it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 717, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' vs. 'Factor Xa'), though it uses a slightly different but acceptable format. The supporting sentence is relevant and covers the answer, but it relies on an indirect inference from the title of the context rather than directly quoting a more explicit sentence about betrixaban inhibiting factor Xa. This makes it slightly less ideal compared to the gold supporting sentence, which explicitly mentions all four drugs as inhibitors of factor Xa.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"[Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].\"  \n\nThis sentence explicitly identifies betrixaban as a direct inhibitor of factor Xa, as it is listed among the drugs in the title alongside other factor Xa inhibitors.", "retries": 1}
{"idx": 718, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and provides context about factor Xa inhibitors, which includes betrixaban. However, it is slightly verbose and indirectly supports the answer by discussing the broader category of anticoagulants rather than directly stating that betrixaban is a factor Xa inhibitor. A more concise and direct supporting sentence would have earned a higher score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.  \n\n**Explanation**: While the context does not explicitly state that betrixaban inhibits Factor Xa, it categorizes betrixaban as a \"novel oral anticoagulant\" within the broader context of \"direct thrombin and factor Xa inhibitors\" as the two new classes of anticoagulants. This implies that betrixaban belongs to one of these classes, and since the answer is \"Factor Xa,\" the sentence about the emergence of factor Xa inhibitors directly supports the classification of betrixaban as targeting this clotting factor.", "retries": 1}
{"idx": 719, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation based on the context, but it does not directly quote the most concise evidence showing upregulation (e.g., 'Upregulated MALAT-1 contributes...'). Instead, it infers upregulation from the effect of silencing, which introduces slight indirectness. This makes it less direct than the gold supporting sentence but still logically sound.\", \"match\": true}", "gold_answer": "upregulated", "gold_support": "Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.", "model_answer": "Answer: Upregulated", "model_support": "Supporting sentence: SiRNA-mediated MALAT-1 silencing impaired in vitro bladder cancer cell migration.  \n**Reasoning**: The study demonstrates that silencing MALAT-1 (downregulating it) impairs cancer cell migration, suggesting that MALAT-1 is functionally active in promoting metastasis. This implies that MALAT-1 is likely **upregulated** in bladder cancer, as its suppression leads to reduced metastatic potential. While the context does not explicitly state \"upregulated,\" the functional consequences of its silencing infer its elevated expression in cancer.", "retries": 1}
{"idx": 720, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about DMAP1's role in DNA methylation, indirectly pointing to DNMT1 as the enzyme involved. However, it does not explicitly mention DNMT1's role in maintenance methylation, making it slightly less direct than the gold supporting sentence.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a co-repressor that supports the maintenance and de novo action of DNMT1.", "model_answer": "Answer: DNA methyltransferase 1 (DNMT1)", "model_support": "Supporting sentence: DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair.  \n\n**Note:** While the sentence does not explicitly name DNMT1 as the enzyme, it establishes DMAP1's role in DNA methylation, and the term \"DNA methyltransferase 1 (DNMT1)\" is inherently tied to the enzyme's function in DNA methylation. The answer is inferred from the context's focus on DNMT1 as the central enzyme in methylation processes.", "retries": 1}
{"idx": 721, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('p53'), but the supporting sentence is incorrect as it states no sentences in the context support the answer. In fact, the gold supporting sentence directly provides the necessary information from the context. The model's supporting sentence does not cover the gold answer.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The oncogenic potential of iPSCs is further underscored by the findings that the critical tumor suppressor p53, known as the guardian of the genome, suppresses induced pluripotency.", "model_answer": "Answer: p53", "model_support": "The context provided does not contain any sentence that mentions \"p53\" or refers to a tumor suppressor as \"the guardian of the genome.\" The question cannot be answered based on the given text. \n\nSupporting sentence: **None of the sentences in the context support the answer.**", "retries": 1}
{"idx": 722, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer states that the question cannot be answered based on the provided context, which is incorrect. The gold answer, beta-TrCP, is explicitly mentioned in the context. However, the supporting sentence provided by the model is relevant but does not directly cover the gold answer, as it discusses Tyk2's general role without identifying beta-TrCP2 as the specific E3 ubiquitin ligase.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.", "model_answer": "The question cannot be answered based on the provided context.", "model_support": "Supporting sentence: \"Tyk2 is required for ligand-induced IFNAR1 serine phosphorylation, ubiquitination and efficient lysosomal proteolysis.\"  \nThis sentence mentions Tyk2's involvement in ubiquitination of IFNAR1 but does not identify the specific E3 ubiquitin ligase responsible, making the question unanswerable with the provided context.", "retries": 1}
{"idx": 723, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking CT-011 to PD-1 blockade and its effect on T-cell responses. However, it is slightly more verbose than necessary and includes additional details not directly required to support the answer, such as the context of myeloma and DC/tumor fusion stimulation. While accurate, the gold supporting sentence is more concise and directly focused on PD-1 blockade.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "Answer: PD-1", "model_support": "Supporting sentence: In summary, we demonstrate that PD-1 expression is increased in T cells of patients with active myeloma, and that CT-011 enhances activated T-cell responses after DC/tumor fusion stimulation.  \n\nThis sentence directly links CT-011 to PD-1 signaling by showing its effect on T-cell responses in the context of PD-1 expression. While the text does not explicitly mention \"MK-3475,\" the question's answer (PD-1) is supported by the focus on PD-1 blockade and CT-011's role in enhancing T-cell activity against PD-1-expressing myeloma cells.", "retries": 1}
{"idx": 724, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard; it incorrectly states that both DNA strands are targeted by transcription-coupled repair (TCR), whereas TCR specifically targets the transcribed strand. The supporting sentence is relevant but fails to cover the gold answer, as it discusses the repair of both strands without clarifying that TCR is specific to the transcribed strand.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Answer: Both DNA strands.", "model_support": "Supporting sentence: Within active genes, however, both DNA strands continue to be proficiently repaired.", "retries": 1}
{"idx": 725, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'RET proto-oncogene' is essentially correct and aligns with the gold standard 'RET,' though it includes an extra word ('proto-oncogene') which is not strictly necessary. The supporting sentence provides relevant information, linking the RET proto-oncogene to MEN2 directly. However, it contains slight redundancy by mentioning details about sporadic MTC cases, which are not needed to support the answer. Overall, the logic is strong, but the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "The susceptibility gene for MEN 2 is the RET proto-oncogene.", "model_answer": "Answer: RET proto-oncogene", "model_support": "Supporting sentence: \"Systematic analysis for germline mutations of the RET proto-oncogene was performed in a series of 67 patients with apparently sporadic MTC to determine whether they were true sporadic cases or unsuspected de novo MEN 2 cases.\"  \n\nThis sentence directly links the **RET proto-oncogene** to **Multiple Endocrine Neoplasia type 2 (MEN2)**, as the study aimed to distinguish sporadic MTC from de novo MEN2 cases by analyzing RET mutations. While Hirschsprung disease is not mentioned in the context, the RET proto-oncogene is well-established in MEN2, and the text explicitly connects RET to MEN2.", "retries": 1}
{"idx": 726, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence correctly identifies that the context does not support the model's answer, but it fails to extract the relevant information from the context that explicitly states 'two of the three genera of the Flaviviridae family,' which would lead to the correct answer.\", \"match\": false}", "gold_answer": "three", "gold_support": "Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e.", "model_answer": "The Flaviviridae family comprises five genera.", "model_support": "The context does not provide any information about the number of genera in the Flaviviridae family. The text mentions \"Yellow Fever Virus (a Flavivirus)\" and references antiviral activity against Flaviviridae, but it does not state or imply the total number of genera within the family. \n\n**Supporting sentence:** None. The answer \"five genera\" is not supported by the provided context.", "retries": 1}
{"idx": 727, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'SERCA2a' is more specific than the gold answer 'SERCA,' but it is still correct and relevant within the context provided. The supporting sentence is accurate and directly supports the answer by emphasizing that SERCA2a is the main isoform in the heart. However, the gold supporting sentence provides a broader focus on SERCA as a whole rather than specifically SERCA2a, making the model's supporting sentence slightly narrower in scope. Overall, the logic is strong, but the model's answer and sentence do not fully align with the generality of the gold standard.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "Answer: SERCA2a", "model_support": "Supporting sentence: \"SERCA is mainly represented by the SERCA2a isoform in the heart.\"", "retries": 1}
{"idx": 728, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('xa' refers to Factor Xa). The supporting sentence is relevant and supports the answer by linking betrixaban to anti-Xa activity. However, it introduces additional information about PRT4445, which is not necessary for directly answering the question, making it slightly verbose.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban inhibits Factor Xa, as the decoy (PRT4445) is designed to counteract anticoagulants with anti-Xa activity, suggesting betrixaban targets Factor Xa.", "retries": 1}
{"idx": 729, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('FSHD'). The supporting sentence is relevant but slightly less informative than the gold supporting sentence. While it correctly identifies that DUX4c is up-regulated in FSHD, it does not provide the additional context about the disease being linked to contractions of the D4Z4 repeat array, which is crucial for a complete understanding. The logic is sound, but the supporting sentence could be more comprehensive.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: DUX4c is up-regulated in FSHD.", "retries": 1}
{"idx": 730, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional context about peer administration, which is not directly necessary to support the answer. While logical and correct, it could be more concise.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Naloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose.", "model_answer": "Answer: Naloxone", "model_support": "Supporting sentence: Experts have suggested that, as part of a comprehensive overdose prevention strategy, naloxone should be provided to heroin users for peer administration after an overdose.", "retries": 1}
{"idx": 731, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Epidermal Growth Factor (EGF),' does not match the gold standard 'EGFRvIII.' However, the supporting sentence is relevant as it correctly identifies EGFRvIII as a variant of EGFR. The issue lies in the interpretation of the question: rindopepimut targets EGFRvIII directly, not EGF itself. Thus, while the supporting sentence provides some logical basis, the answer is incorrect based on the context and question.\",\n  \"match\": false\n}", "gold_answer": "EGFRvIII", "gold_support": "The epidermal growth factor receptor variant III (EGFRvIII) is a naturally occurring mutant of EGFR and is expressed on approximately 20% to 30% of GBMs.", "model_answer": "Answer: Epidermal Growth Factor (EGF)", "model_support": "Supporting sentence: \"EGFRvIII is a variant of the epidermal growth factor receptor (EGFR).\"  \n\n**Analysis**: The context states that EGFRvIII is a variant of the epidermal growth factor receptor (EGFR). While the question asks about rindopepimut being an \"analog of a growth factor,\" the key link here is that EGFR (the receptor) is associated with the growth factor **epidermal growth factor (EGF)**. Although the text does not explicitly state that rindopepimut is an analog of EGF, the mention of EGFRvIII as a variant of EGFR (the EGF receptor) indirectly supports the connection between rindopepimut's therapeutic target (EGFRvIII) and the EGF growth factor. This sentence establishes the foundational relationship between EGFRvIII and EGF, justifying the answer.", "retries": 1}
{"idx": 732, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly verbose and could be more concise. It introduces additional context about a meta-analysis, which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The treatment of acute ischemic stroke was investigated in the MR CLEAN study.", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 733, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, though it is slightly more verbose by including 'The' before 'glucocerebrosidase gene.' The supporting sentence refers to the glucocerebrosidase gene but focuses on a detail about markers rather than directly stating that mutations in this gene cause Gaucher disease. While relevant, it introduces slight redundancy and does not fully capture the core reasoning as concisely as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase.", "model_answer": "Answer: The glucocerebrosidase gene.", "model_support": "Supporting sentence: \"using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.\"  \n\nThis sentence explicitly identifies the **glucocerebrosidase gene** as the gene related to the mutation (D409H) discussed in the context.", "retries": 1}
{"idx": 734, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and directly addresses the mechanism of gevokizumab targeting IL-1β, but it includes slight redundancy by mentioning additional details about the binding affinity and receptor interactions that are not necessary for supporting the specific answer. The logic is strong, but the conciseness could be improved.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is IL-1β.", "model_support": "Supporting sentence: \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"  \nAdditional supporting sentences: \"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor,\" and \"Gevokizumab inhibits both the binding of IL-1β to IL-1RI...\"", "retries": 1}
{"idx": 735, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Phospholamban' matches the gold standard 'PLN'. The supporting sentence is relevant and provides context by mentioning the PLN/SERCA interactome and its role in SR Ca-cycling. However, it contains slight redundancy and does not directly mention SERCA2a as the specific target of PLN regulation, which makes it less concise and precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: Regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.  \n\nThis sentence directly identifies **phospholamban (PLN)** as a central regulatory molecule in the interaction with **SERCA2a** (via the \"PLN/SERCA interactome\"), establishing its role in regulating SR Ca-cycling.", "retries": 1}
{"idx": 736, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by referencing additional context (p27Kip1 and intimal hyperplasia) that is not directly necessary to explain mTOR.\", \"match\": true}", "gold_answer": "mammalian Target of Rapamycin", "gold_support": "One class of agents that are highly effective in the prevention of in-stent restenosis is the mammalian Target of Rapamycin (mTOR) inhibitors.", "model_answer": "Answer: Mammalian Target of Rapamycin", "model_support": "Supporting sentence: Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.", "retries": 1}
{"idx": 737, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('10 nm'). However, the supporting sentence is incorrect as it states that no relevant information is found in the context, while the gold supporting sentence clearly provides the necessary information from the text. Despite this error, the model's answer itself is correct and aligns with the gold answer.\", \"match\": true}", "gold_answer": "10 nm", "gold_support": "Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.", "model_answer": "The average diameter of intermediate filaments is 10 nanometers.", "model_support": "The context provided does not contain any information about the average diameter of intermediate filaments. The supporting sentence for the answer \"The average diameter of intermediate filaments is 10 nanometers\" is not present in the given text. The context focuses on a rare tumor case, its clinical presentation, treatment, and histopathological features, but it does not discuss intermediate filaments or their physical dimensions. \n\n**Answer:** No supporting sentence is found in the context. The question pertains to a general biological fact unrelated to the provided case report.", "retries": 1}
{"idx": 738, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer includes both GPi and VIM, but only GPi matches the gold standard. The supporting sentence mentions the targeting of both nuclei but does not specifically highlight the effectiveness of GPi stimulation alone, which is critical for supporting the gold answer.\", \"match\": false}", "gold_answer": "globus pallidus internus", "gold_support": "After bilateral stimulation of the GPi, the patient showed a clear and stable improvement of the painful dystonic syndrome within hours.", "model_answer": "Neurostimulation of the globus pallidus internus (GPi) and the ventral intermediate thalamic nucleus (VIM) is used for the treatment of dystonia.", "model_support": "Supporting sentence: \"a bilateral stereotactic electrode placement targeting the ventral intermediate thalamic nucleus (VIM) and the globus pallidus internus (GPi) was performed.\"", "retries": 1}
{"idx": 739, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is not as directly relevant or concise as the gold supporting sentence. The chosen sentence discusses the crystal structure of the receptor binding domain and lysine interactions, which, while related to botulinum neurotoxins, does not explicitly state that Clostridium botulinum is responsible for botulism. The gold supporting sentence is more explicit and directly supports the answer with clear reasoning.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans.", "model_answer": "Answer: Clostridium botulinum", "model_support": "Supporting sentence: Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions.  \n\n**Note**: While the context does not explicitly state the full scientific name *Clostridium botulinum*, the term \"botulinum\" in the title and throughout the text directly refers to the bacterium responsible for producing botulinum toxins (e.g., BoNT/C, BoNT/D, and BoNT/CD). This is a well-established biological fact, and the context implicitly identifies \"botulinum\" as the source of the neurotoxins. The answer aligns with general knowledge, but the supporting sentence is the first line of the context, which anchors the discussion to the botulinum toxin.", "retries": 1}
{"idx": 740, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is more specific than the gold answer 'benzothiazepine,' but it is not incorrect and aligns with common biomedical understanding. The supporting sentence from the model focuses on the mechanism of action rather than directly stating the chemical classification, which makes it less ideal compared to the gold supporting sentence that explicitly mentions JTV519 as a benzothiazepine derivative. However, the sentence is relevant and provides context for the drug's function. Thus, while accurate, the supporting sentence has slight redundancy and does not fully cover the gold answer.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: \"K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association.\"  \n\n**Note**: The context provided does not explicitly state that JTV519 is a derivative of 1,4-benzothiazepine. However, based on prior knowledge and the example provided in the user's question, the answer is inferred to be **1,4-benzothiazepine**, as this classification is commonly associated with JTV519 (K201) in biomedical literature. The supporting sentence from the context focuses on its mechanism of action rather than its chemical classification.", "retries": 1}
{"idx": 741, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it lists only 8 specific genes rather than addressing the total number of loci identified by GWAS.\", \"match\": false}", "gold_answer": "more than 30", "gold_support": "Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis.", "model_answer": "Answer: 8", "model_support": "Supporting sentence: The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4.", "retries": 1}
{"idx": 742, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD' is equivalent to 'Facioscapulohumeral muscular dystrophy (FSHD)'). The supporting sentence is relevant and provides additional context about the DUX4 transcript being linked to pathogenesis, but it includes a phrase ('it is unclear how') that introduces slight redundancy. The logic connecting the answer to the supporting sentence is strong, though more concise phrasing would improve the clarity.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: A DUX4 transcript derived from the last repeat unit in a contracted array is associated with pathogenesis but it is unclear how.", "retries": 1}
{"idx": 743, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Immunoaffinity enrichment' is very close to the gold standard 'immunoaffinity purification,' with both terms referring to the same general method of using antibodies for enrichment. The supporting sentence is relevant and aligns well with the gold supporting sentence, though it could be more specific by mentioning 'purification' instead of 'enrichment.' There is slight redundancy in the supporting sentence but overall logical support.\", \"match\": true}", "gold_answer": "immunoaffinity purification", "gold_support": "These antibodies were used to perform immunoaffinity purification of methyl peptides followed by LC-MS/MS analysis to identify and quantify arginine and lysine methylation sites in several model studies.", "model_answer": "Answer: Immunoaffinity enrichment", "model_support": "Supporting sentence: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.", "retries": 1}
{"idx": 744, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to mention beta-Trcp, which is critical to the question.\", \"match\": false}", "gold_answer": "beta-Trcp", "gold_support": "Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.", "model_answer": "Answer: The E3 ubiquitin ligase is not specified in the context.", "model_support": "Supporting sentence: \"Phosphorylation-dependent ubiquitination and ensuing down-regulation and lysosomal degradation of the interferon alpha/beta receptor chain 1 (IFNAR1) of the receptor for Type I interferons play important roles in limiting the cellular responses to these cytokines.\"  \n\nThis sentence describes the ubiquitination and degradation process but does not specify the E3 ubiquitin ligase involved.", "retries": 1}
{"idx": 745, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Kinase' is correct but not as specific as the gold answer 'nonreceptor tyrosine kinase.' The supporting sentence provides relevant information by referencing 'ABL kinase inhibitors,' which logically implies that ABL1 is a kinase. However, it does not explicitly state that ABL1 is a 'nonreceptor tyrosine kinase,' making the support less precise than the gold standard. The reasoning is reasonable but could be more detailed and specific.\", \"match\": false}", "gold_answer": "nonreceptor tyrosine kinase", "gold_support": "The Abelson (ABL) family of nonreceptor tyrosine kinases, ABL1 and ABL2, transduces diverse extracellular signals to protein networks that control proliferation, survival, migration and invasion.", "model_answer": "Answer: Kinase", "model_support": "Supporting sentence: \"small-molecule ABL kinase inhibitors could effectively treat chronic myeloid leukaemia.\"  \nThis sentence implies that ABL1 is a kinase, as it references \"ABL kinase inhibitors,\" directly associating the ABL family (including ABL1) with kinase activity.", "retries": 1}
{"idx": 746, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Sodium-calcium exchanger,' is correct and aligns with the gold standard 'NCX' as NCX stands for sodium-calcium exchanger. However, the gold answer uses the specific abbreviation 'NCX,' which is slightly more precise. The supporting sentence is relevant and directly mentions SEA0400 as an inhibitor of the sodium-calcium exchanger, but it is less detailed compared to the gold supporting sentence, which includes additional specifics about the experimental context and the full name of SEA0400. The model's supporting sentence is accurate but lacks some depth and precision.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The effects of 2-[4-[(2,5-difluorophenyl) methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a newly synthesized Na(+)-Ca(2+) exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943).", "model_answer": "Answer: Sodium-calcium exchanger", "model_support": "Supporting sentence: Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.", "retries": 1}
{"idx": 747, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In addition, CLBs and dystrophic neurites were identified immunohistochemically with antibodies specific for alpha-synuclein and ubiquitin; plaques and tangles were identified by staining with thioflavine S.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: CLBs detected by alpha-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia than the presence of Alzheimer's pathology, which was present in a minority of the cases in this series.", "retries": 1}
{"idx": 748, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'NACP/alpha-synuclein,' is very close to the gold standard 'alpha-synuclein,' with NACP being an alternative name for the same protein. The supporting sentence is relevant and provides logical support for the answer by referencing the study of NACP/alpha-synuclein localization in Lewy bodies. However, it is slightly indirect and could be considered somewhat verbose compared to the gold supporting sentence, which explicitly defines alpha-synuclein and its pathological accumulation.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.", "model_answer": "Answer: NACP/alpha-synuclein", "model_support": "Supporting sentence: Studies of the subcellular localization of NACP/alpha-synuclein within LB-bearing neurons were performed by immunogold electron microscopy.  \n\nThis sentence establishes that the antibodies used in the study (immunogold electron microscopy) were targeting NACP/alpha-synuclein, as the research focused on its subcellular localization in Lewy bodies. Additionally, the mention of \"anti-NAC immunoreactivity\" and \"anti-NAC immunostaining\" later in the context further confirms the antibody's target as NACP/alpha-synuclein.", "retries": 1}
{"idx": 749, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer matches the gold standard (15), but the supporting sentence is incorrect as it claims no sentence in the context supports the answer. The gold supporting sentence directly provides the information from the context, showing that the necessary support was present. Thus, while the answer is correct, the evaluation of the supporting sentence is flawed.\", \"match\": true}", "gold_answer": "15", "gold_support": "The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4.", "model_answer": "The human genome contains 15 tissue kallikrein genes.", "model_support": "The context does not explicitly state the number of tissue kallikrein genes in the human genome. The provided text mentions \"multiple kallikrein genes\" and discusses their reactivation via epigenetic mechanisms but does not include the specific number **15**. Therefore, **no sentence in the context supports the answer**. \n\nIf the answer is derived from external knowledge (e.g., scientific literature stating there are 15 tissue kallikrein genes), the context provided here does not contain the necessary information.", "retries": 1}
{"idx": 750, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning the specific concentration of SEA0400 (0.3 microM), which is not necessary to directly support the answer. The gold supporting sentence is more concise while still providing clear and logical reasoning.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400 is a selective inhibitor of the Na(+)/Ca(2+) exchanger having equal potencies to suppress both the forward and reverse mode operation of the Na(+)/Ca(2+) exchanger.", "model_answer": "Answer: Na(+)/Ca(2+) exchanger", "model_support": "Supporting sentence: Partial blockade of Na(+)/Ca(2+) exchanger was induced by superfusion of the cells with SEA0400 at a concentration of 0.3 microM.", "retries": 1}
{"idx": 751, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer 'Factor Xa' is correct and aligns with the gold answer 'xa.' The supporting sentence provides accurate context about factor Xa inhibitors being a promising target for therapeutic anticoagulation, though it does not explicitly mention betrixaban by name, leading to minor redundancy compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...\"  \n\n(Note: While the context does not explicitly mention \"betrixaban,\" the question assumes knowledge that betrixaban is a direct factor Xa inhibitor. The supporting sentence identifies the general class of drugs (direct factor Xa inhibitors) and their target (factor Xa), which aligns with the answer.)", "retries": 1}
{"idx": 752, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it mentions 'quantitative predictions of protein interactions' which is not directly necessary to support the answer. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The transcriptional silencing of one of the female X-chromosomes is a finely regulated process that requires accumulation in cis of the long non-coding RNA X-inactive-specific transcript (Xist) followed by a series of epigenetic modifications.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: X-inactivation: quantitative predictions of protein interactions in the Xist network.", "retries": 1}
{"idx": 753, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explaining how Bach1 acts as a repressor through binding to enhancers and being inhibited by heme. This aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the enhancers of heme oxygenase-1 (HO-1) gene (Hmox-1) by forming heterodimers with the small Maf proteins such as MafK.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Heme induces expression of Hmox-1 in part by inhibiting the binding of Bach1 to the enhancers and inducing the nuclear export of Bach1.\"  \n\nThis sentence indicates that Bach1 normally binds to enhancers (repressing transcription) and that heme inhibits this binding, thereby inducing Hmox-1 expression. This implies Bach1 acts as a repressor by preventing transcription when bound to enhancers.", "retries": 1}
{"idx": 754, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence, while relevant and discussing the PLN/SERCA interactome, does not directly mention that phospholamban is the regulatory molecule of SERCA2a as clearly as the gold supporting sentence. It contains slight redundancy and could be more concise.\",\n  \"match\": true\n}", "gold_answer": "phospholamban", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: \"regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.\"  \n\nThis sentence directly identifies phospholamban (PLN) as a central regulatory component of SERCA2a function through its interaction with SERCA, as the PLN/SERCA interactome is explicitly cited as the regulatory mechanism governing SR Ca-cycling.", "retries": 1}
{"idx": 755, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade. \n\n**Note**: While the context does not explicitly mention \"betrixaban,\" the question assumes knowledge that betrixaban is a direct factor Xa inhibitor. The supporting sentence establishes that \"direct factor Xa inhibitors\" target **Factor Xa**, which is the correct answer.", "retries": 1}
{"idx": 756, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase', does not match the gold standard 'bcr-abl'. While 'Abl kinase' is mentioned in the context and is relevant, it is incomplete as the gold answer specifies the fusion gene 'bcr-abl', which is more precise. The supporting sentence is relevant but does not cover the gold answer since it focuses on imatinib as an inhibitor without directly mentioning the fusion gene 'bcr-abl'.\", \"match\": false}", "gold_answer": "bcr-abl", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome, which is associated with a balanced translocation involving chromosomes 9 and 22 to produce a fusion gene (bcr-abl) that gives rise to a constitutively activated Abl tyrosine kinase.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: \"This kinase led to the discovery of several small-molecule inhibitors, imatinib being the first and most successful of these.\"  \n\nExplanation: The context explicitly states that \"Abl kinase\" is the target of imatinib, as \"this kinase\" (Abl kinase) is described as the focus of inhibitor development, with imatinib being the first and most successful small-molecule inhibitor.", "retries": 1}
{"idx": 757, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as '5-HT(2A) receptors' is equivalent to '5-HT2A'. The supporting sentence is relevant and provides useful context about the study involving [18F]altanserin and its specificity for 5-HT(2A) receptors. However, it includes additional details that are not directly necessary to support the answer, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.", "model_answer": "Answer: 5-HT(2A) receptors", "model_support": "Supporting sentence: To represent free and nonspecifically bound [18F]altanserin and its radiolabeled metabolites only, cerebellum must show no displacement in 5-HT(2A) displacement studies.", "retries": 1}
{"idx": 758, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is less optimal because it mentions a specific detail about p18Ink4c being a tumor suppressor in medulloblastoma, which does not directly support the claim that medulloblastoma is the most common pediatric cerebellar tumor. The gold supporting sentence provides more relevant and explicit information regarding the prevalence of medulloblastoma. Despite this, the model's supporting sentence still relates to medulloblastoma and offers indirect support.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "Supporting sentence: The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.  \n\n**Note**: While the context does not explicitly state that medulloblastoma is the \"most common\" pediatric cerebellar tumor, the sentence identifies medulloblastoma as the specific tumor type under study, which aligns with the answer. However, the context lacks direct comparative data about prevalence.", "retries": 1}
{"idx": 759, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of 'gevokizumab negatively modulates IL-1β signaling' provides precise support for why IL-1β is the molecule targeted by the drug.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is IL-1β.", "model_support": "Supporting sentence: \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"  \n\nThis sentence directly states that Gevokizumab targets IL-1β by modulating its signaling. Additional support comes from later statements about Gevokizumab decreasing IL-1β's binding affinity for IL-1RI and inhibiting its interaction with the receptor.", "retries": 1}
{"idx": 760, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and could be more concise. The provided context does give accurate support, though it includes extra details that are not strictly necessary to justify the answer.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.", "retries": 1}
{"idx": 761, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies R406 as a spleen tyrosine kinase (Syk) inhibitor, which provides direct support for the answer.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "The spleen tyrosine kinase (Syk) inhibitor R406 is orally administered as the prodrug R788.", "model_answer": "Answer: Spleen tyrosine kinase (Syk)", "model_support": "Supporting sentence: Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey.  \n\nThis sentence explicitly states that R406 is a **spleen tyrosine kinase (Syk) inhibitor**, directly answering the question about the enzyme targeted by the drug (assuming R406 is the compound in question, as fostamatinib is not mentioned in the context).", "retries": 1}
{"idx": 762, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'ZFH1B (ZFXH1B)', is very close to the gold standard 'zfhx1b', with only minor differences in formatting and capitalization. The supporting sentence provided by the model is relevant and supports the answer by linking *zfhx1b* to Mowat-Wilson syndrome and biliary development. However, it contains slight redundancy by mentioning biliary development, which, while accurate, is not directly necessary to establish the gene's role in the syndrome. This makes the sentence slightly more verbose than the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "Answer: ZFH1B (ZFXH1B)", "model_support": "Supporting sentence: Intrahepatic biliary anomalies in a patient with Mowat-Wilson syndrome uncover a role for the zinc finger homeobox gene zfhx1b in vertebrate biliary development.  \n\nThis sentence directly links *zfhx1b* (ZFH1B) to the context of Mowat-Wilson syndrome and its association with biliary development, supporting the conclusion that *ZFH1B* is the gene responsible.", "retries": 1}
{"idx": 763, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' is equivalent to 'benzothiazepine' in this context). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the context mentions S107 rather than JTV519 explicitly, the structure and logic align well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.  \n\n(Note: The context refers to **S107** as the 1,4-benzothiazepine derivative, not JTV519. However, based on the user's provided answer and the structure of the question, the intended supporting sentence likely matches the format of the example, even if there is a discrepancy between the drug name in the question [JTV519] and the context [S107].)", "retries": 1}
{"idx": 764, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('Factor Xa' vs. 'xa'), and the supporting sentence is relevant, referencing factor Xa as a target of certain drugs, which includes betrixaban. However, the supporting sentence is slightly verbose and does not directly mention betrixaban by name, though it logically implies its classification as a factor Xa inhibitor.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. These drugs...  \n\n(Note: The context explicitly mentions \"factor Xa\" as a target for some anticoagulants, though the specific drug \"betrixaban\" is not named in the provided text. The sentence structure suggests that factor Xa inhibitors are part of the class of drugs being discussed, which aligns with the answer.)", "retries": 1}
{"idx": 765, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes slight redundancy by specifying all dosage groups, whereas the gold supporting sentence is more concise and directly mentions the term 'JAK inhibitor.' Overall, the logic is sound and provides necessary support.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: In this 24-week, double-blind, phase IIb study, patients with active RA (n = 507) were randomized to receive placebo or tofacitinib (20 mg/day, 1 mg twice daily, 3 mg twice daily, 5 mg twice daily, 10 mg twice daily, or 15 mg twice daily).  \n\n**Note**: While the context does not explicitly state \"JAK inhibitor,\" the drug name \"tofacitinib\" is directly mentioned, and the question assumes prior knowledge that tofacitinib is a JAK inhibitor. The supporting sentence identifies the drug under study.", "retries": 1}
{"idx": 766, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe),' is correct and matches the gold standard 'SAM' as SAMe is the full name of SAM. The supporting sentence provides relevant information about SAMe's role in producing metabolites like MTA and SAH, which aligns with its function as a methyl donor. However, the supporting sentence is somewhat indirect and does not explicitly state that SAMe is the methyl donor, leading to slight verbosity. The logic connecting SAMe to its role as a methyl donor is strong but could be more concise.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "Answer: S-adenosylmethionine (SAMe)", "model_support": "Supporting sentence: \"Exogenous SAMe is unstable and converts spontaneously to MTA, which is stable and cell-permeant. Treatment with SAMe doubled intracellular MTA and S-adenosylhomocysteine (SAH) levels.\"  \n\nThis sentence implies that S-adenosylmethionine (SAMe) serves as the precursor for MTA and SAH, which are directly involved in modulating histone methylation. While the text does not explicitly state \"methyl donor,\" the context establishes SAMe as the source of methyl groups for these metabolites, aligning with its well-established role as a methyl donor in biological processes.", "retries": 1}
{"idx": 767, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Multiple'), though it is phrased as a complete sentence rather than a single word. The supporting sentence is relevant and aligns with the gold supporting sentence but includes minor redundancy by specifying 'these are the first reports,' which adds slight verbosity without detracting significantly from the logic.\", \"match\": true}", "gold_answer": "Multiple", "gold_support": "Multiple origins of replication in archaea.", "model_answer": "Archaeal genomes can contain multiple origins of replication.", "model_support": "Supporting sentence: These are the first reports of archaea having multiple origins.", "retries": 1}
{"idx": 768, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by not directly emphasizing the specific targeting of EGFRvIII as a growth factor analog. It provides accurate information but lacks the precision found in the gold supporting sentence.\", \"match\": true}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 769, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence clearly identifies betrixaban as one of the inhibitors of factor Xa.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"  \n\nThis sentence explicitly identifies betrixaban as a direct inhibitor of factor Xa, which directly answers the question.", "retries": 1}
{"idx": 770, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'XK gene' is slightly more verbose than the gold standard 'XK', but it is correct and matches the intended meaning. The supporting sentence is relevant and directly links the mutation in the XK gene to McLeod syndrome, providing clear reasoning. However, it includes specific details about the mutation (IVS1-1G>A) and symptoms, which are not necessary to support the answer, making it slightly redundant compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: \"A novel XK splice site mutation (IVS1-1G>A) has been identified in a McLeod patient who has developed hematologic, neuromuscular, and neurologic symptoms.\"  \n\nThis sentence directly links the mutation of the **XK gene** to McLeod syndrome in the context of the patient's diagnosis.", "retries": 1}
{"idx": 771, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions experimental autoimmune encephalomyelitis (EAE) as the murine disease model for multiple sclerosis, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.", "model_answer": "Answer: Experimental autoimmune encephalomyelitis (EAE)", "model_support": "Supporting sentence: In a murine disease model, experimental autoimmune encephalomyelitis (EAE) mice lacking cyclophilin D (CyPD), a key regulator of the mitochondrial permeability transition pore (PTP), developed EAE, but unlike WT mice, they partially recovered.  \n\nThis sentence explicitly identifies **experimental autoimmune encephalomyelitis (EAE)** as the murine disease model used in the study, directly supporting the answer.", "retries": 1}
{"idx": 772, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '5-HT2A receptors' matches the gold standard '5-HT2A' with only a minor difference in phrasing (adding 'receptors'). The supporting sentence provided is relevant and correct but lacks explicit mention of [18F]altanserin, which is central to the question. Although it implies the connection between 5-HT2A receptors and the study, it does not fully cover the gold supporting sentence, which explicitly links [18F]altanserin PET imaging to 5-HT2A receptor binding. Thus, the reasoning is slightly incomplete.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "We investigated 94 healthy individuals (60 men, mean age 47.0±18.7, range 23-86) to determine if trait aggression and trait impulsivity were related to frontal cortex 5-HT2A receptor binding (5-HT2AR) as measured with [18F]-altanserin PET imaging.", "model_answer": "Answer: 5-HT2A receptors", "model_support": "Supporting sentence: Trait aggression and trait impulsivity are not related to frontal cortex 5-HT2A receptor binding in healthy individuals.  \n\n**Note**: The context does not explicitly mention [18F]altanserin. However, the answer \"5-HT2A receptors\" is inferred from the study's focus on 5-HT2A receptor binding, even though the specific ligand [18F]altanserin is not referenced in the provided text. If the question assumes prior knowledge that [18F]altanserin targets 5-HT2A receptors, the supporting sentence would need to include this link, which is absent here.", "retries": 1}
{"idx": 773, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant in pointing out that the model believes no information on subcellular localization exists, yet it fails to capture the explicit statement from the context indicating APOBEC3B is predominantly nuclear. This results in a failure to cover the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The context does not provide information about the subcellular localization of APOBEC3B protein.", "model_support": "Supporting sentence: The context does not provide information about the subcellular localization of APOBEC3B protein.  \n\nExplanation: The context explicitly discusses the functional role of APOBEC3B and APOBEC3F in inhibiting L1 retrotransposition, their deamination-independent mechanism, and experimental observations (e.g., hypermutations, retrotransposed DNA levels). However, **no mention is made of the subcellular localization** (cytoplasmic or nuclear) of APOBEC3B. The absence of such information directly supports the answer.", "retries": 1}
{"idx": 774, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('naloxone') in essence, albeit not explicitly worded as succinctly. The supporting sentence provides relevant context about the study on opioid overdose management but is unnecessarily long and indirect, lacking explicit mention of naloxone within the quoted text. While it logically supports the answer by describing the focus on opioid overdose treatment, it could be more concise and directly tied to the medication (naloxone).\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Answer: Naloxone should be administered when managing patients with suspected acute opioid overdose.", "model_support": "Supporting sentence: A prospective, sequential, observational cohort study of 196 consecutive patients with suspected opioid overdose was conducted in an urban out-of-hospital setting, comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation. (n = 122), for respiratory depression of <10 breaths/min.  \n\n**Note**: While the sentence does not explicitly state \"naloxone\" in the quoted text, the context of the study (comparing routes of naloxone administration and its effects on opioid overdose) implies that naloxone is the medication being managed. The direct mention of naloxone appears later in the text: \"administering naloxone 0.4 mg i.v.\" and \"naloxone 0.8 mg s.q.\" However, the provided context here truncates the full text, and the most relevant supporting sentence in the given text is the one describing the study's focus on opioid overdose management. For precision, the full context should include the explicit mention of naloxone.", "retries": 1}
{"idx": 775, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' is equivalent to 'xa'). The supporting sentence, while not quoting the exact gold supporting sentence, provides a concise and logical explanation based on the context. It correctly infers that betrixaban belongs to the class of Factor Xa inhibitors by reasoning through the classification of related drugs mentioned in the text. This aligns with the gold supporting sentence without introducing irrelevant content or verbosity.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The context does not explicitly state which clotting factor betrixaban inhibits. However, based on the classification of the other drugs mentioned (e.g., rivaroxaban, apixaban, and endoxaban as Factor Xa inhibitors) and the structure of the text, it is implied that betrixaban belongs to the same class of Factor Xa inhibitors, even though this is not directly stated. \n\n**Note:** The provided context does not contain an explicit sentence identifying the clotting factor inhibited by betrixaban. The answer relies on inferred knowledge about the pharmacological class of betrixaban, as the context only lists it among other oral anticoagulants without specifying its mechanism.", "retries": 1}
{"idx": 776, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. Pendred syndrome is indeed associated with thyroid abnormalities, which are linked to hormone-related issues due to the thyroid's role in hormone production. The supporting sentence correctly notes that the context does not explicitly mention hormone abnormalities; however, it fails to connect the thyroid enlargement (goiter) described in the context to potential hormone-related issues, which would have supported the gold answer. The explanation is relevant but incomplete.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).", "model_answer": "Answer: The question is incorrect. Pendred syndrome is not characterized by hormone abnormalities. It is a genetic disorder associated with hearing loss and thyroid abnormalities, but not hormone abnormalities.", "model_support": "Supporting sentence: The context does not mention hormone abnormalities. It states that Pendred syndrome is a genetic disorder associated with hearing loss and thyroid abnormalities, but no hormone-related abnormalities are described.  \n\n**Note**: The context explicitly focuses on genetic mutations (PDS gene), chloride-iodide transport, and thyroid involvement, but it does not reference hormone abnormalities. The answer correctly identifies the question as flawed, as the context provides no evidence of hormone abnormalities in Pendred syndrome.", "retries": 1}
{"idx": 777, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'BCR-ABL1' is very close to the gold standard 'BCR-ABL', with only a minor difference in notation (adding '1'). The supporting sentence provides relevant background information about the translocation causing the Philadelphia chromosome but does not explicitly mention the BCR-ABL fusion gene or its tyrosine kinase activity, which is central to the gold supporting sentence. While accurate, it lacks direct coverage of the specific role of BCR-ABL in pathogenesis compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: Chronic myelogenous leukemia (CML) is a clonal hematopoietic disorder caused by the reciprocal translocation between chromosome 9 and 22.  \n\n**Explanation**: The reciprocal translocation between chromosomes 9 and 22 creates the **Philadelphia chromosome**, which encodes the **BCR-ABL1** tyrosine kinase fusion protein. While the context does not explicitly name *BCR-ABL1*, the mention of the Philadelphia chromosome (resulting from the 9;22 translocation) directly links to the pathogenic mechanism targeted by imatinib. This is the foundational biological context for why imatinib, a tyrosine kinase inhibitor, is effective in Philadelphia-chromosome-positive CML.", "retries": 1}
{"idx": 778, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but less specific than the gold standard. While 'thyroid hormone concentrations' is accurate, the gold answer 'thyroid' is more concise and directly aligns with the expected response. The supporting sentence provides relevant context about thyroid hormone transporters but is somewhat general and does not explicitly mention the altered serum levels or MCT8 mutations that are central to Allan-Herndon-Dudley syndrome. It mixes relevant information with a lack of specificity, making it reasonable but not optimally concise.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation and elevated serum 3,3',5-tri-iodothyronine levels known as the Allan-Herndon-Dudley syndrome, the interest in this area of research has greatly increased.", "model_answer": "Answer: Thyroid hormone concentrations are altered in patients with Allan–Herndon–Dudley syndrome.", "model_support": "Supporting sentence: Thyroid hormone transporters are necessary for the uptake of thyroid hormone into target tissues.  \n\nThis sentence directly links the function of thyroid hormone transporters (such as MCT8, which is implicated in Allan–Herndon–Dudley syndrome) to the regulation of thyroid hormone concentrations. Genetic variations in these transporters would disrupt thyroid hormone uptake, leading to altered hormone levels in target tissues. While the syndrome is not explicitly named in the context, the connection to thyroid hormone concentration changes is implied through the role of transporters in hormone delivery.", "retries": 1}
{"idx": 779, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('1,4-benzothiazepine' is equivalent to 'benzothiazepine' in this context). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor typo in the supporting sentence ('benzothiazipine') is not penalized as it is clearly a typographical issue and does not detract from the logical correctness of the response.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: \"Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519.\"  \n\n(Note: The context contains a typo (\"benzothiazipine\" instead of \"benzothiazepine\"), but the intended term is clearly \"1,4-benzothiazepine,\" as confirmed by the answer and the chemical structure of JTV-519.)", "retries": 1}
{"idx": 780, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable, but none are present here, making it an ideal match.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 781, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides logical reasoning by linking the function of PRT4445 to betrixaban's inhibition of Factor Xa. However, it introduces additional information about a reversal agent (PRT4445), which is not necessary to directly support the answer. This makes the explanation slightly more verbose than needed.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban targets Factor Xa, as the decoy (PRT4445) is designed to reverse anticoagulants with anti-Xa activity, suggesting betrixaban itself inhibits Factor Xa.", "retries": 1}
{"idx": 782, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer, but it includes additional details about the non-transcribed strand, making it slightly more verbose than necessary. The core information about TCR targeting the transcribed strand is present, but the extra content reduces conciseness.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of an active gene.", "model_support": "Supporting sentence: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"", "retries": 1}
{"idx": 783, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('The literature does not cite the number of clinical trials for off-label drugs in neonates') is technically correct but does not directly match the gold standard ('0'). The supporting sentence reflects the absence of explicit data in the text, but it does not directly reference or logically connect to the gold answer. It acknowledges an inference rather than providing a clear and concise explanation tied to the gold supporting sentence, which mentions the clinical trials included in the decisions. Thus, while relevant, the supporting sentence lacks precision and direct alignment with the gold answer.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The literature does not cite the number of clinical trials for off-label drugs in neonates.", "model_support": "Supporting sentence: The literature does not cite the number of clinical trials for off-label drugs in neonates.  \n**Note**: The context provided does not explicitly mention clinical trials for off-label drugs in neonates. The answer reflects that the literature (as described in the context) does not include this specific data. However, the context itself does not directly state this; the conclusion only addresses the lack of new drugs for pain management. The supporting sentence is inferred from the absence of such information in the text.", "retries": 1}
{"idx": 784, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Therefore, while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!\"", "retries": 1}
{"idx": 785, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while not as direct as the gold supporting sentence, still logically implies the relationship between alpha-synuclein and Lewy bodies by referencing alpha-synuclein deposition in DLB. It is concise and relevant.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: \"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\n**Note**: While the context does not explicitly state \"the main component of Lewy bodies is alpha-synuclein,\" the question's answer is a well-established biological fact. The provided sentence references alpha-synuclein deposition in DLB, which implies its association with Lewy bodies. However, the context does not directly state the composition of Lewy bodies.", "retries": 1}
{"idx": 786, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer incorrectly states the incidence of Edwards syndrome as 1:3000-3500, which is actually the incidence of oesophageal atresia. The gold answer (1:5000) is found in the context but was not correctly identified by the model. The supporting sentence refers to the wrong condition (oesophageal atresia), making it relevant but incorrect for supporting the gold answer.\", \"match\": false}", "gold_answer": "1:5000", "gold_support": "The incidence of Edwards syndrome is 1:5000 of live-born.", "model_answer": "Answer: The incidence of Edwards syndrome is 1:3000-3500 of live-born.", "model_support": "Supporting sentence: Its incidence is 1:3000-3500 of live-born.  \n\nNote: The sentence refers to the incidence of **oesophageal atresia** (not Edwards syndrome). The context does not explicitly state the incidence of Edwards syndrome. The answer provided in the question appears to conflate the two conditions.", "retries": 1}
{"idx": 787, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about the ROSIER scale being used for stroke evaluation in the emergency room, but it contains slight redundancy by mentioning 'Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale,' which could be more concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.", "retries": 1}
{"idx": 788, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'BCR-ABL1', is essentially correct and matches the gold standard 'Bcr-Abl' in meaning, though formatted slightly differently. The supporting sentence provides relevant information about the t(9;22) translocation being the genetic lesion associated with CML, which leads to the formation of the BCR-ABL fusion gene. However, it does not explicitly mention the fusion gene or its tyrosine kinase activity, making it less direct and slightly less comprehensive compared to the gold supporting sentence. There is some redundancy in discussing 'targeted therapy' without directly linking it to the deregulated tyrosine kinase encoded by the fusion gene.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "As a consequence of this translocation, a BCR-ABL fusion gene is formed on the 22q- derivative (traditionally known as the Philadelphia chromosome) and the deregulated tyrosine kinase activity of the protein encoded by this gene has been shown to be both necessary and sufficient for initiation and maintenance of the disease.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: Chronic myeloid leukemia (CML) is the first human malignancy for which the promise of targeted therapy has come true. CML is invariably associated with a specific genetic lesion--the t(9;22) chromosomal translocation.  \n\n**Explanation**: The context identifies the t(9;22) chromosomal translocation (Philadelphia chromosome) as the genetic lesion underlying CML. This translocation results in the BCR-ABL1 fusion gene, which encodes a constitutively active tyrosine kinase targeted by imatinib. While the term \"BCR-ABL1\" is not explicitly mentioned, the t(9;22) translocation is the direct genetic basis for this tyrosine kinase, making it the supporting evidence for the answer.", "retries": 1}
{"idx": 789, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by referencing the close evolutionary relationship with zygomycetes, a group within fungi. However, it introduces slight redundancy by elaborating on implications rather than directly citing the evidence as concisely as the gold supporting sentence.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \nThis sentence implies that microsporidia are classified within the fungi kingdom, as zygomycetes are a group of fungi. The context frames microsporidia in comparison to fungal lineages (e.g., zygomycetes), supporting their placement in the kingdom Fungi.", "retries": 1}
{"idx": 790, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It ties BCR-ABL to its role in Philadelphia-chromosome-positive CML and connects it to imatinib's mechanism of action through the context of dasatinib’s efficacy.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Dasatinib is a dual Abl/Src tyrosine kinase inhibitor (TKI) designed as a prototypic short-acting BCR-ABL-targeted TKI that inhibits BCR-ABL with greater potency compared with imatinib, nilotinib, bosutinib, and ponatinib and has been shown to have potential immunomodulatory effects.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: Dasatinib demonstrates efficacy against most BCR-ABL mutations arising during imatinib therapy.  \n\nThis sentence directly identifies **BCR-ABL** as the tyrosine kinase target, which is central to Philadelphia-chromosome-positive CML and the mechanism of action for both imatinib and dasatinib. While the question focuses on imatinib, the context explicitly ties BCR-ABL to the disease and dasatinib's efficacy, implying its relevance as the target of imatinib.", "retries": 1}
{"idx": 791, "gptscore_json": "{\"score\": 2, \"reason\": \"Answer does not match gold standard but is present in context; supporting sentence is relevant but does not cover gold answer. The model incorrectly identifies PTEN as the 'guardian of the genome,' while the gold answer specifies p53. Although PTEN is discussed as a 'new guardian' in the context, this does not align with the widely established term referring to p53.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "Answer: PTEN", "model_support": "Supporting sentence: Thus, we propose that PTEN is a new guardian of the genome.", "retries": 1}
{"idx": 792, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "Rigel Pharmaceuticals Inc is developing fostamatinib, a prodrug of the spleen tyrosine kinase (Syk) inhibitor R-406, for the potential treatment of autoimmune diseases such as rheumatoid arthritis (RA), idiopathic thrombocytopenic purpura (ITP) and B-cell lymphomas.", "model_answer": "Answer: Syk", "model_support": "Supporting sentence: Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.", "retries": 1}
{"idx": 793, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' with only a minor difference in specificity. The supporting sentence is relevant and covers the answer well but contains slight redundancy by specifying 'in the emergency room,' which is implied in the context of the ROSIER scale. Overall, the logic is strong and directly supports the answer.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 794, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence provided by the model is incorrect because it states that the context does not mention betrixaban, while the gold supporting sentence clearly includes betrixaban as an example of an orally active direct factor Xa inhibitor. Despite this, the model's answer itself is correct, and the discrepancy in the supporting sentence is due to oversight rather than irrelevance or verbosity. Therefore, a score of 4 is appropriate.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or the specific clotting factor it inhibits. The supporting sentence for the answer \"Factor Xa\" is not present in the provided text. The context only discusses dabigatran, rivaroxaban, and other anticoagulants but does not reference betrixaban. \n\n**Answer:** The context does not contain a sentence supporting the answer, as betrixaban is not mentioned.", "retries": 1}
{"idx": 795, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by emphasizing the importance of ZFHX1B in diagnosing Mowat-Wilson syndrome, but it contains slight redundancy by mentioning the phenotypic spectrum, which is not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: molecular genetic analysis of ZFHX1B is important for a definite diagnosis of MWS which has a wide phenotypic spectrum of congenital anomalies.", "retries": 1}
{"idx": 796, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by identifying Fanconi anemia as the disease under study and aligning with the question's focus on sensitivity to DNA crosslinking agents and chromosomal abnormalities.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "Fanconi anemia (FA) is characterized at the cellular level by a high frequency of spontaneous chromosomal aberrations; crosslinking agents cause an abnormal increase in the frequency of chromosomal damage, and semiconservative DNA synthesis is severely inhibited.", "model_answer": "Answer: Fanconi anemia", "model_support": "Supporting sentence: Effect of hydroxyurea and normal plasma on DNA synthesis in lymphocytes from Fanconi anemia patients.  \n\nThis sentence explicitly identifies \"Fanconi anemia\" as the disease being studied, which aligns with the question's focus on a condition characterized by sensitivity to DNA crosslinking agents and chromosomal abnormalities. Additionally, the context later connects Fanconi anemia (FA) cells to hypersensitivity to hydroxyurea (HU) and deficiencies in DNA repair mechanisms, reinforcing the association.", "retries": 1}
{"idx": 797, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly ties the ROSIER scale to stroke recognition, but it is slightly redundant as it includes extra details like 'in Chinese patients in Hong Kong,' which are not necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.\"  \n\nThis sentence explicitly states the purpose of the ROSIER scale as \"Recognition of Stroke,\" confirming its use for stroke.", "retries": 1}
{"idx": 798, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer matches the gold standard exactly ('medicarpin'). The supporting sentence is concise and directly relevant, clearly linking medicarpin to its role as the major phytoalexin in alfalfa through its biosynthetic pathway. While minor additional details are present, the logic is strong and focused.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa is medicarpin.", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence directly identifies **medicarpin** as the phytoalexin associated with the biosynthetic pathway involving isoflavone reductase (IFR), confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 799, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for the ZEB2 gene in relation to Mowat-Wilson syndrome, but it is slightly more verbose than necessary and does not directly mention haploinsufficiency or mutations as the gold supporting sentence does. The logic is strong, but the extra detail reduces conciseness.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "Answer: ZEB2 gene", "model_support": "Supporting sentence: Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.  \n\nThis sentence explicitly states that the ZEB2 gene is the focus of the analysis in relation to Mowat-Wilson syndrome, directly linking the gene to the condition.", "retries": 1}
{"idx": 800, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and states that the question is not addressed in the context, which is false. The gold answer (H3K36me3) is explicitly mentioned in the context. The supporting sentence provided by the model is also incorrect, as it claims the context does not mention histone trimethylation, while the gold supporting sentence clearly identifies H3K36me3 and its association with RNA splicing. Both the answer and supporting sentence fail to address the gold standard and are irrelevant.\", \"match\": false}", "gold_answer": "H3K36me3", "gold_support": "Moreover, recent observations indicate that chromatin structure, transcription and splicing are functionally intertwined, and that modified nucleosomes with trimethylation of lysine 36 in histone subunit 3 (H3K36me3) are enriched at internal exons and the downstream flanking intronic regions of highly expressed genes.", "model_answer": "Answer: The question is not addressed in the provided context.", "model_support": "Supporting sentence: The context does not mention any specific histone trimethylation marks or their association with RNA splicing. The phrase \"modification status\" in the sentence \"independent of their modification status\" refers to general epigenetic modifications but does not specify histone trimethylation or link it to RNA splicing. \n\nAnswer: The question is not addressed in the provided context.", "retries": 1}
{"idx": 801, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by indicating that BACH1 serves as a feedback inhibitor, which implies its repressive role. However, it does not explicitly state that BACH1 functions as a transcriptional repressor, leading to slight ambiguity compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: We conclude that BACH1 is a bona fide Nrf2 target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.", "retries": 1}
{"idx": 802, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning leukemic stem cells, which is not directly necessary to explain the target of imatinib.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib induces a durable response in most patients with Philadelphia chromosome-positive chronic myeloid leukemia, but it is currently unclear whether imatinib reduces the leukemic stem cell (LSC) burden, which may be an important step toward enabling safe discontinuation of therapy.", "model_answer": "Answer: BCR-ABL", "model_support": "Supporting sentence: BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.  \n\nThis sentence directly identifies **BCR-ABL** as the key molecular target in the context of imatinib (Gleevec) therapy for Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 803, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it includes details about other drugs (rivaroxaban, apixaban, edoxaban) rather than focusing solely on betrixaban. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"", "retries": 1}
{"idx": 804, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and identifies calsequestrin as the protein being discussed, but it is somewhat vague and lacks the specific details provided in the gold supporting sentence, such as 'low-affinity, high-capacity calcium binding protein' and its location in the terminal cisternae of the sarcoplasmic reticulum. This makes the model's supporting sentence slightly less precise than the gold standard.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen of terminal cisternae (TC) of the sarcoplasmic reticulum (SR).", "model_answer": "The main calcium binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "Supporting sentence: Calsequestrin targeting to sarcoplasmic reticulum of skeletal muscle fibers.  \n\nThis sentence directly identifies **calsequestrin** (CS) as the protein under investigation for its role in sarcoplasmic reticulum (SR) calcium handling, implicitly establishing it as the main calcium-binding protein in the context. The rest of the text elaborates on its targeting mechanisms and functional roles, reinforcing this conclusion.", "retries": 1}
{"idx": 805, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'SECIS element' is correct and matches the gold standard 'SECIS'. The supporting sentence mentions SECIS-binding protein 2 but does not explicitly describe the stem-loop structure or directly reference the SECIS element. While the model's supporting sentence provides relevant context, it lacks explicit coverage of the gold answer and is slightly indirect compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: SECIS-binding protein 2, a key player in selenoprotein synthesis, is an intrinsically disordered protein.  \n\n**Note**: While the context does not explicitly mention \"SECIS element,\" the term \"SECIS-binding protein 2\" implies the presence of a SECIS element (a stem-loop structure in the 3' UTR of selenoprotein genes) as the binding target. However, the provided context lacks a direct reference to \"SECIS element.\" If the answer is expected to align with external knowledge, the supporting sentence would require explicit mention of the term, which is absent here.", "retries": 1}
{"idx": 806, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about factor Xa inhibitors, but it is slightly general and does not explicitly mention betrixaban. The logic is sound, but the supporting sentence could be more specific to directly reference betrixaban as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: These drugs include the factor Xa inhibitors and IIa (thrombin) inhibitors.  \n\n**Note**: The context does not explicitly mention \"betrixaban,\" but the answer \"Factor Xa\" is supported by the classification of betrixaban (a known factor Xa inhibitor) within the broader category of \"factor Xa inhibitors\" described in the text. The sentence above establishes the general classification of such drugs, which aligns with the answer.", "retries": 1}
{"idx": 807, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase', does not fully match the gold standard 'Bcr-Abl', although 'Abl' is a component of the fusion protein and is mentioned in the context. The supporting sentence refers to 'Abl kinase inhibitors' but does not explicitly mention Bcr-Abl or provide sufficient context for the full answer. It focuses on resistance rather than directly explaining the target of imatinib in CML.\", \"match\": false}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) is caused by Bcr-Abl, a constitutively active tyrosine kinase that is the result of a reciprocal translocation between chromosomes 9 and 22 and cytogenetically evident as the Philadelphia chromosome.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: \"resistance to imatinib and the potential of second-generation Abl kinase inhibitors in the setting of clinical resistance are considered.\"  \n\nThis sentence explicitly identifies **Abl kinase** as the target of imatinib (Gleevec) in the context of Philadelphia-chromosome positive chronic myelogenous leukemia, as it references \"Abl kinase inhibitors\" in the framework of imatinib resistance.", "retries": 1}
{"idx": 808, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('thyroid') in essence by specifying 'thyroid hormone concentrations,' which is a correct interpretation of the gold answer. The supporting sentence is relevant but slightly indirect, as it references the 'thyroid profile' without explicitly stating that thyroid hormone concentrations are altered. While logical and aligned with the context, the supporting sentence could be more concise and direct.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile.", "model_answer": "Answer: Thyroid hormone concentrations are altered.", "model_support": "Supporting sentence: \"our case and the review of the pertinent literature suggest that Allan-Herndon-Dudley syndrome should be suspected in males with the typical neurological and thyroid profile.\"  \n\nThis sentence implies that thyroid hormone-related abnormalities (thyroid profile) are part of the syndrome's characteristics, even though the context does not explicitly state \"thyroid hormone concentrations are altered.\" The reference to \"thyroid profile\" aligns with the answer.", "retries": 1}
{"idx": 809, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that pridopidine treatment was studied in patients with Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.", "retries": 1}
{"idx": 810, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('xa'), though it could be slightly more concise. The supporting sentence is relevant and supports the answer by explaining that direct factor Xa inhibitors target factor Xa, but it does not explicitly mention betrixaban, leading to slight redundancy. Despite this, the logic is sound and aligns with the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.\" \n\nThis sentence establishes that \"direct factor Xa inhibitors\" target factor Xa, and although betrixaban is not explicitly mentioned, the question's answer (\"Factor Xa\") aligns with the context's general description of this class of drugs.", "retries": 1}
{"idx": 811, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence discusses stabilization of IFNAR1 by Tyk2 and its independence from beta-Trcp binding and ubiquitination, which is relevant but does not cover the gold answer (beta-Trcp). It fails to directly address or identify the E3 ubiquitin ligase responsible for IFNAR1 degradation.\", \"match\": false}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: The E3 ubiquitin ligase is not explicitly mentioned in the context.", "model_support": "Supporting sentence: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"  \n\nThis sentence implies that the mechanism of IFNAR1 stabilization by Tyk2 does not involve beta-Trcp (a component of the SCF E3 ligase complex) or ubiquitination, but it does not explicitly identify the E3 ubiquitin ligase responsible for IFNAR1 degradation. The context provides no direct mention of a specific E3 ligase.", "retries": 1}
{"idx": 812, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa', as betrixaban is indeed a Factor Xa inhibitor. However, the supporting sentence provided by the model does not directly support the answer because it mentions that the context does not discuss betrixaban or its mechanism of action, which is incorrect. The gold supporting sentence clearly identifies betrixaban as an orally active direct factor Xa inhibitor, but the model fails to extract this information. The model's supporting sentence mixes confusion about the context with some correct but indirect reasoning, making it less concise and logically weaker than ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or its mechanism of action. Therefore, there is no supporting sentence in the provided text to answer the question about which clotting factor is inhibited by betrixaban. The context only discusses dabigatran and rivaroxaban, which are mentioned as new anticoagulants, but it does not specify their target clotting factors. \n\n**Note:** The answer \"Factor Xa\" is correct for rivaroxaban (a Factor Xa inhibitor), but since the context does not explicitly state this and the question refers to \"betrixaban\" (which is not mentioned), the answer cannot be directly supported by the given text.", "retries": 1}
{"idx": 813, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and is correct in the context of the question. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for differentiating acute stroke, but it is slightly more verbose than necessary. The gold supporting sentence is more concise while still providing the essential information.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 814, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context by mentioning tofacitinib as a JAK inhibitor, but it is slightly redundant because it focuses on inflammatory bowel disease rather than rheumatoid arthritis. Despite this, the logical connection to the correct answer is maintained.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib is an oral janus kinase (JAK) inhibitor that inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors.", "model_answer": "Answer: Tofacitinib", "model_support": "Supporting sentence: Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment.  \n(Note: While the context does not explicitly mention rheumatoid arthritis, the question assumes knowledge that tofacitinib is a JAK inhibitor approved for RA. The provided context only discusses its potential in inflammatory bowel disease, not RA. However, based on the user's answer, the sentence referencing \"tocafitinib\" as the JAK inhibitor is the closest relevant part.)", "retries": 1}
{"idx": 815, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Stroke'). The supporting sentence is relevant and provides context for the ROSIER scale, but it is slightly redundant as it repeats the full name of the scale without directly emphasizing its use for stroke. The logic is clear, but a more concise supporting sentence would improve the response.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong.\"", "retries": 1}
{"idx": 816, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Three') does not match the gold standard ('7'), but it is plausible given external knowledge about TAp73 isoforms. However, the provided context does not explicitly state the number of TAp73 isoforms, so the answer cannot be verified from the text alone. The supporting sentence discusses the role of TAp73 isoforms in tumorigenesis and genomic stability but does not provide any information about the number of isoforms, making it irrelevant to the specific question asked.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Three", "model_support": "Supporting sentence: The role of various p73 isoforms in tumorigenesis has been controversial. However, as we have recently shown, the generation of TAp73-deficient (TAp73(-/-)) mice reveals that TAp73 isoforms exert tumor-suppressive functions, indicating an emerging role for Trp-73 in the maintenance of genomic stability.  \n\n**Note**: The context does not explicitly state the number of TAp73 isoforms. The answer \"three\" may rely on external knowledge (e.g., known p73 isoforms: TAp73α, TAp73β, TAp73γ), but the provided text does not directly specify this number.", "retries": 1}
{"idx": 817, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It provides a detailed description of specific abnormalities, which goes beyond the concise gold answer. The supporting sentence is relevant and supports the model's answer, but it does not cover the gold answer, which focuses on the broader concept of impaired thyroid hormone synthesis. The model's supporting sentence is precise but too specific to align with the more general gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Answer: Abnormalities in thyroid function tests, including larger thyroid volume, higher serum thyroglobulin levels, and greater radioiodine discharge after perchlorate.", "model_support": "Supporting sentence: Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.", "retries": 1}
{"idx": 818, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence incorrectly states that there is no relevant information in the context, while the gold supporting sentence shows that the context does indeed contain relevant information about benserazide and its interaction with L-DOPA. Despite this, the logic connecting the answer to the gold standard is still present.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "Co-administration of benserazide (i.t.), a DOPA decarboxylase inhibitor, abolished the antinociceptive effect of L-DOPA.", "model_answer": "Answer: L-DOPA", "model_support": "The context provided does not mention benserazide or its co-administration with any drug. Therefore, there is no supporting sentence in the given context to answer the question about benserazide. \n\n**Note:** In real-world pharmacology, benserazide is typically co-administered with L-DOPA to prevent peripheral decarboxylation of L-DOPA to dopamine, but this information is not present in the provided context.", "retries": 1}
{"idx": 819, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, as it logically connects APP isoforms to alpha-synuclein deposition in Lewy bodies, which supports the idea that alpha-synuclein is the main component of Lewy bodies. Minor extra details are acceptable since the logic is strong and focused.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\nThis sentence implies that **alpha-synuclein** is a key component involved in the pathogenesis of Lewy bodies (as DLB is characterized by Lewy body accumulation), even though the context does not explicitly state \"the main component of Lewy bodies is alpha-synuclein.\" The focus on alpha-synuclein deposition in DLB indirectly supports the answer.", "retries": 1}
{"idx": 820, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('RET gene' is equivalent to 'RET'). The supporting sentence is relevant and directly links the RET gene to the diseases in question. However, it includes a slight redundancy by referencing the specific mutation (Tyr791Phe), which is not necessary for answering the question. The logic is strong, but this additional detail makes the sentence slightly less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "RET", "gold_support": "Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR).", "model_answer": "Answer: RET gene", "model_support": "Supporting sentence: RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.  \n\nThis sentence directly identifies the **RET gene** as the genetic cause of diseases (including MEN2 and HSCR) discussed in the context. Additionally, the mention of \"exon 13 of the RET proto-oncogene\" further confirms the gene's role, but the first sentence explicitly links the mutation to the diseases.", "retries": 1}
{"idx": 821, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Hypotonia,' does not match the gold standard, 'craniosynostosis,' but is present in the context as a feature of Shprintzen-Goldberg syndrome. The supporting sentence is relevant to hypotonia but does not cover the gold answer, craniosynostosis, and instead focuses on other features like developmental delay and hernia. Thus, while relevant, it fails to support the correct answer.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "The Shprintzen-Goldberg syndrome (SGS) is a disorder of unknown cause comprising craniosynostosis, a marfanoid habitus and skeletal, neurological, cardiovascular, and connective-tissue anomalies.", "model_answer": "Answer: Hypotonia", "model_support": "Supporting sentence: \"Other commonly reported manifestations include hypotonia in at least the neonatal period, developmental delay, and inguinal or umbilical hernia.\"", "retries": 1}
{"idx": 822, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'XIST/Xist RNA' is very close to the gold standard 'XIST', though it includes both human and mouse notations. The supporting sentence is relevant and covers the answer well, but it contains slight redundancy by mentioning 'cell biology of a novel chromosomal RNA' when this level of detail is not necessary for direct support.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "X chromosome inactivation begins when a novel chromosomal RNA (cRNA) from the imprinted mouse Xist or human XIST locus coats or \"paints\" one X chromosome in cis and initiates a cascade of chromosome remodeling events.", "model_answer": "Answer: XIST/Xist RNA", "model_support": "Supporting sentence: The cell biology of a novel chromosomal RNA: chromosome painting by XIST/Xist RNA initiates a remodeling cascade.", "retries": 1}
{"idx": 823, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that RANKL is a ligand, which aligns with Denosumab's mechanism of action. Although the sentence focuses on RANKL's role in mammary carcinogenesis, it still supports the answer clearly without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Whether the factor has the same role in humans is of clinical interest because an inhibitor for RANKL, denosumab, is already used for the treatment of bone disease and might benefit breast cancer patients.", "model_answer": "Answer: RANKL", "model_support": "Supporting sentence: \"Receptor activator of nuclear factor κB ligand (RANKL) has been identified as a pivotal paracrine mediator of progesterone function in mouse mammary gland development and mammary carcinogenesis.\"  \n\n**Note**: While the context does not explicitly mention *Denosumab (Prolia)*, the answer \"RANKL\" is supported by the identification of RANKL as the ligand for the Receptor activator of nuclear factor κB (RANK), which is the target of Denosumab. The sentence above defines RANKL as a ligand, aligning with the mechanism of action of Denosumab.", "retries": 1}
{"idx": 824, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is close to the gold standard but slightly more specific by mentioning 'congenital hypothyroidism' rather than just 'thyroid.' The supporting sentence is relevant and supports the answer well, though it includes additional details about the case. The logic is strong, but the extra specificity in the answer and some redundancy in the supporting sentence prevent a perfect score.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Common hormone abnormalities in Williams syndrome include congenital hypothyroidism.", "model_support": "Supporting sentence: \"We describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"", "retries": 1}
{"idx": 825, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Hypotonia,' does not match the gold standard 'craniosynostosis.' However, hypotonia is mentioned in the context as an additional finding in Goldberg-Shprintzen syndrome, making it relevant but incorrect for the specific question asked. The supporting sentence includes hypotonia as one of several features, but it does not directly support the gold answer (craniosynostosis). Therefore, while the content is somewhat related, it fails to address the gold standard specifically.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome.", "model_answer": "Answer: Hypotonia", "model_support": "Supporting sentence: Additional common findings include other craniofacial anomalies, hypotonia, obstructive apnea, foot deformity, and congenital weakness of the abdominal wall.", "retries": 1}
{"idx": 826, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('fungi'). However, the supporting sentence is unnecessarily verbose and includes redundant information about the lack of an explicit statement in the context, which detracts from conciseness. While it eventually acknowledges that microsporidia are classified as fungi, this could have been stated more directly and succinctly. The gold supporting sentence is much more concise and directly relevant.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Microsporidia are ubiquitous fungi with genomes that have undergone a strong reduction to the extreme cases of Encephalitozoon cuniculi and Encephalitozoon intestinalis.", "model_answer": "Answer: Fungi", "model_support": "The context does not explicitly state the kingdom to which microsporidia belong. While microsporidia are widely classified as fungi in current taxonomic schemes, the provided text does not include a direct statement or supporting sentence confirming this classification. The study focuses on genetic variability within *Encephalitozoon intestinalis* but does not address broader taxonomic classifications. \n\n**Answer:** The context does not contain a sentence explicitly stating the kingdom of microsporidia.", "retries": 1}
{"idx": 827, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard, as both indicate that thyroid hormone concentrations are altered. However, the supporting sentence provided by the model is less directly relevant compared to the gold supporting sentence. While the model's supporting sentence establishes the general importance of thyroid hormones, it does not specifically mention MCT8 mutations or how they alter thyroid hormone concentrations in Allan-Herndon-Dudley syndrome. The gold supporting sentence provides more precise and direct reasoning by linking MCT8 mutations to the syndrome and its effects on thyroid hormones. The model's supporting sentence is relevant but lacks specificity and could be improved.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Recently, the monocarboxylate transporter 8 (MCT8) was identified as a thyroid hormone transporter, and MCT8 mutations have been associated with Allan-Herndon-Dudley syndrome, an X linked condition characterized by severe mental retardation, dysarthria, athetoid movements, muscle hypoplasia, and spastic paraplegia.", "model_answer": "Answer: Thyroid hormone concentrations are altered in patients with Allan–Herndon–Dudley syndrome.", "model_support": "Supporting sentence: \"Thyroid hormones are known to be essential for growth, development, and metabolism.\"  \n\n**Note:** While the context does not explicitly state that \"hormone concentrations are altered,\" the mention of MCT8 mutation (a thyroid hormone transporter) and the focus on thyroid hormone function tests in the conclusion imply that thyroid hormone regulation is disrupted. The first sentence establishes the relevance of thyroid hormones, and the syndrome's pathophysiology (MCT8 mutation) directly links to altered thyroid hormone transport and function. The answer is inferred from the context's emphasis on thyroid hormone-related abnormalities.", "retries": 1}
{"idx": 828, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides correct information about medicarpin, but it contains slight redundancy by discussing the methylation process in more detail than necessary to support the answer. While logical, it could be more concise to directly focus on medicarpin as the major phytoalexin.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: \"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\"  \n\nThis sentence directly identifies **medicarpin** as a key compound in the context of isoflavone metabolism and phytoalexin biosynthesis in alfalfa, aligning with the answer. Additionally, the study's focus on enzymes involved in \"medicarpin biosynthesis\" further reinforces its role as the major phytoalexin.", "retries": 1}
{"idx": 829, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by focusing on the exon 5 mutation's effect rather than directly stating the presence of two mutated HEXA alleles. The logic is sound but slightly indirect.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.", "model_answer": "Answer: HEXA", "model_support": "Supporting sentence: The exon 5 mutated allele with the premature translation termination resulted in severe deficiency of Hex A.", "retries": 1}
{"idx": 830, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard, but its supporting sentence incorrectly claims that the context does not mention DX-88 or its association with ecallantide. In fact, the context explicitly states that Ecallantide was previously known as DX-88, which directly supports the gold answer. The supporting sentence provided by the model is inaccurate and fails to recognize the relevant information in the context.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.", "model_answer": "Answer: Ecallantide", "model_support": "The context provided does not mention \"DX-88\" or its association with any drug. Therefore, there is no supporting sentence in the given text to confirm that DX-88 is the investigational name of ecallantide. The answer \"Ecallantide\" cannot be validated by the provided context. \n\nIf the question assumes prior knowledge (e.g., DX-88 is a known investigational name for ecallantide in external sources), the context here does not include this information.", "retries": 1}
{"idx": 831, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke', with only a minor addition of the word 'acute', which does not detract from the correctness. The supporting sentence is relevant and covers the answer logically, but it paraphrases information rather than directly quoting the gold supporting sentence, leading to slight verbosity. Overall, the logic is sound, and the essential meaning matches well.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 832, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "Answer: FSHD (Facioscapulohumeral muscular dystrophy)", "model_support": "Supporting sentence: Here, we show that the misexpression of very low levels of human DUX4 in zebrafish development recapitulates the phenotypes seen in human FSHD patients.", "retries": 1}
{"idx": 833, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'gene regulation,' does not match the gold standard 'development,' but it is a plausible inference based on the context. The supporting sentence discusses sequence conservation and functional regions but does not directly address the regulation of development, which is central to the gold answer. While the model's response is relevant, it does not fully capture or support the gold answer.\", \"match\": false}", "gold_answer": "development", "gold_support": "Organization of conserved elements near key developmental regulators in vertebrate genomes.", "model_answer": "The process that conserved noncoding elements mostly regulate is gene regulation.", "model_support": "Supporting sentence: Sequence conservation has traditionally been used as a means to target functional regions of complex genomes.  \n\nThis sentence implies that conserved noncoding elements are part of \"functional regions,\" which are associated with regulatory processes like gene regulation. While the text does not explicitly state \"gene regulation,\" the context frames conserved elements as critical for identifying functional genomic regions, which aligns with their role in regulating gene expression.", "retries": 1}
{"idx": 834, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('ZEB2'), but the supporting sentence is incorrect. The context explicitly mentions the ZEB2 gene as the cause of Mowat-Wilson syndrome, contradicting the model's claim that no sentence supports the answer. The supporting sentence should have referenced the provided context accurately, which clearly identifies ZEB2 as responsible for the disorder.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "A case of Mowat-Wilson syndrome caused by a truncating mutation within exon 8 of the ZEB2 gene.", "model_answer": "Answer: The ZEB2 gene.", "model_support": "The context provided does not mention the ZEB2 gene or any specific gene associated with Mowat-Wilson syndrome. Therefore, **no sentence in the given context supports the answer**. The text only describes the clinical features and diagnostic criteria of MWS but does not identify the genetic cause. \n\nIf the answer is \"ZEB2,\" this information must come from external knowledge, not the provided context.", "retries": 1}
{"idx": 835, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Factor Xa') is correct based on external knowledge, but it does not match the gold standard format ('xa'). The supporting sentence acknowledges that the context does not provide specific information about betrixaban, which is accurate. However, the supporting sentence does not directly cover the gold answer ('xa') and instead focuses on general information about factor Xa inhibitors, making it somewhat relevant but not fully aligned with the gold standard.\", \"match\": false}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or its target clotting factor. Therefore, there is no supporting sentence in the provided text to answer the question. \n\nHowever, based on external knowledge, betrixaban is a factor Xa inhibitor, but this information is not present in the given context. \n\n**Note:** The answer \"Factor Xa\" is correct in real-world pharmacology, but the context provided does not include any information about betrixaban or its mechanism of action.", "retries": 1}
{"idx": 836, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('repressor'). The supporting sentence provided by the model is relevant and explains that BACH1 acts as a repressor through 'negative control' and 'repression,' which aligns with the gold answer. However, it includes an additional sentence mentioning the negation of repression during differentiation, which, while accurate, adds slight redundancy and is not directly necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE).", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "Supporting sentence: \"Bach1 regulates the oxidation state through the negative control of HO-1 expression prior to terminal keratinocyte differentiation.\"  \nAnother supporting sentence: \"Bach1-mediated repression is negated during keratinocyte differentiation.\"  \n\nThese sentences explicitly state that BACH1 acts as a repressor by \"negative control\" and \"repression\" of HO-1 expression.", "retries": 1}
{"idx": 837, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('E3 ligase activity' is a concise version of 'E3 ubiquitin ligase activity'). The supporting sentence is relevant and correctly references the E3 ligase activity, but it introduces additional information about BRCT phosphoprotein binding, which is not directly necessary for supporting the answer. This makes the sentence slightly redundant but still logically sound.\", \"match\": true}", "gold_answer": "E3 ubiquitin ligase activity", "gold_support": "The BRCA1 protein displays E3 ubiquitin ligase activity, and this enzymatic function is thought to be required for tumor suppression.", "model_answer": "Answer: E3 ligase activity", "model_support": "Supporting sentence: BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.", "retries": 1}
{"idx": 838, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the model's answer but does not cover the gold answer, which states that small-cell lung cancer is the type most strongly associated with Lambert-Eaton syndrome.\", \"match\": false}", "gold_answer": "small-cell lung cancer", "gold_support": "LEMS is generally associated with small cell lung cancer occurring in three percent of cases.", "model_answer": "Answer: Non-small-cell lung cancer", "model_support": "Supporting sentence: \"the case that we report shows the unusual association of LEMS with non small-cell lung cancer.\"", "retries": 1}
{"idx": 839, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, as 'thyroid' encompasses thyroid dysfunction like congenital hypothyroidism. The supporting sentence is relevant but slightly more general than the gold supporting sentence, which specifically mentions thyroid hypoplasia and functional abnormalities being common in WBS patients. The model’s supporting sentence could be more precise by including these specifics, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia is a frequent characteristic of WBS and abnormalities of thyroid function are common in patients with this feature.", "model_answer": "Common hormone abnormalities in Williams syndrome include thyroid dysfunction, such as congenital hypothyroidism.", "model_support": "Supporting sentence: \"In the Williams-Beuren syndrome (WBS), disorders of the thyroid function and morphology have been reported...\"  \n\nThis sentence directly states that thyroid dysfunction (including structural and functional abnormalities) is associated with Williams syndrome, supporting the answer about common hormone abnormalities.", "retries": 1}
{"idx": 840, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct compared to the gold supporting sentence. The model's supporting sentence mentions the identification of variants in XK but does not explicitly state that XK is responsible for MLS, which would have made it more concise and directly aligned with the gold standard.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.  \n\n**Note:** While the context does not explicitly state that *XK* is associated with McLeod syndrome (MLS), the answer \"XK\" is inferred based on prior knowledge that McLeod syndrome is caused by mutations in the *XK* gene. The provided context mentions *XK* in the context of neuroacanthocytosis-related genes and psychiatric disorders, which aligns with its known association with MLS. However, the supporting sentence directly referencing *XK* in the study is as above.", "retries": 1}
{"idx": 841, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'DNMT3A and DNMT3B', does not match the gold standard 'DNMT1'. However, the supporting sentence is relevant as it correctly identifies DNMT3A and DNMT3B as de novo DNA methyltransferases. The model fails to cover the gold answer, which highlights DNMT1 as the maintenance enzyme involved in DNA (cytosine-5-)-methylation. Therefore, while the context is present in the supporting sentence, the answer is incorrect.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases.", "model_answer": "Answer: DNMT3A and DNMT3B", "model_support": "Supporting sentence: The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases.  \n\nThis sentence explicitly identifies DNMT3A and DNMT3B as de novo DNA methyltransferases, which are directly involved in the maintenance of DNA (cytosine-5-)-methylation through their methyltransferase activity.", "retries": 1}
{"idx": 842, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence discusses consequences of p53 loss rather than directly quoting the 'guardian of the genome' phrase, which makes it slightly less concise compared to the gold standard.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "Answer: p53", "model_support": "Supporting sentence: \"Loss of p53 function confers genomic instability, impaired apoptosis and diminished cell cycle restraint. Therefore, p53 mutations select for certain critical features of malignancy.\"  \n\nThis sentence highlights p53's critical role in maintaining genomic stability, which aligns with its widely recognized designation as \"the guardian of the genome\" in scientific literature. While the exact phrase is not explicitly stated in the context, the description of p53's functions directly supports this characterization.", "retries": 1}
{"idx": 843, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context, as the context implies multiple isoforms without specifying the number. The supporting sentence is relevant but too general and does not directly cover the gold answer ('7').\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: \"This protein exists in a wide range of isoforms with different, even antagonistic, functions.\"  \n\nThis sentence indicates that p73 has multiple isoforms but does not specify the exact number of TAp73 isoforms, which aligns with the answer that the context does not provide a numerical count.", "retries": 1}
{"idx": 844, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('Xa' and 'Factor Xa' are effectively equivalent in this context). The supporting sentence is relevant and provides logical support for the answer by discussing a factor Xa decoy in relation to betrixaban. However, it contains slight redundancy by introducing additional information about PRT4445 as a reversal agent, which is not necessary to directly answer the question.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban targets Factor Xa (as PRT4445 is a \"factor Xa decoy\" and is evaluated as a reversal agent for anticoagulants with \"anti-Xa activity,\" which includes Factor Xa inhibitors like betrixaban).", "retries": 1}
{"idx": 845, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).", "retries": 1}
{"idx": 846, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'CRISPR RNA interference,' is very close to the gold standard 'CRISPR-Cas' but not an exact match. The supporting sentence is relevant and describes the CRISPR RNA-guided cleavage mechanism, which aligns with the gold answer. However, it does not explicitly mention the 'CRISPR-Cas system' as in the gold supporting sentence, making it slightly less precise despite being logically connected.\",\n  \"match\": false\n}", "gold_answer": "CRISPR-Cas", "gold_support": "Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders.", "model_answer": "Answer: CRISPR RNA interference", "model_support": "Supporting sentence: RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.  \n\nThis sentence directly describes the process of RNA interference in prokaryotes, where the CRISPR RNA-Cas complex guides RNA cleavage, analogous to RNAi in eukaryotes. The term \"CRISPR RNA interference\" is inferred from the mechanism described, even though the exact phrase is not explicitly used in the context.", "retries": 1}
{"idx": 847, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer well by describing the stroke recognition instrument, but it contains slightly more detail than necessary, leading to minor redundancy. The logic is sound, but a more concise version could have sufficed.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: A seven-item (total score from -2 to +5) stroke recognition instrument was constructed on the basis of clinical history (loss of consciousness, convulsive fits) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect).  \n\n**Note**: The context does not explicitly mention the \"ROSIER scale,\" but the answer \"stroke\" is supported by the development and validation of a stroke recognition instrument described in the text. If \"ROSIER scale\" is a specific tool referenced elsewhere, it is not included in the provided context.", "retries": 1}
{"idx": 848, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('xa'). However, the supporting sentence provided by the model is incorrect because it states that the context does not mention betrixaban or its target, which is factually wrong. The gold supporting sentence correctly identifies that betrixaban belongs to the class of direct factor Xa inhibitors. Despite the model's error in the supporting sentence, the answer itself is correct, and the supporting sentence could have been accurate with the information from the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention betrixaban or the specific clotting factor it inhibits. The supporting sentence for the answer is missing in the provided text. \n\n**Answer:** The context does not include information about betrixaban or its target clotting factor.", "retries": 1}
{"idx": 849, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically. However, it is more verbose than necessary, as it lists details about gene expression that are not required to confirm the total number of kallikrein genes. The gold supporting sentence is more concise and directly states the key fact.\", \"match\": true}", "gold_answer": "15", "gold_support": "The human kallikrein gene family consists of 15 serine proteases.", "model_answer": "Answer: 15", "model_support": "Supporting sentence: \"KLK1, 4, 5, 6, 7, 8, 10, 11, 13 and 14 are expressed in both cerebral cortex and hippocampus. KLK9 is expressed in cortex but not hippocampus, whereas KLK2, 3, 12 and 15 are not expressed in either tissue.\"  \n\nThis sentence explicitly lists all 15 kallikrein genes (KLK1–KLK15), including those expressed and those not expressed in the studied tissues, confirming the total number of tissue kallikrein genes in the human genome.", "retries": 1}
{"idx": 850, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides useful context by mentioning dermatitis herpetiformis and its association with gluten, but it includes additional details about jejunal villous atrophy that are not necessary to directly support the answer. This makes it slightly redundant compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: These results confirm that most children with dermatitis herpetiformis have jejunal villous atrophy, though they rarely have gastrointestinal symptoms.", "retries": 1}
{"idx": 851, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'CaN (calcineurin)' is equivalent to the gold standard 'phosphatase 2B' as CaN is another name for phosphatase 2B. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning that matches the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Answer: CaN (calcineurin)", "model_support": "Supporting sentence: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 852, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about alpha-synuclein and its interaction with synphilin-1, but it does not explicitly state that alpha-synuclein is the main component of Lewy bodies. The supporting sentence has slight redundancy by introducing synphilin-1 without directly focusing on the key point about alpha-synuclein being the main component.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.", "retries": 1}
{"idx": 853, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies that the context does not explicitly mention DUSP8 or its activation. However, the model fails to infer that JNK is affected based on the provided context, which discusses JNK phosphatase down-regulation leading to JNK activation. The supporting sentence is relevant but does not cover the gold answer.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.", "model_answer": "Answer: The question does not provide information about DUSP8 activation or its target protein.", "model_support": "Supporting sentence: The question does not provide information about DUSP8 activation or its target protein.  \n\n**Note**: The context explicitly does not mention *DUSP8* or its activation. The supporting sentence here is the answer itself, as the context contains no information about DUSP8. The answer correctly identifies that the question cannot be addressed with the provided context.", "retries": 1}
{"idx": 854, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by mentioning cardiovascular and skeletal muscle development, which is not directly necessary for answering the question about calcineurin's role in NFAT activation.\", \"match\": true}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: \"Recent studies have demonstrated the vital nature of calcium/calcineurin/NFAT signaling in cardiovascular and skeletal muscle development.\"  \n\nThis sentence explicitly links **calcineurin** to **NFAT activation** via the calcium/calmodulin-dependent signaling pathway, directly answering the question.", "retries": 1}
{"idx": 855, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but includes additional details about other disorders that are not directly necessary to explain the association between XK and McLeod syndrome. This makes it slightly redundant but still accurate.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "Answer: XK", "model_support": "Supporting sentence: \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\"", "retries": 1}
{"idx": 856, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and less concise than the gold supporting sentence. It mentions APP isoforms being instrumental in alpha-synuclein deposition, which implies alpha-synuclein's role but is not as straightforward as the gold sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\nThis sentence directly references **alpha-synuclein** as the key protein involved in the pathogenesis of Lewy bodies in dementia with Lewy bodies (DLB), which are the main components of the pathology.", "retries": 1}
{"idx": 857, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the broader context of biomedical knowledge. The supporting sentence correctly identifies that the context provided does not contain information about the number of TAp73 isoforms, hence it is relevant but does not cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: 12", "model_support": "The context does not mention the number of TAp73 isoforms identified in humans. Therefore, there is no supporting sentence for the answer \"12\" in the provided text. The context only refers to TAp73 and DeltaNp73 as distinct isoforms but does not specify the total number of TAp73 isoforms. \n\n**Supporting sentence:** None. The context does not provide numerical data about TAp73 isoforms.", "retries": 1}
{"idx": 858, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD'). The supporting sentence is relevant and provides a correct explanation of the disease mechanism, aligning with the gold supporting sentence. However, it includes additional details about the D4Z4 contraction and polyadenylation signal that are not strictly necessary to support the answer, making it slightly more verbose than the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "SUMMARY: Recent studies have provided a plausible disease mechanism for FSHD in which FSHD results from inappropriate expression of the germline transcription factor DUX4.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "Supporting sentence: In the majority of cases, FSHD is caused by contraction of the D4Z4 repeat array (FSHD1). This results in local chromatin relaxation and stable expression of the DUX4 retrogene in skeletal muscle, but only when a polymorphic DUX4 polyadenylation signal is present.", "retries": 1}
{"idx": 859, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the classification of microsporidia within the fungal kingdom by referencing their close evolutionary relationship with zygomycetes, a group within fungi. However, the supporting sentence could be seen as slightly indirect compared to the gold supporting sentence, which explicitly mentions the 'preponderance of evidence' and the possibility of microsporidia being either within or closely related to fungi. This makes the model's reasoning slightly less comprehensive than the gold standard.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \n\nThis sentence implies microsporidia are classified within the kingdom Fungi, as zygomycetes are a group of fungi. While the text does not explicitly state \"Fungi,\" the evolutionary relationship with zygomycetes (a fungal group) supports the classification of microsporidia in the fungal kingdom.", "retries": 1}
{"idx": 860, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'acute stroke' is slightly more specific than the gold standard 'stroke,' but it is still correct and aligns with the context. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for differentiating acute stroke, though it could be seen as slightly redundant by emphasizing 'stroke mimics,' which is not necessary for the answer. Overall, the logic is strong, but minor verbosity lowers the score.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 861, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is missing because the model incorrectly claims that the context does not explicitly state the mode of inheritance, when in fact the gold supporting sentence is present in the context. Although the model's reasoning acknowledges external correctness, it fails to identify the direct support available in the text, leading to a slight deduction in score.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "Answer: Autosomal dominant.", "model_support": "The context provided does not explicitly state the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD). While the answer \"Autosomal dominant\" is biologically accurate based on external knowledge, the text does not include a sentence that directly supports this claim. The context focuses on clinical presentation, diagnosis (genetic deletion of D4Z4), and management, but it does not mention inheritance patterns. \n\n**Supporting sentence:** None explicitly stated in the context. \n\nThe answer relies on external medical knowledge rather than the provided text.", "retries": 1}
{"idx": 862, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('stroke'). Although the model notes that the context does not explicitly mention the ROSIER scale, it correctly identifies the purpose of the instrument as being used for stroke recognition. The gold supporting sentence directly confirms this use and aligns with the model’s reasoning. Despite the lack of explicit naming in the context, the model accurately infers the correct usage from the broader information provided.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: The ROSIER scale is used for stroke.", "model_support": "The context does not mention the \"ROSIER scale\" or its specific use. The provided text refers to a \"seven-item stroke recognition instrument\" but does not explicitly name it as the ROSIER scale. Therefore, **no supporting sentence** exists in the given context to confirm the answer. \n\nIf the answer is \"stroke,\" it would align with the study's focus on stroke recognition, but the specific mention of \"ROSIER scale\" is absent. \n\n**Note:** The answer may be based on external knowledge, but the context provided does not include the ROSIER scale.", "retries": 1}
{"idx": 863, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer, but it is slightly more verbose than necessary. The key point about KN-93 being a CaM kinase II inhibitor is present, though additional details about phosphorylation and force are not needed to answer the question.\", \"match\": true}", "gold_answer": "CaM kinase II", "gold_support": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM).", "model_answer": "Answer: CaM kinase II", "model_support": "Supporting sentence: \"the effect of a CaM kinase II inhibitor (KN-93) on CaM kinase II activation, phosphorylation of myosin regulatory light chains (MLC(20)), and force.\"  \n\nThis sentence explicitly states that KN-93 is a CaM kinase II inhibitor, directly answering the question.", "retries": 1}
{"idx": 864, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly supports the answer by discussing abnormal deposition of alpha-synuclein. However, it is slightly more general and does not specifically mention Lewy bodies as the gold supporting sentence does, leading to a minor deduction for lack of specificity.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.  \n\nThis sentence directly states that alpha-synuclein is the abnormal deposit in these disorders, which aligns with the answer that alpha-synuclein is the main component of Lewy bodies (a type of neuronal inclusion in alpha-synucleinopathies).", "retries": 1}
{"idx": 865, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('stroke') conceptually, as 'acute stroke' is a specific and accurate description within the context of the question. The supporting sentence is concise, directly relevant, and logically explains that the ROSIER scale differentiates acute stroke from mimics, aligning well with the gold supporting sentence's intent.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 866, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('papulovesicular rash') describes a characteristic of the condition but does not directly match the gold standard ('Dermatitis herpetiformis'). The supporting sentence is relevant and mentions the rash, but it does not cover the gold answer or fully explain the condition. Therefore, while there is some relevance, the answer does not align with the gold standard.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is a papulovesicular rash.", "model_support": "Supporting sentence: \"It presents as a papulovesicular rash and is often associated with enteropathy.\"", "retries": 1}
{"idx": 867, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('Factor Xa' vs. 'xa'). However, the supporting sentence provided by the model does not directly mention betrixaban's inhibition of Factor Xa, instead discussing general characteristics of newer oral anticoagulants. While this provides some relevant context, it lacks specificity regarding betrixaban's mechanism of action, making the reasoning less direct and somewhat ambiguous compared to the concise and specific gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The recently introduced oral anticoagulants, dabigatran, rivaroxaban and apixaban, were shown, in randomized controlled trials, to be at least as effective and safe as monitored warfarin therapy for the treatment of venous thromboembolism and stroke prevention in atrial fibrillation.  \n\n**Note:** While the context does not explicitly state that betrixaban inhibits Factor Xa, it is implied by the classification of betrixaban as part of the \"new oral anticoagulants\" alongside rivaroxaban and apixaban, which are known to inhibit Factor Xa. However, the exact sentence linking betrixaban to Factor Xa inhibition is not present in the provided context. The answer relies on external knowledge, as the context only mentions the broader class of anticoagulants without specifying betrixaban's mechanism.", "retries": 1}
{"idx": 868, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and directly references Xist, but it includes additional details about histone hypoacetylation that are not necessary to support the answer. The logic is sound, but slight redundancy reduces conciseness.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "Ectopic expression of the X-inactive-specific transcript (Xist) gene from an autosome imposed the same synchronous replication pattern.", "model_answer": "Answer: Xist", "model_support": "Supporting sentence: We used mutations and chemical inhibition affecting different epigenetic marks as well as inducible Xist expression and we demonstrate that histone hypoacetylation has a key role in controlling Xi replication. \n\nThis sentence directly references \"Xist\" as a critical factor in the study of X-chromosome inactivation (Xi), aligning with the answer \"Xist\" as the transcript responsible for this process.", "retries": 1}
{"idx": 869, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "retries": 1}
{"idx": 870, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning 'whole-exome sequencing' which is not directly necessary to support the answer. Overall, it provides logical support.\", \"match\": true}", "gold_answer": "non-synonymous", "gold_support": "We identified 101 single-nucleotide variants (SNVs) including 77 non-synonymous SNVs (67 missense and 10 nonsense mutations) and 11 INDELs causing frameshifts.", "model_answer": "Answer: Non-synonymous.", "model_support": "Supporting sentence: We used whole-exome sequencing to identify novel non-synonymous somatic mutations in squamous cell lung cancer.", "retries": 1}
{"idx": 871, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Bcr-Abl' matches the gold standard 'BCR-ABL' in essence, though there is a minor formatting difference (lowercase vs. uppercase). The supporting sentence is relevant and supports the answer by mentioning the Bcr-Abl signaling pathway, but it focuses on resistance to imatinib rather than directly explaining that BCR-ABL is the target of Imatinib. It contains slight redundancy when compared to the gold supporting sentence, which is more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia cells contain a BCR-ABL oncoprotein with an enhanced tyrosine kinase activity, which is considered to be the principal 'cause' of the leukemia.", "model_answer": "Answer: Bcr-Abl", "model_support": "Supporting sentence: In patients with chronic myeloid leukaemia who develop resistance to imatinib, the Bcr-Abl signaling pathway is often re-established.", "retries": 1}
{"idx": 872, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Kallikrein 5 (hK5),' does not match the gold standard, 'LEKTI.' However, it is present in the context as a related protein involved in the molecular cascades of Netherton syndrome. The supporting sentence is relevant but focuses on hK5 rather than LEKTI-1, failing to cover the gold answer. The information provided is accurate but does not align with the gold standard.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome is caused by loss-of-function mutations in SPINK5 encoding the Kazal-type inhibitor LEKTI-1 leading to dysregulation of proteolytic cascades involving several kallikreins.", "model_answer": "Answer: Kallikrein 5 (hK5)", "model_support": "Supporting sentence: human kallikrein 5 (hK5), a serine protease (trypsin-like) that plays a central role in the initiation of the molecular cascades leading to the Netherton syndrome phenotype.", "retries": 1}
{"idx": 873, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly ('stroke'). The supporting sentence is concise, directly relevant, and logically explains that the instrument described is a stroke recognition tool, which aligns with the ROSIER scale's purpose. Although the model omits explicitly naming the ROSIER scale, the context and support are strong and accurate.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: The ROSIER scale is used for stroke.", "model_support": "Supporting sentence: A seven-item (total score from -2 to +5) stroke recognition instrument was constructed on the basis of clinical history (loss of consciousness, convulsive fits) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect).  \n\n**Note**: The context does not explicitly mention the \"ROSIER scale,\" but the instrument described is designed for stroke recognition. The answer \"stroke\" aligns with the context, though the specific name \"ROSIER scale\" is not referenced. If \"ROSIER\" is a misstatement or alternative name for the instrument, the above sentence supports the conclusion.", "retries": 1}
{"idx": 874, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is unnecessarily verbose and includes reasoning based on external knowledge rather than directly citing the key evidence available in the context. While the logic connecting eosinophil reduction to IL-5 targeting is accurate, the gold supporting sentence provides a much more concise and direct explanation by simply stating that mepolizumab is described as an 'anti-interleukin-5 monoclonal antibody' in the context. The model's supporting sentence could be improved by reducing verbosity and focusing on quoting the relevant part of the context.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Subjects received infusions of either mepolizumab, an anti-interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year.", "model_answer": "Answer: Interleukin-5 (IL-5)", "model_support": "Supporting sentence: The context does not explicitly state that Mepolizumab targets Interleukin-5 (IL-5). However, based on the study's focus on eosinophilic asthma and the mechanism of action of Mepolizumab (a monoclonal antibody), the answer is inferred from external knowledge. The provided context mentions that Mepolizumab \"significantly lowered eosinophil counts in the blood and sputum,\" which aligns with its known mechanism of targeting IL-5, a cytokine critical for eosinophil survival and activation. \n\n**Note**: The exact sentence supporting the answer is not present in the provided context, as the target molecule (IL-5) is not explicitly mentioned. The answer relies on external pharmacological knowledge about Mepolizumab's mechanism.", "retries": 1}
{"idx": 875, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'SERCA' matches the gold standard conceptually, as SERCA is an abbreviation for 'Sarcoplasmic reticulum Ca(2+)-ATPase.' However, the supporting sentence provided by the model does not directly define SERCA as the calcium pump crucial for calcium homeostasis. Instead, it discusses modulation of SERCA activity in the context of therapy, which is relevant but lacks the precision and clarity of the gold supporting sentence. The model's supporting sentence is slightly less direct and contains minor redundancy.\", \"match\": true}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA.", "model_support": "Supporting sentence: Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.  \nThis sentence explicitly identifies SERCA as the primary calcium pump (sarcoplasmic reticulum Ca²⁺-ATPase) targeted for modulation, aligning with the answer.", "retries": 1}
{"idx": 876, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence provides a broader context by mentioning RANK and osteoprotegerin, which, while accurate, are not directly necessary to answer the question.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Initials studies have demonstrated that targeting RANK/ RANKL signaling with the fully human monoclonal antibody denosumab prevented skeletal complications in patients with MM and other cancers with bone metastases.", "model_answer": "Answer: RANKL", "model_support": "Supporting sentence: Recent advances in the pathobiology of MM-related bone disease and other cancer-related bone metastases have led to the identification of novel therapeutic targets, such as receptor activator of nuclear factor-kappaB (RANK); its ligand (RANKL); and a decoy receptor, osteoprotegerin, for the development of potential targeted agents.  \n\nThis sentence explicitly identifies **RANKL** as the ligand of **RANK**, and Denosumab is a targeted agent discussed in the context of cancer-related bone destruction.", "retries": 1}
{"idx": 877, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by specifying that the ROSIER scale was used as a stroke recognition tool, which aligns perfectly with the gold answer.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 878, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'ABL' is very close to the gold standard 'BCR-ABL,' as ABL is a component of the fusion protein BCR-ABL. However, it does not fully match the gold answer, which specifies the complete fusion protein targeted by Imatinib. The supporting sentence is relevant and mentions ABL in the context of inhibiting pathways, but it does not explicitly link ABL to BCR-ABL or directly confirm it as the target of Imatinib. While the reasoning is strong based on external biomedical knowledge, the lack of explicit mention of BCR-ABL reduces the precision.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by constitutively activated BCR-ABL and SRC family tyrosine kinases.", "model_answer": "Answer: ABL", "model_support": "Supporting sentence: \"oridonin inhibiting activations of LYN (one of SRC family kinases) and ABL and their downstream Akt/mTOR, Raf/MEK/ERK and STAT5 pathways\"  \n**Note**: While the context does not explicitly state that Imatinib targets ABL, the answer \"ABL\" is inferred from the broader biomedical knowledge that Imatinib (Gleevec) specifically targets the BCR-ABL tyrosine kinase in Philadelphia-chromosome-positive leukemias. However, the context mentions \"ABL\" in the context of oridonin's mechanism, which indirectly aligns with the known target of Imatinib. If strict adherence to the context is required, the answer may lack a direct supporting sentence, but \"ABL\" is the correct target based on external knowledge.", "retries": 1}
{"idx": 879, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less comprehensive compared to the gold supporting sentence. It mentions H3K36Me3 levels being comparable among alternative polyadenylation sites, which is related but doesn't fully capture the specific comparison between genes using multiple versus single polyadenylation sites as in the gold standard.\", \"match\": true}", "gold_answer": "H3K36Me3", "gold_support": "We also observe that the histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3), exhibits different patterns around the cleavage sites of genes using multiple polyadenylation sites from those of genes using a single polyadenylation site.", "model_answer": "Answer: H3K36Me3", "model_support": "Supporting sentence: Surprisingly, the H3K36Me3 levels are comparable among the alternative polyadenylation sites themselves.", "retries": 1}
{"idx": 880, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The answer matches the gold standard exactly. Although the model's supporting sentence initially seems to question the context, it correctly identifies that JTV519 is referred to as K201 in the text and acknowledges the classification as a 1,4-benzothiazepine derivative. The gold supporting sentence is concise and directly relevant, covering the answer with clear reasoning.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention JTV519 or its classification as a 1,4-benzothiazepine derivative. The question appears to reference information from a different context (e.g., the example provided earlier in the conversation), but within the given text, there is no sentence that explicitly identifies JTV519 or its chemical group. \n\n**Supporting sentence**: None (the context does not mention JTV519 or its classification). \n\nHowever, if the question assumes a prior context (e.g., the example where JTV519 is referred to as K201), the answer would rely on a different text. Within the provided context, no such sentence exists.", "retries": 1}
{"idx": 881, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It provides a more detailed description of specific abnormalities, which goes beyond the concise gold answer. The supporting sentence is relevant but too verbose and includes information about patients without mutations, which is not directly related to the gold answer or supporting sentence. The logic is reasonable but could be more focused on the key thyroid-related abnormalities.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Answer: Thyroid dysfunction, including hypothyroidism, goiter, and increased radioiodine discharge after perchlorate.", "model_support": "Supporting sentence: The remaining 10 patients had no mutations in the SLC26A4 gene: 4 of them were hypothyroid, 2 with goiter and positive perchlorate discharge test, 2 without goiter and with negative perchlorate discharge test. Two patients without mutations were euthyroid with positive perchlorate discharge test. Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.", "retries": 1}
{"idx": 882, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains some redundancy by including an analogy to the lac repressor, which is not necessary for directly supporting the answer. The logic is strong, but the extra details could be omitted for conciseness.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Bach1 (by analogy to lac repressor sensitivity to lactose), generating a simple feedback loop whereby the substrate effects repressor-activator antagonism.\"  \n\nThis sentence explicitly identifies BACH1 as a repressor by comparing it to the lac repressor, a well-known repressive regulatory protein, and describes its role in a repressor-activator antagonism. Additionally, the context notes that Bach1 deficiency leads to constitutive HO-1 expression, further supporting its repressive function.", "retries": 1}
{"idx": 883, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'Acute stroke' is equivalent to the gold standard 'stroke,' as both terms refer to the same condition in this context. The supporting sentence is concise, directly relevant, and logically explains the purpose of the ROSIER scale in differentiating acute stroke, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 884, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning TCR and its focus on the transcribed strand, but it includes additional information about Cockayne syndrome gene products that is not directly necessary to answer the question, making it slightly verbose.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.", "retries": 1}
{"idx": 885, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a relevant phylogenetic context that aligns with the gold supporting sentence, even though it emphasizes zygomycetes specifically. This still logically supports the classification of microsporidia within the fungi kingdom.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \n\nThis sentence implies that microsporidia are classified within the fungal kingdom, as zygomycetes are a group of fungi. The context further reinforces this by discussing genomic and evolutionary similarities between microsporidia and fungal lineages like zygomycetes.", "retries": 1}
{"idx": 886, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 887, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'Xa'. The supporting sentence acknowledges that the context does not explicitly mention betrixaban but correctly identifies that the answer could be inferred from the list of direct factor Xa inhibitors in the context. However, the supporting sentence is slightly redundant by stating 'None' initially and then providing relevant information from the text. A more concise explanation would improve the score.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Answer: Factor Xa", "model_support": "The context does not mention \"betrixaban\" or specify the clotting factor it inhibits. The answer \"Factor Xa\" is not supported by any sentence in the provided text. \n\n**Supporting sentence:** None (the context does not reference betrixaban or its mechanism of action). \n\n**Note:** The context mentions dabigatran and rivaroxaban (Factor Xa inhibitor) but not betrixaban. The answer may be based on external knowledge rather than the given text.", "retries": 1}
{"idx": 888, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about aggregation but remains focused on alpha-synuclein as the main component.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "Answer: Alpha-synuclein", "model_support": "Supporting sentence: Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation, so that antiaggregation strategies would be very useful to prevent alpha-synuclein fibril formation. \n\nExplanation: The sentence explicitly states that the aggregation of \"its\" (alpha-synuclein) precedes Lewy body formation, identifying alpha-synuclein as the primary component of Lewy bodies.", "retries": 1}
{"idx": 889, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'SERCA2a', is very close to the gold standard 'SERCA2', and in the context of calcium pumps in the sarcoplasmic reticulum, SERCA2a is a specific isoform of SERCA2. The supporting sentence provides relevant information about SERCA2a but includes additional details about immunosuppression that are not directly necessary to support the answer. While it supports the role of SERCA2a, it could be more concise.\", \"match\": true}", "gold_answer": "SERCA2", "gold_support": "The calcium pump SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF).", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA2a.", "model_support": "Supporting sentence: Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression.  \n\n**Note**: While the context does not explicitly state \"SERCA2a is the main calcium pump,\" the term \"SERCA2a\" is directly referenced in the context, and \"SERCA\" (Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase) is a well-established nomenclature for the primary calcium pump in the sarcoplasmic reticulum. The sentence above highlights the role of SERCA2a in calcium-related processes, supporting the answer.", "retries": 1}
{"idx": 890, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard ('beta-Trcp'), but the supporting sentence does not logically cover the gold answer. The chosen supporting sentence discusses Tyk2's stabilization of IFNAR1 rather than directly addressing beta-Trcp's role in ubiquitination and degradation. While the context supports beta-Trcp as the correct answer, the provided sentence does not effectively explain this connection.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "Answer: The E3 ubiquitin ligase beta-Trcp mediates the ubiquitination and degradation of IFNAR1.", "model_support": "Supporting sentence: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"  \n\n**Analysis**: The context states that Tyk2 stabilizes IFNAR1 independently of its binding to beta-Trcp or IFNAR1 ubiquitination. This implies that beta-Trcp is the E3 ubiquitin ligase involved in IFNAR1 degradation, as its absence (or lack of binding) does not affect Tyk2's stabilizing effect. Thus, beta-Trcp is the mediator of ubiquitination and degradation.", "retries": 1}
{"idx": 891, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard. The supporting sentence is relevant and supports the answer by highlighting the close evolutionary relationship between microsporidia and zygomycetes, which are part of the fungi kingdom. However, it does not explicitly state that microsporidia belong to the fungi kingdom as clearly as the gold supporting sentence, leading to slight redundancy and less direct coverage of the gold answer.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Answer: Fungi", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.  \n\nThis sentence implies that microsporidia are classified within the fungi kingdom, as zygomycetes are a group of fungi. The context further reinforces this by discussing genomic and evolutionary similarities between microsporidia and fungal lineages like zygomycetes.", "retries": 1}
{"idx": 892, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '1,4-benzothiazepine,' is technically correct and matches the gold standard 'benzothiazepine' with only a minor difference in specificity (including '1,4-' as an additional detail). The supporting sentence provided by the model references an external example not present in the original context but correctly identifies JTV519 as a derivative of 1,4-benzothiazepine. However, this results in slight redundancy because the gold supporting sentence directly from the context is more concise while still being fully accurate and sufficient. Thus, the score is reduced slightly for verbosity.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention JTV519 or its chemical classification. Therefore, there is no supporting sentence in the given context to answer the question. \n\nHowever, if the context were the one from the example (which includes JTV519), the supporting sentence would be:  \n**\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"**  \n\nThis sentence directly states that JTV519 is a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 893, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('cytoplasmic') does not match the gold standard ('nuclear'). The supporting sentence is relevant but focuses on APOBEC3B being excluded from chromatin during mitosis, which does not address its localization after mitosis when it becomes nuclear. Thus, the supporting sentence fails to cover the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "Supporting sentence: \"However, APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.\"  \n\nThis sentence indicates that APOBEC3B is not associated with chromatin (which is part of the nucleus) during mitosis, implying it remains in the cytoplasm, as the nuclear envelope is disassembled and chromatin is no longer confined to the nucleus.", "retries": 1}
{"idx": 894, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The correct answer is 'antiparallel,' but the model incorrectly states 'parallel.' The supporting sentence discusses supercoiling, which the model interprets as evidence of parallel alignment, but this interpretation is incorrect given the context. While the supporting sentence itself contains relevant information about spectrin assembly, it fails to accurately support the gold answer ('antiparallel') and instead leads to an incorrect conclusion.\",\n  \"match\": false\n}", "gold_answer": "antiparallel", "gold_support": "The antiparallel side-to-side association of spectrin alpha and beta monomers is a two-step process which occurs in seconds even at 0 degrees C and at low concentrations.", "model_answer": "Answer: Parallel", "model_support": "Supporting sentence: \"After initial nucleation site binding, the remainder of the subunits quickly associate along their full lengths to reconstitute a normal dimer by supercoiling around each other to form a rope-like, flexible rod.\"  \n\nThis sentence implies that the subunits align in the same direction (parallel) during assembly, as \"supercoiling around each other\" suggests a parallel, helical arrangement rather than an antiparallel one.", "retries": 1}
{"idx": 895, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is slightly more specific than the gold standard by mentioning T3 and T4 explicitly, but it still aligns with the general concept of 'thyroid' hormone alteration as per the gold answer. The supporting sentence is relevant and supports the answer by linking MCT8 mutations to the syndrome; however, it does not directly mention the lack of T3 transport, which is a key element in the gold supporting sentence. This makes the model's supporting sentence somewhat less precise, though still logical and relevant.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Mct8 transports thyroid hormones (T4 and T3), and the Allan-Herndon-Dudley syndrome is likely caused by lack of T3 transport to neurons during critical periods of fetal brain development.", "model_answer": "Answer: Thyroid hormone (T3 and T4) concentrations are altered.", "model_support": "Supporting sentence: Mutations of the monocarboxylate transporter 8 gene (MCT8, SLC16A2) cause the Allan-Herndon-Dudley syndrome, an X-linked syndrome of severe intellectual deficit and neurological impairment.  \n\nThis sentence directly links the syndrome to mutations in a thyroid hormone transporter (MCT8), implying that thyroid hormone (T3 and T4) concentrations or their cellular availability are altered in the condition. While the context does not explicitly state \"concentrations are altered,\" the causal relationship between MCT8 dysfunction and the syndrome inherently involves impaired thyroid hormone transport, leading to functional deficits in the fetal brain. The answer is inferred from the role of MCT8 in thyroid hormone transport, which is central to the syndrome's pathophysiology.", "retries": 1}
{"idx": 896, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. The model's supporting sentence provides context about the study but does not directly emphasize the specific inhibition of CYP17A1 as clearly as the gold supporting sentence.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.", "retries": 1}
{"idx": 897, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly indirect compared to the gold supporting sentence. The model's supporting sentence focuses on the attenuation of repression by IHABP rather than directly stating Bach1's role as a repressor, introducing slight redundancy.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a transcriptional repressor of heme oxygenase-1 (HO-1) and the beta-globin genes.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner.", "retries": 1}
{"idx": 898, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'SERCA2a', is more specific than the gold standard 'SERCA', but it is still correct and contextually appropriate since SERCA2a is the primary isoform in the heart. The supporting sentence is relevant and directly supports the answer by stating that SERCA is mainly represented by the SERCA2a isoform in the heart. However, it contains slight redundancy as it could be more concise while still covering the answer logically.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA2a.", "model_support": "Supporting sentence: SERCA is mainly represented by the SERCA2a isoform in the heart.", "retries": 1}
{"idx": 899, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is not directly relevant to the definition of mTOR, as it discusses the JAK-2 mutation and MPN pathogenesis rather than explicitly mentioning the PI3K/Akt/mTOR pathway or mTOR itself. While the answer is correct, a more appropriate supporting sentence would have been one that directly references mTOR in the context of the PI3K/Akt/mTOR pathway.\", \"match\": true}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Beyond the JAK/signal transducer and activator of transcription network, a wide number of molecular alterations were described in MPN including the fosfatidilinositolo-3-chinasi (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway constitutive activation.", "model_answer": "mTOR stands for mammalian target of rapamycin.", "model_support": "Supporting sentence: The chronic myeloproliferative neoplasms (MPNs), are characterized by a Janus Kinase (JAK)-2 V617F point mutation but this molecular abnormality does not explain by itself the pathogenesis of these disorders, or the phenotypic diversity associated with essential thrombocythemia, polycythemia vera (PV), and myelofibrosis.  \n\n**Note**: While the context does not explicitly expand \"mTOR\" in the provided text, the answer \"mammalian target of rapamycin\" is a well-established scientific definition for mTOR. The question assumes prior knowledge of the acronym, as the context focuses on the PI3K/Akt/mTOR pathway without further clarification. If a direct expansion were required, the context would need to include it explicitly.", "retries": 1}
{"idx": 900, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Collagen' matches the gold standard 'collagen'. However, the supporting sentence is somewhat lengthy and includes details that are not directly relevant to the question of dating and species identification. It discusses issues with the T. rex samples but does not clearly or concisely support why collagen is used in archaeology. The logic is reasonable but could be more focused.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "(Reports, 13 April 2007, p.", "model_answer": "Collagen", "model_support": "Supporting sentence: Although the mastodon samples pass these tests, absence of amino acid composition data, lack of evidence for peptide deamidation, and association of alpha1(I) collagen sequences with amphibians rather than birds suggest that T. rex does not.", "retries": 1}
{"idx": 901, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the supporting sentence is not present in the given text, this is accurate because the context indeed lacks an explicit supporting sentence. The gold supporting sentence confirms the correct reasoning, and the model appropriately acknowledges the source of the answer.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Romano-Ward syndrome is a subtype of prolonged QT syndrome with autosomal dominant inheritance.", "model_answer": "Answer: Autosomal dominant", "model_support": "The context provided does not include any information about the mode of inheritance of Romano-Ward long QT syndrome. The supporting sentence is not present in the given text. \n\n**Answer:** The context does not contain a sentence that explicitly states the mode of inheritance of Romano-Ward syndrome. The answer \"Autosomal dominant\" is based on general medical knowledge but is not supported by the provided text. \n\n**Note:** If the question assumes the answer is derived from the context, there is no valid supporting sentence here. The context focuses on clinical presentation, treatment, and outcomes, not genetic inheritance patterns.", "retries": 1}
{"idx": 902, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('cysteine'). However, the supporting sentence is slightly misleading because it mentions a 'cysteine-sparing' mutation, which could imply that cysteine is not involved. Despite this, the broader context of CADASIL syndrome and NOTCH3 mutations strongly associates cysteine with the disease, making the support logical but less direct than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "cysteine", "gold_support": "Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.", "model_answer": "Answer: Cysteine", "model_support": "Supporting sentence: \"a novel cysteine-sparing mutation in exon 29 of the NOTCH3 gene\"  \n\n**Note**: While the sentence mentions a \"cysteine-sparing\" mutation (implying the mutation does not affect cysteine), the broader context of CADASIL syndrome is tied to **cysteine mutations** in the *NOTCH3* gene. The answer \"Cysteine\" is inferred from general knowledge of CADASIL pathogenesis, as most reported mutations in *NOTCH3* involve cysteine residues. However, the provided context does not explicitly state this.", "retries": 1}
{"idx": 903, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor differences in formatting (e.g., 'adempas' vs. 'Adempas') do not affect the meaning or correctness.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "model_answer": "Answer: Riociguat", "model_support": "Supporting sentence: Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "retries": 1}
{"idx": 904, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies Xist RNA and links it to X-chromosome inactivation, aligning perfectly with the context.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X-chromosome inactivation (XCI) in female mammals depends on the noncoding RNA X inactivation specific transcript (Xist).", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: The Xist RNA A-repeat comprises a novel AUCG tetraloop fold and a platform for multimerization.  \n\nThis sentence explicitly identifies **Xist RNA** as the transcript under discussion, which is directly linked to X-chromosome inactivation through its role in silencing mechanisms described in the context.", "retries": 1}
{"idx": 905, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it includes additional details about immunosuppressive drugs that are not directly necessary for answering the question. This makes the sentence slightly more verbose than needed.\", \"match\": true}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated T cells), a family of transcription factors required for the synthesis of several cytokine genes.", "model_answer": "Answer: Calcineurin", "model_support": "Supporting sentence: Calcineurin is the target of the immunosuppressive drugs cyclosporin A and FK506 complexed with their cytoplasmic receptors cyclophilin and FKBP12, respectively.  \nThis sentence identifies calcineurin as the calcium/calmodulin-dependent protein phosphatase targeted by immunosuppressive drugs, which are known to regulate NFAT activation. Additionally, the context links CHP's inhibition of calcineurin to impaired NFAT activity, reinforcing calcineurin's role in NFAT activation.", "retries": 1}
{"idx": 906, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but specifies 'hypothyroidism' rather than the more general 'thyroid,' which is acceptable given the context. The supporting sentence is somewhat lengthy and includes information about treatment necessity, which is not directly relevant to the question. It could be more concise while still covering the key point about thyroid abnormalities.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "New case of thyroid dysgenesis and clinical signs of hypothyroidism in Williams syndrome.", "model_answer": "Answer: Hypothyroidism is common in Williams syndrome.", "model_support": "Supporting sentence: Moreover, our case shows that clinical manifestations of hypothyroidism may be present and the treatment may be necessary as it is in isolated congenital hypothyroidism.", "retries": 1}
{"idx": 907, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by explaining the construction of LepChorionDB, which aligns well with the context and supports the answer effectively.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "Answer: LepChorionDB", "model_support": "Supporting sentence: A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 908, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking the ectopic expression of DUX4 to FSHD1, which falls under the broader category of FSHD.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "Answer: FSHD (Facioscapulohumeral Dystrophy)", "model_support": "Supporting sentence: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"  \n\nThis sentence directly links the ectopic (variegated) expression of *DUX4* to FSHD1, the most common form of Facioscapulohumeral Dystrophy (FSHD).", "retries": 1}
{"idx": 909, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by focusing on the neurological phenotype rather than directly mentioning the mutation or elevated T3 levels as in the gold supporting sentence.\", \"match\": true}", "gold_answer": "MCT8", "gold_support": "Mutations of the monocarboxylate transporter 8 (MCT8) gene determine a distinct X-linked phenotype of severe psychomotor retardation and consistently elevated T(3) levels.", "model_answer": "Answer: MCT8", "model_support": "Supporting sentence: Lack of MCT8 transport of T(3) in neurons could explain the neurological phenotype.", "retries": 1}
{"idx": 910, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Abl kinase', does not fully match the gold standard 'BCR-ABL'. While Abl kinase is a component of the fusion protein BCR-ABL and relevant to the mechanism of Imatinib, it is not the complete or precise answer. The supporting sentence mentions mutations in Abl kinase but does not directly connect it to the Philadelphia chromosome or the BCR-ABL fusion gene, which are critical for the gold answer. Thus, the supporting sentence is relevant but does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "The fusion gene that results (BCR-ABL) produces a constitutively activated tyrosine kinase that exists in different isoforms depending on BCR break-points.", "model_answer": "Answer: Abl kinase", "model_support": "Supporting sentence: \"17% of patients in the chronic phase will either relapse or develop resistance resulting mainly from one or more point mutations affecting at least 30 amino acids within the Abl kinase protein.\"  \n\nThis sentence directly identifies **Abl kinase** as the target of Imatinib (Gleevec), as the drug's mechanism involves inhibiting this kinase, and resistance arises from mutations in it.", "retries": 1}
{"idx": 911, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by highlighting the role of IFR in medicarpin biosynthesis, which aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa is medicarpin.", "model_support": "Supporting sentence: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"  \n\nThis sentence directly identifies **medicarpin** as the phytoalexin in question, as IFR is described as a key enzyme in its biosynthesis. Additionally, the context mentions \"the accumulation of medicarpin\" and \"phytoalexin biosynthesis,\" further confirming its role as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 912, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "retries": 1}
{"idx": 913, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'acute stroke' is slightly more specific than the gold standard 'stroke,' but it is still correct and aligns with the context. The supporting sentence is relevant and supports the answer well, though it could be seen as slightly redundant because it mentions 'stroke mimics,' which is not necessary for the direct answer. Overall, the logic is sound.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 914, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. There is no excessive content, and the reasoning aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The tumor suppressor p53 is often referred to as \"the guardian of the genome\" because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "retries": 1}
{"idx": 915, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is more verbose than necessary. It introduces additional context about functional significance and second-site suppressors, which, while related, are not directly required to support the answer.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Lysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1.", "model_answer": "Answer: NF1", "model_support": "Supporting sentence: Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes.  \n\n**Note:** While the context does not explicitly state \"NF1\" as the gene name, the term \"neurofibromin\" refers to the protein product of the *NF1* gene. The question asks for the gene mutated in type 1 neurofibromatosis, and the context focuses on mutations in neurofibromin (the *NF1* gene's protein), making this the supporting sentence.", "retries": 1}
{"idx": 916, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for BACH1 being a repressor by describing its role as a counter-regulator to NRF2. However, it contains slight redundancy by introducing additional context about phenylpropanoid glycosides, which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In HaCaT cells, FB and EC (200 μM) induced nuclear translocation of NRF2 protein after 24 h and reduced nuclear protein levels of BACH1, a repressor of the antioxidant response element.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors.  \n\nThis sentence implies that BACH1 functions as a counter-regulator to NRF2 (an established activator of phase II genes), suggesting BACH1 acts as a repressor to maintain homeostasis. The context further supports this by linking BACH1 to the suppression of HMOX1 induction when its balance with NRF2 is disrupted.", "retries": 1}
{"idx": 917, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.", "retries": 1}
{"idx": 918, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard in essence, as both describe Groucho as a transcriptional repressor/corepressor. However, the model's answer adds extra details about the mechanism (histone deacetylation and nucleosome density), which are accurate but not required to match the gold answer exactly. The supporting sentence is relevant and supports the answer well, though it is slightly more focused on the proposed model rather than directly quoting the gold supporting sentence. This makes it slightly less concise but still logically sound.\", \"match\": true}", "gold_answer": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor", "gold_support": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3.", "model_answer": "The Drosophila melanogaster Groucho protein is a transcriptional repressor that mediates gene repression through histone deacetylation and increased nucleosome density.", "model_support": "Supporting sentence: We propose a model in which Gro-mediated histone deacetylation results in increased nucleosome density leading to transcriptional repression.  \n\nThis sentence directly states that the Groucho protein (Gro) mediates gene repression through histone deacetylation and increased nucleosome density, which aligns with the answer.", "retries": 1}
{"idx": 919, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for the interaction between gevokizumab and IL-1β, but it contains more detail than necessary, introducing information about crystal structures that is not directly needed to support the answer.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Answer: Interleukin-1β (IL-1β)", "model_support": "Supporting sentence: We have analyzed the crystal structures of canakinumab and gevokizumab antibody binding fragment (Fab) as well as of their binary complexes with IL-1β.", "retries": 1}
{"idx": 920, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that the diagnosis of SCLC was confirmed through cytologic examination. Minor extra details in the supporting sentence are acceptable as they support the logical connection between the cancer type and the syndrome.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.", "model_answer": "Answer: Small cell lung cancer (SCLC)", "model_support": "Supporting sentence: Cytologic examination of ultrasound-guided fine needle aspiration disclosed SCLC.", "retries": 1}
{"idx": 921, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence does not directly reference the prevalence or the 5.2:1 ratio of women to men with RA, which is critical for fully supporting the answer. Instead, it discusses risk factors for women with RA, which is relevant but less precise and slightly indirect. The reasoning is strong but could be more concise and directly tied to the gold supporting sentence.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "Supporting sentence: Colombian women with RA are more at risk of having an early age at onset and developing polyautoimmunity and abdominal obesity, and they perform more household duties than their male counterparts.  \n\n**Note**: While the context does not explicitly state that RA is *more common* in women (i.e., higher prevalence), the sentence highlights that women are at greater risk for specific disease-related factors (e.g., early onset, polyautoimmunity), which could indirectly support the inference that RA may disproportionately affect women in this population. However, the answer \"more common in women\" is not directly confirmed by the text, as prevalence rates are not explicitly mentioned.", "retries": 1}
{"idx": 922, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but omits the specific 'A' in 'interleukin-17A,' which slightly reduces precision. The supporting sentence is relevant and explains that IL-17 (or interleukin-17) is a key cytokine targeted by secukinumab, though it does not explicitly include the 'A' either. The logic connecting the answer to the context is strong, but there is minor room for improvement in exactness.\", \"match\": false}", "gold_answer": "interleukin-17A", "gold_support": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.", "model_answer": "Answer: IL-17", "model_support": "Supporting sentence: Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis, the prototypical form of spondyloarthritis.  \n\nThis sentence establishes that IL-17 is the target of secukinumab, as the study focuses on its role in the disease and secukinumab is a monoclonal antibody designed to inhibit this cytokine.", "retries": 1}
{"idx": 923, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer mentions SEA0400, which is correct according to the gold standard, but the context provided does not contain any information about SEA0400. Thus, the supporting sentence is entirely missing or incorrect as it references unrelated molecules like PPADS instead of addressing SEA0400. The model's supporting statement does not logically connect to the gold answer and lacks relevance.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: The small molecule SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger.", "model_support": "The context does not mention \"SEA0400\" at all. The supporting sentence for the answer would need to reference \"SEA0400\" as an inhibitor of the Na⁺/Ca²⁺ exchanger, but this molecule is not discussed in the provided text. The context only refers to **PPADS**, **KB-R7943**, **SN-6**, **D600**, and **nifedipine**. \n\n**Corrected Analysis:**  \nThe answer provided (\"SEA0400\") is unrelated to the context, which focuses on **PPADS** as a blocker of the Na⁺/Ca²⁺ exchanger's reverse mode. There is **no supporting sentence** in the context for \"SEA0400.\"  \n\nIf the intended molecule was **PPADS**, the supporting sentence would be:  \n\"PPADS, a P2X receptor antagonist, as a novel inhibitor of the reverse mode of the Na⁺/Ca²⁺ exchanger in guinea pig airway smooth muscle.\"  \n\nHowever, based on the exact question and context provided, **no valid supporting sentence exists** for \"SEA0400.\"", "retries": 1}
{"idx": 924, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model supporting sentence does not explicitly mention that Jnk phosphorylates c-Jun, it implies Jnk's role as part of the MAP kinase group, which is consistent with the context provided. Minor extra details in the supporting sentence are acceptable since they do not detract from the strong logical connection.\", \"match\": true}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "Answer: Jnk", "model_support": "Supporting sentence: Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group that is activated by dual phosphorylation at Tyr and Thr.  \n\n**Note**: While the context does not explicitly state that Jnk phosphorylates c-Jun, it identifies Jnk as a MAP kinase (a \"distant relative of the MAP kinase group\") and mentions that MAP kinases regulate transcription factors like c-Jun. The answer relies on the implication that Jnk, as a MAP kinase, participates in this pathway, even though the direct connection is not explicitly stated.", "retries": 1}
{"idx": 925, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'β-TrCP' is very close to the gold standard 'SCF(β-TrCP)', as β-TrCP is a component of the SCF complex. However, it does not fully match the gold answer because it omits 'SCF'. The supporting sentence is relevant and provides logical reasoning about β-TrCP's role in IκB degradation, but it does not explicitly mention 'E3 ubiquitin ligase' or 'SCF', which would make it more precise. Thus, while the logic is strong, the omission of key details lowers the score slightly.\", \"match\": false}", "gold_answer": "SCF(β-TrCP)", "gold_support": "IKK activation and IκB degradation involve different ubiquitination modes; the latter is mediated by a specific E3 ubiquitin ligase SCF(β-TrCP) .", "model_answer": "Answer: β-TrCP", "model_support": "Supporting sentence: In vivo ablation of β-TrCP results in accumulation of all the IκBs and complete NF-κB inhibition.  \n\nThis sentence implies that β-TrCP is required for the degradation of IκBs, as its absence leads to their accumulation, suggesting β-TrCP's role in ubiquitinating IκBs for proteasomal degradation. While the text does not explicitly state \"E3 ubiquitin ligase,\" the context links β-TrCP directly to IκB degradation through this experimental outcome.", "retries": 1}
{"idx": 926, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Iron deficiency' is correct for restless leg syndrome (RLS) and matches the gold standard ('iron'). However, the supporting sentence does not adequately cover the gold answer. It mentions that the context does not address iron deficiency, which is incorrect since the gold supporting sentence clearly lists iron deficiency as a cause of secondary PLMD, related to RLS. The failure to extract this information results in a lack of logical support for the answer.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS), aging, pregnancy, uraemia, iron deficiency, polyneuropathy are some of the common causes of secondary PLMD.", "model_answer": "Answer: Iron deficiency.", "model_support": "The context provided does not mention iron deficiency or any specific deficiency as a cause of restless leg syndrome (RLS). The text focuses on **periodic limb movement disorder (PLMD)**, not RLS, and does not address etiological factors like iron deficiency. \n\n**Supporting sentence:** None. The context does not contain information about the cause of RLS or iron deficiency. \n\nNote: The answer \"Iron deficiency\" is correct for **restless leg syndrome (RLS)**, but the context discusses **periodic limb movement disorder (PLMD)**, which is a distinct condition. The confusion between PLMD and RLS may have led to a mismatch between the question and the provided context.", "retries": 1}
{"idx": 927, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and less direct compared to the gold supporting sentence. It provides context but does not directly highlight the specific inhibition of CYP17A1 as clearly.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.", "retries": 1}
{"idx": 928, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that SEA0400 is not mentioned, while the gold answer correctly identifies NCX as the target of SEA0400. The supporting sentence is also incorrect because it repeats the claim that SEA0400 is not mentioned, which is factually wrong based on the context provided. Both the answer and supporting sentence fail to address the correct information.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "Answer: The text does not mention SEA0400.", "model_support": "Supporting sentence: The text does not mention SEA0400.  \n(Note: The context explicitly does not reference \"SEA0400\" at all, making the absence of mention the direct support for the answer.)", "retries": 1}
{"idx": 929, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Thyroid hormone synthesis abnormalities') does not match the gold standard ('thyroid'), though it is related to the context of Pendred syndrome. The supporting sentence is relevant but focuses on the relocation of Duox and TPO, which is more specific than the general concept of thyroid abnormalities implied by the gold answer. It provides some logical support but does not cover the gold answer directly.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "CONTEXT: Pendred syndrome is caused by mutations in the gene coding for pendrin, an apical Cl-/I- exchanger.", "model_answer": "Answer: Thyroid hormone synthesis abnormalities.", "model_support": "Supporting sentence: \"Duox and TPO are relocated in the cytosol, leading to abnormal intracellular thyroid hormone synthesis, which results in cell destruction presumably because intracellular OS cannot be buffered by antioxidant defenses.\"", "retries": 1}
{"idx": 930, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning the KFERQ motifs and their role in CMA, but it includes additional details (e.g., 'six KFERQ motifs') that are not necessary to directly answer the question, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.", "model_answer": "Answer: Chaperone-mediated autophagy (CMA)", "model_support": "Supporting sentence: \"In silico analysis also revealed that the RyR2 sequence harbours six KFERQ motifs which are required for the recognition Hsc70 and its degradation via CMA.\"", "retries": 1}
{"idx": 931, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The inverse relationship mentioned in the supporting sentence succinctly conveys the repressive function of BACH1 on HO-1 expression.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Thus, expression of HO-1 and Bach1 is inversely regulated.\"  \n\nThis sentence directly indicates that Bach1 acts as a repressor of HO-1, as increased Bach1 expression correlates with reduced HO-1 expression, and vice versa. The inverse relationship implies Bach1 suppresses HO-1 transcription.", "retries": 1}
{"idx": 932, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('the template strand') does not match the gold standard ('the transcribed strand'), but it is a plausible answer based on general biological knowledge. The supporting sentence acknowledges that the context does not explicitly provide the information needed to answer the question, which is accurate. However, it fails to reference the gold supporting sentence from the context, which directly mentions the 'transcribed strands' as the target of TCR. Thus, while the supporting sentence is relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Answer: The gene strand targeted by transcription-coupled repair (TCR) is the template strand.", "model_support": "The context provided does not contain a sentence explicitly stating which gene strand is targeted by transcription-coupled repair (TCR). The answer \"the template strand\" is a general biological fact (TCR specifically repairs the template strand during transcription), but the context here does not include this information. \n\n**Supporting sentence:** None found in the provided context.", "retries": 1}
{"idx": 933, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly ('Acute stroke' is a precise match to 'stroke'); supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about differentiation from stroke mimics are acceptable as they enhance clarity without excessive content.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 934, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical connection to the answer by referencing the meta-analysis on endovascular therapies for acute ischemic stroke. However, it is slightly indirect and does not explicitly mention the MR CLEAN study, which results in minor redundancy when compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The treatment of acute ischemic stroke was investigated in the MR CLEAN study.", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.  \n\nThe context explicitly states that the meta-analysis investigated \"endovascular therapies for acute ischemic stroke,\" which aligns with the answer that the MR CLEAN study (a real-world trial focused on this disease) would address. While the MR CLEAN study is not mentioned by name in the context, the question's answer is supported by the broader focus of the study described in the text.", "retries": 1}
{"idx": 935, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for dermatitis herpetiformis being associated with gluten ingestion, but it includes details about the oat challenge that are not directly necessary to support the answer, leading to slight redundancy.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: Eleven patients with dermatitis herpetiformis in remission on a gluten-free diet were challenged daily with 50 g oats for six months.  \n\nThis sentence explicitly identifies \"dermatitis herpetiformis\" as the condition under study, which is the typical rash associated with gluten sensitivity (coeliac disease). The context frames the entire study around this rash, confirming its association with gluten through the clinical and immunological findings described.", "retries": 1}
{"idx": 936, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 937, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and matches the context well. The supporting sentence is relevant and covers the answer, but it includes slightly more detail than necessary, introducing minor redundancy by specifying 'acute stroke' and 'stroke mimics,' which adds verbosity without changing the core meaning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 938, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about the conjugation of medicarpin, which makes it slightly more verbose than necessary. The gold supporting sentence is more concise while still providing clear and direct support for the answer.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "Answer: Medicarpin", "model_support": "Supporting sentence: During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.", "retries": 1}
{"idx": 939, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is somewhat redundant as it includes additional context that is not strictly necessary to directly support the answer. The first part of the supporting sentence introduces the study's broader context rather than focusing solely on the relationship between Orteronel and CYP17A1, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Answer: CYP17A1", "model_support": "Supporting sentence: \"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.\"  \n\nAdditionally, the summary explicitly states: \"orteronel can suppress serum estradiol concentrations... through selective inhibition of CYP17A1 activity.\"  \n\nHowever, the direct identification of the enzyme is first introduced in the opening sentence.", "retries": 1}
{"idx": 940, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('papulovesicular rash') does not match the gold standard ('Dermatitis herpetiformis'), but it is present in the context as a description of the rash associated with gluten sensitivity. The supporting sentence is relevant and accurate but does not cover the gold answer, which requires mentioning 'Dermatitis herpetiformis' specifically.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is a papulovesicular rash.", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 941, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the Maf recognition element (MARE) by forming antagonizing hetero-oligomers with the small Maf family proteins.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1.", "retries": 1}
{"idx": 942, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the significance of Ser129 phosphorylation in the context of Lewy bodies, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Parkinson", "gold_support": "Approximately 90% of α-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129).", "model_answer": "Answer: Ser129", "model_support": "Supporting sentence: This suggests that the accumulation of Ser129-phosphorylated α-syn leads to the formation of Lewy bodies and dopaminergic neurodegeneration in Parkinson's disease.", "retries": 1}
{"idx": 943, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('SECIS'), though it includes 'element,' which is slightly more verbose but still correct. The supporting sentence provided by the model mentions 'SECIS elements' and ties them to selenoprotein mRNAs, which is relevant but less precise than the gold supporting sentence. The gold sentence directly defines the SECIS as a '3'-UTR mRNA stem-loop' and explains its role in recoding UGA, making it more concise and informative. The model's supporting sentence is relevant but contains some unnecessary details (e.g., 'derivatized with photoreactive groups') that do not directly contribute to explaining the SECIS.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "The machinery comprises the tRNA(Sec), a 3'-UTR mRNA stem-loop termed SElenoCysteine Insertion Sequence (SECIS), which is mandatory for recoding UGA as a Sec codon, the SECIS Binding Protein 2 (SBP2), and other proteins.", "model_answer": "Answer: SECIS element", "model_support": "Supporting sentence: \"engineered minimal selenoprotein mRNAs containing SECIS elements derivatized with photoreactive groups.\"  \n\nThis sentence explicitly identifies the \"SECIS elements\" as the stem-loop structure present in the 3' end of selenoprotein genes, which is the focus of the study.", "retries": 1}
{"idx": 944, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer '1,4-benzothiazepine' is very close to the gold standard 'benzothiazepine,' but it includes additional specificity (the '1,4-' prefix) not present in the gold answer. The supporting sentence discusses diltiazem as a '1,5-benzothiazepine derivative,' which is relevant but does not directly support the classification of JTV519. While the logic connecting JTV519 to benzothiazepine derivatives is reasonable, the supporting sentence could be more concise and directly tied to JTV519.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.  \n\n**Note:** While the context explicitly identifies diltiazem as a \"1,5-benzothiazepine derivative,\" it does not directly state that JTV519 is a \"1,4-benzothiazepine derivative.\" The answer provided (\"1,4-benzothiazepine\") may be based on external knowledge or a contextual assumption, as the supporting sentence for JTV519's chemical classification is not explicitly present in the given text.", "retries": 1}
{"idx": 945, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about other loci (DMD, CYBB, ETX1, RPGR, OTC, DXS709) that are not necessary for directly supporting the answer. This makes it slightly more verbose than the gold supporting sentence, which is concise and directly states the cause of McLeod syndrome.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "It is caused by XK gene defects and may include large deletions in the Xp21 region.", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Analysis of three unrelated McLeod patients for the presence of the XK, DMD, CYBB, ETX1, RPGR and OTC loci, as well as for the DXS709 marker, revealed deletions from the XK to RPGR loci (patient Bi) and from the XK to CYBB loci (patient Lh).", "retries": 1}
{"idx": 946, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard (H3K4). The supporting sentence is relevant as it mentions the MLL histone methylase complex, which is indirectly associated with H3K4 methylation. However, the sentence is slightly vague and does not explicitly mention H3K4 or provide clear logical reasoning for the specific residue methylated by MLL1, unlike the more detailed gold supporting sentence.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "While androgen suppresses EZH2 in CRPC cells, in LNCaP cells, physiological concentrations of androgen stimulate expression of PRC2 genes (EZH2, SUZ12, and EED), which is mediated by androgen-induced ANCCA and involves E2F and histone H3K4me3 methylase MLL1 complex.", "model_answer": "Answer: H3K4", "model_support": "Supporting sentence: Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.  \n\n**Note**: The context explicitly mentions \"MLL histone methylase complex\" but does not explicitly state the specific histone residue (H3K4) methylated by MLL1. The answer \"H3K4\" is biologically accurate (as MLL complexes are known to methylate H3K4), but the context provided does not include a direct statement confirming this. The title/reference to \"MLL histone methylase complex\" is the closest relevant sentence, though it lacks specificity.", "retries": 1}
{"idx": 947, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('epidural blood patch'), and the supporting sentence is relevant, referencing the optimal volume and safety of the procedure. However, it includes slight redundancy by mentioning complications, which is not directly necessary to support the answer. The gold supporting sentence is more concise and directly addresses the timing and context for performing the epidural blood patch.\", \"match\": true}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch should be performed within 24-48 h of dural puncture.", "model_answer": "Answer: The definitive treatment for low-pressure headache is an epidural blood patch (AEBP).", "model_support": "Supporting sentence: The optimum volume of blood has been shown to be 12-20 mL for adult patients. Complications of AEBP are rare.  \n\n**Note:** While the context does not explicitly state \"definitive treatment\" for low-pressure headache, the mention of **epidural blood patch (AEBP)** as a procedure with a defined optimal blood volume and rare complications implies its role as the standard therapeutic intervention for PDPH. The absence of alternative treatments in the text further supports this interpretation.", "retries": 1}
{"idx": 948, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explaining that the ROSIER scale was used as a stroke recognition tool, which aligns perfectly with the gold answer.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "ROSIER scale is used for stroke.", "model_support": "Supporting sentence: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 949, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer does not match the gold standard exactly but is present in the context. The model's answer, 'Calcitonin gene-related peptide receptor,' is more specific than the gold answer, 'calcitonin gene-related peptide,' which focuses on the ligand rather than the receptor. The supporting sentence is overly verbose and includes irrelevant details about pharmacokinetics and tolerability that do not directly support the answer. It lacks conciseness and logical relevance to the gold answer.\",\n  \"match\": false\n}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is a novel, orally active, and selective calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.", "model_answer": "Answer: Calcitonin gene-related peptide receptor", "model_support": "Supporting sentence: Three separate clinical studies were conducted to evaluate the pharmacokinetics and tolerability of telcagepant following single oral doses in healthy young and elderly men and women and multiple oral doses in men. Telcagepant was rapidly absorbed with a time to maximum concentration of approximately 1.5 hours. The terminal half-life was approximately 6 hours. A greater than dose-proportional increase was observed in the area under the plasma concentration versus time curve from zero to infinity. Following twice-daily dosing, with each dose separated by 2 hours, steady state was achieved in approximately 3 to 4 days with an accumulation ratio of approximately 2. There were no clinically meaningful pharmacokinetic differences when compared across age and gender. Telcagepant was generally well tolerated up to single doses of 1200 mg and multiple doses of 400 mg twice daily.", "retries": 1}
{"idx": 950, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('flumazenil'). The supporting sentence is concise and directly relevant, logically covering the use of flumazenil as an antidote in benzodiazepine overdose. Although it references the title, the explanation clarifies its relevance, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "STUDY OBJECTIVE: To develop clinical rules for the safe and effective use of flumazenil in suspected benzodiazepine overdose.", "model_answer": "Answer: Flumazenil", "model_support": "Supporting sentence: Empiric use of flumazenil in comatose patients: limited applicability of criteria to define low risk.  \n**Note**: While the title is part of the context, the sentence directly associates flumazenil with its use in comatose patients, implying its role as an antidote for benzodiazepine overdose. For a body text example: \"Efficacy of flumazenil was categorized as complete awakening...\" (methods section) also supports its application as an antidote.", "retries": 1}
{"idx": 951, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by quoting the title instead of focusing on a more specific sentence that directly links 'lubag' to 'X-linked dystonia-parkinsonism.' The logic is clear, though the support could be more precise.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Regional and global metabolic rates for glucose (rCMRGlc and GMR) were estimated using [18F]fluorodeoxyglucose and positron emission tomography in 3 patients with Filipino X-linked dystonia-parkinsonism (lubag).", "model_answer": "Answer: X-linked dystonia-parkinsonism", "model_support": "Supporting sentence: Positron emission tomographic findings in Filipino X-linked dystonia-parkinsonism.  \n\nThe title explicitly identifies \"X-linked dystonia-parkinsonism\" as the condition being studied, while the body of the context refers to it as \"lubag,\" establishing the synonym.", "retries": 1}
{"idx": 952, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, using the correct terminology 'Na+/Ca2+ exchanger (NCX)' which aligns with 'NCX' in the gold answer. The supporting sentence is concise, directly relevant, and provides clear reasoning by linking SEA0400's mechanism to its role as an inhibitor of the Na+/Ca2+ exchanger involved in Ca²+ overload. This logical connection mirrors the context provided.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: The Ca²+ overload by Ca²+ influx via Na⁺/Ca²+ exchanger (NCX) is a critical mechanism in myocardial ischemia/reperfusion injury.  \n\nThis sentence establishes that the Na⁺/Ca²+ exchanger (NCX) is the ion antiporter/exchanger involved in Ca²+ overload, which is the target of SEA0400's mechanism of action as inferred from the study's context and conclusions.", "retries": 1}
{"idx": 953, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'RET proto-oncogene,' is slightly more detailed than the gold standard 'RET,' but it still matches the intended gene. The supporting sentence is relevant and provides additional context about a specific mutation in the RET proto-oncogene; however, it includes extra details (e.g., 'exon 10 at codon C609Y') that are not necessary to directly support the answer. The gold supporting sentence is more concise while remaining accurate. Thus, the model's supporting sentence contains slight redundancy but is still logically sound.\", \"match\": true}", "gold_answer": "RET", "gold_support": "The RET proto-oncogene is involved in neural crest disorders.", "model_answer": "Answer: RET proto-oncogene", "model_support": "Supporting sentence: Direct fluorescent sequencing of genomic DNA revealed a heterozygous mutation in the RET proto-oncogene in exon 10 at codon C609Y in both persons tested.", "retries": 1}
{"idx": 954, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke,' differing only in specificity but still accurate. The supporting sentence is relevant and covers the answer well, though it contains slight redundancy by specifying 'initial differentiation' when the gold supporting sentence is more concise. Overall, the logic is strong, but the extra detail lowers the score slightly.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.", "retries": 1}
{"idx": 955, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly; supporting sentence is relevant and provides information about p53, but it does not explicitly mention 'the guardian of the genome,' which slightly reduces its directness and clarity.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.  \n\n**Note**: While the context does not explicitly state \"the guardian of the genome,\" the question assumes prior knowledge that p53 is commonly referred to as \"the guardian of the genome.\" The supporting sentence identifies the tumor suppressor in question as **p53**.", "retries": 1}
{"idx": 956, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard but is present in context indirectly. The supporting sentence provided by the model incorrectly states that there is no mention of PBT2 in the context, when in fact it is mentioned in the gold supporting sentence. The model fails to extract the relevant information from the context, leading to an incorrect evaluation of the supporting evidence.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective.", "model_answer": "PBT2 has been tested for Alzheimer's disease.", "model_support": "The context provided does not mention PBT2 or its testing for any disorder. Therefore, there is no supporting sentence in the given text to confirm that \"PBT2 has been tested for Alzheimer's disease.\" The answer cannot be derived from the provided context. \n\n**Note:** If this question is based on external knowledge, the context provided here does not include information about PBT2.", "retries": 1}
{"idx": 957, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'the template strand,' does not match the gold standard, 'the transcribed strand.' However, the answer is biologically plausible and present in the broader context of transcription-coupled repair (TCR). The supporting sentence correctly identifies that the context does not explicitly state which strand is targeted, but it fails to cover the gold answer ('the transcribed strand') or directly reference the gold supporting sentence from the text. Instead, it relies on external knowledge, missing the key point about TCR targeting the transcribed strand as stated in the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Answer: The gene strand targeted by transcription-coupled repair (TCR) is the template strand.", "model_support": "The context provided does not explicitly mention which gene strand (template or coding) is targeted by transcription-coupled repair (TCR). The answer \"the template strand\" is based on general biological knowledge (TCR specifically repairs the template strand to maintain transcription fidelity), but **no sentence in the given context directly states this**. \n\nIf forced to identify a supporting sentence, none exist in the provided text. The context focuses on TCR's role in NER, its complexity, and required factors but does not address the specific DNA strand targeted. \n\n**Correct response**: The context does not contain a sentence supporting the answer. The answer relies on external knowledge, not the provided text.", "retries": 1}
{"idx": 958, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to Factor Xa). The supporting sentence provides relevant information by referencing the category of 'Factor X inhibitors,' which aligns with the gold supporting sentence. However, it includes slight redundancy and verbosity when explaining the lack of explicit mention of betrixaban in the context, making it less concise than ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "X (rivaroxaban, apixaban, edoxaban, betrixaban)", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The context does not mention betrixaban or its target clotting factor. The provided text lists various anticoagulants and their targets (e.g., \"inhibitors of activated factor II,\" \"Factor X inhibitors\"), but **betrixaban is not explicitly referenced** in the context. \n\nHowever, if the answer \"Factor Xa\" is assumed to align with the broader category of \"Factor X inhibitors\" mentioned in the text, the relevant sentence would be:  \n**\"direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.\"**  \n\nNote: The context does not directly link betrixaban to Factor Xa, so the answer may rely on external knowledge rather than the provided text.", "retries": 1}
{"idx": 959, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Three') does not match the gold standard ('7'), but the number 'three' is plausible given the mention of 'various p73 isoforms' in the context. The supporting sentence is relevant as it highlights the existence of multiple isoforms but fails to provide any logical basis for the specific number in the model's answer or the gold standard. Therefore, while the answer is incorrect, the supporting sentence connects indirectly to the idea of multiple isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: Three", "model_support": "The context does not explicitly state the number of TAp73 isoforms identified in humans. However, the phrase \"various p73 isoforms\" (line 2) implies the existence of multiple isoforms, though it does not specify the exact number. The answer \"three\" may rely on external knowledge (e.g., known p73 isoforms like TAp73, ΔNp73, and others), but the context itself does not provide a direct supporting sentence for this specific number. \n\n**Supporting sentence (if inferred):**  \n\"The role of various p73 isoforms in tumorigenesis has been controversial.\"  \n\nThis sentence suggests the existence of multiple isoforms but does not confirm the count of \"three.\"", "retries": 1}
{"idx": 960, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence provides a detailed explanation of the RANKL-RANK-OPG pathway in general, which includes RANKL but is not as direct as the gold supporting sentence that explicitly connects Denosumab to RANKL.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Denosumab, an anti-RANKL monoclonal antibody with proven antiosteoclast activity, may suppress immune responses.", "model_answer": "Answer: RANKL", "model_support": "Supporting sentence: The skeletal and immune systems share various cytokines, receptors, and transcription factors that regulate signal transduction pathways involved in osteoclastogenesis and immune system activation, including the receptor activator of nuclear factor-κΒ ligand/receptor activator of nuclear factor-κΒ/osteoprotegerin (RANKL-RANK-OPG) pathway. \n\n**Note**: While the context does not explicitly mention *Denosumab (Prolia)*, the answer \"RANKL\" is derived from the established biological knowledge that Denosumab targets RANKL. The supporting sentence in the context identifies the RANKL-RANK-OPG pathway as a shared mechanism between the skeletal and immune systems, which aligns with the pharmacological action of Denosumab.", "retries": 1}
{"idx": 961, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is correct in stating that the gold standard is not explicitly mentioned in the context. The supporting sentence is relevant but overly focused on the absence of explicit mention rather than leveraging the comparison with AUS, which indirectly points to the gold standard. It could have been more concise and closer to the gold supporting sentence.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "Answer: The gold standard treatment is not explicitly mentioned in the context.", "model_support": "Supporting sentence: The context does not explicitly mention the gold standard treatment for iatrogenic male incontinence. The study evaluates the effectiveness of bone-anchor sub-urethral sling (BAUS) but does not compare it to other treatments or identify a \"gold standard\" explicitly.  \n\n**Note**: The answer \"The gold standard treatment is not explicitly mentioned in the context\" is correct, as no sentence in the text states what the gold standard is. The study only describes BAUS as a \"safe, effective, minimally invasive option,\" not the definitive standard of care.", "retries": 1}
{"idx": 962, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK gene' vs. 'XK'), though it is slightly more verbose. The supporting sentence provides relevant information and covers the answer logically but includes extra details about the functionality of the mutated protein, which adds slight redundancy.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK gene", "model_support": "Supporting sentence: Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional.", "retries": 1}
{"idx": 963, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes extra details (mentioning both manual and automatic methods instead of just 'ultrasound'). The supporting sentence is somewhat lengthy and mixes relevant content with additional information about measurement variation and device limitations, which are not necessary to directly support the gold answer. While the logic is reasonable, the supporting sentence could be more concise.\", \"match\": false}", "gold_answer": "ultrasound", "gold_support": "To compare repeatability and agreement of conventional ultrasound bladder wall thickness (BWT) measurements with automatically obtained BWT measurements by the BVM 6500 device.", "model_answer": "Bladder wall thickness is measured using either manual or automatic methods, specifically through conventional ultrasound or the BVM 6500 device.", "model_support": "Supporting sentence: Measurement variation between replicate measurements was smaller for conventional ultrasound and the smallest for 250 ml bladder filling. The BVM 6500 device was not able to correctly measure BWTs above 4 mm.  \n\nThis sentence explicitly mentions the two methods (conventional ultrasound and BVM 6500 device) used for measuring bladder wall thickness, as well as their limitations, directly supporting the answer.", "retries": 1}
{"idx": 964, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "Answer: p53", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 965, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect because it states that the context does not mention the target molecule, while the gold supporting sentence explicitly mentions 'Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.' Despite this, the answer itself is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.", "model_answer": "Answer: Interleukin-17A (IL-17A)", "model_support": "The context does not explicitly mention the target molecule of secukinumab (Interleukin-17A/IL-17A). While secukinumab is a well-known monoclonal antibody targeting IL-17A in clinical practice, the provided text does not include a sentence directly stating this. The supporting sentence required by the question is not present in the given context. \n\n**Note:** The answer (IL-17A) is accurate based on external knowledge, but it is not explicitly supported by the text provided.", "retries": 1}
{"idx": 966, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly, identifying 'Xist' as the transcript responsible for X-chromosome inactivation. The supporting sentence provided by the model acknowledges that the context does not explicitly mention Xist but correctly implies that the answer is based on external biological knowledge. The gold supporting sentence confirms the relevance of Xist to the failure of X-inactivation when deleted or mutated, aligning with the model's reasoning.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "Answer: The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The context provided does not explicitly mention the transcript responsible for X-chromosome inactivation (e.g., *Xist*). The text discusses the Xce locus, the X inactivation center (XIC), and mechanisms of X-chromosome inactivation but does not reference *Xist* or its role. \n\n**Supporting sentence:** None.  \nThe answer \"*Xist*\" is based on external biological knowledge (e.g., *Xist* is a non-coding RNA gene critical for X-chromosome inactivation), but the context provided does not contain a sentence identifying *Xist* as the transcript.", "retries": 1}
{"idx": 967, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard exactly. The supporting sentence is relevant and covers the answer logically by discussing p53's tumor suppressor role and its oncogenic mutations. However, it contains slight redundancy and does not directly quote the more concise 'guardian of the genome' phrase from the context, which would have made it more precise.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.", "model_answer": "Answer: p53", "model_support": "Supporting sentence: Not only do such mutations result in the abrogation of wild-type p53 activity, but the expressed p53 mutant proteins also tend to gain oncogenic functions, such as interference with wild-type p53-independent apoptosis.  \n\n**Explanation**: While the context does not explicitly use the phrase \"guardian of the genome,\" the repeated emphasis on p53's role in tumor suppression (e.g., abrogation of wild-type activity, oncogenic gain-of-function mutations, and reactivation to eliminate cancer) aligns with its well-established designation as \"the guardian of the genome\" in biomedical literature. The sentence directly identifies p53 as the tumor suppressor under discussion.", "retries": 1}
{"idx": 968, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by mentioning phosphorylated alpha-synuclein, which is not necessary for directly supporting the answer about alpha-synuclein.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "Answer: alpha-synuclein", "model_support": "Supporting sentence: The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals.", "retries": 1}
{"idx": 969, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly more detailed than necessary. The additional details about haploinsufficiency are accurate but not required to directly support the answer.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "It is caused by de novo heterozygous mutations or deletions of the ZFHX1B gene located at 2q22.", "model_answer": "Answer: ZFHX1B", "model_support": "Supporting sentence: Over 100 mutations have been described in patients with clinically typical MWS, who almost always have whole gene deletions or truncating mutations (nonsense or frameshift) of ZFHX1B, suggesting that haploinsufficiency is the basis of MWS pathology.", "retries": 1}
{"idx": 970, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes slight redundancy by mentioning 'multiple partner inputs,' which is not necessary to directly support the answer. The logic is strong, but the extra detail makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "The fly complex contains a catalytic SET domain subunit, E(Z), plus three noncatalytic subunits, SU(Z)12, ESC, and NURF-55.", "model_answer": "The characteristic domain of histone methyltransferases is the SET domain.", "model_support": "Supporting sentence: \"Thus, the E(Z) SET domain requires multiple partner inputs to produce active HMTase.\"", "retries": 1}
{"idx": 971, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct compared to the gold supporting sentence. It mentions the association of FANCA with the SWI/SNF complex but does not explicitly name BRG1 as the specific subunit involved, which would make it more precise.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: FANCA was demonstrated to associate with the endogenous SWI/SNF complex.", "retries": 1}
{"idx": 972, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it discusses the existence of 'several p73 isoforms' without specifying the number of TAp73 isoforms. Additionally, the model fails to extract or infer the correct numerical value from the broader context.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Answer: The text does not specify the number of TAp73 isoforms identified in humans.", "model_support": "Supporting sentence: \"In addition to alternative splicing at the carboxyl terminus which yields several p73 isoforms, a p73 variant lacking the N-terminal transactivation domain (Delta Np73) was described in mice.\"  \n\nThis sentence indicates that \"several p73 isoforms\" exist due to alternative splicing but does not specify the exact number of TAp73 isoforms. The text does not provide a numerical count for TAp73 isoforms in humans.", "retries": 1}
{"idx": 973, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose and indirect. The model supporting sentence does not directly explain the role of PLN in regulating SERCA2a as clearly as the gold supporting sentence. However, it still logically supports the answer by referencing the PLN/SERCA interactome.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Answer: Phospholamban", "model_support": "Supporting sentence: \"the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.\"  \n\nThis sentence explicitly identifies phospholamban (PLN) as a key component of the regulatory complex (PLN/SERCA interactome) that governs SERCA2a function in cardiac muscle, directly supporting the answer that phospholamban is the main regulatory molecule.", "retries": 1}
{"idx": 974, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes 'transient ischaemic attack (TIA),' which is not part of the gold answer. The supporting sentence provides relevant information, mentioning the use of the ROSIER scale for stroke identification, but it also introduces additional details about the study's objective that are somewhat unnecessary. While the logic is reasonable, the sentence could be more concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: ROSIER scale is used for the identification of stroke and transient ischaemic attack (TIA).", "model_support": "Supporting sentence: Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.  \n\nThis sentence explicitly states the purpose of the study, which includes the use of the ROSIER scale for identifying stroke and TIA. Additionally, the objective reinforces this by mentioning \"bedside diagnostic stroke scales\" for patients with suspected stroke, aligning with the ROSIER scale's application.", "retries": 1}
{"idx": 975, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'BCR-ABL1,' is very close to the gold standard 'BCR-ABL' and is considered correct in a biomedical context since both terms refer to the same fusion protein. However, the supporting sentence provided by the model does not directly come from the context and instead references external knowledge, which slightly deviates from the task requirement to use the context. The gold supporting sentence, while not explicitly naming Imatinib’s target, ties the Philadelphia chromosome and BCR-ABL positivity to Imatinib treatment, making it a more appropriate support. Therefore, the model's answer matches the gold standard, but its supporting logic could be improved by being more concise and directly tied to the context.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "All 1,063 patients selected met the following inclusion criteria: aged 18 or older and in chronic phase at the time of diagnosis, Philadelphia chromosome and/or BCR-ABL positive, received first-line treatment with imatinib, and not enrolled in a randomized clinical trial during the period of retrospective review.", "model_answer": "Answer: BCR-ABL1", "model_support": "The context does not explicitly mention the target of Imatinib (Gleevec) or the BCR-ABL1 tyrosine kinase. While the study references Philadelphia-chromosome positive CML, it does not include a direct statement about the molecular target of Imatinib. Therefore, **no supporting sentence** exists in the provided context to confirm the answer. \n\nHowever, based on external biomedical knowledge, Imatinib targets BCR-ABL1, a fusion tyrosine kinase resulting from the Philadelphia chromosome translocation. This is a well-established fact in CML treatment, but it is not explicitly stated in the given text. \n\nIf the task strictly requires a sentence from the context, the answer cannot be supported by the provided material.", "retries": 1}
{"idx": 976, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the context does not explicitly mention Lewy bodies, the supporting sentence provided is concise and directly relevant, referencing alpha-synuclein, which is described as central to PD pathogenesis in the context. This aligns logically with the gold answer even if 'Lewy bodies' are not explicitly mentioned in the chosen sentence.\", \"match\": true}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The context does not mention Lewy bodies or their main component. The provided text focuses on autophagy, the ATG5 gene, and alpha-synuclein degradation but does not explicitly reference Lewy bodies. The answer \"alpha-synuclein\" is correct in general biomedical knowledge, but there is **no supporting sentence in the given context** that directly addresses Lewy bodies. \n\nIf forced to select a sentence related to alpha-synuclein (even though it does not mention Lewy bodies), the closest would be:  \n**\"Accumulating evidence indicates that macroautophagy (hereafter referred to as autophagy) is involved in alpha-synuclein degradation.\"**  \n\nHowever, this sentence does not support the claim about Lewy bodies. The question and answer appear to be outside the scope of the provided context.", "retries": 1}
{"idx": 977, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides direct evidence for Xist being responsible for X-chromosome inactivation, but it includes additional details about other genes (B-raf and Drwms2) that are not necessary to support the answer, introducing slight redundancy. The logic is strong, but the extra information makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "Xist (X-inactive specific transcript) is a major effector of the X-inactivation process, and X-linked genes are highly expressed in brain tissue and consistent with a role in brain developments.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "Supporting sentence: \"By microarray, upregulation of Xist, B-raf and Drwms2 were detected. Especially, mRNA expression of Xist was increased in a concentration-dependent manner in male and female mice.\"  \n\nThis sentence directly identifies *Xist* as the transcript whose expression is altered, aligning with its established role in X-chromosome inactivation (XCI). Additionally, the mention of *Tsix* as a \"crucial noncoding antisense partner of Xist\" further contextualizes *Xist* as the primary transcript involved in XCI.", "retries": 1}
{"idx": 978, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('L-dopa'), but the supporting sentence is somewhat confused and unnecessarily verbose. While it acknowledges that benserazide is not mentioned in the context provided, it goes into excessive detail about tolcapone, which detracts from clarity. The gold supporting sentence directly links benserazide with L-dopa administration, whereas the model’s sentence does not clearly or concisely establish this relationship. However, the logic connecting benserazide to L-dopa is still present indirectly, hence a score of 3.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "The administration of L-dopa (20 and 60 mg/kg p.o.) + benserazide (15 mg/kg p.o.) resulted in dose-dependent increase of dialysate levels of L-dopa and 3-O-methyl-DOPA.", "model_answer": "Answer: L-dopa", "model_support": "The context provided does not mention **benserazide** at all. The question appears to be unrelated to the given context, which focuses on **tolcapone** rather than benserazide. Therefore, **no sentence in the context supports the answer** \"L-dopa\" for the question about benserazide. \n\nIf the question were about **tolcapone**, the supporting sentence would be:  \n\"**Tolcapone (30 mg/kg p.o.), given as adjunct to both doses of L-dopa, markedly enhanced the elevation or extracellular L-dopa...**\"  \n\nHowever, since the question explicitly mentions **benserazide**, the context does not provide relevant information.", "retries": 1}
{"idx": 979, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer 'H3K4' matches the gold standard exactly. The supporting sentence provided by the model acknowledges that the context does not explicitly state the residue but correctly identifies that the answer is biologically accurate based on external knowledge. The gold supporting sentence is concise and directly mentions H3K4 in the context of transcriptional activation, aligning with the logical reasoning required. The model's response is clear, relevant, and appropriately concise.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "Trimethylation of histone H3 Lys4 (H3K4) is associated with transcriptional activation.", "model_answer": "Answer: H3K4", "model_support": "The context provided does not explicitly mention the specific histone residue methylated by MLL1. The answer \"H3K4\" is biologically accurate (MLL1 is known to methylate histone H3 at lysine 4), but the supporting sentence is not present in the given context. \n\n**Correct response:**  \nThe context does not include a sentence specifying the histone residue methylated by MLL1. The answer \"H3K4\" is based on external biological knowledge, not the provided text.", "retries": 1}
{"idx": 980, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'BCR-ABL tyrosine kinase' is slightly more verbose than the gold standard 'BCR-ABL,' but it is still correct and closely matches the intended target. The supporting sentence provided by the model is relevant and explains the connection between BCR-ABL and Imatinib, though it contains some redundancy by mentioning both the oncogene and the tyrosyl phosphorylation control, which adds slight verbosity. Overall, the logic is clear and accurate.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "Answer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: \"Chronic myeloid leukemia (CML) is caused by the BCR-ABL oncogene.\"  \nThis sentence establishes that BCR-ABL is the oncogene involved in CML, which is the target of Imatinib. Additionally, the context states that \"Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling,\" directly linking Imatinib's mechanism to the BCR-ABL tyrosine kinase.", "retries": 1}
{"idx": 981, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The mention of phosphorylated, nitrated, and monoubiquitinated AS aligns well with the context provided.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "The main component of Lewy bodies is α-synuclein.", "model_support": "Supporting sentence: Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.", "retries": 1}
{"idx": 982, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively ties BCR-ABL1 to the molecular pathogenesis of CML and its role as a target for Imatinib, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a paradigm for neoplasias that are defined by a unique genetic aberration, the BCR-ABL1 fusion gene.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: \"the development of protein tyrosine kinase inhibitor, imatinib, has entirely changed the strategy of therapy for CML. Nonetheless, many fields of pathogenesis for CML have not been elucidated, such as ... oncogenic signaling pathways downstreams of the BCR-ABL1 fusion gene product.\"  \n\n**Analysis**: While the context does not explicitly state that Imatinib targets *BCR-ABL1*, it implicitly connects Imatinib's role as a \"protein tyrosine kinase inhibitor\" (TKI) to CML, which is driven by the *BCR-ABL1* fusion gene (Philadelphia chromosome). The phrase \"oncogenic signaling pathways downstream of the BCR-ABL1 fusion gene product\" directly ties *BCR-ABL1* to the molecular pathogenesis of CML, making it the logical target of Imatinib, a TKI. This inference aligns with established medical knowledge, even if the context does not explicitly name *BCR-ABL1* as the target.", "retries": 1}
{"idx": 983, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'The catalytic domain,' does not match the gold standard, 'SET domain.' However, the supporting sentence is relevant and discusses mutations in the catalytic region, which is related to the function of the enzyme. Despite this, it does not cover the gold answer, as it fails to mention the SET domain specifically, which is the characteristic domain highlighted in the gold supporting sentence.\", \"match\": false}", "gold_answer": "SET domain", "gold_support": "Murine G9a is a 1263 amino acid H3-K9 methyltransferase that possesses characteristic SET domain and ANK repeats.", "model_answer": "Answer: The catalytic domain.", "model_support": "Supporting sentence: \"mutation of conserved amino acids R1097A, W1103A, Y1120A, Y1138A and R1162A, or the metal binding C1168A in the catalytic region, resulted in catalytically impaired enzymes, thereby confirming the involvement of the C-terminus of G9a in catalysis.\"  \n\nThis sentence directly links the catalytic region (a key component of the catalytic domain) to enzymatic function, supporting the conclusion that the catalytic domain is a defining feature of histone methyltransferases.", "retries": 1}
{"idx": 984, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct than the gold supporting sentence. It mentions the association of FANCA with the SWI/SNF complex but does not explicitly name BRG1 as the specific subunit involved, which makes it less precise.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "Answer: BRG1", "model_support": "Supporting sentence: FANCA was demonstrated to associate with the endogenous SWI/SNF complex.", "retries": 1}
{"idx": 985, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "Answer: The transcribed strand.", "model_support": "Supporting sentence: The stalled RNA polymerase complex may then mediate recruitment of repair proteins to damage in the transcribed strand.", "retries": 1}
{"idx": 986, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban.\"  \n\nThis sentence explicitly identifies betrixaban as a direct inhibitor of **factor Xa**, aligning with the answer.", "retries": 1}
{"idx": 987, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'None' when the gold answer clearly identifies HSP70 as being upregulated during Hsp90 inhibition. The supporting sentence is also incorrect because it claims that no heat shock protein upregulation is mentioned, while the context explicitly states that HSP70 is induced in vitro. Both the answer and supporting sentence fail to address the correct information and are thus irrelevant.\", \"match\": false}", "gold_answer": "HSP70", "gold_support": "Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro.", "model_answer": "None. The context does not indicate that any heat shock protein is upregulated during Hsp90 inhibition.", "model_support": "Supporting sentence: The context does not mention any heat shock protein being upregulated during HSP90 inhibition. The results explicitly state that HSP90 inhibition diminished phosphorylation of Akt, Erk, and STAT3, but no upregulation of heat shock proteins is described. \n\n**Note**: The answer \"None. The context does not indicate that any heat shock protein is upregulated during Hsp90 inhibition\" is supported by the absence of any mention of heat shock protein upregulation in the text. The provided context focuses on the effects of HSP90 inhibition on signaling pathways (e.g., Akt, Erk, STAT3) and liver regeneration, but never refers to increased expression of other heat shock proteins.", "retries": 1}
{"idx": 988, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Factor Xa' is equivalent to 'xa'). The supporting sentence is relevant and supports the answer by referencing a 'factor Xa decoy,' which logically implies that betrixaban inhibits Factor Xa. However, the sentence contains slight redundancy because it delves into PRT4445 as a reversal agent, which is not strictly necessary to establish the answer. The gold supporting sentence is more concise and directly states the relationship between betrixaban and Factor Xa inhibition.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: \"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"  \n\nThis sentence implies that betrixaban is an anticoagulant with anti-Xa activity (inhibiting Factor Xa), as PRT4445 is described as a reversal agent for anticoagulants targeting Factor Xa. While the text does not explicitly state that betrixaban directly inhibits Factor Xa, the context frames it as a novel anticoagulant with pharmacokinetic properties aligning with Factor Xa inhibition, and the mention of PRT4445 as a \"factor Xa decoy\" supports the conclusion that betrixaban acts on Factor Xa.", "retries": 1}
{"idx": 989, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa' and 'Factor Xa' are equivalent in this context). The supporting sentence is relevant and correct but includes slight redundancy by explaining the study's title (Explore-Xa) in detail. While logical, this explanation adds unnecessary verbosity when the gold supporting sentence provides a more concise and direct statement from the context.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: The study's title, \"Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa),\" implies that betrixaban targets Factor Xa, as \"Xa\" refers to Factor Xa. While the main text does not explicitly state the clotting factor, the study's name (Explore-Xa) directly correlates with Factor Xa inhibition, which is a well-established mechanism for this class of drugs. \n\n**Note:** The context provided does not explicitly state \"Factor Xa\" in the main text, but the study's title (Explore-Xa) is the closest supporting reference. If strict textual evidence is required, the answer might rely on external knowledge, but the title is the only contextual clue here.", "retries": 1}
{"idx": 990, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model does not directly mention the chemical classification of JTV519 as a 1,4-benzothiazepine derivative, which is critical for supporting the answer. Instead, the model's supporting sentence discusses a property of JTV519 (its protective effect against Ca²⁺ overload-induced myocardial injury), which is relevant to the drug's function but not its chemical group. The gold supporting sentence explicitly mentions the drug’s classification, making it more appropriate. Despite this, the model's answer is correct and the reasoning is sound, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: JTV519 is known to have a protective effect against Ca²⁺ overload-induced myocardial injury.  \n\n**Note:** The context provided does not explicitly mention \"1,4-benzothiazepine\" as the chemical group for JTV519. However, based on prior knowledge and the example provided in the user's initial query, the answer assumes that JTV519 is classified as a 1,4-benzothiazepine derivative. The supporting sentence from the context here is the only reference to JTV519's properties, though it does not directly state its chemical classification. If the context were to include the specific chemical group, it would likely appear in a sentence similar to the example (e.g., \"a 1,4-benzothiazepine derivative\").", "retries": 1}
{"idx": 991, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX'). The supporting sentence is relevant and supports the answer by linking SEA0400 to its inhibitory effect on Ca²⁺ influx, which is mediated by NCX. However, it includes slightly more detail than necessary (e.g., mentioning nifedipine), making it somewhat redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The specific NCX inhibitor SEA0400 blocked SNP-induced phosphorylation of ERK, JNK and p38 MAPK, and decrease in cell viability.", "model_answer": "Answer: Na+/Ca2+ exchanger (NCX)", "model_support": "Supporting sentence: \"SNP treatment caused an increase in (45)Ca(2+) influx. This increase in (45)Ca(2+) influx was blocked by SEA0400, but not the Ca(2+) channel blocker nifedipine.\"  \n\nThis sentence directly links SEA0400 to the inhibition of Ca²⁺ influx, which is mediated by the Na⁺/Ca²⁺ exchanger (NCX) as established earlier in the context. The distinction between SEA0400 (a NCX inhibitor) and nifedipine (a Ca²⁺ channel blocker) confirms the specificity of SEA0400 for the NCX.", "retries": 1}
{"idx": 992, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and correctly identifies betrixaban as a direct inhibitor of factor Xa. However, the choice of the supporting sentence from the context is unnecessarily long and includes information not directly relevant to the specific question, which reduces conciseness.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Answer: Factor Xa", "model_support": "Supporting sentence: [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban]. \n\nThis sentence explicitly states that the drugs listed (including betrixaban) are \"direct inhibitors of factor Xa,\" directly answering the question.", "retries": 1}
{"idx": 993, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly ('Xist RNA' vs. 'Xist'). The supporting sentence is relevant and covers the answer logically, but it introduces additional information about the mechanisms being poorly understood, which is not directly necessary to support the answer. This makes it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The process is mediated by the non-coding RNA X inactive specific transcript (Xist) that binds in cis and propagates along the inactive X chromosome elect, triggering chromosome-wide silencing.", "model_answer": "Answer: Xist RNA", "model_support": "Supporting sentence: The mechanisms by which Xist RNA binds and spreads along the chromosome, and initiates Xist-mediated chromosome silencing remain poorly understood.", "retries": 1}
{"idx": 994, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'Insulin receptor', matches the gold standard conceptually (as 'insulin' refers to the hormone acting on the insulin receptor), though it is slightly more specific than the gold answer. The supporting sentence is relevant and covers the answer adequately but contains some redundancy by mentioning molecular analysis and fibroblasts, which are not necessary to directly support the answer. Overall, the logic is strong, but a more concise supporting sentence would improve clarity.\", \"match\": true}", "gold_answer": "insulin", "gold_support": "Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.", "model_answer": "Answer: Insulin receptor", "model_support": "Supporting sentence: \"INSR gene molecular analysis and insulin receptor (IR) autophosphorylation on cultured fibroblasts were performed.\"  \n\nThis sentence directly identifies the insulin receptor (IR) as the target of analysis, linking the mutation in the *INSR* gene to altered receptor function.", "retries": 1}
{"idx": 995, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer correctly identifies Bach1 as a 'repressor,' matching the gold answer. The supporting sentence provides accurate and relevant evidence from the context but includes additional details that, while correct, are not strictly necessary to justify the answer. This makes it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: Repressor", "model_support": "Supporting sentence: \"Gene targeting experiments in mice revealed that, in the absence of Bach1, ho-1 became expressed constitutively at high levels in various tissues under normal physiological conditions.\"  \nAdditionally: \"Bach1... generating a simple feedback loop whereby the substrate effects repressor-activator antagonism.\"  \n\nThese sentences indicate that Bach1 acts as a repressor by preventing constitutive expression of *ho-1* and through its role in repressor-activator antagonism.", "retries": 1}
{"idx": 996, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly mentions 'antiparallel spectrin heterodimers,' and aligns well with the gold answer through clear reasoning.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Answer: Antiparallel", "model_support": "Supporting sentence: Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.", "retries": 1}
{"idx": 997, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'Iron deficiency' is correct based on general medical knowledge and matches the gold standard 'iron'. However, the supporting sentence provided by the model states that the context does not mention restless leg syndrome, which is true but fails to utilize the available context effectively. The gold supporting sentence demonstrates that the context does imply iron deficiency can cause symptoms (including restless leg syndrome implicitly), making the model's supporting sentence less relevant and incomplete in covering the gold answer.\", \"match\": true}", "gold_answer": "iron", "gold_support": "That iron deficiency, per se, can cause these symptoms is poorly recognized.", "model_answer": "Answer: Iron deficiency", "model_support": "The context does not mention \"restless leg syndrome\" or any specific link between iron deficiency and this condition. The provided text focuses on iron deficiency anemia in chronic kidney disease (CKD) and its hematological and nonhematological effects, but it does not address restless leg syndrome. \n\n**Supporting sentence**: None. The context does not contain information about restless leg syndrome or its causes. \n\n**Note**: While iron deficiency is a known cause of restless leg syndrome in general medical knowledge, the provided context does not include this specific information.", "retries": 1}
{"idx": 998, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence references the study focusing on 5-aminolevulinic acid, which aligns perfectly with the gold answer.\", \"match\": true}", "gold_answer": "5-aminolevulinic acid", "gold_support": "OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(®)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6).", "model_answer": "Answer: 5-aminolevulinic acid", "model_support": "Supporting sentence: Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).  \n\n**Note**: While the context does not explicitly mention \"Gliolan,\" the generic name of the drug is **5-aminolevulinic acid**, which is directly stated in the title. Gliolan is the brand name for 5-aminolevulinic acid, but the context only references the generic name.", "retries": 1}
{"idx": 999, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer (BCR-ABL1) is very close to the gold standard (BCR-ABL), differing only by the inclusion of '1,' which is a common notation in medical literature but not strictly necessary here. The supporting sentence acknowledges that the context does not explicitly mention BCR-ABL1 but correctly infers it from general biomedical knowledge related to Imatinib's mechanism. The explanation is logical and relevant, though slightly verbose due to the additional commentary about external knowledge.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is a genetically associated malignancy of haematopoietic stem cells, characterized by a t(9;22) translocation that forms the Philadelphia chromosome and creates a novel fusion gene, BCR-ABL.", "model_answer": "Answer: BCR-ABL1", "model_support": "Supporting sentence: The context does not explicitly mention BCR-ABL1 as the target of Imatinib. However, the question's answer (BCR-ABL1) is inferred from general medical knowledge about Imatinib's mechanism in Philadelphia-chromosome positive CML, even though the provided context does not directly state this. \n\n**Note:** The context provided does not contain a sentence explicitly stating that BCR-ABL1 is the target of Imatinib. The answer relies on external biomedical knowledge rather than the given text.", "retries": 1}
